Drug name	STITCH ID	Phase	Drug status	Smiles	Level 1 ATC Codes
DNCB	CIDs00000006	Phase 1	unapproved	O=[N+]([O-])c1ccc(Cl)c([N+](=O)[O-])c1	
2-deoxy-D-galactopyranose	CIDs00000040	Phase 3	unapproved	OCC1OC(O)CC(O)C1O	
carnitine	CIDs00000085	Phase 3	unapproved	C[N+](C)(C)CC(O)CC(=O)[O-]	
gamma-aminobutyric acid (GABA	CIDs00000119	Phase 1	unapproved	NCCCC(=O)O	N - NERVOUS SYSTEM
delta-aminovaleric acid	CIDs00000138	Phase 1	unapproved	NCCCCC(=O)O	
polyethylene glycol	CIDs00000174	Phase 4	approved	OCCO	A - ALIMENTARY TRACT AND METABOLISM | A - ALIMENTARY TRACT AND METABOLISM
acetate	CIDs00000175	Phase 4	approved	CC(=O)O	S - SENSORY ORGANS | G - GENITO URINARY SYSTEM AND SEX HORMONES
N-acetylglutamate	CIDs00000185	Phase 4	approved	CC(=O)NC(CCC(=O)O)C(=O)O	
acetylcholine	CIDs00000187	Phase 4	approved	CC(=O)OCC[N+](C)(C)C	S - SENSORY ORGANS
adenine	CIDs00000190	Phase 3	unapproved	Nc1ncnc2[nH]cnc12	
ammonia	CIDs00000222	Phase 4	approved	N	
quinacrine	CIDs00000237	Phase 2	unapproved	CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12	P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
benzyl alcohol	CIDs00000244	Phase 4	approved	OCc1ccccc1	P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
betaine	CIDs00000247	Phase 4	approved	C[N+](C)(C)CC(=O)O	A - ALIMENTARY TRACT AND METABOLISM
calcium ions	CIDs00000271	Phase 4	approved	[CaH2]	
carbon dioxide	CIDs00000280	Phase 3	unapproved	O=C=O	V - VARIOUS
flue gas	CIDs00000281	Phase 3	unapproved	[C-]#[O+]	V - VARIOUS
methane	CIDs00000297	Phase 3	unapproved	[C]	A - ALIMENTARY TRACT AND METABOLISM | A - ALIMENTARY TRACT AND METABOLISM
citric acid	CIDs00000311	Phase 4	approved	O=C(O)CC(O)(CC(=O)O)C(=O)O	A - ALIMENTARY TRACT AND METABOLISM
chloride	CIDs00000312	Phase 4	approved	Cl.N	B - BLOOD AND BLOOD FORMING ORGANS | G - GENITO URINARY SYSTEM AND SEX HORMONES
coumarin	CIDs00000323	Phase 4	approved	O=c1ccc2ccccc2o1	
phloroglucinol	CIDs00000359	Phase 4	approved	Oc1cc(O)cc(O)c1	A - ALIMENTARY TRACT AND METABOLISM
gallic acid	CIDs00000370	Phase 2	unapproved	O=C(O)c1cc(O)c(O)c(O)c1	
octanoate	CIDs00000379	Phase 2	unapproved	CCCCCCCC(=O)O	
sulfur	CIDs00000402	Phase 4	approved	[S]	D - DERMATOLOGICALS | D - DERMATOLOGICALS
beta-hydroxybutyrate	CIDs00000441	Phase 1	unapproved	CC(O)CC(=O)O	
bupropion	CIDs00000444	Phase 4	approved	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	N - NERVOUS SYSTEM
N1-methylnicotinamide	CIDs00000457	Phase 2	unapproved	C[n+]1cccc(C(N)=O)c1	
guaiacol	CIDs00000460	Phase 3	unapproved	COc1ccccc1O	
malate	CIDs00000525	Phase 4	approved	O=C(O)CC(O)C(=O)O	
EACA	CIDs00000564	Phase 4	approved	NCCCCCC(=O)O	B - BLOOD AND BLOOD FORMING ORGANS
creatine	CIDs00000586	Phase 3	unapproved	CN(CC(=O)O)C(=N)N	
creatinine	CIDs00000588	Phase 3	unapproved	CN1CC(=O)N=C1N	
cytosine	CIDs00000597	Phase 2	unapproved	Nc1cc[nH]c(=O)n1	
mesna	CIDs00000598	Phase 4	approved	O=S(=O)(O)CCS	
alanine	CIDs00000602	Phase 3	unapproved	CC(N)C(=O)O	
lactate	CIDs00000612	Phase 4	approved	CC(O)C(=O)O	G - GENITO URINARY SYSTEM AND SEX HORMONES
glyceraldehyde	CIDs00000670	Phase 4	approved	O=C(CO)CO	
DMSO	CIDs00000679	Phase 4	approved	C[S+](C)[O-]	G - GENITO URINARY SYSTEM AND SEX HORMONES | M - MUSCULO-SKELETAL SYSTEM
dopamine	CIDs00000681	Phase 4	approved	NCCc1ccc(O)c(O)c1	C - CARDIOVASCULAR SYSTEM
ethanol	CIDs00000702	Phase 4	approved	CCO	D - DERMATOLOGICALS | V - VARIOUS | V - VARIOUS
formalin	CIDs00000712	Phase 4	approved	C=O	
lindane	CIDs00000727	Phase 4	approved	Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@@H](Cl)[C@H](Cl)[C@H]1Cl	P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
glycine	CIDs00000750	Phase 4	approved	NCC(=O)O	B - BLOOD AND BLOOD FORMING ORGANS
glycerol	CIDs00000753	Phase 4	approved	OCC(O)CO	A - ALIMENTARY TRACT AND METABOLISM | A - ALIMENTARY TRACT AND METABOLISM
glycolic acid	CIDs00000757	Phase 2	unapproved	O=C(O)CO	
guanine	CIDs00000764	Phase 3	unapproved	Nc1nc2[nH]cnc2c(=O)[nH]1	
bicarbonate	CIDs00000767	Phase 3	unapproved	O=C(O)O	
histamine	CIDs00000774	Phase 4	approved	NCCc1c[nH]cn1	
hydrogen peroxide	CIDs00000784	Phase 4	approved	OO	A - ALIMENTARY TRACT AND METABOLISM | D - DERMATOLOGICALS | D - DERMATOLOGICALS | S - SENSORY ORGANS
quinol	CIDs00000785	Phase 4	approved	Oc1ccc(O)cc1	D - DERMATOLOGICALS
iodine	CIDs00000807	Phase 4	approved	II	D - DERMATOLOGICALS
lipoic acid	CIDs00000864	Phase 4	approved	O=C(O)CCCCC1CCSS1	A - ALIMENTARY TRACT AND METABOLISM
magnesium	CIDs00000888	Phase 3	unapproved	[MgH2]	
phytate	CIDs00000890	Phase 3	unapproved	O=P(O)(O)O[C@H]1[C@H](OP(=O)(O)O)[C@@H](OP(=O)(O)O)[C@H](OP(=O)(O)O)[C@@H](OP(=O)(O)O)[C@H]1OP(=O)(O)O	
melatonin	CIDs00000896	Phase 4	approved	COc1ccc2[nH]cc(CCNC(C)=O)c2c1	N - NERVOUS SYSTEM
naphthalene	CIDs00000931	Phase 1	unapproved	c1ccc2ccccc2c1	
vitamin B	CIDs00000936	Phase 4	approved	NC(=O)c1cccnc1	A - ALIMENTARY TRACT AND METABOLISM
niacin	CIDs00000937	Phase 4	approved	O=C(O)c1cccnc1	C - CARDIOVASCULAR SYSTEM | C - CARDIOVASCULAR SYSTEM | C - CARDIOVASCULAR SYSTEM
Nicorette	CIDs00000942	Phase 2	unapproved	CN1CCCC1c1cccnc1	
nitrate	CIDs00000943	Phase 3	unapproved	O=[N+]([O-])O	
nitrous oxide	CIDs00000948	Phase 4	approved	N#[N+][O-]	N - NERVOUS SYSTEM | N - NERVOUS SYSTEM
octanol	CIDs00000957	Phase 2	unapproved	CCCCCCCCO	
distilled water	CIDs00000961	Phase 4	approved	O	
orotic acid	CIDs00000967	Phase 2	unapproved	O=C(O)c1cc(=O)[nH]c(=O)[nH]1	
oxaloacetate	CIDs00000970	Phase 2	unapproved	O=C(O)CC(=O)C(=O)O	
oxygen	CIDs00000977	Phase 4	approved	O=O	V - VARIOUS
p-aminobenzoic acid	CIDs00000978	Phase 4	approved	Nc1ccc(C(=O)O)cc1	D - DERMATOLOGICALS
polyphosphate	CIDs00000983	Phase 3	unapproved	O=P(O)(O)OP(=O)(O)OP(=O)(O)O	
phenanthrene	CIDs00000995	Phase 1	unapproved	c1ccc2c(c1)ccc1ccccc12	
phenol	CIDs00000996	Phase 4	approved	Oc1ccccc1	R - RESPIRATORY SYSTEM | C - CARDIOVASCULAR SYSTEM | N - NERVOUS SYSTEM | D - DERMATOLOGICALS
phenylacetic acid	CIDs00000999	Phase 4	approved	O=C([O-])Cc1ccccc1.[Na+]	
phosphate	CIDs00001003	Phase 4	approved	O=P(O)(O)O	
ethanolamine phosphate	CIDs00001015	Phase 2	unapproved	NCCOP(=O)(O)O	
pyrophosphate	CIDs00001023	Phase 2	unapproved	O=P(O)(O)OP(=O)(O)O	
1,2-propanediol	CIDs00001030	Phase 3	unapproved	CC(O)CO	
propionate	CIDs00001032	Phase 2	unapproved	CCC(=O)O	
putrescine	CIDs00001045	Phase 3	unapproved	NCCCCN	
pyrazinamide	CIDs00001046	Phase 4	approved	NC(=O)c1cnccn1	J - ANTIINFECTIVES FOR SYSTEMIC USE
pyridoxal	CIDs00001050	Phase 3	unapproved	Cc1ncc(CO)c(C=O)c1O	
pyridoxal phosphate	CIDs00001051	Phase 3	unapproved	Cc1ncc(COP(=O)(O)O)c(C=O)c1O	
vitamin B complex	CIDs00001052	Phase 2	unapproved	Cc1ncc(CO)c(CN)c1O	
pyridoxine	CIDs00001054	Phase 4	approved	Cc1ncc(CO)c(CO)c1O	A - ALIMENTARY TRACT AND METABOLISM
pyrogallol	CIDs00001057	Phase 4	approved	Oc1cccc(O)c1O	
pyruvic acid	CIDs00001060	Phase 2	unapproved	CC(=O)C(=O)O	
thiosulfate	CIDs00001084	Phase 4	approved	O=S(=O)(O)S	V - VARIOUS
sarcosine	CIDs00001088	Phase 2	unapproved	CNCC(=O)O	
selenite	CIDs00001090	Phase 4	approved	O=[Se](O)O	
succinate	CIDs00001110	Phase 3	unapproved	O=C(O)CCC(=O)O	
sulphate	CIDs00001117	Phase 4	approved	O=S(=O)([O-])[O-].[Na+].[Na+]	
taurine	CIDs00001123	Phase 4	approved	NCCS(=O)(=O)O	
thiamine	CIDs00001130	Phase 4	approved	Cc1ncc(C[n+]2csc(CCO)c2C)c(N)n1	
toluene	CIDs00001140	Phase 2	unapproved	Cc1ccccc1	
uric acid	CIDs00001175	Phase 2	unapproved	Oc1nc(O)c2nc(O)[nH]c2n1	
lotion	CIDs00001176	Phase 4	approved	NC(N)=O	D - DERMATOLOGICALS | B - BLOOD AND BLOOD FORMING ORGANS | D - DERMATOLOGICALS
gallopamil	CIDs00001234	Phase 2	unapproved	COc1ccc(CCN(C)CCCC(C#N)(c2cc(OC)c(OC)c(OC)c2)C(C)C)cc1OC	C - CARDIOVASCULAR SYSTEM
menthol	CIDs00001254	Phase 4	approved	CC1CCC(C(C)C)C(O)C1	
m-chlorophenylpiperazine	CIDs00001355	Phase 2	unapproved	Clc1cccc(N2CCNCC2)c1	
2,4-dinitrophenol	CIDs00001493	Phase 2	unapproved	O=[N+]([O-])c1ccc(O)c([N+](=O)[O-])c1	
pyrithione	CIDs00001569	Phase 4	approved	On1ccccc1=S	
3,4-methylenedioxyamphetamine	CIDs00001614	Phase 1	unapproved	CC(N)Cc1ccc2c(c1)OCO2	
MDMA	CIDs00001615	Phase 3	unapproved	CNC(C)Cc1ccc2c(c1)OCO2	
homotaurine	CIDs00001646	Phase 3	unapproved	NCCCS(=O)(=O)O	
pleconaril	CIDs00001684	Phase 2	unapproved	Cc1cc(CCCOc2c(C)cc(-c3noc(C(F)(F)F)n3)cc2C)on1	J - ANTIINFECTIVES FOR SYSTEMIC USE
4-aminopyridine	CIDs00001727	Phase 4	approved	Nc1ccncc1	N - NERVOUS SYSTEM
phenytoin	CIDs00001775	Phase 4	approved	O=C1N=C(O)NC1(c1ccccc1)c1ccccc1	N - NERVOUS SYSTEM | N - NERVOUS SYSTEM
tacrine	CIDs00001935	Phase 4	approved	Nc1c2c(nc3ccccc13)CCCC2	N - NERVOUS SYSTEM
acebutolol	CIDs00001978	Phase 4	approved	CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(C(C)=O)c1	C - CARDIOVASCULAR SYSTEM
aceclidine	CIDs00001979	Phase 2	unapproved	CC(=O)OC1CN2CCC1CC2	S - SENSORY ORGANS | S - SENSORY ORGANS
paracetamol	CIDs00001983	Phase 4	approved	CC(=O)Nc1ccc(O)cc1	N - NERVOUS SYSTEM | N - NERVOUS SYSTEM | N - NERVOUS SYSTEM
acetazolamide	CIDs00001986	Phase 4	approved	CC(=O)Nc1nnc(S(N)(=O)=O)s1	S - SENSORY ORGANS
acetohexamide	CIDs00001989	Phase 4	approved	CC(=O)c1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1	A - ALIMENTARY TRACT AND METABOLISM
acetohydroxamic acid	CIDs00001990	Phase 4	approved	CC(=O)NO	G - GENITO URINARY SYSTEM AND SEX HORMONES
methacholine	CIDs00001993	Phase 4	approved	CC(=O)OC(C)C[N+](C)(C)C	V - VARIOUS
acyclovir	CIDs00002022	Phase 4	approved	Nc1nc(O)c2ncn(COCCO)c2n1	J - ANTIINFECTIVES FOR SYSTEMIC USE | S - SENSORY ORGANS | D - DERMATOLOGICALS | D - DERMATOLOGICALS
albendazole	CIDs00002082	Phase 4	approved	CCCSc1ccc2nc(NC(=O)OC)[nH]c2c1	P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
salbutamol	CIDs00002083	Phase 4	approved	CC(C)(C)NCC(O)c1ccc(O)c(CO)c1	R - RESPIRATORY SYSTEM | R - RESPIRATORY SYSTEM
alendronate	CIDs00002088	Phase 4	approved	NCCCC(O)(P(=O)(O)O)P(=O)(O)O	M - MUSCULO-SKELETAL SYSTEM
alfuzosin	CIDs00002092	Phase 4	approved	COc1cc2nc(N(C)CCCNC(=O)C3CCCO3)nc(N)c2cc1OC	G - GENITO URINARY SYSTEM AND SEX HORMONES
allopurinol	CIDs00002094	Phase 4	approved	O=c1ncnc2[nH][nH]cc1-2	M - MUSCULO-SKELETAL SYSTEM | M - MUSCULO-SKELETAL SYSTEM
alosetron	CIDs00002099	Phase 4	approved	Cc1[nH]cnc1CN1CCc2c(c3ccccc3n2C)C1=O	A - ALIMENTARY TRACT AND METABOLISM
alprazolam	CIDs00002118	Phase 4	approved	Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2	N - NERVOUS SYSTEM
amantadine	CIDs00002130	Phase 4	approved	NC12CC3CC(CC(C3)C1)C2	N - NERVOUS SYSTEM
ambenonium	CIDs00002131	Phase 4	approved	CC[N+](CC)(CCNC(=O)C(=O)NCC[N+](CC)(CC)Cc1ccccc1Cl)Cc1ccccc1Cl	N - NERVOUS SYSTEM
ambroxol	CIDs00002132	Phase 3	unapproved	Nc1c(Br)cc(Br)cc1CN[C@H]1CC[C@H](O)CC1	R - RESPIRATORY SYSTEM
Hypaque	CIDs00002140	Phase 4	approved	CC(=O)Nc1c(I)c(NC(C)=O)c(I)c(C(=O)O)c1I	V - VARIOUS
amifostine	CIDs00002141	Phase 4	approved	NCCCNCCSP(=O)(O)O	V - VARIOUS
aminoguanidine	CIDs00002146	Phase 1	unapproved	NN=C(N)N	
p-aminohippurate	CIDs00002148	Phase 4	approved	Nc1ccc(C(=O)NCC(=O)O)cc1	V - VARIOUS
theophylline	CIDs00002153	Phase 4	approved	Cn1c(=O)c2nc[nH]c2n(C)c1=O	R - RESPIRATORY SYSTEM | R - RESPIRATORY SYSTEM | R - RESPIRATORY SYSTEM
amiodarone	CIDs00002156	Phase 4	approved	CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1	C - CARDIOVASCULAR SYSTEM
amisulpride	CIDs00002159	Phase 4	approved	CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)c(N)cc1OC	N - NERVOUS SYSTEM
amitriptyline	CIDs00002160	Phase 4	approved	CN(C)CCC=C1c2ccccc2CCc2ccccc21	N - NERVOUS SYSTEM
amlexanox	CIDs00002161	Phase 4	approved	CC(C)c1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1	A - ALIMENTARY TRACT AND METABOLISM | R - RESPIRATORY SYSTEM
amlodipine	CIDs00002162	Phase 4	approved	CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl	C - CARDIOVASCULAR SYSTEM
amobarbital	CIDs00002163	Phase 4	approved	CCC1(CCC(C)C)C(=O)N=C(O)NC1=O	N - NERVOUS SYSTEM
amodiaquine	CIDs00002165	Phase 4	approved	CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O	P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
amoxapine	CIDs00002170	Phase 4	approved	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	N - NERVOUS SYSTEM
anisindione	CIDs00002197	Phase 4	approved	COc1ccc(C2C(=O)c3ccccc3C2=O)cc1	
antazoline	CIDs00002200	Phase 4	approved	c1ccc(CN(CC2=NCCN2)c2ccccc2)cc1	R - RESPIRATORY SYSTEM | R - RESPIRATORY SYSTEM
dithranol	CIDs00002202	Phase 4	approved	O=C1c2c(O)cccc2Cc2cccc(O)c21	D - DERMATOLOGICALS | D - DERMATOLOGICALS
antipyrine	CIDs00002206	Phase 4	approved	Cc1cc(=O)n(-c2ccccc2)n1C	N - NERVOUS SYSTEM | S - SENSORY ORGANS | N - NERVOUS SYSTEM | N - NERVOUS SYSTEM
apocynin	CIDs00002214	Phase 1	unapproved	COc1cc(C(C)=O)ccc1O	
apraclonidine	CIDs00002216	Phase 4	approved	Nc1cc(Cl)c(N=C2NCCN2)c(Cl)c1	S - SENSORY ORGANS
arotinolol	CIDs00002239	Phase 3	unapproved	CC(C)(C)NCC(O)CSc1nc(-c2ccc(C(N)=O)s2)cs1	
aspirin	CIDs00002244	Phase 4	approved	CC(=O)Oc1ccccc1C(=O)O	B - BLOOD AND BLOOD FORMING ORGANS | N - NERVOUS SYSTEM | N - NERVOUS SYSTEM | A - ALIMENTARY TRACT AND METABOLISM | N - NERVOUS SYSTEM
astemizole	CIDs00002247	Phase 4	approved	COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1	R - RESPIRATORY SYSTEM
atenolol	CIDs00002249	Phase 4	approved	CC(C)NCC(O)COc1ccc(CC(N)=O)cc1	C - CARDIOVASCULAR SYSTEM
azathioprine	CIDs00002265	Phase 4	approved	Cn1cnc([N+](=O)[O-])c1Sc1ncnc2nc[nH]c12	L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
azelaic acid	CIDs00002266	Phase 4	approved	O=C(O)CCCCCCCC(=O)O	D - DERMATOLOGICALS
azelastine	CIDs00002267	Phase 4	approved	CN1CCCC(n2nc(Cc3ccc(Cl)cc3)c3ccccc3c2=O)CC1	R - RESPIRATORY SYSTEM | R - RESPIRATORY SYSTEM | S - SENSORY ORGANS
azosemide	CIDs00002273	Phase 3	unapproved	NS(=O)(=O)c1cc(-c2nn[nH]n2)c(NCc2cccs2)cc1Cl	
baclofen	CIDs00002284	Phase 4	approved	NCC(CC(=O)O)c1ccc(Cl)cc1	M - MUSCULO-SKELETAL SYSTEM
barbital	CIDs00002294	Phase 4	approved	CCC1(CC)C(=O)NC(=O)NC1=O	N - NERVOUS SYSTEM
bendrofluazide	CIDs00002315	Phase 4	approved	NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NC(Cc1ccccc1)NS2(=O)=O	C - CARDIOVASCULAR SYSTEM
benserazide	CIDs00002327	Phase 4	approved	NC(CO)C(=O)NNCc1ccc(O)c(O)c1O	
benzalkonium chloride	CIDs00002330	Phase 4	approved	CCCCCCCCCCCCC[N+](C)(C)Cc1ccccc1	D - DERMATOLOGICALS | R - RESPIRATORY SYSTEM | D - DERMATOLOGICALS
benzbromarone	CIDs00002333	Phase 4	approved	CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1	M - MUSCULO-SKELETAL SYSTEM
benzocaine	CIDs00002337	Phase 4	approved	CCOC(=O)c1ccc(N)cc1	D - DERMATOLOGICALS | C - CARDIOVASCULAR SYSTEM | N - NERVOUS SYSTEM | R - RESPIRATORY SYSTEM
benzquinamide	CIDs00002342	Phase 4	approved	CCN(CC)C(=O)C1CN2CCc3cc(OC)c(OC)cc3C2CC1OC(C)=O	
benzthiazide	CIDs00002343	Phase 4	approved	NS(=O)(=O)c1cc2c(cc1Cl)N=C(CSCc1ccccc1)NS2(=O)=O	
bepridil	CIDs00002351	Phase 4	approved	CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1	C - CARDIOVASCULAR SYSTEM
berberine	CIDs00002353	Phase 3	unapproved	COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2	
bergapten	CIDs00002355	Phase 4	approved	COc1c2ccoc2cc2oc(=O)ccc12	D - DERMATOLOGICALS
betahistine	CIDs00002366	Phase 4	approved	CNCCc1ccccn1	N - NERVOUS SYSTEM
bethanidine	CIDs00002368	Phase 4	approved	C/N=C(\NC)NCc1ccccc1	C - CARDIOVASCULAR SYSTEM
betaxolol	CIDs00002369	Phase 4	approved	CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1	S - SENSORY ORGANS | C - CARDIOVASCULAR SYSTEM | S - SENSORY ORGANS
bethanechol	CIDs00002370	Phase 4	approved	CC(C[N+](C)(C)C)OC(N)=O	N - NERVOUS SYSTEM
bifonazole	CIDs00002378	Phase 4	approved	c1ccc(-c2ccc(C(c3ccccc3)n3ccnc3)cc2)cc1	D - DERMATOLOGICALS | D - DERMATOLOGICALS
biperiden	CIDs00002381	Phase 4	approved	OC(CCN1CCCCC1)(c1ccccc1)C1CC2C=CC1C2	N - NERVOUS SYSTEM
lacO	CIDs00002391	Phase 4	approved	CC(=O)Oc1ccc(C(c2ccc(OC(C)=O)cc2)c2ccccn2)cc1	A - ALIMENTARY TRACT AND METABOLISM | A - ALIMENTARY TRACT AND METABOLISM | A - ALIMENTARY TRACT AND METABOLISM
bisoprolol	CIDs00002405	Phase 4	approved	CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1	C - CARDIOVASCULAR SYSTEM
bithionol	CIDs00002406	Phase 4	approved	Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O	D - DERMATOLOGICALS | P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
bretylium	CIDs00002431	Phase 4	approved	CC[N+](C)(C)Cc1ccccc1Br	
brimonidine	CIDs00002435	Phase 4	approved	Brc1c(NC2=NCCN2)ccc2nccnc12	S - SENSORY ORGANS | S - SENSORY ORGANS | D - DERMATOLOGICALS
bromazepam	CIDs00002441	Phase 4	approved	O=C1CN=C(c2ccccn2)c2cc(Br)ccc2N1	N - NERVOUS SYSTEM
bromodiphenhydramine	CIDs00002444	Phase 4	approved	CN(C)CCOC(c1ccccc1)c1ccc(Br)cc1	R - RESPIRATORY SYSTEM
bromperidol	CIDs00002448	Phase 4	approved	O=C(CCCN1CCC(O)(c2ccc(Br)cc2)CC1)c1ccc(F)cc1	N - NERVOUS SYSTEM
brotizolam	CIDs00002451	Phase 3	unapproved	Cc1nnc2n1-c1sc(Br)cc1C(c1ccccc1Cl)=NC2	N - NERVOUS SYSTEM
bumetanide	CIDs00002471	Phase 4	approved	CCCCNc1cc(C(=O)O)cc(S(N)(=O)=O)c1Oc1ccccc1	C - CARDIOVASCULAR SYSTEM
bunazosin	CIDs00002472	Phase 3	unapproved	CCCC(=O)N1CCCN(c2nc(N)c3cc(OC)c(OC)cc3n2)CC1	
bupivacaine	CIDs00002474	Phase 4	approved	CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C	N - NERVOUS SYSTEM | N - NERVOUS SYSTEM
buspirone	CIDs00002477	Phase 4	approved	O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1	N - NERVOUS SYSTEM
butabarbital	CIDs00002479	Phase 4	approved	CCC(C)C1(CC)C(=O)NC(=O)NC1=O	
profundal	CIDs00002481	Phase 4	approved	C=CCC1(CC(C)C)C(=O)NC(=O)NC1=O	
butenafine	CIDs00002484	Phase 4	approved	CN(Cc1ccc(C(C)(C)C)cc1)Cc1cccc2ccccc12	D - DERMATOLOGICALS
caffeine	CIDs00002519	Phase 4	approved	Cn1c(=O)c2c(ncn2C)n(C)c1=O	N - NERVOUS SYSTEM | D - DERMATOLOGICALS
verapamil	CIDs00002520	Phase 4	approved	COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC	C - CARDIOVASCULAR SYSTEM | C - CARDIOVASCULAR SYSTEM
camostate	CIDs00002536	Phase 3	unapproved	CN(C)C(=O)COC(=O)Cc1ccc(OC(=O)c2ccc(NC(=N)N)cc2)cc1	B - BLOOD AND BLOOD FORMING ORGANS
candesartan cilexetil	CIDs00002540	Phase 4	approved	CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1	C - CARDIOVASCULAR SYSTEM
candesartan	CIDs00002541	Phase 3	unapproved	CCOc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1	C - CARDIOVASCULAR SYSTEM
cannabinol	CIDs00002543	Phase 3	unapproved	CCCCCc1cc(O)c2c(c1)OC(C)(C)c1ccc(C)cc1-2	
carbachol	CIDs00002551	Phase 4	approved	C[N+](C)(C)CCOC(N)=O	
carbamazepine	CIDs00002554	Phase 4	approved	NC(=O)N1c2ccccc2C=Cc2ccccc21	N - NERVOUS SYSTEM
carbetapentane	CIDs00002562	Phase 4	approved	CCN(CC)CCOCCOC(=O)C1(c2ccccc2)CCCC1	R - RESPIRATORY SYSTEM
carbinoxamine	CIDs00002564	Phase 4	approved	CN(C)CCOC(c1ccc(Cl)cc1)c1ccccn1	R - RESPIRATORY SYSTEM
carisoprodol	CIDs00002576	Phase 4	approved	CCCC(C)(COC(N)=O)COC(=O)NC(C)C	M - MUSCULO-SKELETAL SYSTEM | M - MUSCULO-SKELETAL SYSTEM | M - MUSCULO-SKELETAL SYSTEM
carprofen	CIDs00002581	Phase 4	approved	CC(C(=O)O)c1ccc2c(c1)[nH]c1ccc(Cl)cc12	
carteolol	CIDs00002583	Phase 4	approved	CC(C)(C)NCC(O)COc1cccc2c1CCC(=O)N2	S - SENSORY ORGANS | C - CARDIOVASCULAR SYSTEM | S - SENSORY ORGANS
carvedilol	CIDs00002585	Phase 4	approved	COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12	C - CARDIOVASCULAR SYSTEM
celiprolol	CIDs00002663	Phase 4	approved	CCN(CC)C(=O)Nc1ccc(OCC(O)CNC(C)(C)C)c(C(C)=O)c1	C - CARDIOVASCULAR SYSTEM
cetirizine	CIDs00002678	Phase 4	approved	O=C(O)COCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1	R - RESPIRATORY SYSTEM
hexadecanol	CIDs00002682	Phase 4	approved	CCCCCCCCCCCCCCCCO	
cetylpyridinium chloride	CIDs00002683	Phase 4	approved	CCCCCCCCCCCCCCCC[n+]1ccccc1	D - DERMATOLOGICALS | B - BLOOD AND BLOOD FORMING ORGANS | D - DERMATOLOGICALS | R - RESPIRATORY SYSTEM
chloral hydrate	CIDs00002707	Phase 4	approved	OC(O)C(Cl)(Cl)Cl	N - NERVOUS SYSTEM
chlorcyclizine	CIDs00002710	Phase 1	unapproved	CN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1	R - RESPIRATORY SYSTEM
chlordiazepoxide	CIDs00002712	Phase 4	approved	CNC1=Nc2ccc(Cl)cc2C(c2ccccc2)=[N+]([O-])C1	N - NERVOUS SYSTEM
chlormezanone	CIDs00002717	Phase 4	approved	CN1C(=O)CCS(=O)(=O)C1c1ccc(Cl)cc1	M - MUSCULO-SKELETAL SYSTEM | M - MUSCULO-SKELETAL SYSTEM | M - MUSCULO-SKELETAL SYSTEM
chloroquine	CIDs00002719	Phase 4	approved	CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12	P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
thiazide	CIDs00002720	Phase 4	approved	NS(=O)(=O)c1cc2c(cc1Cl)N=CNS2(=O)=O	C - CARDIOVASCULAR SYSTEM | C - CARDIOVASCULAR SYSTEM
chlorpheniramine	CIDs00002725	Phase 4	approved	CN(C)CCC(c1ccc(Cl)cc1)c1ccccn1	R - RESPIRATORY SYSTEM | R - RESPIRATORY SYSTEM
chlorpromazine	CIDs00002726	Phase 4	approved	CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21	N - NERVOUS SYSTEM
chlorpropamide	CIDs00002727	Phase 4	approved	CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1	A - ALIMENTARY TRACT AND METABOLISM
chlorthalidone	CIDs00002732	Phase 4	approved	NS(=O)(=O)c1cc(C2(O)NC(=O)c3ccccc32)ccc1Cl	C - CARDIOVASCULAR SYSTEM
stealth	CIDs00002733	Phase 4	approved	O=c1[nH]c2cc(Cl)ccc2o1	M - MUSCULO-SKELETAL SYSTEM | M - MUSCULO-SKELETAL SYSTEM | M - MUSCULO-SKELETAL SYSTEM
acetyldinaline	CIDs00002746	Phase 3	unapproved	CC(=O)Nc1ccc(C(=O)Nc2ccccc2N)cc1	
ciclopirox	CIDs00002749	Phase 4	approved	Cc1cc(C2CCCCC2)n(O)c(=O)c1	D - DERMATOLOGICALS | G - GENITO URINARY SYSTEM AND SEX HORMONES
cilostazol	CIDs00002754	Phase 4	approved	O=C1CCc2cc(OCCCCc3nnnn3C3CCCCC3)ccc2N1	B - BLOOD AND BLOOD FORMING ORGANS
cimetidine	CIDs00002756	Phase 4	approved	CN/C(=N/CCSCc1nc[nH]c1C)NC#N	A - ALIMENTARY TRACT AND METABOLISM | A - ALIMENTARY TRACT AND METABOLISM
1,8-cineole	CIDs00002758	Phase 3	unapproved	CC12CCC(CC1)C(C)(C)O2	R - RESPIRATORY SYSTEM
cinoxacin	CIDs00002762	Phase 4	approved	CCn1nc(C(=O)O)c(=O)c2cc3c(cc21)OCO3	J - ANTIINFECTIVES FOR SYSTEMIC USE
ciprofibrate	CIDs00002763	Phase 4	approved	CC(C)(Oc1ccc(C2CC2(Cl)Cl)cc1)C(=O)O	C - CARDIOVASCULAR SYSTEM
ciprofloxacin	CIDs00002764	Phase 4	approved	O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O	J - ANTIINFECTIVES FOR SYSTEMIC USE | S - SENSORY ORGANS | S - SENSORY ORGANS | S - SENSORY ORGANS
cisapride	CIDs00002769	Phase 4	approved	COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC	A - ALIMENTARY TRACT AND METABOLISM
citalopram	CIDs00002771	Phase 4	approved	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	N - NERVOUS SYSTEM
clebopride	CIDs00002780	Phase 4	approved	COc1cc(N)c(Cl)cc1C(=O)NC1CCN(Cc2ccccc2)CC1	A - ALIMENTARY TRACT AND METABOLISM
clemizole	CIDs00002782	Phase 2	unapproved	Clc1ccc(Cn2c(CN3CCCC3)nc3ccccc32)cc1	
clenbuterol	CIDs00002783	Phase 4	approved	CC(C)(C)NCC(O)c1cc(Cl)c(N)c(Cl)c1	R - RESPIRATORY SYSTEM | R - RESPIRATORY SYSTEM
clidinium bromide	CIDs00002784	Phase 4	approved	C[N+]12CCC(CC1)C(OC(=O)C(O)(c1ccccc1)c1ccccc1)C2	
clioquinol	CIDs00002788	Phase 4	approved	Oc1c(I)cc(Cl)c2cccnc12	D - DERMATOLOGICALS | P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS | P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS | S - SENSORY ORGANS | G - GENITO URINARY SYSTEM AND SEX HORMONES | D - DERMATOLOGICALS
clobazam	CIDs00002789	Phase 4	approved	CN1C(=O)CC(=O)N(c2ccccc2)c2cc(Cl)ccc21	N - NERVOUS SYSTEM
clofazimine	CIDs00002794	Phase 4	approved	CC(C)/N=c1\cc2n(-c3ccc(Cl)cc3)c3ccccc3nc-2cc1Nc1ccc(Cl)cc1	J - ANTIINFECTIVES FOR SYSTEMIC USE
chlophedianol	CIDs00002795	Phase 4	approved	CN(C)CCC(O)(c1ccccc1)c1ccccc1Cl	R - RESPIRATORY SYSTEM
clofibrate	CIDs00002796	Phase 4	approved	CCOC(=O)C(C)(C)Oc1ccc(Cl)cc1	C - CARDIOVASCULAR SYSTEM
clomipramine	CIDs00002801	Phase 4	approved	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21	N - NERVOUS SYSTEM
clonazepam	CIDs00002802	Phase 4	approved	O=C1CN=C(c2ccccc2Cl)c2cc([N+](=O)[O-])ccc2N1	N - NERVOUS SYSTEM
clonidine	CIDs00002803	Phase 4	approved	Clc1cccc(Cl)c1N=C1NCCN1	C - CARDIOVASCULAR SYSTEM | N - NERVOUS SYSTEM | S - SENSORY ORGANS
clorazepate	CIDs00002809	Phase 4	approved	O=C(O)C1N=C(c2ccccc2)c2cc(Cl)ccc2NC1=O	
clotiazepam	CIDs00002811	Phase 4	approved	CCc1cc2c(s1)N(C)C(=O)CN=C2c1ccccc1Cl	N - NERVOUS SYSTEM
clotrimazole	CIDs00002812	Phase 4	approved	Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1	A - ALIMENTARY TRACT AND METABOLISM | G - GENITO URINARY SYSTEM AND SEX HORMONES | D - DERMATOLOGICALS
clozapine	CIDs00002818	Phase 4	approved	CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1	N - NERVOUS SYSTEM
sodium cromoglycate	CIDs00002881	Phase 4	approved	O=C(O)c1cc(=O)c2c(OCC(O)COc3cccc4oc(C(=O)O)cc(=O)c34)cccc2o1	R - RESPIRATORY SYSTEM | R - RESPIRATORY SYSTEM | A - ALIMENTARY TRACT AND METABOLISM | D - DERMATOLOGICALS | R - RESPIRATORY SYSTEM | S - SENSORY ORGANS | S - SENSORY ORGANS
cyclandelate	CIDs00002893	Phase 4	approved	CC1CC(OC(=O)C(O)c2ccccc2)CC(C)(C)C1	C - CARDIOVASCULAR SYSTEM
cyclobenzaprine	CIDs00002895	Phase 4	approved	CN(C)CCC=C1c2ccccc2C=Cc2ccccc21	M - MUSCULO-SKELETAL SYSTEM
cyclofenil	CIDs00002898	Phase 4	approved	CC(=O)Oc1ccc(C(=C2CCCCC2)c2ccc(OC(C)=O)cc2)cc1	G - GENITO URINARY SYSTEM AND SEX HORMONES
cyclopentolate	CIDs00002905	Phase 4	approved	CN(C)CCOC(=O)C(c1ccccc1)C1(O)CCCC1	S - SENSORY ORGANS | S - SENSORY ORGANS
cyclothiazide	CIDs00002910	Phase 4	approved	NS(=O)(=O)c1cc2c(cc1Cl)NC(C1CC3C=CC1C3)NS2(=O)=O	C - CARDIOVASCULAR SYSTEM
cycrimine	CIDs00002911	Phase 4	approved	OC(CCN1CCCCC1)(c1ccccc1)C1CCCC1	
cyproheptadine	CIDs00002913	Phase 4	approved	CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1	R - RESPIRATORY SYSTEM
danthron	CIDs00002950	Phase 4	approved	O=C1c2cccc(O)c2C(=O)c2c(O)cccc21	A - ALIMENTARY TRACT AND METABOLISM | A - ALIMENTARY TRACT AND METABOLISM
dapsone	CIDs00002955	Phase 4	approved	Nc1ccc(S(=O)(=O)c2ccc(N)cc2)cc1	J - ANTIINFECTIVES FOR SYSTEMIC USE | D - DERMATOLOGICALS
debrisoquine	CIDs00002965	Phase 4	approved	N=C(N)N1CCc2ccccc2C1	C - CARDIOVASCULAR SYSTEM
decamethonium	CIDs00002968	Phase 4	approved	C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C	
deferiprone	CIDs00002972	Phase 4	approved	Cc1c(O)c(=O)ccn1C	V - VARIOUS
deferoxamine	CIDs00002973	Phase 4	approved	CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN	V - VARIOUS
dequalinium	CIDs00002993	Phase 4	approved	Cc1cc(N)c2ccccc2[n+]1CCCCCCCCCC[n+]1c(C)cc(N)c2ccccc21	G - GENITO URINARY SYSTEM AND SEX HORMONES | D - DERMATOLOGICALS | R - RESPIRATORY SYSTEM
desipramine	CIDs00002995	Phase 4	approved	CNCCCN1c2ccccc2CCc2ccccc21	N - NERVOUS SYSTEM
amphetamine	CIDs00003007	Phase 4	approved	CC(N)Cc1ccccc1	N - NERVOUS SYSTEM
diazepam	CIDs00003016	Phase 4	approved	CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21	N - NERVOUS SYSTEM
diazoxide	CIDs00003019	Phase 4	approved	CC1=NS(=O)(=O)c2cc(Cl)ccc2N1	V - VARIOUS | C - CARDIOVASCULAR SYSTEM
dibucaine	CIDs00003025	Phase 4	approved	CCCCOc1cc(C(=O)NCCN(CC)CC)c2ccccc2n1	S - SENSORY ORGANS | S - SENSORY ORGANS | D - DERMATOLOGICALS | N - NERVOUS SYSTEM | C - CARDIOVASCULAR SYSTEM
diclofenac	CIDs00003032	Phase 4	approved	O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl	M - MUSCULO-SKELETAL SYSTEM | S - SENSORY ORGANS | D - DERMATOLOGICALS | M - MUSCULO-SKELETAL SYSTEM | M - MUSCULO-SKELETAL SYSTEM
p,p'-DDT	CIDs00003036	Phase 4	approved	Clc1ccc(C(c2ccc(Cl)cc2)C(Cl)(Cl)Cl)cc1	P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS | P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
dichlorphenamide	CIDs00003038	Phase 4	approved	NS(=O)(=O)c1cc(Cl)c(Cl)c(S(N)(=O)=O)c1	S - SENSORY ORGANS
dicyclomine	CIDs00003042	Phase 4	approved	CCN(CC)CCOC(=O)C1(C2CCCCC2)CCCCC1	A - ALIMENTARY TRACT AND METABOLISM
diethylcarbamazine	CIDs00003052	Phase 4	approved	CCN(CC)C(=O)N1CCN(C)CC1	P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
gadopentetate dimeglumine (Gd	CIDs00003053	Phase 4	approved	O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O	
diphenidol	CIDs00003055	Phase 4	approved	OC(CCCN1CCCCC1)(c1ccccc1)c1ccccc1	
diflunisal	CIDs00003059	Phase 4	approved	O=C(O)c1cc(-c2ccc(F)cc2F)ccc1O	N - NERVOUS SYSTEM
3,3'-diindolylmethane	CIDs00003071	Phase 3	unapproved	c1ccc2c(Cc3c[nH]c4ccccc34)c[nH]c2c1	
dimercaprol	CIDs00003080	Phase 4	approved	OCC(S)CS	V - VARIOUS
dimethothiazine	CIDs00003089	Phase 4	approved	CC(CN1c2ccccc2Sc2ccc(S(=O)(=O)N(C)C)cc21)N(C)C	N - NERVOUS SYSTEM
diphenhydramine	CIDs00003100	Phase 4	approved	CN(C)CCOC(c1ccccc1)c1ccccc1	D - DERMATOLOGICALS | R - RESPIRATORY SYSTEM | R - RESPIRATORY SYSTEM
diphenylpyraline	CIDs00003103	Phase 4	approved	CN1CCC(OC(c2ccccc2)c2ccccc2)CC1	R - RESPIRATORY SYSTEM | R - RESPIRATORY SYSTEM
dipivefrin	CIDs00003105	Phase 4	approved	CNCC(O)c1ccc(OC(=O)C(C)(C)C)c(OC(=O)C(C)(C)C)c1	S - SENSORY ORGANS
dipyridamole	CIDs00003108	Phase 4	approved	OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1	B - BLOOD AND BLOOD FORMING ORGANS
dipyrone	CIDs00003110	Phase 4	approved	Cc1c(N(C)CS(=O)(=O)O)c(=O)n(-c2ccccc2)n1C	
disopyramide	CIDs00003114	Phase 4	approved	CC(C)N(CCC(C(N)=O)(c1ccccc1)c1ccccn1)C(C)C	C - CARDIOVASCULAR SYSTEM
distigmine bromide	CIDs00003116	Phase 4	approved	CN(CCCCCCN(C)C(=O)Oc1ccc[n+](C)c1)C(=O)Oc1ccc[n+](C)c1	N - NERVOUS SYSTEM
disulfiram	CIDs00003117	Phase 4	approved	CCN(CC)C(=S)SSC(=S)N(CC)CC	P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS | P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS | N - NERVOUS SYSTEM
valproate	CIDs00003121	Phase 4	approved	CCCC(CCC)C(=O)O	N - NERVOUS SYSTEM
alpha-methyl-p-tyrosine	CIDs00003125	Phase 3	unapproved	CC(N)(Cc1ccc(O)cc1)C(=O)O	
domiphen bromide	CIDs00003149	Phase 4	approved	CCCCCCCCCCCC[N+](C)(C)CCOc1ccccc1	A - ALIMENTARY TRACT AND METABOLISM
domperidone	CIDs00003151	Phase 4	approved	O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1	A - ALIMENTARY TRACT AND METABOLISM
donepezil	CIDs00003152	Phase 4	approved	COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2	N - NERVOUS SYSTEM
doxapram	CIDs00003156	Phase 4	approved	CCN1CC(CCN2CCOCC2)C(c2ccccc2)(c2ccccc2)C1=O	R - RESPIRATORY SYSTEM
doxazosin	CIDs00003157	Phase 4	approved	COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC	C - CARDIOVASCULAR SYSTEM
Z-doxepin	CIDs00003158	Phase 4	approved	CN(C)CCC=C1c2ccccc2COc2ccccc21	D - DERMATOLOGICALS | N - NERVOUS SYSTEM
doxylamine	CIDs00003162	Phase 4	approved	CN(C)CCOC(C)(c1ccccc1)c1ccccn1	R - RESPIRATORY SYSTEM | R - RESPIRATORY SYSTEM
droperidol	CIDs00003168	Phase 4	approved	O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1	N - NERVOUS SYSTEM
dyclonine	CIDs00003180	Phase 4	approved	CCCCOc1ccc(C(=O)CCN2CCCCC2)cc1	R - RESPIRATORY SYSTEM | N - NERVOUS SYSTEM
diprophylline	CIDs00003182	Phase 4	approved	Cn1c(=O)c2c(ncn2CC(O)CO)n(C)c1=O	R - RESPIRATORY SYSTEM | R - RESPIRATORY SYSTEM
ebastine	CIDs00003191	Phase 3	unapproved	CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1	R - RESPIRATORY SYSTEM
ebselen	CIDs00003194	Phase 3	unapproved	O=c1c2ccccc2[se]n1-c1ccccc1	
econazole	CIDs00003198	Phase 4	approved	Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1	D - DERMATOLOGICALS | G - GENITO URINARY SYSTEM AND SEX HORMONES
edrophonium	CIDs00003202	Phase 4	approved	CC[N+](C)(C)c1cccc(O)c1	V - VARIOUS
emedastine	CIDs00003219	Phase 4	approved	CCOCCn1c(N2CCCN(C)CC2)nc2ccccc21	S - SENSORY ORGANS
enflurane	CIDs00003226	Phase 4	approved	FC(F)OC(F)(F)C(F)Cl	N - NERVOUS SYSTEM
enoxacin	CIDs00003229	Phase 4	approved	CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)nc21	J - ANTIINFECTIVES FOR SYSTEMIC USE
eperisone	CIDs00003236	Phase 3	unapproved	CCc1ccc(C(=O)C(C)CN2CCCCC2)cc1	M - MUSCULO-SKELETAL SYSTEM
epinastine	CIDs00003241	Phase 4	approved	NC1=NCC2c3ccccc3Cc3ccccc3N12	S - SENSORY ORGANS | R - RESPIRATORY SYSTEM
estazolam	CIDs00003261	Phase 4	approved	Clc1ccc2c(c1)C(c1ccccc1)=NCc1nncn1-2	N - NERVOUS SYSTEM
etazolate	CIDs00003277	Phase 2	unapproved	CCOC(=O)c1cnc2c(cnn2CC)c1NN=C(C)C	
ethacrynic acid	CIDs00003278	Phase 4	approved	C=C(CC)C(=O)c1ccc(OCC(=O)O)c(Cl)c1Cl	C - CARDIOVASCULAR SYSTEM
ether	CIDs00003283	Phase 2	unapproved	CCOCC	N - NERVOUS SYSTEM
ethinamate	CIDs00003284	Phase 4	approved	C#CC1(OC(N)=O)CCCCC1	
ethion	CIDs00003286	Phase 2	unapproved	CCOP(=S)(OCC)SCSP(=S)(OCC)OCC	
ethopropazine	CIDs00003290	Phase 4	approved	CCN(CC)C(C)CN1c2ccccc2Sc2ccccc21	N - NERVOUS SYSTEM
ethosuximide	CIDs00003291	Phase 4	approved	CCC1(C)CC(=O)NC1=O	N - NERVOUS SYSTEM | N - NERVOUS SYSTEM
ethotoin	CIDs00003292	Phase 4	approved	CCN1C(=O)NC(c2ccccc2)C1=O	N - NERVOUS SYSTEM
ethoxzolamide	CIDs00003295	Phase 4	approved	CCOc1ccc2nc(S(N)(=O)=O)sc2c1	
etidronate	CIDs00003305	Phase 4	approved	CC(O)(P(=O)(O)O)P(=O)(O)O	M - MUSCULO-SKELETAL SYSTEM
etilefrine	CIDs00003306	Phase 4	approved	CCNCC(O)c1cccc(O)c1	C - CARDIOVASCULAR SYSTEM | C - CARDIOVASCULAR SYSTEM
etodolac	CIDs00003308	Phase 4	approved	CCc1cccc2c3c([nH]c12)C(CC)(CC(=O)O)OCC3	M - MUSCULO-SKELETAL SYSTEM
felbamate	CIDs00003331	Phase 4	approved	NC(=O)OCC(COC(N)=O)c1ccccc1	N - NERVOUS SYSTEM
EMEC	CIDs00003332	Phase 4	approved	O=C(O)Cc1ccc(-c2ccccc2)cc1	M - MUSCULO-SKELETAL SYSTEM
felodipine	CIDs00003333	Phase 4	approved	CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl	C - CARDIOVASCULAR SYSTEM
fenbufen	CIDs00003335	Phase 4	approved	O=C(O)CCC(=O)c1ccc(-c2ccccc2)cc1	M - MUSCULO-SKELETAL SYSTEM
fenfluramine	CIDs00003337	Phase 4	approved	CCNC(C)Cc1cccc(C(F)(F)F)c1	N - NERVOUS SYSTEM | A - ALIMENTARY TRACT AND METABOLISM
fenofibrate	CIDs00003339	Phase 4	approved	CC(C)OC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1	C - CARDIOVASCULAR SYSTEM
fenoldopam	CIDs00003340	Phase 4	approved	Oc1ccc(C2CNCCc3c2cc(O)c(O)c3Cl)cc1	C - CARDIOVASCULAR SYSTEM
fenoprofen	CIDs00003342	Phase 4	approved	CC(C(=O)O)c1cccc(Oc2ccccc2)c1	M - MUSCULO-SKELETAL SYSTEM
fenoterol	CIDs00003343	Phase 4	approved	CC(Cc1ccc(O)cc1)NCC(O)c1cc(O)cc(O)c1	G - GENITO URINARY SYSTEM AND SEX HORMONES | R - RESPIRATORY SYSTEM | R - RESPIRATORY SYSTEM
fentanyl	CIDs00003345	Phase 4	approved	CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1	N - NERVOUS SYSTEM | N - NERVOUS SYSTEM | N - NERVOUS SYSTEM
fexofenadine	CIDs00003348	Phase 4	approved	CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1	R - RESPIRATORY SYSTEM
fipexide	CIDs00003351	Phase 4	approved	O=C(COc1ccc(Cl)cc1)N1CCN(Cc2ccc3c(c2)OCO3)CC1	N - NERVOUS SYSTEM
flavoxate	CIDs00003354	Phase 4	approved	Cc1c(-c2ccccc2)oc2c(C(=O)OCCN3CCCCC3)cccc2c1=O	G - GENITO URINARY SYSTEM AND SEX HORMONES
flecainide	CIDs00003355	Phase 4	approved	O=C(NCC1CCCCN1)c1cc(OCC(F)(F)F)ccc1OCC(F)(F)F	C - CARDIOVASCULAR SYSTEM
fluconazole	CIDs00003365	Phase 4	approved	OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F	J - ANTIINFECTIVES FOR SYSTEMIC USE | D - DERMATOLOGICALS
flucytosine	CIDs00003366	Phase 4	approved	Nc1[nH]c(=O)ncc1F	J - ANTIINFECTIVES FOR SYSTEMIC USE | D - DERMATOLOGICALS
flufenamic acid	CIDs00003371	Phase 4	approved	O=C(O)c1ccccc1Nc1cccc(C(F)(F)F)c1	M - MUSCULO-SKELETAL SYSTEM
fluphenazine	CIDs00003372	Phase 4	approved	OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1	N - NERVOUS SYSTEM
flumazenil	CIDs00003373	Phase 4	approved	CCOC(=O)c1ncn2c1CN(C)C(=O)c1cc(F)ccc1-2	V - VARIOUS
flunitrazepam	CIDs00003380	Phase 4	approved	CN1C(=O)CN=C(c2ccccc2F)c2cc([N+](=O)[O-])ccc21	N - NERVOUS SYSTEM
fluoxetine	CIDs00003386	Phase 4	approved	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1	N - NERVOUS SYSTEM
fluphenazine decanoate	CIDs00003388	Phase 4	approved	CCCCCCCCCC(=O)OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1	N - NERVOUS SYSTEM
fluphenazine enanthate	CIDs00003389	Phase 4	approved	CCCCCCC(=O)OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1	N - NERVOUS SYSTEM
flurazepam	CIDs00003393	Phase 4	approved	CCN(CC)CCN1C(=O)CN=C(c2ccccc2F)c2cc(Cl)ccc21	N - NERVOUS SYSTEM
flurbiprofen	CIDs00003394	Phase 4	approved	CC(C(=O)O)c1ccc(-c2ccccc2)c(F)c1	M - MUSCULO-SKELETAL SYSTEM | S - SENSORY ORGANS | M - MUSCULO-SKELETAL SYSTEM | R - RESPIRATORY SYSTEM
fluspirilene	CIDs00003396	Phase 4	approved	O=C1NCN(c2ccccc2)C12CCN(CCCC(c1ccc(F)cc1)c1ccc(F)cc1)CC2	N - NERVOUS SYSTEM
flutamide	CIDs00003397	Phase 4	approved	CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1	L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
4-methylpyrazole	CIDs00003406	Phase 4	approved	Cc1cn[nH]c1	V - VARIOUS
formoterol	CIDs00003410	Phase 4	approved	COc1ccc(CC(C)NCC(O)c2ccc(O)c(NC=O)c2)cc1	R - RESPIRATORY SYSTEM
foscarnet	CIDs00003414	Phase 4	approved	O=C(O)P(=O)(O)O	J - ANTIINFECTIVES FOR SYSTEMIC USE
furosemide	CIDs00003440	Phase 4	approved	NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl	C - CARDIOVASCULAR SYSTEM
gabapentin	CIDs00003446	Phase 4	approved	NCC1(CC(=O)O)CCCCC1	N - NERVOUS SYSTEM
gabexate mesilate	CIDs00003447	Phase 3	unapproved	CCOC(=O)c1ccc(OC(=O)CCCCCN=C(N)N)cc1	
gaboxadol	CIDs00003448	Phase 3	unapproved	Oc1noc2c1CCNC2	
gallamine triethiodide	CIDs00003450	Phase 4	approved	CC[N+](CC)(CC)CCOc1cccc(OCC[N+](CC)(CC)CC)c1OCC[N+](CC)(CC)CC	M - MUSCULO-SKELETAL SYSTEM
ganciclovir	CIDs00003454	Phase 4	approved	Nc1nc(O)c2ncn(COC(CO)CO)c2n1	S - SENSORY ORGANS | J - ANTIINFECTIVES FOR SYSTEMIC USE
vanoxerine	CIDs00003455	Phase 3	unapproved	Fc1ccc(C(OCCN2CCN(CCCc3ccccc3)CC2)c2ccc(F)cc2)cc1	
gemfibrozil	CIDs00003463	Phase 4	approved	Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1	C - CARDIOVASCULAR SYSTEM
crystal violet	CIDs00003468	Phase 4	approved	CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1	
gliclazide	CIDs00003475	Phase 4	approved	Cc1ccc(S(=O)(=O)NC(=O)NN2CC3CCCC3C2)cc1	A - ALIMENTARY TRACT AND METABOLISM
glimepiride	CIDs00003476	Phase 4	approved	CCC1=C(C)CN(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3)cc2)C1=O	A - ALIMENTARY TRACT AND METABOLISM
glipizide	CIDs00003478	Phase 4	approved	Cc1cnc(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc2)cn1	A - ALIMENTARY TRACT AND METABOLISM
glutethimide	CIDs00003487	Phase 4	approved	CCC1(c2ccccc2)CCC(=O)NC1=O	N - NERVOUS SYSTEM
glibenclamide	CIDs00003488	Phase 4	approved	COc1ccc(Cl)cc1C(=O)NCCc1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1	A - ALIMENTARY TRACT AND METABOLISM
glycopyrrolate	CIDs00003494	Phase 4	approved	C[N+]1(C)CCC(OC(=O)C(O)(c2ccccc2)C2CCCC2)C1	D - DERMATOLOGICALS
gossypol	CIDs00003503	Phase 3	unapproved	Cc1cc2c(C(C)C)c(O)c(O)c(C=O)c2c(O)c1-c1c(C)cc2c(C(C)C)c(O)c(O)c(C=O)c2c1O	
granisetron	CIDs00003510	Phase 4	approved	CN1C2CCCC1CC(NC(=O)c1nn(C)c3ccccc13)C2	A - ALIMENTARY TRACT AND METABOLISM
guaifenesin	CIDs00003516	Phase 4	approved	COc1ccccc1OCC(O)CO	R - RESPIRATORY SYSTEM
guanethidine	CIDs00003518	Phase 4	approved	NC(N)=NCCN1CCCCCCC1	S - SENSORY ORGANS | C - CARDIOVASCULAR SYSTEM
guanfacine	CIDs00003519	Phase 4	approved	N=C(N)NC(=O)Cc1c(Cl)cccc1Cl	C - CARDIOVASCULAR SYSTEM
guanidinium	CIDs00003520	Phase 4	approved	N=C(N)N	
fasudil	CIDs00003547	Phase 3	unapproved	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1	C - CARDIOVASCULAR SYSTEM
haloperidol	CIDs00003559	Phase 4	approved	O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1	N - NERVOUS SYSTEM
halothane	CIDs00003562	Phase 4	approved	FC(F)(F)C(Cl)Br	N - NERVOUS SYSTEM
pre-op	CIDs00003598	Phase 4	approved	Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl	D - DERMATOLOGICALS
miltefosine	CIDs00003599	Phase 4	approved	CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C	P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
hexafluorenium	CIDs00003601	Phase 4	approved	C[N+](C)(CCCCCC[N+](C)(C)C1c2ccccc2-c2ccccc21)C1c2ccccc2-c2ccccc21	M - MUSCULO-SKELETAL SYSTEM
hexylresorcinol	CIDs00003610	Phase 4	approved	CCCCCCc1ccc(O)cc1O	R - RESPIRATORY SYSTEM
hydralazine	CIDs00003637	Phase 4	approved	NNc1nncc2ccccc12	C - CARDIOVASCULAR SYSTEM
hydrochlorothiazide	CIDs00003639	Phase 4	approved	NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O	C - CARDIOVASCULAR SYSTEM | C - CARDIOVASCULAR SYSTEM
hydroflumethiazide	CIDs00003647	Phase 4	approved	NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NCNS2(=O)=O	C - CARDIOVASCULAR SYSTEM | C - CARDIOVASCULAR SYSTEM
hydroxychloroquine	CIDs00003652	Phase 4	approved	CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12	P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
hydroxyzine	CIDs00003658	Phase 4	approved	OCCOCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1	N - NERVOUS SYSTEM | N - NERVOUS SYSTEM
ibudilast	CIDs00003671	Phase 3	unapproved	CC(C)C(=O)c1c(C(C)C)nn2ccccc12	R - RESPIRATORY SYSTEM
ibuprofen	CIDs00003672	Phase 4	approved	CC(C)Cc1ccc(C(C)C(=O)O)cc1	G - GENITO URINARY SYSTEM AND SEX HORMONES | M - MUSCULO-SKELETAL SYSTEM | M - MUSCULO-SKELETAL SYSTEM | R - RESPIRATORY SYSTEM | C - CARDIOVASCULAR SYSTEM | M - MUSCULO-SKELETAL SYSTEM
phenelzine	CIDs00003675	Phase 4	approved	NNCCc1ccccc1	N - NERVOUS SYSTEM
lidocaine	CIDs00003676	Phase 4	approved	CCN(CC)CC(=O)Nc1c(C)cccc1C	R - RESPIRATORY SYSTEM | D - DERMATOLOGICALS | N - NERVOUS SYSTEM | S - SENSORY ORGANS | C - CARDIOVASCULAR SYSTEM | N - NERVOUS SYSTEM | S - SENSORY ORGANS | C - CARDIOVASCULAR SYSTEM
mephentermine	CIDs00003677	Phase 4	approved	CNC(C)(C)Cc1ccccc1	C - CARDIOVASCULAR SYSTEM
alverine citrate	CIDs00003678	Phase 4	approved	CCN(CCCc1ccccc1)CCCc1ccccc1	A - ALIMENTARY TRACT AND METABOLISM | A - ALIMENTARY TRACT AND METABOLISM
idebenone	CIDs00003686	Phase 4	approved	COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O	N - NERVOUS SYSTEM
ifenprodil	CIDs00003689	Phase 4	approved	CC(C(O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1	C - CARDIOVASCULAR SYSTEM
imipramine	CIDs00003696	Phase 4	approved	CN(C)CCCN1c2ccccc2CCc2ccccc21	N - NERVOUS SYSTEM
amrinone	CIDs00003698	Phase 4	approved	Nc1cc(-c2ccncc2)c[nH]c1=O	C - CARDIOVASCULAR SYSTEM
indapamide	CIDs00003702	Phase 4	approved	CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1	C - CARDIOVASCULAR SYSTEM
indole-3-carbinol	CIDs00003712	Phase 2	unapproved	OCc1c[nH]c2ccccc12	
indomethacin	CIDs00003715	Phase 4	approved	COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1	C - CARDIOVASCULAR SYSTEM | M - MUSCULO-SKELETAL SYSTEM | M - MUSCULO-SKELETAL SYSTEM | S - SENSORY ORGANS | M - MUSCULO-SKELETAL SYSTEM
indoprofen	CIDs00003718	Phase 4	approved	CC(C(=O)O)c1ccc(N2Cc3ccccc3C2=O)cc1	M - MUSCULO-SKELETAL SYSTEM
iohexol	CIDs00003730	Phase 4	approved	CC(=O)N(CC(O)CO)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I	V - VARIOUS
iomeprol	CIDs00003731	Phase 3	unapproved	CN(C(=O)CO)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I	V - VARIOUS
iopanoic acid	CIDs00003735	Phase 4	approved	CCC(Cc1c(I)cc(I)c(N)c1I)C(=O)O	V - VARIOUS
iodipamide	CIDs00003739	Phase 4	approved	O=C(CCCCC(=O)Nc1c(I)cc(I)c(C(=O)O)c1I)Nc1c(I)cc(I)c(C(=O)O)c1I	V - VARIOUS
ioversol	CIDs00003741	Phase 4	approved	O=C(NCC(O)CO)c1c(I)c(C(=O)NCC(O)CO)c(I)c(N(CCO)C(=O)CO)c1I	V - VARIOUS
ioxilan	CIDs00003743	Phase 4	approved	CC(=O)N(CC(O)CO)c1c(I)c(C(=O)NCCO)c(I)c(C(=O)NCC(O)CO)c1I	V - VARIOUS
iproniazid	CIDs00003748	Phase 4	approved	CC(C)NNC(=O)c1ccncc1	N - NERVOUS SYSTEM
irbesartan	CIDs00003749	Phase 4	approved	CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1	C - CARDIOVASCULAR SYSTEM
isocarboxazid	CIDs00003759	Phase 4	approved	Cc1cc(C(=O)NNCc2ccccc2)no1	N - NERVOUS SYSTEM
isoetharine	CIDs00003762	Phase 4	approved	CCC(NC(C)C)C(O)c1ccc(O)c(O)c1	R - RESPIRATORY SYSTEM | R - RESPIRATORY SYSTEM
isoflurane	CIDs00003763	Phase 4	approved	FC(F)OC(Cl)C(F)(F)F	N - NERVOUS SYSTEM
isoniazid	CIDs00003767	Phase 4	approved	NNC(=O)c1ccncc1	J - ANTIINFECTIVES FOR SYSTEMIC USE | J - ANTIINFECTIVES FOR SYSTEMIC USE
isopropamide	CIDs00003775	Phase 4	approved	CC(C)[N+](C)(CCC(C(N)=O)(c1ccccc1)c1ccccc1)C(C)C	A - ALIMENTARY TRACT AND METABOLISM
isopropanol	CIDs00003776	Phase 4	approved	CC(C)O	D - DERMATOLOGICALS
isoproterenol	CIDs00003779	Phase 4	approved	CC(C)NCC(O)c1ccc(O)c(O)c1	C - CARDIOVASCULAR SYSTEM | R - RESPIRATORY SYSTEM | R - RESPIRATORY SYSTEM | R - RESPIRATORY SYSTEM
isoxsuprine	CIDs00003783	Phase 4	approved	CC(COc1ccccc1)NC(C)C(O)c1ccc(O)cc1	C - CARDIOVASCULAR SYSTEM
isradipine	CIDs00003784	Phase 4	approved	COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc2nonc12	C - CARDIOVASCULAR SYSTEM
itopride	CIDs00003792	Phase 3	unapproved	COc1ccc(C(=O)NCc2ccc(OCCN(C)C)cc2)cc1OC	A - ALIMENTARY TRACT AND METABOLISM
WHI-P131	CIDs00003794	Phase 1	unapproved	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC	
ketamine	CIDs00003821	Phase 4	approved	CNC1(c2ccccc2Cl)CCCCC1=O	N - NERVOUS SYSTEM
ketanserin	CIDs00003822	Phase 4	approved	O=C(c1ccc(F)cc1)C1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1	C - CARDIOVASCULAR SYSTEM
ketoconazole (KTZ	CIDs00003823	Phase 4	approved	CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1	D - DERMATOLOGICALS | G - GENITO URINARY SYSTEM AND SEX HORMONES | H - SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS | J - ANTIINFECTIVES FOR SYSTEMIC USE
ketoprofen	CIDs00003825	Phase 4	approved	CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1	M - MUSCULO-SKELETAL SYSTEM | M - MUSCULO-SKELETAL SYSTEM | M - MUSCULO-SKELETAL SYSTEM
ketorolac	CIDs00003826	Phase 4	approved	O=C(c1ccccc1)c1ccc2n1CCC2C(=O)O	S - SENSORY ORGANS | M - MUSCULO-SKELETAL SYSTEM
ketotifen	CIDs00003827	Phase 4	approved	CN1CCC(=C2c3ccccc3CC(=O)c3sccc32)CC1	R - RESPIRATORY SYSTEM | S - SENSORY ORGANS
kynurenate	CIDs00003845	Phase 1	unapproved	O=C(O)c1cc(=O)c2ccccc2[nH]1	
labetalol	CIDs00003869	Phase 4	approved	CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1	C - CARDIOVASCULAR SYSTEM
lamotrigine	CIDs00003878	Phase 4	approved	Nc1nnc(-c2cccc(Cl)c2Cl)c(N)n1	N - NERVOUS SYSTEM
lansoprazole	CIDs00003883	Phase 4	approved	Cc1c(OCC(F)(F)F)ccnc1C[S+]([O-])c1nc2ccccc2[nH]1	A - ALIMENTARY TRACT AND METABOLISM | A - ALIMENTARY TRACT AND METABOLISM
beta-lapachone	CIDs00003885	Phase 2	unapproved	CC1(C)CCC2=C(O1)c1ccccc1C(=O)C2=O	
leflunomide	CIDs00003899	Phase 4	approved	Cc1oncc1C(=O)Nc1ccc(C(F)(F)F)cc1	L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
lidoflazine	CIDs00003926	Phase 4	approved	Cc1cccc(C)c1NC(=O)CN1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1	C - CARDIOVASCULAR SYSTEM
lofepramine	CIDs00003947	Phase 4	approved	CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1	N - NERVOUS SYSTEM
lomefloxacin	CIDs00003948	Phase 4	approved	CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNC(C)C3)c(F)c21	J - ANTIINFECTIVES FOR SYSTEMIC USE | S - SENSORY ORGANS
loperamide	CIDs00003954	Phase 4	approved	CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1	A - ALIMENTARY TRACT AND METABOLISM | A - ALIMENTARY TRACT AND METABOLISM
loratadine	CIDs00003957	Phase 4	approved	CCOC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC1	R - RESPIRATORY SYSTEM
lorazepam	CIDs00003958	Phase 4	approved	O=C1Nc2ccc(Cl)cc2C(c2ccccc2Cl)=NC1O	N - NERVOUS SYSTEM | N - NERVOUS SYSTEM
losartan	CIDs00003961	Phase 4	approved	CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1	C - CARDIOVASCULAR SYSTEM
loxapine	CIDs00003964	Phase 4	approved	CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1	N - NERVOUS SYSTEM
loxoprofen	CIDs00003965	Phase 3	unapproved	CC(C(=O)O)c1ccc(CC2CCCC2=O)cc1	
mafenide acetate	CIDs00003998	Phase 4	approved	NCc1ccc(S(N)(=O)=O)cc1	D - DERMATOLOGICALS
malathion	CIDs00004004	Phase 4	approved	CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC	P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
manidipine	CIDs00004008	Phase 3	unapproved	COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN2CCN(C(c3ccccc3)c3ccccc3)CC2)C1c1cccc([N+](=O)[O-])c1	C - CARDIOVASCULAR SYSTEM
maprotiline	CIDs00004011	Phase 4	approved	CNCCCC12CCC(c3ccccc31)c1ccccc12	N - NERVOUS SYSTEM
mazindol	CIDs00004020	Phase 4	approved	OC1(c2ccc(Cl)cc2)c2ccccc2C2=NCCN21	A - ALIMENTARY TRACT AND METABOLISM
edaravone	CIDs00004021	Phase 4	approved	CC1=NN(c2ccccc2)C(=O)C1	N - NERVOUS SYSTEM
mebendazole	CIDs00004030	Phase 4	approved	COC(=O)Nc1nc2ccc(C(=O)c3ccccc3)cc2[nH]1	P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS | P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
mebeverine	CIDs00004031	Phase 4	approved	CCN(CCCCOC(=O)c1ccc(OC)c(OC)c1)C(C)Cc1ccc(OC)cc1	A - ALIMENTARY TRACT AND METABOLISM
mecamylamine	CIDs00004032	Phase 4	approved	CNC1(C)C2CCC(C2)C1(C)C	C - CARDIOVASCULAR SYSTEM
meclizine	CIDs00004034	Phase 4	approved	Cc1cccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)c1	R - RESPIRATORY SYSTEM | R - RESPIRATORY SYSTEM
meclofenamate	CIDs00004036	Phase 4	approved	Cc1ccc(Cl)c(Nc2ccccc2C(=O)O)c1Cl	M - MUSCULO-SKELETAL SYSTEM | M - MUSCULO-SKELETAL SYSTEM
medazepam	CIDs00004041	Phase 4	approved	CN1CCN=C(c2ccccc2)c2cc(Cl)ccc21	N - NERVOUS SYSTEM
mefenamic acid	CIDs00004044	Phase 4	approved	Cc1cccc(Nc2ccccc2C(=O)O)c1C	M - MUSCULO-SKELETAL SYSTEM
Suton	CIDs00004046	Phase 4	approved	OC(c1cc(C(F)(F)F)nc2c(C(F)(F)F)cccc12)C1CCCCN1	P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
meloxicam	CIDs00004051	Phase 4	approved	Cc1cnc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)s1	M - MUSCULO-SKELETAL SYSTEM | M - MUSCULO-SKELETAL SYSTEM
memantine	CIDs00004054	Phase 4	approved	CC12CC3CC(C)(C1)CC(N)(C3)C2	N - NERVOUS SYSTEM
menadione	CIDs00004055	Phase 4	approved	CC1=CC(=O)c2ccccc2C1=O	B - BLOOD AND BLOOD FORMING ORGANS
mepenzolate	CIDs00004057	Phase 4	approved	C[N+]1(C)CCCC(OC(=O)C(O)(c2ccccc2)c2ccccc2)C1	A - ALIMENTARY TRACT AND METABOLISM
meperidine	CIDs00004058	Phase 4	approved	CCOC(=O)C1(c2ccccc2)CCN(C)CC1	N - NERVOUS SYSTEM | N - NERVOUS SYSTEM | N - NERVOUS SYSTEM
mephenytoin	CIDs00004060	Phase 4	approved	CCC1(c2ccccc2)NC(=O)N(C)C1=O	N - NERVOUS SYSTEM | N - NERVOUS SYSTEM
mepivacaine	CIDs00004062	Phase 4	approved	Cc1cccc(C)c1NC(=O)C1CCCCN1C	N - NERVOUS SYSTEM | N - NERVOUS SYSTEM
meprobamate	CIDs00004064	Phase 4	approved	CCCC(C)(COC(N)=O)COC(N)=O	N - NERVOUS SYSTEM | N - NERVOUS SYSTEM | N - NERVOUS SYSTEM
mequitazine	CIDs00004066	Phase 4	approved	c1ccc2c(c1)Sc1ccccc1N2CC1CN2CCC1CC2	R - RESPIRATORY SYSTEM
mesalazine	CIDs00004075	Phase 4	approved	Nc1ccc(O)c(C(=O)O)c1	A - ALIMENTARY TRACT AND METABOLISM
mesoridazine	CIDs00004078	Phase 4	approved	CN1CCCCC1CCN1c2ccccc2Sc2ccc([S+](C)[O-])cc21	N - NERVOUS SYSTEM
metaproterenol	CIDs00004086	Phase 4	approved	CC(C)NCC(O)c1cc(O)cc(O)c1	R - RESPIRATORY SYSTEM | R - RESPIRATORY SYSTEM
metformin	CIDs00004091	Phase 4	approved	CN(C)C(=N)NC(=N)N	A - ALIMENTARY TRACT AND METABOLISM
methadone	CIDs00004095	Phase 4	approved	CCC(=O)C(CC(C)N(C)C)(c1ccccc1)c1ccccc1	N - NERVOUS SYSTEM | N - NERVOUS SYSTEM
banthine	CIDs00004097	Phase 4	approved	CC[N+](C)(CC)CCOC(=O)C1c2ccccc2Oc2ccccc21	A - ALIMENTARY TRACT AND METABOLISM
histidyl	CIDs00004098	Phase 4	approved	CN(C)CCN(Cc1cccs1)c1ccccn1	R - RESPIRATORY SYSTEM
metharbital	CIDs00004099	Phase 4	approved	CCC1(CC)C(=O)NC(=O)N(C)C1=O	N - NERVOUS SYSTEM
methazolamide	CIDs00004100	Phase 4	approved	CC(=O)/N=c1/sc(S(N)(=O)=O)nn1C	S - SENSORY ORGANS
methocarbamol	CIDs00004107	Phase 4	approved	COc1ccccc1OCC(O)COC(N)=O	M - MUSCULO-SKELETAL SYSTEM | M - MUSCULO-SKELETAL SYSTEM | M - MUSCULO-SKELETAL SYSTEM
8-methoxypsoralen	CIDs00004114	Phase 4	approved	COc1c2occc2cc2ccc(=O)oc12	D - DERMATOLOGICALS | D - DERMATOLOGICALS
methoxyflurane	CIDs00004116	Phase 4	approved	COC(F)(F)C(Cl)Cl	N - NERVOUS SYSTEM
methyclothiazide	CIDs00004121	Phase 4	approved	CN1C(CCl)Nc2cc(Cl)c(S(N)(=O)=O)cc2S1(=O)=O	C - CARDIOVASCULAR SYSTEM
HEET	CIDs00004133	Phase 4	approved	COC(=O)c1ccccc1O	
methyldopa	CIDs00004138	Phase 1	unapproved	CC(N)(Cc1ccc(O)c(O)c1)C(=O)O	C - CARDIOVASCULAR SYSTEM
methylene blue	CIDs00004139	Phase 4	approved	CN(C)c1ccc2nc3ccc(=[N+](C)C)cc-3sc2c1	
methylphenidate	CIDs00004158	Phase 4	approved	COC(=O)C(c1ccccc1)C1CCCCN1	N - NERVOUS SYSTEM
methyprylon	CIDs00004162	Phase 4	approved	CCC1(CC)C(=O)NCC(C)C1=O	N - NERVOUS SYSTEM
tREST	CIDs00004167	Phase 4	approved	CN1CCCC(CC2c3ccccc3Sc3ccccc32)C1	N - NERVOUS SYSTEM
metoclopramide	CIDs00004168	Phase 4	approved	CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC	A - ALIMENTARY TRACT AND METABOLISM
metolazone	CIDs00004170	Phase 4	approved	Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C	C - CARDIOVASCULAR SYSTEM
metoprolol	CIDs00004171	Phase 4	approved	COCCc1ccc(OCC(O)CNC(C)C)cc1	C - CARDIOVASCULAR SYSTEM
metronidazole	CIDs00004173	Phase 4	approved	Cc1ncc([N+](=O)[O-])n1CCO	D - DERMATOLOGICALS | P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS | G - GENITO URINARY SYSTEM AND SEX HORMONES | A - ALIMENTARY TRACT AND METABOLISM | P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS | J - ANTIINFECTIVES FOR SYSTEMIC USE
metyrapone	CIDs00004174	Phase 4	approved	CC(C)(C(=O)c1cccnc1)c1cccnc1	V - VARIOUS
mexiletine	CIDs00004178	Phase 4	approved	Cc1cccc(C)c1OCC(C)N	C - CARDIOVASCULAR SYSTEM
mianserin	CIDs00004184	Phase 4	approved	CN1CCN2c3ccccc3Cc3ccccc3C2C1	N - NERVOUS SYSTEM
miconazole	CIDs00004189	Phase 4	approved	Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1	G - GENITO URINARY SYSTEM AND SEX HORMONES | S - SENSORY ORGANS | J - ANTIINFECTIVES FOR SYSTEMIC USE | A - ALIMENTARY TRACT AND METABOLISM | D - DERMATOLOGICALS | A - ALIMENTARY TRACT AND METABOLISM | D - DERMATOLOGICALS
midazolam	CIDs00004192	Phase 4	approved	Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2	N - NERVOUS SYSTEM
midodrine	CIDs00004195	Phase 4	approved	COc1ccc(OC)c(C(O)CNC(=O)CN)c1	C - CARDIOVASCULAR SYSTEM
milrinone	CIDs00004197	Phase 4	approved	Cc1[nH]c(=O)c(C#N)cc1-c1ccncc1	C - CARDIOVASCULAR SYSTEM
minaprine	CIDs00004199	Phase 4	approved	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	N - NERVOUS SYSTEM
minoxidil	CIDs00004201	Phase 4	approved	Nc1cc(N2CCCCC2)nc(N)[n+]1[O-]	C - CARDIOVASCULAR SYSTEM | D - DERMATOLOGICALS
mirtazapine	CIDs00004205	Phase 4	approved	CN1CCN2c3ncccc3Cc3ccccc3C2C1	N - NERVOUS SYSTEM
moclobemide	CIDs00004235	Phase 4	approved	O=C(NCCN1CCOCC1)c1ccc(Cl)cc1	N - NERVOUS SYSTEM
modafinil	CIDs00004236	Phase 4	approved	NC(=O)C[S+]([O-])C(c1ccccc1)c1ccccc1	N - NERVOUS SYSTEM
muscimol	CIDs00004266	Phase 1	unapproved	NCc1cc(O)no1	
DETA	CIDs00004284	Phase 4	approved	CCN(CC)C(=O)c1cccc(C)c1	P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
diphenylamine-2-carboxylate	CIDs00004386	Phase 1	unapproved	O=C(O)c1ccccc1Nc1ccccc1	
nabumetone	CIDs00004409	Phase 4	approved	COc1ccc2cc(CCC(C)=O)ccc2c1	M - MUSCULO-SKELETAL SYSTEM
nafamostat mesilate	CIDs00004413	Phase 3	unapproved	N=C(N)Nc1ccc(C(=O)Oc2ccc3cc(C(=N)N)ccc3c2)cc1	
naftopidil	CIDs00004418	Phase 3	unapproved	COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1	
nalidixic acid	CIDs00004421	Phase 4	approved	CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21	J - ANTIINFECTIVES FOR SYSTEMIC USE
all clear	CIDs00004436	Phase 4	approved	c1ccc2c(CC3=NCCN3)cccc2c1	R - RESPIRATORY SYSTEM | S - SENSORY ORGANS | S - SENSORY ORGANS | R - RESPIRATORY SYSTEM
naratriptan	CIDs00004440	Phase 4	approved	CNS(=O)(=O)CCc1ccc2[nH]cc(C3CCN(C)CC3)c2c1	N - NERVOUS SYSTEM
nefazodone	CIDs00004449	Phase 4	approved	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1	N - NERVOUS SYSTEM
neostigmine	CIDs00004456	Phase 4	approved	CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1	S - SENSORY ORGANS | N - NERVOUS SYSTEM | N - NERVOUS SYSTEM
nevirapine	CIDs00004463	Phase 4	approved	Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1	J - ANTIINFECTIVES FOR SYSTEMIC USE
nialamide	CIDs00004472	Phase 4	approved	O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1	N - NERVOUS SYSTEM
nicardipine	CIDs00004473	Phase 4	approved	COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1	C - CARDIOVASCULAR SYSTEM
niclosamide	CIDs00004477	Phase 4	approved	O=C(Nc1ccc([N+](=O)[O-])cc1Cl)c1cc(Cl)ccc1O	P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
nifedipine	CIDs00004485	Phase 4	approved	COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1[N+](=O)[O-]	C - CARDIOVASCULAR SYSTEM | C - CARDIOVASCULAR SYSTEM
nilvadipine	CIDs00004494	Phase 3	unapproved	COC(=O)C1=C(C#N)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1	C - CARDIOVASCULAR SYSTEM
nimesulide	CIDs00004495	Phase 4	approved	CS(=O)(=O)Nc1ccc([N+](=O)[O-])cc1Oc1ccccc1	M - MUSCULO-SKELETAL SYSTEM | M - MUSCULO-SKELETAL SYSTEM
nimodipine	CIDs00004497	Phase 4	approved	COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1	C - CARDIOVASCULAR SYSTEM
nisoldipine	CIDs00004499	Phase 4	approved	COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1c1ccccc1[N+](=O)[O-]	C - CARDIOVASCULAR SYSTEM
nitrazepam	CIDs00004506	Phase 4	approved	O=C1CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc2N1	N - NERVOUS SYSTEM
nitrendipine	CIDs00004507	Phase 4	approved	CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc([N+](=O)[O-])c1	C - CARDIOVASCULAR SYSTEM
glyceryl trinitrate	CIDs00004510	Phase 4	approved	O=[N+]([O-])OCC(CO[N+](=O)[O-])O[N+](=O)[O-]	C - CARDIOVASCULAR SYSTEM | C - CARDIOVASCULAR SYSTEM | C - CARDIOVASCULAR SYSTEM
nomifensine	CIDs00004528	Phase 4	approved	CN1Cc2c(N)cccc2C(c2ccccc2)C1	N - NERVOUS SYSTEM
norfloxacin	CIDs00004539	Phase 4	approved	CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21	J - ANTIINFECTIVES FOR SYSTEMIC USE | S - SENSORY ORGANS
nortriptyline	CIDs00004543	Phase 4	approved	CNCCC=C1c2ccccc2CCc2ccccc21	N - NERVOUS SYSTEM
O(6)-benzylguanine	CIDs00004578	Phase 3	unapproved	Nc1nc(OCc2ccccc2)c2nc[nH]c2n1	
ofloxacin	CIDs00004583	Phase 4	approved	CC1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23	J - ANTIINFECTIVES FOR SYSTEMIC USE | S - SENSORY ORGANS | S - SENSORY ORGANS
olanzapine	CIDs00004585	Phase 4	approved	Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1	N - NERVOUS SYSTEM
omeprazole	CIDs00004594	Phase 4	approved	COc1ccc2[nH]c([S+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1	A - ALIMENTARY TRACT AND METABOLISM
ondansetron	CIDs00004595	Phase 4	approved	Cc1nccn1CC1CCc2c(c3ccccc3n2C)C1=O	A - ALIMENTARY TRACT AND METABOLISM
orphenadrine	CIDs00004601	Phase 4	approved	Cc1ccccc1C(OCCN(C)C)c1ccccc1	M - MUSCULO-SKELETAL SYSTEM
potassium oxonate	CIDs00004604	Phase 3	unapproved	O=C(O)c1nc(=O)[nH]c(=O)[nH]1	
oxaprozin	CIDs00004614	Phase 4	approved	O=C(O)CCc1nc(-c2ccccc2)c(-c2ccccc2)o1	M - MUSCULO-SKELETAL SYSTEM
oxatomide	CIDs00004615	Phase 4	approved	O=c1[nH]c2ccccc2n1CCCN1CCN(C(c2ccccc2)c2ccccc2)CC1	R - RESPIRATORY SYSTEM
oxazepam	CIDs00004616	Phase 4	approved	O=C1Nc2ccc(Cl)cc2C(c2ccccc2)=NC1O	N - NERVOUS SYSTEM
oxprenolol	CIDs00004631	Phase 4	approved	C=CCOc1ccccc1OCC(O)CNC(C)C	C - CARDIOVASCULAR SYSTEM
benzophenone-3	CIDs00004632	Phase 4	approved	COc1ccc(C(=O)c2ccccc2)c(O)c1	
oxybuprocaine	CIDs00004633	Phase 4	approved	CCCCOc1cc(C(=O)OCCN(CC)CC)ccc1N	D - DERMATOLOGICALS | S - SENSORY ORGANS
oxybutynin	CIDs00004634	Phase 4	approved	CCN(CC)CC#CCOC(=O)C(O)(c1ccccc1)C1CCCCC1	G - GENITO URINARY SYSTEM AND SEX HORMONES
oxymetazoline	CIDs00004636	Phase 4	approved	Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1	R - RESPIRATORY SYSTEM | S - SENSORY ORGANS | R - RESPIRATORY SYSTEM
oxyphenbutazone	CIDs00004641	Phase 4	approved	CCCCC1C(=O)N(c2ccccc2)N(c2ccc(O)cc2)C1=O	
oxyphencyclimine	CIDs00004642	Phase 4	approved	CN1CCCN=C1COC(=O)C(O)(c1ccccc1)C1CCCCC1	A - ALIMENTARY TRACT AND METABOLISM
oxypurinol	CIDs00004644	Phase 4	approved	O=c1[nH]c(=O)c2c[nH]nc2[nH]1	
APAs	CIDs00004649	Phase 4	approved	Nc1ccc(C(=O)O)c(O)c1	J - ANTIINFECTIVES FOR SYSTEMIC USE
palmitoylethanolamide	CIDs00004671	Phase 2	unapproved	CCCCCCCCCCCCCCCC(=O)NCCO	
pamidronate	CIDs00004673	Phase 4	approved	NCCC(O)(P(=O)(O)O)P(=O)(O)O	M - MUSCULO-SKELETAL SYSTEM
pantoprazole	CIDs00004679	Phase 4	approved	COc1ccnc(C[S+]([O-])c2nc3cc(OC(F)F)ccc3[nH]2)c1OC	A - ALIMENTARY TRACT AND METABOLISM
papaverine	CIDs00004680	Phase 4	approved	COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC	G - GENITO URINARY SYSTEM AND SEX HORMONES | G - GENITO URINARY SYSTEM AND SEX HORMONES | A - ALIMENTARY TRACT AND METABOLISM
pargyline	CIDs00004688	Phase 4	approved	C#CCN(C)Cc1ccccc1	C - CARDIOVASCULAR SYSTEM
pemoline	CIDs00004723	Phase 4	approved	NC1=NC(=O)C(c2ccccc2)O1	N - NERVOUS SYSTEM
pentamidine	CIDs00004735	Phase 4	approved	N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1	
dl-pentazocine	CIDs00004736	Phase 4	approved	CC(C)=CCN1CCC2(C)c3cc(O)ccc3CC1C2C	N - NERVOUS SYSTEM
pentobarbital	CIDs00004737	Phase 4	approved	CCCC(C)C1(CC)C(=O)NC(=O)NC1=O	N - NERVOUS SYSTEM
pentoxifylline	CIDs00004740	Phase 4	approved	CC(=O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O	C - CARDIOVASCULAR SYSTEM
perazine	CIDs00004744	Phase 3	unapproved	CN1CCN(CCCN2c3ccccc3Sc3ccccc32)CC1	N - NERVOUS SYSTEM
perhexiline	CIDs00004746	Phase 4	approved	C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1	C - CARDIOVASCULAR SYSTEM
propericiazine	CIDs00004747	Phase 4	approved	N#Cc1ccc2c(c1)N(CCCN1CCC(O)CC1)c1ccccc1S2	N - NERVOUS SYSTEM
perphenazine	CIDs00004748	Phase 4	approved	OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1	N - NERVOUS SYSTEM
phenacemide	CIDs00004753	Phase 4	approved	NC(=O)NC(=O)Cc1ccccc1	N - NERVOUS SYSTEM
phenacetin	CIDs00004754	Phase 4	approved	CCOc1ccc(NC(C)=O)cc1	N - NERVOUS SYSTEM | N - NERVOUS SYSTEM | N - NERVOUS SYSTEM
phenazopyridine	CIDs00004756	Phase 4	approved	Nc1ccc(/N=N/c2ccccc2)c(N)n1	G - GENITO URINARY SYSTEM AND SEX HORMONES
phenindione	CIDs00004760	Phase 4	approved	O=C1c2ccccc2C(=O)C1c1ccccc1	B - BLOOD AND BLOOD FORMING ORGANS
pheniramine	CIDs00004761	Phase 4	approved	CN(C)CCC(c1ccccc1)c1ccccn1	D - DERMATOLOGICALS | R - RESPIRATORY SYSTEM
phenmetrazine	CIDs00004762	Phase 4	approved	CC1NCCOC1c1ccccc1	
phenobarbital	CIDs00004763	Phase 4	approved	CCC1(c2ccccc2)C(=O)NC(=O)NC1=O	N - NERVOUS SYSTEM
phenolphthalein	CIDs00004764	Phase 4	approved	O=C1OC(c2ccc(O)cc2)(c2ccc(O)cc2)c2ccccc21	A - ALIMENTARY TRACT AND METABOLISM
phenoxybenzamine	CIDs00004768	Phase 4	approved	CC(COc1ccccc1)N(CCCl)Cc1ccccc1	C - CARDIOVASCULAR SYSTEM
phentermine	CIDs00004771	Phase 4	approved	CC(C)(N)Cc1ccccc1	A - ALIMENTARY TRACT AND METABOLISM
4-phenylbutyrate	CIDs00004775	Phase 4	approved	O=C(O)CCCc1ccccc1	
phenylbutazone	CIDs00004781	Phase 4	approved	CCCCC1C(=O)N(c2ccccc2)N(c2ccccc2)C1=O	M - MUSCULO-SKELETAL SYSTEM | M - MUSCULO-SKELETAL SYSTEM
moxonidine	CIDs00004810	Phase 4	approved	COc1nc(C)nc(Cl)c1NC1=NCCN1	C - CARDIOVASCULAR SYSTEM
picotamide	CIDs00004814	Phase 4	approved	COc1ccc(C(=O)NCc2cccnc2)cc1C(=O)NCc1cccnc1	B - BLOOD AND BLOOD FORMING ORGANS
pinacidil	CIDs00004826	Phase 4	approved	CC(N/C(=N\C#N)Nc1ccncc1)C(C)(C)C	
pindolol	CIDs00004828	Phase 4	approved	CC(C)NCC(O)COc1cccc2[nH]ccc12	C - CARDIOVASCULAR SYSTEM
pioglitazone	CIDs00004829	Phase 4	approved	CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1	A - ALIMENTARY TRACT AND METABOLISM
pipamperone	CIDs00004830	Phase 3	unapproved	NC(=O)C1(N2CCCCC2)CCN(CCCC(=O)c2ccc(F)cc2)CC1	N - NERVOUS SYSTEM
pipemidic acid	CIDs00004831	Phase 4	approved	CCn1cc(C(=O)O)c(=O)c2cnc(N3CCNCC3)nc21	J - ANTIINFECTIVES FOR SYSTEMIC USE
piperazine	CIDs00004837	Phase 4	approved	C1CNCCN1	P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
Dactil	CIDs00004839	Phase 4	approved	CCN1CCCC(OC(=O)C(c2ccccc2)c2ccccc2)C1	A - ALIMENTARY TRACT AND METABOLISM
pirbuterol	CIDs00004845	Phase 4	approved	CC(C)(C)NCC(O)c1ccc(O)c(CO)n1	R - RESPIRATORY SYSTEM | R - RESPIRATORY SYSTEM
pirenzepine	CIDs00004848	Phase 4	approved	CN1CCN(CC(=O)N2c3ccccc3C(=O)Nc3cccnc32)CC1	A - ALIMENTARY TRACT AND METABOLISM
piretanide	CIDs00004849	Phase 4	approved	NS(=O)(=O)c1cc(C(=O)O)cc(N2CCCC2)c1Oc1ccccc1	C - CARDIOVASCULAR SYSTEM
piribedil	CIDs00004850	Phase 4	approved	c1cnc(N2CCN(Cc3ccc4c(c3)OCO4)CC2)nc1	N - NERVOUS SYSTEM
polythiazide	CIDs00004870	Phase 4	approved	CN1C(CSCC(F)(F)F)Nc2cc(Cl)c(S(N)(=O)=O)cc2S1(=O)=O	C - CARDIOVASCULAR SYSTEM
potassium chloride	CIDs00004873	Phase 4	approved	[Cl-].[K+]	A - ALIMENTARY TRACT AND METABOLISM | A - ALIMENTARY TRACT AND METABOLISM | B - BLOOD AND BLOOD FORMING ORGANS
practolol	CIDs00004883	Phase 4	approved	CC(=O)Nc1ccc(OCC(O)CNC(C)C)cc1	C - CARDIOVASCULAR SYSTEM
pranlukast	CIDs00004887	Phase 3	unapproved	O=C(Nc1cccc2c(=O)cc(-c3nn[nH]n3)oc12)c1ccc(OCCCCc2ccccc2)cc1	R - RESPIRATORY SYSTEM
prazepam	CIDs00004890	Phase 4	approved	O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1CC1CC1	N - NERVOUS SYSTEM
prazosin	CIDs00004893	Phase 4	approved	COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC	C - CARDIOVASCULAR SYSTEM
prilocaine	CIDs00004906	Phase 4	approved	CCCNC(C)C(=O)Nc1ccccc1C	N - NERVOUS SYSTEM | N - NERVOUS SYSTEM
primaquine	CIDs00004908	Phase 4	approved	COc1cc(NC(C)CCCN)c2ncccc2c1	P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
primidone	CIDs00004909	Phase 4	approved	CCC1(c2ccccc2)C(=O)NCNC1=O	N - NERVOUS SYSTEM
probenecid	CIDs00004911	Phase 4	approved	CCCN(CCC)S(=O)(=O)c1ccc(C(=O)O)cc1	M - MUSCULO-SKELETAL SYSTEM
probucol	CIDs00004912	Phase 4	approved	CC(C)(Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1	C - CARDIOVASCULAR SYSTEM
procainamide	CIDs00004913	Phase 4	approved	CCN(CC)CCNC(=O)c1ccc(N)cc1	C - CARDIOVASCULAR SYSTEM
procaine	CIDs00004914	Phase 4	approved	CCN(CC)CCOC(=O)c1ccc(N)cc1	N - NERVOUS SYSTEM | N - NERVOUS SYSTEM | S - SENSORY ORGANS | C - CARDIOVASCULAR SYSTEM
procaterol	CIDs00004916	Phase 3	unapproved	CCC(NC(C)C)C(O)c1ccc(O)c2[nH]c(=O)ccc12	R - RESPIRATORY SYSTEM | R - RESPIRATORY SYSTEM
prochlorperazine	CIDs00004917	Phase 4	approved	CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1	N - NERVOUS SYSTEM
procyclidine	CIDs00004919	Phase 4	approved	OC(CCN1CCCC1)(c1ccccc1)C1CCCCC1	N - NERVOUS SYSTEM
proglumide	CIDs00004922	Phase 4	approved	CCCN(CCC)C(=O)C(CCC(=O)O)NC(=O)c1ccccc1	A - ALIMENTARY TRACT AND METABOLISM
promazine	CIDs00004926	Phase 4	approved	CN(C)CCCN1c2ccccc2Sc2ccccc21	N - NERVOUS SYSTEM
promethazine	CIDs00004927	Phase 4	approved	CC(CN1c2ccccc2Sc2ccccc21)N(C)C	R - RESPIRATORY SYSTEM | D - DERMATOLOGICALS | R - RESPIRATORY SYSTEM
propafenone	CIDs00004932	Phase 4	approved	CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1	C - CARDIOVASCULAR SYSTEM
propantheline	CIDs00004934	Phase 4	approved	CC(C)[N+](C)(CCOC(=O)C1c2ccccc2Oc2ccccc21)C(C)C	A - ALIMENTARY TRACT AND METABOLISM
proparacaine	CIDs00004935	Phase 4	approved	CCCOc1ccc(C(=O)OCCN(CC)CC)cc1N	S - SENSORY ORGANS
propiomazine	CIDs00004940	Phase 4	approved	CCC(=O)c1ccc2c(c1)N(CC(C)N(C)C)c1ccccc1S2	N - NERVOUS SYSTEM
propofol	CIDs00004943	Phase 4	approved	CC(C)c1cccc(C(C)C)c1O	N - NERVOUS SYSTEM
propranolol	CIDs00004946	Phase 4	approved	CC(C)NCC(O)COc1cccc2ccccc12	C - CARDIOVASCULAR SYSTEM
propyl ester	CIDs00004947	Phase 1	unapproved	CCCOC(=O)c1cc(O)c(O)c(O)c1	
protriptyline	CIDs00004976	Phase 4	approved	CNCCCC1c2ccccc2C=Cc2ccccc21	N - NERVOUS SYSTEM
pyridostigmine	CIDs00004991	Phase 4	approved	CN(C)C(=O)Oc1ccc[n+](C)c1	N - NERVOUS SYSTEM
mepyramine	CIDs00004992	Phase 4	approved	COc1ccc(CN(CCN(C)C)c2ccccn2)cc1	R - RESPIRATORY SYSTEM | D - DERMATOLOGICALS
pyrimethamine	CIDs00004993	Phase 4	approved	CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1	P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS | P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
pyroxamide	CIDs00004996	Phase 1	unapproved	O=C(CCCCCCC(=O)Nc1cccnc1)NO	
quazepam	CIDs00004999	Phase 4	approved	Fc1ccccc1C1=NCC(=S)N(CC(F)(F)F)c2ccc(Cl)cc21	N - NERVOUS SYSTEM
quetiapine	CIDs00005002	Phase 4	approved	OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1	N - NERVOUS SYSTEM
rabeprazole	CIDs00005029	Phase 4	approved	COCCCOc1ccnc(C[S+]([O-])c2nc3ccccc3[nH]2)c1C	A - ALIMENTARY TRACT AND METABOLISM | A - ALIMENTARY TRACT AND METABOLISM
raloxifene	CIDs00005035	Phase 4	approved	O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12	G - GENITO URINARY SYSTEM AND SEX HORMONES
rebamipide	CIDs00005042	Phase 3	unapproved	O=C(NC(Cc1cc(=O)[nH]c2ccccc12)C(=O)O)c1ccc(Cl)cc1	A - ALIMENTARY TRACT AND METABOLISM
resorcinol	CIDs00005054	Phase 4	approved	Oc1cccc(O)c1	S - SENSORY ORGANS | D - DERMATOLOGICALS
riluzole	CIDs00005070	Phase 4	approved	Nc1nc2ccc(OC(F)(F)F)cc2s1	N - NERVOUS SYSTEM
risperidone	CIDs00005073	Phase 4	approved	Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2	N - NERVOUS SYSTEM
ritanserin	CIDs00005074	Phase 2	unapproved	Cc1nc2sccn2c(=O)c1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1	
rizatriptan	CIDs00005078	Phase 4	approved	CN(C)CCc1c[nH]c2ccc(Cn3cncn3)cc12	N - NERVOUS SYSTEM
rofecoxib	CIDs00005090	Phase 4	approved	CS(=O)(=O)c1ccc(C2=C(c3ccccc3)C(=O)OC2)cc1	M - MUSCULO-SKELETAL SYSTEM
rolipram	CIDs00005092	Phase 2	unapproved	COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1	
ropinirole	CIDs00005095	Phase 4	approved	CCCN(CCC)CCc1cccc2c1CC(=O)N2	N - NERVOUS SYSTEM
saccharin	CIDs00005143	Phase 3	unapproved	O=C1NS(=O)(=O)c2ccccc21	
salmeterol	CIDs00005152	Phase 4	approved	OCc1cc(C(O)CNCCCCCCOCCCCc2ccccc2)ccc1O	R - RESPIRATORY SYSTEM
sarpogrelate	CIDs00005160	Phase 3	unapproved	COc1cccc(CCc2ccccc2OCC(CN(C)C)OC(=O)CCC(=O)O)c1	
salsalate	CIDs00005161	Phase 4	approved	O=C(Oc1ccccc1C(=O)O)c1ccccc1O	N - NERVOUS SYSTEM
secobarbital	CIDs00005193	Phase 4	approved	C=CCC1(C(C)CCC)C(=O)NC(=O)NC1=O	N - NERVOUS SYSTEM
serotonine	CIDs00005202	Phase 3	unapproved	NCCc1c[nH]c2ccc(O)cc12	
sevoflurane	CIDs00005206	Phase 4	approved	FCOC(C(F)(F)F)C(F)(F)F	N - NERVOUS SYSTEM
sibutramine	CIDs00005210	Phase 4	approved	CC(C)CC(N(C)C)C1(c2ccc(Cl)cc2)CCC1	A - ALIMENTARY TRACT AND METABOLISM
sildenafil	CIDs00005212	Phase 4	approved	CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12	G - GENITO URINARY SYSTEM AND SEX HORMONES
sulfadiazine	CIDs00005215	Phase 4	approved	Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1	J - ANTIINFECTIVES FOR SYSTEMIC USE
NaCl	CIDs00005234	Phase 4	approved	[Cl-].[Na+]	A - ALIMENTARY TRACT AND METABOLISM | S - SENSORY ORGANS | B - BLOOD AND BLOOD FORMING ORGANS | B - BLOOD AND BLOOD FORMING ORGANS
sodium fluoride	CIDs00005235	Phase 4	approved	[F-].[Na+]	A - ALIMENTARY TRACT AND METABOLISM | A - ALIMENTARY TRACT AND METABOLISM | A - ALIMENTARY TRACT AND METABOLISM
risedronate	CIDs00005245	Phase 4	approved	O=P(O)(O)C(O)(Cc1cccnc1)P(=O)(O)O	M - MUSCULO-SKELETAL SYSTEM
sotalol	CIDs00005253	Phase 4	approved	CC(C)NCC(O)c1ccc(NS(C)(=O)=O)cc1	C - CARDIOVASCULAR SYSTEM
stearic acid	CIDs00005281	Phase 1	unapproved	CCCCCCCCCCCCCCCCCC(=O)[O-].CCCCCCCCCCCCCCCCCC(=O)[O-].[Mg+2]	
suxamethonium	CIDs00005314	Phase 4	approved	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C	M - MUSCULO-SKELETAL SYSTEM
sulfabenzamide	CIDs00005319	Phase 4	approved	Nc1ccc(S(=O)(=O)NC(=O)c2ccccc2)cc1	
sulfacetamide	CIDs00005320	Phase 4	approved	CC(=O)NS(=O)(=O)c1ccc(N)cc1	S - SENSORY ORGANS | D - DERMATOLOGICALS
sulfamethazine	CIDs00005327	Phase 4	approved	Cc1cc(C)nc(NS(=O)(=O)c2ccc(N)cc2)n1	J - ANTIINFECTIVES FOR SYSTEMIC USE
sulfamethoxazole	CIDs00005329	Phase 4	approved	Cc1cc(NS(=O)(=O)c2ccc(N)cc2)no1	J - ANTIINFECTIVES FOR SYSTEMIC USE
sulfonamide	CIDs00005333	Phase 4	approved	Nc1ccc(S(N)(=O)=O)cc1	D - DERMATOLOGICALS | J - ANTIINFECTIVES FOR SYSTEMIC USE
sulfaphenazole	CIDs00005335	Phase 4	approved	Nc1ccc(S(=O)(=O)Nc2ccnn2-c2ccccc2)cc1	J - ANTIINFECTIVES FOR SYSTEMIC USE | S - SENSORY ORGANS
sulfapyridine	CIDs00005336	Phase 4	approved	Nc1ccc(S(=O)(=O)Nc2ccccn2)cc1	J - ANTIINFECTIVES FOR SYSTEMIC USE
sulfathiazole	CIDs00005340	Phase 4	approved	Nc1ccc(S(=O)(=O)Nc2nccs2)cc1	D - DERMATOLOGICALS | J - ANTIINFECTIVES FOR SYSTEMIC USE
sulfinpyrazone	CIDs00005342	Phase 4	approved	O=C1C(CC[S+]([O-])c2ccccc2)C(=O)N(c2ccccc2)N1c1ccccc1	M - MUSCULO-SKELETAL SYSTEM
sulfisoxazole	CIDs00005344	Phase 4	approved	Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C	J - ANTIINFECTIVES FOR SYSTEMIC USE | S - SENSORY ORGANS
sulforaphane	CIDs00005350	Phase 3	unapproved	C[S+]([O-])CCCCN=C=S	
Diamidin	CIDs00005351	Phase 4	approved	O=S(O)CNc1ccc(S(=O)(=O)c2ccc(NCS(=O)O)cc2)cc1	
sulpiride	CIDs00005355	Phase 4	approved	CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC	N - NERVOUS SYSTEM
sulthiame	CIDs00005356	Phase 4	approved	NS(=O)(=O)c1ccc(N2CCCCS2(=O)=O)cc1	N - NERVOUS SYSTEM
sumatriptan	CIDs00005358	Phase 4	approved	CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1	N - NERVOUS SYSTEM
suprofen	CIDs00005359	Phase 4	approved	CC(C(=O)O)c1ccc(C(=O)c2cccs2)cc1	M - MUSCULO-SKELETAL SYSTEM
gatifloxacin	CIDs00005379	Phase 4	approved	COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12	S - SENSORY ORGANS | J - ANTIINFECTIVES FOR SYSTEMIC USE
tazarotene	CIDs00005381	Phase 4	approved	CCOC(=O)c1ccc(C#Cc2ccc3c(c2)C(C)(C)CCS3)nc1	D - DERMATOLOGICALS
telenzepine	CIDs00005387	Phase 1	unapproved	Cc1scc2c1N(C(=O)CN1CCN(C)CC1)c1ccccc1NC2=O	
temazepam	CIDs00005391	Phase 4	approved	CN1C(=O)C(O)N=C(c2ccccc2)c2cc(Cl)ccc21	N - NERVOUS SYSTEM
terazosin	CIDs00005401	Phase 4	approved	COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC	G - GENITO URINARY SYSTEM AND SEX HORMONES
terbutaline	CIDs00005403	Phase 4	approved	CC(C)(C)NCC(O)c1cc(O)cc(O)c1	R - RESPIRATORY SYSTEM | R - RESPIRATORY SYSTEM | R - RESPIRATORY SYSTEM
terfenadine	CIDs00005405	Phase 4	approved	CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1	R - RESPIRATORY SYSTEM
tetracaine	CIDs00005411	Phase 4	approved	CCCCNc1ccc(C(=O)OCCN(C)C)cc1	C - CARDIOVASCULAR SYSTEM | D - DERMATOLOGICALS | S - SENSORY ORGANS | N - NERVOUS SYSTEM
krypton	CIDs00005416	Phase 4	approved	[Kr]	
YxiN	CIDs00005419	Phase 4	approved	c1ccc2c(c1)CCCC2C1=NCCN1	S - SENSORY ORGANS | R - RESPIRATORY SYSTEM | R - RESPIRATORY SYSTEM | S - SENSORY ORGANS
thalidomide	CIDs00005426	Phase 4	approved	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
theobromine	CIDs00005429	Phase 3	unapproved	Cn1cnc2c1c(=O)[nH]c(=O)n2C	R - RESPIRATORY SYSTEM | C - CARDIOVASCULAR SYSTEM | R - RESPIRATORY SYSTEM
thiabendazole	CIDs00005430	Phase 4	approved	c1ccc2[nH]c(-c3cscn3)nc2c1	D - DERMATOLOGICALS | P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
2, 4-dioxothiazolidin-3-yl	CIDs00005437	Phase 3	unapproved	O=C1CSC(=O)N1	
thiethylperazine	CIDs00005440	Phase 4	approved	CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2	R - RESPIRATORY SYSTEM
thioridazine	CIDs00005452	Phase 4	approved	CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2	N - NERVOUS SYSTEM
tiapride	CIDs00005467	Phase 3	unapproved	CCN(CC)CCNC(=O)c1cc(S(C)(=O)=O)ccc1OC	N - NERVOUS SYSTEM
tiaprofenic acid	CIDs00005468	Phase 4	approved	CC(C(=O)O)c1ccc(C(=O)c2ccccc2)s1	M - MUSCULO-SKELETAL SYSTEM
ticlopidine	CIDs00005472	Phase 4	approved	Clc1ccccc1CN1CCc2sccc2C1	B - BLOOD AND BLOOD FORMING ORGANS
tinidazole	CIDs00005479	Phase 4	approved	CCS(=O)(=O)CCn1c([N+](=O)[O-])cnc1C	P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS | J - ANTIINFECTIVES FOR SYSTEMIC USE
tinoridine	CIDs00005480	Phase 3	unapproved	CCOC(=O)c1c(N)sc2c1CCN(Cc1ccccc1)C2	
tioconazole	CIDs00005482	Phase 4	approved	Clc1ccc(C(Cn2ccnc2)OCc2ccsc2Cl)c(Cl)c1	G - GENITO URINARY SYSTEM AND SEX HORMONES | D - DERMATOLOGICALS
tiopronin	CIDs00005483	Phase 4	approved	CC(S)C(=O)NCC(=O)O	G - GENITO URINARY SYSTEM AND SEX HORMONES
tizanidine	CIDs00005487	Phase 4	approved	Clc1ccc2nsnc2c1NC1=NCCN1	M - MUSCULO-SKELETAL SYSTEM
tolazamide	CIDs00005503	Phase 4	approved	Cc1ccc(S(=O)(=O)NC(=O)NN2CCCCCC2)cc1	A - ALIMENTARY TRACT AND METABOLISM
tolazoline	CIDs00005504	Phase 4	approved	c1ccc(CC2=NCCN2)cc1	M - MUSCULO-SKELETAL SYSTEM | C - CARDIOVASCULAR SYSTEM
tolbutamide	CIDs00005505	Phase 4	approved	CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1	V - VARIOUS | A - ALIMENTARY TRACT AND METABOLISM
tolmetin	CIDs00005508	Phase 4	approved	Cc1ccc(C(=O)c2ccc(CC(=O)O)n2C)cc1	M - MUSCULO-SKELETAL SYSTEM | M - MUSCULO-SKELETAL SYSTEM
tolnaftate	CIDs00005510	Phase 4	approved	Cc1cccc(N(C)C(=S)Oc2ccc3ccccc3c2)c1	D - DERMATOLOGICALS
tolperisone	CIDs00005511	Phase 3	unapproved	Cc1ccc(C(=O)C(C)CN2CCCCC2)cc1	M - MUSCULO-SKELETAL SYSTEM | M - MUSCULO-SKELETAL SYSTEM
tranexamic acid	CIDs00005526	Phase 4	approved	NC[C@H]1CC[C@H](C(=O)O)CC1	B - BLOOD AND BLOOD FORMING ORGANS
trazodone	CIDs00005533	Phase 4	approved	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	N - NERVOUS SYSTEM
triamterene	CIDs00005546	Phase 4	approved	Nc1nc(N)c2nc(-c3ccccc3)c(N)nc2n1	C - CARDIOVASCULAR SYSTEM
triazolam	CIDs00005556	Phase 4	approved	Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1Cl)=NC2	N - NERVOUS SYSTEM
trichlormethiazide	CIDs00005560	Phase 4	approved	NS(=O)(=O)c1cc2c(cc1Cl)NC(C(Cl)Cl)NS2(=O)=O	C - CARDIOVASCULAR SYSTEM
triclosan	CIDs00005564	Phase 4	approved	Oc1cc(Cl)ccc1Oc1ccc(Cl)cc1Cl	D - DERMATOLOGICALS | D - DERMATOLOGICALS
trien	CIDs00005565	Phase 4	approved	NCCNCCNCCN	A - ALIMENTARY TRACT AND METABOLISM
trifluoperazine	CIDs00005566	Phase 4	approved	CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1	N - NERVOUS SYSTEM
trifluperidol	CIDs00005567	Phase 4	approved	O=C(CCCN1CCC(O)(c2cccc(C(F)(F)F)c2)CC1)c1ccc(F)cc1	N - NERVOUS SYSTEM
triflupromazine	CIDs00005568	Phase 4	approved	CN(C)CCCN1c2ccccc2Sc2ccc(C(F)(F)F)cc21	N - NERVOUS SYSTEM
trihexyphenidyl	CIDs00005572	Phase 4	approved	OC(CCN1CCCCC1)(c1ccccc1)C1CCCCC1	N - NERVOUS SYSTEM
trimebutine	CIDs00005573	Phase 3	unapproved	CCC(COC(=O)c1cc(OC)c(OC)c(OC)c1)(c1ccccc1)N(C)C	A - ALIMENTARY TRACT AND METABOLISM
trimeprazine	CIDs00005574	Phase 4	approved	CC(CN(C)C)CN1c2ccccc2Sc2ccccc21	R - RESPIRATORY SYSTEM
trimethadione	CIDs00005576	Phase 4	approved	CN1C(=O)OC(C)(C)C1=O	N - NERVOUS SYSTEM
TGen	CIDs00005577	Phase 4	approved	COc1cc(C(=O)NCc2ccc(OCCN(C)C)cc2)cc(OC)c1OC	R - RESPIRATORY SYSTEM
trimethoprim	CIDs00005578	Phase 4	approved	COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC	J - ANTIINFECTIVES FOR SYSTEMIC USE
trimipramine	CIDs00005584	Phase 4	approved	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	N - NERVOUS SYSTEM
tripelennamine	CIDs00005587	Phase 4	approved	CN(C)CCN(Cc1ccccc1)c1ccccn1	R - RESPIRATORY SYSTEM | D - DERMATOLOGICALS
troglitazone	CIDs00005591	Phase 4	approved	Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2	A - ALIMENTARY TRACT AND METABOLISM
tropicamide	CIDs00005593	Phase 4	approved	CCN(Cc1ccncc1)C(=O)C(CO)c1ccccc1	S - SENSORY ORGANS | S - SENSORY ORGANS
tulobuterol	CIDs00005606	Phase 4	approved	CC(C)(C)NCC(O)c1ccccc1Cl	R - RESPIRATORY SYSTEM | R - RESPIRATORY SYSTEM
tyramine	CIDs00005610	Phase 3	unapproved	NCCc1ccc(O)cc1	
delavirdine	CIDs00005625	Phase 4	approved	CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1	J - ANTIINFECTIVES FOR SYSTEMIC USE
urapidil	CIDs00005639	Phase 3	unapproved	COc1ccccc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1	C - CARDIOVASCULAR SYSTEM
urethane	CIDs00005641	Phase 4	approved	CCOC(N)=O	
venlafaxine	CIDs00005656	Phase 4	approved	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	N - NERVOUS SYSTEM
vesnarinone	CIDs00005663	Phase 2	unapproved	COc1ccc(C(=O)N2CCN(c3ccc4c(c3)CCC(=O)N4)CC2)cc1OC	
vigabatrin	CIDs00005665	Phase 4	approved	C=CC(N)CCC(=O)O	N - NERVOUS SYSTEM
viloxazine	CIDs00005666	Phase 4	approved	CCOc1ccccc1OCC1CNCCO1	N - NERVOUS SYSTEM
xylometazoline	CIDs00005709	Phase 4	approved	Cc1cc(C(C)(C)C)cc(C)c1CC1=NCCN1	S - SENSORY ORGANS | R - RESPIRATORY SYSTEM | R - RESPIRATORY SYSTEM | S - SENSORY ORGANS
zafirlukast	CIDs00005717	Phase 4	approved	COc1cc(C(=O)NS(=O)(=O)c2ccccc2C)ccc1Cc1cn(C)c2ccc(NC(=O)OC3CCCC3)cc12	R - RESPIRATORY SYSTEM
zaleplon	CIDs00005719	Phase 4	approved	CCN(C(C)=O)c1cccc(-c2ccnc3c(C#N)cnn23)c1	N - NERVOUS SYSTEM
zolpidem	CIDs00005732	Phase 4	approved	Cc1ccc(-c2nc3ccc(C)cn3c2CC(=O)N(C)C)cc1	N - NERVOUS SYSTEM
zomepirac	CIDs00005733	Phase 4	approved	Cc1cc(CC(=O)O)n(C)c1C(=O)c1ccc(Cl)cc1	M - MUSCULO-SKELETAL SYSTEM
zonisamide	CIDs00005734	Phase 4	approved	N=S(=O)(O)Cc1noc2ccccc12	N - NERVOUS SYSTEM
zopiclone	CIDs00005735	Phase 4	approved	CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1	N - NERVOUS SYSTEM
zotepine	CIDs00005736	Phase 4	approved	CN(C)CCOC1=Cc2ccccc2Sc2ccc(Cl)cc21	N - NERVOUS SYSTEM
dexamethasone	CIDs00005743	Phase 4	approved	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO	R - RESPIRATORY SYSTEM | A - ALIMENTARY TRACT AND METABOLISM | R - RESPIRATORY SYSTEM | S - SENSORY ORGANS | S - SENSORY ORGANS | D - DERMATOLOGICALS | D - DERMATOLOGICALS | S - SENSORY ORGANS | C - CARDIOVASCULAR SYSTEM | D - DERMATOLOGICALS | H - SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS | S - SENSORY ORGANS
cortisone acetate	CIDs00005745	Phase 4	approved	CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3C(=O)C[C@@]21C	S - SENSORY ORGANS | H - SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
oxyphenonium	CIDs00005748	Phase 4	approved	CC[N+](C)(CC)CCOC(=O)C(O)(c1ccccc1)C1CCCCC1	A - ALIMENTARY TRACT AND METABOLISM | A - ALIMENTARY TRACT AND METABOLISM
corticosterone	CIDs00005753	Phase 3	unapproved	C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2C(=O)CO	
cortisol	CIDs00005754	Phase 4	approved	C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO	A - ALIMENTARY TRACT AND METABOLISM | S - SENSORY ORGANS | D - DERMATOLOGICALS | S - SENSORY ORGANS | D - DERMATOLOGICALS | A - ALIMENTARY TRACT AND METABOLISM | R - RESPIRATORY SYSTEM | C - CARDIOVASCULAR SYSTEM | H - SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS | S - SENSORY ORGANS
prednisolone	CIDs00005755	Phase 4	approved	C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO	S - SENSORY ORGANS | D - DERMATOLOGICALS | R - RESPIRATORY SYSTEM | D - DERMATOLOGICALS | R - RESPIRATORY SYSTEM | C - CARDIOVASCULAR SYSTEM | S - SENSORY ORGANS | A - ALIMENTARY TRACT AND METABOLISM | H - SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS | A - ALIMENTARY TRACT AND METABOLISM | S - SENSORY ORGANS | S - SENSORY ORGANS
estriol	CIDs00005756	Phase 4	approved	C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1C[C@@H](O)[C@@H]2O	G - GENITO URINARY SYSTEM AND SEX HORMONES | G - GENITO URINARY SYSTEM AND SEX HORMONES
estradiol	CIDs00005757	Phase 4	approved	C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O	G - GENITO URINARY SYSTEM AND SEX HORMONES | G - GENITO URINARY SYSTEM AND SEX HORMONES
lysergic acid diethylamide	CIDs00005761	Phase 2	unapproved	CCN(CC)C(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1	
reserpine	CIDs00005770	Phase 4	approved	COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC	C - CARDIOVASCULAR SYSTEM | C - CARDIOVASCULAR SYSTEM
phentolamine	CIDs00005775	Phase 4	approved	Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1	C - CARDIOVASCULAR SYSTEM | V - VARIOUS
sorbitol	CIDs00005780	Phase 4	approved	OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO	V - VARIOUS | B - BLOOD AND BLOOD FORMING ORGANS | A - ALIMENTARY TRACT AND METABOLISM | A - ALIMENTARY TRACT AND METABOLISM
thymidine	CIDs00005789	Phase 2	unapproved	Cc1cn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)[nH]c1=O	
glucose	CIDs00005793	Phase 4	approved	OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O	B - BLOOD AND BLOOD FORMING ORGANS | C - CARDIOVASCULAR SYSTEM | V - VARIOUS | V - VARIOUS
TRIAC	CIDs00005803	Phase 2	unapproved	O=C(O)Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1	H - SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS | D - DERMATOLOGICALS
epinephrine	CIDs00005815	Phase 4	approved	CNC[C@H](O)c1ccc(O)c(O)c1	R - RESPIRATORY SYSTEM | S - SENSORY ORGANS | R - RESPIRATORY SYSTEM | B - BLOOD AND BLOOD FORMING ORGANS | S - SENSORY ORGANS | A - ALIMENTARY TRACT AND METABOLISM | C - CARDIOVASCULAR SYSTEM | R - RESPIRATORY SYSTEM
thyroxine	CIDs00005819	Phase 4	approved	N[C@@H](Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)O	
d-amphetamine	CIDs00005825	Phase 4	approved	C[C@H](N)Cc1ccccc1	N - NERVOUS SYSTEM
norethisterone acetate	CIDs00005832	Phase 4	approved	C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C	
spironolactone	CIDs00005833	Phase 4	approved	CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34CCC(=O)O4)[C@@H]21	C - CARDIOVASCULAR SYSTEM
aldosterone	CIDs00005839	Phase 1	unapproved	C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C=O)[C@@H](C(=O)CO)CC[C@@H]12	H - SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
pentolinium	CIDs00005849	Phase 4	approved	C[N+]1(CCCCC[N+]2(C)CCCC2)CCCC1	
D-penicillamine	CIDs00005852	Phase 4	approved	CC(C)(S)[C@@H](N)C(=O)O	M - MUSCULO-SKELETAL SYSTEM
metrifonate	CIDs00005853	Phase 4	approved	COP(=O)(OC)C(O)C(Cl)(Cl)Cl	P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
lynestrenol	CIDs00005857	Phase 3	unapproved	C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CCCC[C@@H]4[C@H]3CC[C@@]21C	G - GENITO URINARY SYSTEM AND SEX HORMONES | G - GENITO URINARY SYSTEM AND SEX HORMONES
cystein	CIDs00005862	Phase 4	approved	N[C@@H](CS)C(=O)O	
prednisone	CIDs00005865	Phase 4	approved	C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO	A - ALIMENTARY TRACT AND METABOLISM | H - SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
estrone	CIDs00005870	Phase 4	approved	C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CCC2=O	G - GENITO URINARY SYSTEM AND SEX HORMONES | G - GENITO URINARY SYSTEM AND SEX HORMONES
demethyl	CIDs00005877	Phase 4	approved	CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C	
oxandrolone	CIDs00005878	Phase 4	approved	C[C@]12COC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O	A - ALIMENTARY TRACT AND METABOLISM
DHEA	CIDs00005881	Phase 4	approved	C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CCC2=O	A - ALIMENTARY TRACT AND METABOLISM | G - GENITO URINARY SYSTEM AND SEX HORMONES
penicillin G	CIDs00005904	Phase 4	approved	CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O	J - ANTIINFECTIVES FOR SYSTEMIC USE | S - SENSORY ORGANS
IUdR	CIDs00005905	Phase 4	approved	O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1I	D - DERMATOLOGICALS | J - ANTIINFECTIVES FOR SYSTEMIC USE | S - SENSORY ORGANS
metaraminol	CIDs00005906	Phase 4	approved	C[C@H](N)[C@H](O)c1cccc(O)c1	C - CARDIOVASCULAR SYSTEM
pilocarpine	CIDs00005909	Phase 4	approved	CC[C@@H]1C(=O)OC[C@@H]1Cc1cncn1C	N - NERVOUS SYSTEM | S - SENSORY ORGANS | S - SENSORY ORGANS
pentylenetetrazol	CIDs00005917	Phase 2	unapproved	C1CCc2nnnn2CC1	R - RESPIRATORY SYSTEM | R - RESPIRATORY SYSTEM
3,4-diaminopyridine	CIDs00005918	Phase 4	approved	Nc1ccncc1N	N - NERVOUS SYSTEM
3,5,3'-triiodothyronine	CIDs00005920	Phase 4	approved	N[C@@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(=O)O	
diisopropylfluorophosphate (DFP	CIDs00005936	Phase 4	approved	CC(C)OP(=O)(F)OC(C)C	S - SENSORY ORGANS
cantharidin	CIDs00005944	Phase 4	approved	C[C@]12C(=O)OC(=O)[C@@]1(C)[C@@H]1CC[C@H]2O1	
D-serine	CIDs00005951	Phase 3	unapproved	N[C@@H](CO)C(=O)O	
deoxycorticosterone acetate	CIDs00005952	Phase 4	approved	CC(=O)OCC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C	H - SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
MgATP	CIDs00005957	Phase 2	unapproved	Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O	
chloramphenicol	CIDs00005959	Phase 4	approved	O=C(N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1)C(Cl)Cl	S - SENSORY ORGANS | S - SENSORY ORGANS | D - DERMATOLOGICALS | G - GENITO URINARY SYSTEM AND SEX HORMONES | S - SENSORY ORGANS | D - DERMATOLOGICALS | J - ANTIINFECTIVES FOR SYSTEMIC USE
aspartic acid	CIDs00005960	Phase 3	unapproved	N[C@@H](CC(=O)O)C(=O)O	
glutamine	CIDs00005961	Phase 4	approved	NC(=O)CC[C@H](N)C(=O)O	A - ALIMENTARY TRACT AND METABOLISM
lysine	CIDs00005962	Phase 4	approved	NCCCC[C@H](N)C(=O)O	B - BLOOD AND BLOOD FORMING ORGANS
demecarium bromide	CIDs00005965	Phase 4	approved	CN(CCCCCCCCCCN(C)C(=O)Oc1cccc([N+](C)(C)C)c1)C(=O)Oc1cccc([N+](C)(C)C)c1	S - SENSORY ORGANS
chloretone	CIDs00005977	Phase 4	approved	CC(C)(O)C(Cl)(Cl)Cl	A - ALIMENTARY TRACT AND METABOLISM | A - ALIMENTARY TRACT AND METABOLISM
physostigmine	CIDs00005983	Phase 4	approved	CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C	S - SENSORY ORGANS | V - VARIOUS
sucrose	CIDs00005988	Phase 4	approved	OC[C@H]1O[C@H](O[C@]2(CO)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O	
ethynylestradiol	CIDs00005991	Phase 4	approved	C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@@]21C	L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | G - GENITO URINARY SYSTEM AND SEX HORMONES
progesterone	CIDs00005994	Phase 4	approved	CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C	G - GENITO URINARY SYSTEM AND SEX HORMONES
testosterone propionate	CIDs00005995	Phase 4	approved	CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C	G - GENITO URINARY SYSTEM AND SEX HORMONES
cholesterol	CIDs00005997	Phase 4	approved	CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C	
curare	CIDs00006000	Phase 4	approved	COc1cc2c3cc1Oc1cc(ccc1O)C[C@@H]1c4c(cc(OC)c(O)c4Oc4ccc(cc4)C[C@@H]3N(C)CC2)CC[N+]1(C)C	M - MUSCULO-SKELETAL SYSTEM
apomorphine	CIDs00006005	Phase 4	approved	CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3	N - NERVOUS SYSTEM | G - GENITO URINARY SYSTEM AND SEX HORMONES
folinic acid	CIDs00006006	Phase 4	approved	Nc1nc(=O)c2c([nH]1)NCC(CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1)N2C=O	
aminopyrine	CIDs00006009	Phase 4	approved	Cc1c(N(C)C)c(=O)n(-c2ccccc2)n1C	N - NERVOUS SYSTEM | N - NERVOUS SYSTEM | N - NERVOUS SYSTEM
17alpha-methyltestosterone	CIDs00006010	Phase 4	approved	C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C	G - GENITO URINARY SYSTEM AND SEX HORMONES | G - GENITO URINARY SYSTEM AND SEX HORMONES
testosterone	CIDs00006013	Phase 4	approved	C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O	G - GENITO URINARY SYSTEM AND SEX HORMONES
tetrabenazine	CIDs00006018	Phase 4	approved	COc1cc2c(cc1OC)C1CC(=O)C(CC(C)C)CN1CC2	N - NERVOUS SYSTEM
inosine	CIDs00006021	Phase 3	unapproved	O=c1[nH]cnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O	D - DERMATOLOGICALS | G - GENITO URINARY SYSTEM AND SEX HORMONES | S - SENSORY ORGANS
cephalothin	CIDs00006024	Phase 4	approved	CC(=O)OCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)Cc3cccs3)[C@H]2SC1	J - ANTIINFECTIVES FOR SYSTEMIC USE
uridine	CIDs00006029	Phase 3	unapproved	O=c1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)[nH]1	
kanamycin	CIDs00006032	Phase 4	approved	NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O	J - ANTIINFECTIVES FOR SYSTEMIC USE | S - SENSORY ORGANS | A - ALIMENTARY TRACT AND METABOLISM
BrdUrd	CIDs00006035	Phase 2	unapproved	O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1Br	
galactoside	CIDs00006036	Phase 1	unapproved	OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O	
folate	CIDs00006037	Phase 4	approved	Nc1nc(=O)c2nc(CNc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)cnc2[nH]1	V - VARIOUS | B - BLOOD AND BLOOD FORMING ORGANS | B - BLOOD AND BLOOD FORMING ORGANS
phenylephrine	CIDs00006041	Phase 4	approved	CNC[C@H](O)c1cccc(O)c1	R - RESPIRATORY SYSTEM | R - RESPIRATORY SYSTEM | R - RESPIRATORY SYSTEM | S - SENSORY ORGANS | S - SENSORY ORGANS | C - CARDIOVASCULAR SYSTEM | S - SENSORY ORGANS | R - RESPIRATORY SYSTEM
levodopa	CIDs00006047	Phase 4	approved	N[C@@H](Cc1ccc(O)c(O)c1)C(=O)O	N - NERVOUS SYSTEM
tyrosine	CIDs00006057	Phase 4	approved	N[C@@H](Cc1ccc(O)cc1)C(=O)O	
cysteamine	CIDs00006058	Phase 4	approved	NCCS	A - ALIMENTARY TRACT AND METABOLISM | S - SENSORY ORGANS
mepazine	CIDs00006075	Phase 4	approved	CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1	
methoxamine	CIDs00006081	Phase 4	approved	COc1ccc(OC)c(C(O)C(C)N)c1	C - CARDIOVASCULAR SYSTEM
adenosine monophosphate	CIDs00006083	Phase 4	approved	Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]1O	
methicillin	CIDs00006087	Phase 4	approved	COc1cccc(OC)c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)O)C(C)(C)S[C@H]12	J - ANTIINFECTIVES FOR SYSTEMIC USE
cloxacillin	CIDs00006098	Phase 4	approved	Cc1onc(-c2ccccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)O)C(C)(C)S[C@H]12	J - ANTIINFECTIVES FOR SYSTEMIC USE
leucine	CIDs00006106	Phase 3	unapproved	CC(C)C[C@H](N)C(=O)O	
diphemanil	CIDs00006126	Phase 4	approved	C[N+]1(C)CCC(=C(c2ccccc2)c2ccccc2)CC1	A - ALIMENTARY TRACT AND METABOLISM
carbaryl	CIDs00006129	Phase 4	approved	CNC(=O)Oc1cccc2ccccc12	
uridine 5'-triphosphate	CIDs00006133	Phase 3	unapproved	O=c1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]2O)c(=O)[nH]1	
lactose	CIDs00006134	Phase 3	unapproved	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O	
methionine	CIDs00006137	Phase 4	approved	CSCC[C@H](N)C(=O)O	V - VARIOUS
phenylalanine	CIDs00006140	Phase 3	unapproved	N[C@@H](Cc1ccccc1)C(=O)O	
colchicine	CIDs00006167	Phase 4	approved	COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1[C@@H](NC(C)=O)CC2	M - MUSCULO-SKELETAL SYSTEM
yohimbine	CIDs00006169	Phase 4	approved	COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21	G - GENITO URINARY SYSTEM AND SEX HORMONES
cytidine	CIDs00006175	Phase 2	unapproved	Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1	
oxacillin	CIDs00006196	Phase 4	approved	Cc1onc(-c2ccccc2)c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)O)C(C)(C)S[C@H]12	J - ANTIINFECTIVES FOR SYSTEMIC USE
psoralen	CIDs00006199	Phase 1	unapproved	O=c1ccc2cc3ccoc3cc2o1	
chloroform	CIDs00006212	Phase 4	approved	ClC(Cl)Cl	N - NERVOUS SYSTEM
fluocinolone acetonide	CIDs00006215	Phase 4	approved	CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1	S - SENSORY ORGANS | S - SENSORY ORGANS | D - DERMATOLOGICALS | C - CARDIOVASCULAR SYSTEM
Milli	CIDs00006230	Phase 4	approved	C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C	G - GENITO URINARY SYSTEM AND SEX HORMONES | G - GENITO URINARY SYSTEM AND SEX HORMONES
norethynodrel	CIDs00006231	Phase 4	approved	C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C	
cycloserine	CIDs00006234	Phase 4	approved	N[C@@H]1CONC1=O	J - ANTIINFECTIVES FOR SYSTEMIC USE
17-hydroxyprogesterone	CIDs00006238	Phase 2	unapproved	CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C	
ampicillin	CIDs00006249	Phase 4	approved	CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)O	J - ANTIINFECTIVES FOR SYSTEMIC USE | J - ANTIINFECTIVES FOR SYSTEMIC USE | S - SENSORY ORGANS
mannitol	CIDs00006251	Phase 4	approved	OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO	B - BLOOD AND BLOOD FORMING ORGANS | B - BLOOD AND BLOOD FORMING ORGANS | A - ALIMENTARY TRACT AND METABOLISM | R - RESPIRATORY SYSTEM | V - VARIOUS
D-maltose	CIDs00006255	Phase 3	unapproved	OC[C@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O	
ornithine	CIDs00006262	Phase 3	unapproved	NCCC[C@H](N)C(=O)O	
tosylamido	CIDs00006269	Phase 3	unapproved	Cc1ccc(S(N)(=O)=O)cc1	
histidine	CIDs00006274	Phase 2	unapproved	N[C@@H](Cc1c[nH]cn1)C(=O)O	
1,1,1-trichloroethane	CIDs00006278	Phase 4	approved	CC(Cl)(Cl)Cl	
progestins	CIDs00006279	Phase 4	approved	CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C	L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | G - GENITO URINARY SYSTEM AND SEX HORMONES | G - GENITO URINARY SYSTEM AND SEX HORMONES
L-valine	CIDs00006287	Phase 1	unapproved	CC(C)[C@H](N)C(=O)O	
Threonine	CIDs00006288	Phase 1	unapproved	C[C@@H](O)[C@H](N)C(=O)O	
mestranol	CIDs00006291	Phase 4	approved	C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(OC)ccc4[C@H]3CC[C@@]21C	
methandrostenolone	CIDs00006300	Phase 4	approved	C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O	D - DERMATOLOGICALS | A - ALIMENTARY TRACT AND METABOLISM
cordycepin	CIDs00006303	Phase 1	unapproved	Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)C[C@H]1O	
tryptophan	CIDs00006305	Phase 4	approved	N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	N - NERVOUS SYSTEM
isoleucine	CIDs00006306	Phase 2	unapproved	CC[C@H](C)[C@H](N)C(=O)O	
quinethazone	CIDs00006307	Phase 4	approved	CCC1NC(=O)c2cc(S(N)(=O)=O)c(Cl)cc2N1	C - CARDIOVASCULAR SYSTEM
ethylene	CIDs00006325	Phase 3	unapproved	C=C	
vinyl chloride	CIDs00006338	Phase 4	approved	C=CCl	
trichloroacetic acid	CIDs00006421	Phase 4	approved	O=C(O)C(Cl)(Cl)Cl	
triamcinolone acetonide	CIDs00006436	Phase 4	approved	CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1	
fluoxymesterone	CIDs00006446	Phase 4	approved	C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C	G - GENITO URINARY SYSTEM AND SEX HORMONES
butobarbital	CIDs00006473	Phase 4	approved	CCCCC1(CC)C(=O)NC(=O)NC1=O	N - NERVOUS SYSTEM
methsuximide	CIDs00006476	Phase 4	approved	CN1C(=O)CC(C)(c2ccccc2)C1=O	N - NERVOUS SYSTEM
Tris-HCl	CIDs00006503	Phase 4	approved	NC(CO)(CO)CO	B - BLOOD AND BLOOD FORMING ORGANS | B - BLOOD AND BLOOD FORMING ORGANS
triparanol	CIDs00006536	Phase 4	approved	CCN(CC)CCOc1ccc(C(O)(Cc2ccc(Cl)cc2)c2ccc(C)cc2)cc1	
trichloroethylene	CIDs00006575	Phase 4	approved	ClC=C(Cl)Cl	N - NERVOUS SYSTEM
pantothenic acid	CIDs00006613	Phase 4	approved	CC(C)(CO)[C@@H](O)C(=O)NCCC(=O)O	
wellcome	CIDs00006726	Phase 4	approved	CN1CCN(C(c2ccccc2)c2ccccc2)CC1	R - RESPIRATORY SYSTEM | R - RESPIRATORY SYSTEM
buclizine	CIDs00006729	Phase 4	approved	CC(C)(C)c1ccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)cc1	R - RESPIRATORY SYSTEM | R - RESPIRATORY SYSTEM
methylprednisolone	CIDs00006741	Phase 4	approved	C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)C=CC(=O)C=C12	H - SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS | D - DERMATOLOGICALS | D - DERMATOLOGICALS | H - SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
pipamazine	CIDs00006761	Phase 4	approved	NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1	
D-isomer	CIDs00006834	Phase 4	approved	CN(C)CCC(c1ccc(Br)cc1)c1ccccn1	R - RESPIRATORY SYSTEM | R - RESPIRATORY SYSTEM
penicillin V	CIDs00006869	Phase 4	approved	CC1(C)S[C@@H]2[C@H](NC(=O)COc3ccccc3)C(=O)N2[C@H]1C(=O)O	J - ANTIINFECTIVES FOR SYSTEMIC USE
isosorbide dinitrate	CIDs00006883	Phase 4	approved	O=[N+]([O-])O[C@H]1CO[C@H]2[C@@H]1OC[C@H]2O[N+](=O)[O-]	C - CARDIOVASCULAR SYSTEM | C - CARDIOVASCULAR SYSTEM | C - CARDIOVASCULAR SYSTEM
xylitol	CIDs00006912	Phase 3	unapproved	OC[C@H](O)[C@@H](O)[C@H](O)CO	
thymol	CIDs00006989	Phase 4	approved	Cc1ccc(C(C)C)c(O)c1	
sparteine	CIDs00007014	Phase 4	approved	C1CCN2C[C@H]3C[C@H](CN4CCCC[C@H]34)[C@@H]2C1	C - CARDIOVASCULAR SYSTEM
glucono-delta-lactone	CIDs00007027	Phase 4	approved	O=C1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O	
pseudoephedrine	CIDs00007028	Phase 4	approved	CN[C@@H](C)[C@@H](O)c1ccccc1	R - RESPIRATORY SYSTEM | R - RESPIRATORY SYSTEM
linea	CIDs00007029	Phase 4	approved	CCN(CC)C(C)C(=O)c1ccccc1	A - ALIMENTARY TRACT AND METABOLISM
proflavine	CIDs00007099	Phase 4	approved	Nc1ccc2cc3ccc(N)cc3nc2c1	
benzoyl peroxide	CIDs00007187	Phase 4	approved	O=C(OOC(=O)c1ccccc1)c1ccccc1	D - DERMATOLOGICALS | D - DERMATOLOGICALS
pyroglutamate	CIDs00007405	Phase 2	unapproved	O=C1CC[C@@H](C(=O)O)N1	
trehalose	CIDs00007427	Phase 3	unapproved	OC[C@H]1O[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O	
TEOA	CIDs00007618	Phase 4	approved	OCCN(CCO)CCO	D - DERMATOLOGICALS
borate	CIDs00007628	Phase 4	approved	OB(O)O	S - SENSORY ORGANS
monobenzone	CIDs00007638	Phase 4	approved	Oc1ccc(OCc2ccccc2)cc1	D - DERMATOLOGICALS
benzonatate	CIDs00007699	Phase 4	approved	CCCCNc1ccc(C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOC)cc1	R - RESPIRATORY SYSTEM
betazole	CIDs00007741	Phase 4	approved	NCCc1cc[nH]n1	V - VARIOUS
radio frequency	CIDs00007843	Phase 1	unapproved	CCCC	
DMAE	CIDs00007902	Phase 2	unapproved	CN(C)CCO	
pyrrole	CIDs00008027	Phase 3	unapproved	c1cc[nH]c1	
cyclohexane	CIDs00008078	Phase 1	unapproved	C1CCCCC1	
undecanoic acid	CIDs00008180	Phase 3	unapproved	CCCCCCCCCCC(=O)O	
ergotamine	CIDs00008223	Phase 4	approved	CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21	N - NERVOUS SYSTEM | N - NERVOUS SYSTEM | N - NERVOUS SYSTEM
UTERINE	CIDs00008226	Phase 4	approved	CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1	G - GENITO URINARY SYSTEM AND SEX HORMONES
phenformin	CIDs00008249	Phase 4	approved	N=C(N)NC(=N)NCCc1ccccc1	A - ALIMENTARY TRACT AND METABOLISM
mephobarbital	CIDs00008271	Phase 4	approved	CCC1(c2ccccc2)C(=O)NC(=O)N(C)C1=O	N - NERVOUS SYSTEM
talbutal	CIDs00008275	Phase 4	approved	C=CCC1(C(C)CC)C(=O)NC(=O)NC1=O	N - NERVOUS SYSTEM
paramethadione	CIDs00008280	Phase 4	approved	CCC1(C)OC(=O)N(C)C1=O	N - NERVOUS SYSTEM
neomycin	CIDs00008378	Phase 3	unapproved	NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O	R - RESPIRATORY SYSTEM | D - DERMATOLOGICALS | S - SENSORY ORGANS
deserpidine	CIDs00008550	Phase 4	approved	COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5ccccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC	C - CARDIOVASCULAR SYSTEM
meglumine	CIDs00008567	Phase 4	approved	CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO	
2-chloroprocaine	CIDs00008612	Phase 4	approved	CCN(CC)CCOC(=O)c1ccc(N)cc1Cl	N - NERVOUS SYSTEM
D-thyroxine	CIDs00008730	Phase 4	approved	N[C@H](Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)O	C - CARDIOVASCULAR SYSTEM
sodium dodecyl sulfate	CIDs00008778	Phase 3	unapproved	CCCCCCCCCCCCOS(=O)(=O)[O-].[Na+]	
anileridine	CIDs00008944	Phase 4	approved	CCOC(=O)C1(c2ccccc2)CCN(CCc2ccc(N)cc2)CC1	N - NERVOUS SYSTEM
nafcillin	CIDs00008982	Phase 4	approved	CCOc1ccc2ccccc2c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)O)C(C)(C)S[C@H]12	J - ANTIINFECTIVES FOR SYSTEMIC USE
4-hydroxyanisole	CIDs00009015	Phase 4	approved	COc1ccc(O)cc1	D - DERMATOLOGICALS
methohexital	CIDs00009034	Phase 4	approved	C=CCC1(C(C)C#CCC)C(=O)NC(=O)N(C)C1=O	N - NERVOUS SYSTEM | N - NERVOUS SYSTEM
quinestrol	CIDs00009046	Phase 4	approved	C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(OC5CCCC5)ccc4[C@H]3CC[C@@]21C	
longum	CIDs00009047	Phase 4	approved	COc1nccnc1NS(=O)(=O)c1ccc(N)cc1	J - ANTIINFECTIVES FOR SYSTEMIC USE
dydrogesterone	CIDs00009051	Phase 4	approved	CC(=O)[C@H]1CC[C@H]2[C@@H]3C=CC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C	G - GENITO URINARY SYSTEM AND SEX HORMONES
ethynodiol diacetate	CIDs00009270	Phase 4	approved	C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=C[C@@H](OC(C)=O)CC[C@@H]4[C@H]3CC[C@@]21C	G - GENITO URINARY SYSTEM AND SEX HORMONES
ephedrine	CIDs00009294	Phase 4	approved	CN[C@@H](C)[C@H](O)c1ccccc1	C - CARDIOVASCULAR SYSTEM | R - RESPIRATORY SYSTEM | A - ALIMENTARY TRACT AND METABOLISM | R - RESPIRATORY SYSTEM | S - SENSORY ORGANS
chlormadinone acetate	CIDs00009324	Phase 4	approved	CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C	G - GENITO URINARY SYSTEM AND SEX HORMONES
ethamivan	CIDs00009363	Phase 4	approved	CCN(CC)C(=O)c1ccc(O)c(OC)c1	R - RESPIRATORY SYSTEM
dexamethasone	CIDs00009400	Phase 4	approved	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(=O)(O)O	
testosterone enanthate	CIDs00009416	Phase 4	approved	CCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C	G - GENITO URINARY SYSTEM AND SEX HORMONES
opipramol	CIDs00009417	Phase 3	unapproved	OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1	N - NERVOUS SYSTEM
dibenzepin	CIDs00009418	Phase 4	approved	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	N - NERVOUS SYSTEM
triflusal	CIDs00009458	Phase 3	unapproved	CC(=O)Oc1cc(C(F)(F)F)ccc1C(=O)O	B - BLOOD AND BLOOD FORMING ORGANS
glycodiazine	CIDs00009565	Phase 4	approved	COCCOc1cnc(NS(=O)(=O)c2ccccc2)nc1	A - ALIMENTARY TRACT AND METABOLISM
perfluorohexane	CIDs00009639	Phase 4	approved	FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F	
fluocinonide	CIDs00009642	Phase 4	approved	CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C	C - CARDIOVASCULAR SYSTEM | D - DERMATOLOGICALS
galantamine	CIDs00009651	Phase 4	approved	COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2	N - NERVOUS SYSTEM
nandrolone decanoate	CIDs00009677	Phase 4	approved	CCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C	S - SENSORY ORGANS | A - ALIMENTARY TRACT AND METABOLISM
citrulline	CIDs00009750	Phase 3	unapproved	NC(=O)NCCC[C@H](N)C(=O)O	
betamethasone	CIDs00009782	Phase 4	approved	C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO	D - DERMATOLOGICALS | D - DERMATOLOGICALS | H - SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS | S - SENSORY ORGANS | S - SENSORY ORGANS | S - SENSORY ORGANS | R - RESPIRATORY SYSTEM | S - SENSORY ORGANS | A - ALIMENTARY TRACT AND METABOLISM | R - RESPIRATORY SYSTEM | C - CARDIOVASCULAR SYSTEM
Segontin	CIDs00009801	Phase 4	approved	CC(Cc1ccccc1)NCCC(c1ccccc1)c1ccccc1	C - CARDIOVASCULAR SYSTEM | C - CARDIOVASCULAR SYSTEM
fluorometholone	CIDs00009878	Phase 4	approved	CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C	S - SENSORY ORGANS | D - DERMATOLOGICALS | D - DERMATOLOGICALS | D - DERMATOLOGICALS | S - SENSORY ORGANS | C - CARDIOVASCULAR SYSTEM
cyproterone acetate	CIDs00009880	Phase 4	approved	CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C	G - GENITO URINARY SYSTEM AND SEX HORMONES
nandrolone	CIDs00009904	Phase 3	unapproved	C[C@]12CC[C@@H]3[C@H]4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@H]2O	
propoxyphene	CIDs00010100	Phase 4	approved	CCC(=O)O[C@](Cc1ccccc1)(c1ccccc1)[C@H](C)CN(C)C	N - NERVOUS SYSTEM
CaCO3	CIDs00010112	Phase 4	approved	O=C([O-])[O-].[Ca+2]	A - ALIMENTARY TRACT AND METABOLISM | A - ALIMENTARY TRACT AND METABOLISM
glycyrrhetinic acid	CIDs00010114	Phase 2	unapproved	CC1(C)[C@@H](O)CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@@](C)(C(=O)O)CC[C@]3(C)CC[C@]21C	D - DERMATOLOGICALS
cDCs	CIDs00010133	Phase 4	approved	C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@H]3[C@H](CC[C@@]21C)[C@@]1(C)CC[C@@H](O)C[C@H]1C[C@H]3O	A - ALIMENTARY TRACT AND METABOLISM
glycocholate	CIDs00010140	Phase 3	unapproved	C[C@H](CCC(=O)NCC(=O)O)[C@H]1CC[C@H]2[C@H]3[C@H](C[C@H](O)[C@@]21C)[C@@]1(C)CC[C@@H](O)C[C@H]1C[C@H]3O	
lucanthone	CIDs00010180	Phase 2	unapproved	CCN(CC)CCNc1ccc(C)c2sc3ccccc3c(=O)c12	
plumbagin	CIDs00010205	Phase 1	unapproved	CC1=CC(=O)c2c(O)cccc2C1=O	
cytisine	CIDs00010235	Phase 3	unapproved	O=c1cccc2n1C[C@@H]1CNC[C@H]2C1	N - NERVOUS SYSTEM
thymoquinone	CIDs00010281	Phase 2	unapproved	CC1=CC(=O)C(C(C)C)=CC1=O	
melarsoprol	CIDs00010311	Phase 3	unapproved	Nc1nc(N)nc(Nc2ccc([As]3SCC(CO)S3)cc2)n1	P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
4-hydroxy	CIDs00010413	Phase 4	approved	O=C(O)CCCO	
silver nanoparticles	CIDs00010474	Phase 3	unapproved	[Ag+]	D - DERMATOLOGICALS
dihydroergotamine	CIDs00010531	Phase 4	approved	CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21	N - NERVOUS SYSTEM | N - NERVOUS SYSTEM
echothiophate	CIDs00010547	Phase 4	approved	CCOP(=O)(OCC)SCC[N+](C)(C)C	S - SENSORY ORGANS
podophyllotoxin	CIDs00010607	Phase 4	approved	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC	D - DERMATOLOGICALS
hesperidin	CIDs00010621	Phase 3	unapproved	COc1ccc([C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2)cc1O	
psilocybin	CIDs00010624	Phase 2	unapproved	CN(C)CCc1c[nH]c2cccc(OP(=O)(O)O)c12	
dihydrotestosterone	CIDs00010635	Phase 2	unapproved	C[C@]12CC[C@H]3[C@@H](CC[C@H]4CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O	A - ALIMENTARY TRACT AND METABOLISM | G - GENITO URINARY SYSTEM AND SEX HORMONES
dimenhydrinate	CIDs00010660	Phase 4	approved	CN(C)CCOC(c1ccccc1)c1ccccc1.Cn1c(=O)c2[nH]c(Cl)nc2n(C)c1=O	
Flavone	CIDs00010680	Phase 2	unapproved	O=c1cc(-c2ccccc2)oc2ccccc12	
hexylcaine	CIDs00010770	Phase 4	approved	CC(CNC1CCCCC1)OC(=O)c1ccccc1	
chlormethiazole	CIDs00010783	Phase 4	approved	Cc1ncsc1CCCl	N - NERVOUS SYSTEM | N - NERVOUS SYSTEM
methamphetamine	CIDs00010836	Phase 4	approved	CN[C@@H](C)Cc1ccccc1	N - NERVOUS SYSTEM
L-carnitine	CIDs00010917	Phase 4	approved	C[N+](C)(C)C[C@H](O)CC(=O)[O-]	A - ALIMENTARY TRACT AND METABOLISM
methanesulfonyl fluoride	CIDs00011207	Phase 1	unapproved	CS(=O)(=O)F	
17-dione	CIDs00011273	Phase 4	approved	C[C@]12CC[C@H]3[C@@H](CCC4=C(O)C(=O)CC[C@@]43C)[C@@H]1CCC2=O	L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
chlorotrianisene	CIDs00011289	Phase 4	approved	COc1ccc(C(Cl)=C(c2ccc(OC)cc2)c2ccc(OC)cc2)cc1	G - GENITO URINARY SYSTEM AND SEX HORMONES
thephorin	CIDs00011290	Phase 4	approved	CN1CCC2=C(C1)C(c1ccccc1)c1ccccc12	R - RESPIRATORY SYSTEM
levulinic acid	CIDs00011578	Phase 3	unapproved	CC(=O)CCC(=O)O	
N-acetylcysteine	CIDs00012035	Phase 4	approved	CC(=O)N[C@@H](CS)C(=O)O	R - RESPIRATORY SYSTEM | S - SENSORY ORGANS | V - VARIOUS
ethyl pyruvate	CIDs00012041	Phase 2	unapproved	CCOC(=O)C(C)=O	
tridecanoic acid	CIDs00012530	Phase 2	unapproved	CCCCCCCCCCCCC(=O)O	
benzydamine	CIDs00012555	Phase 4	approved	CN(C)CCCOc1nn(Cc2ccccc2)c2ccccc12	G - GENITO URINARY SYSTEM AND SEX HORMONES | M - MUSCULO-SKELETAL SYSTEM | M - MUSCULO-SKELETAL SYSTEM | A - ALIMENTARY TRACT AND METABOLISM | R - RESPIRATORY SYSTEM
erythromycin	CIDs00012560	Phase 4	approved	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O	S - SENSORY ORGANS | J - ANTIINFECTIVES FOR SYSTEMIC USE | D - DERMATOLOGICALS | D - DERMATOLOGICALS
isosorbide	CIDs00012597	Phase 4	approved	O[C@H]1CO[C@@H]2[C@H](O)CO[C@H]12	
docosanol	CIDs00012620	Phase 4	approved	CCCCCCCCCCCCCCCCCCCCCCO	D - DERMATOLOGICALS
levonorgestrel	CIDs00013109	Phase 4	approved	C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21CC	G - GENITO URINARY SYSTEM AND SEX HORMONES | G - GENITO URINARY SYSTEM AND SEX HORMONES
diphenoxylate	CIDs00013505	Phase 4	approved	CCOC(=O)C1(c2ccccc2)CCN(CCC(C#N)(c2ccccc2)c2ccccc2)CC1	A - ALIMENTARY TRACT AND METABOLISM
deoxycytidine	CIDs00013711	Phase 2	unapproved	Nc1ccn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1	
canrenone	CIDs00013789	Phase 4	approved	C[C@]12CC[C@H]3[C@@H](C=CC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@]21CCC(=O)O1	C - CARDIOVASCULAR SYSTEM
E-state	CIDs00013791	Phase 4	approved	CCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@]12C	G - GENITO URINARY SYSTEM AND SEX HORMONES | G - GENITO URINARY SYSTEM AND SEX HORMONES
ethambutol	CIDs00014051	Phase 4	approved	CC[C@@H](CO)NCCN[C@@H](CC)CO	J - ANTIINFECTIVES FOR SYSTEMIC USE
TTAB	CIDs00014250	Phase 4	approved	CCCCCCCCCCCCCC[N+](C)(C)C	
pyrovalerone	CIDs00014372	Phase 4	approved	CCCC(C(=O)c1ccc(C)cc1)N1CCCC1	
methdilazine	CIDs00014676	Phase 4	approved	CN1CCC(CN2c3ccccc3Sc3ccccc32)C1	R - RESPIRATORY SYSTEM
phenazocine	CIDs00014706	Phase 4	approved	CC1C2Cc3ccc(O)cc3C1(C)CCN2CCc1ccccc1	N - NERVOUS SYSTEM
calcium hydroxide	CIDs00014777	Phase 4	approved	[Ca+2].[OH-].[OH-]	
hydroxyapatite	CIDs00014781	Phase 4	approved	O=P([O-])([O-])[O-].O=P([O-])([O-])[O-].O=P([O-])([O-])[O-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[OH-]	
sodium sulfide	CIDs00014804	Phase 2	unapproved	[Na+].[Na+].[S-2]	
fluoride	CIDs00014917	Phase 3	unapproved	F	
vancomycin	CIDs00014969	Phase 4	approved	CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O	S - SENSORY ORGANS | A - ALIMENTARY TRACT AND METABOLISM | J - ANTIINFECTIVES FOR SYSTEMIC USE
glycyrrhizin	CIDs00014982	Phase 2	unapproved	CC1(C)[C@@H](O[C@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@@](C)(C(=O)O)CC[C@]3(C)CC[C@]21C	A - ALIMENTARY TRACT AND METABOLISM
l-alpha-acetylmethadol	CIDs00015130	Phase 4	approved	CC[C@H](OC(C)=O)C(C[C@H](C)N(C)C)(c1ccccc1)c1ccccc1	N - NERVOUS SYSTEM
flurandrenolone	CIDs00015209	Phase 4	approved	CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1	D - DERMATOLOGICALS
melperone	CIDs00015386	Phase 3	unapproved	CC1CCN(CCCC(=O)c2ccc(F)cc2)CC1	N - NERVOUS SYSTEM
spectinomycin	CIDs00015541	Phase 4	approved	CN[C@H]1[C@@H](O)[C@@H](NC)[C@H](O)[C@H]2O[C@@H]3O[C@H](C)CC(=O)[C@]3(O)O[C@H]12	J - ANTIINFECTIVES FOR SYSTEMIC USE
omega-3 fatty acid	CIDs00016078	Phase 4	approved	CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(C)=C[C@@H]21	A - ALIMENTARY TRACT AND METABOLISM
bisphosphonates	CIDs00016124	Phase 3	unapproved	O=P(O)(O)CP(=O)(O)O	
amiloride	CIDs00016230	Phase 4	approved	N=C(N)NC(=O)c1nc(Cl)c(N)nc1N	C - CARDIOVASCULAR SYSTEM
pimozide	CIDs00016362	Phase 4	approved	O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1	N - NERVOUS SYSTEM
benperidol	CIDs00016363	Phase 4	approved	O=C(CCCN1CCC(n2c(O)nc3ccccc32)CC1)c1ccc(F)cc1	N - NERVOUS SYSTEM
azaribine	CIDs00016574	Phase 4	approved	CC(=O)OC[C@H]1O[C@@H](n2ncc(=O)[nH]c2=O)[C@H](OC(C)=O)[C@@H]1OC(C)=O	
hydrocortisone sodium succinate	CIDs00016623	Phase 4	approved	C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)COC(=O)CCC(=O)O	
L-menthol	CIDs00016666	Phase 3	unapproved	CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O	
Solu-Medrol	CIDs00016923	Phase 4	approved	C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)COC(=O)CCC(=O)O)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)C=CC(=O)C=C12	
dexbrompheniramine	CIDs00016960	Phase 4	approved	CN(C)CC[C@@H](c1ccc(Br)cc1)c1ccccn1	R - RESPIRATORY SYSTEM | R - RESPIRATORY SYSTEM
fucose	CIDs00017106	Phase 1	unapproved	C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O	
sulfadoxine	CIDs00017134	Phase 4	approved	COc1ncnc(NS(=O)(=O)c2ccc(N)cc2)c1OC	
calcium dobesilate	CIDs00017507	Phase 4	approved	O=S(=O)(O)c1cc(O)ccc1O	
acadesine	CIDs00017513	Phase 3	unapproved	NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1N	C - CARDIOVASCULAR SYSTEM
Tindal	CIDs00017676	Phase 4	approved	CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2	N - NERVOUS SYSTEM
carphenazine	CIDs00018103	Phase 4	approved	CCC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2	
stavudine	CIDs00018283	Phase 4	approved	Cc1cn([C@H]2C=C[C@@H](CO)O2)c(=O)[nH]c1=O	J - ANTIINFECTIVES FOR SYSTEMIC USE
5'-DFUR	CIDs00018343	Phase 3	unapproved	C[C@H]1O[C@@H](n2cc(F)c(=O)[nH]c2=O)[C@H](O)[C@@H]1O	
dicloxacillin	CIDs00018381	Phase 4	approved	Cc1onc(-c2c(Cl)cccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)O)C(C)(C)S[C@H]12	J - ANTIINFECTIVES FOR SYSTEMIC USE
mannose	CIDs00018950	Phase 2	unapproved	OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O	
streptomycin	CIDs00019648	Phase 4	approved	CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@@H]3[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]3O)O[C@@H](C)[C@]2(O)C=O)O[C@@H](CO)[C@H](O)[C@H]1O	J - ANTIINFECTIVES FOR SYSTEMIC USE | A - ALIMENTARY TRACT AND METABOLISM | A - ALIMENTARY TRACT AND METABOLISM
azatadine	CIDs00019861	Phase 4	approved	CN1CCC(=C2c3ccccc3CCc3cccnc32)CC1	R - RESPIRATORY SYSTEM
2',3',5'-tri-O-acetyluridine	CIDs00020058	Phase 4	approved	CC(=O)OC[C@H]1O[C@@H](n2ccc(=O)[nH]c2=O)[C@H](OC(C)=O)[C@@H]1OC(C)=O	A - ALIMENTARY TRACT AND METABOLISM
tridihexethyl chloride	CIDs00020298	Phase 4	approved	CC[N+](CC)(CC)CCC(O)(c1ccccc1)C1CCCCC1	A - ALIMENTARY TRACT AND METABOLISM
beclomethasone	CIDs00020469	Phase 2	unapproved	C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO	
carbenicillin	CIDs00020824	Phase 4	approved	CC1(C)S[C@@H]2[C@H](NC(=O)C(C(=O)O)c3ccccc3)C(=O)N2[C@H]1C(=O)O	J - ANTIINFECTIVES FOR SYSTEMIC USE
metocurine	CIDs00021233	Phase 4	approved	COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)[C@H]3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1[C@@H](C2)[N+](C)(C)CC3	
caprine	CIDs00021236	Phase 1	unapproved	CCCC[C@H](N)C(=O)O	
flucloxacillin	CIDs00021319	Phase 4	approved	Cc1onc(-c2c(F)cccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)O)C(C)(C)S[C@H]12	J - ANTIINFECTIVES FOR SYSTEMIC USE
beclomethasone dipropionate	CIDs00021700	Phase 4	approved	CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@@]21C	R - RESPIRATORY SYSTEM | D - DERMATOLOGICALS | R - RESPIRATORY SYSTEM | A - ALIMENTARY TRACT AND METABOLISM
vidarabine	CIDs00021704	Phase 4	approved	Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O	S - SENSORY ORGANS | J - ANTIINFECTIVES FOR SYSTEMIC USE
iprindole	CIDs00021722	Phase 4	approved	CN(C)CCCn1c2c(c3ccccc31)CCCCCC2	N - NERVOUS SYSTEM
butriptyline	CIDs00021771	Phase 4	approved	CC(CC1c2ccccc2CCc2ccccc21)CN(C)C	N - NERVOUS SYSTEM
dimethindene	CIDs00021855	Phase 4	approved	CC(C1=C(CCN(C)C)Cc2ccccc21)c1ccccn1	R - RESPIRATORY SYSTEM | D - DERMATOLOGICALS
isometheptene	CIDs00022296	Phase 4	approved	CNC(C)CCC=C(C)C	A - ALIMENTARY TRACT AND METABOLISM
NMDA	CIDs00022880	Phase 2	unapproved	CN[C@H](CC(=O)O)C(=O)O	
L-DOPA methyl ester	CIDs00023497	Phase 1	unapproved	COC(=O)[C@@H](N)Cc1ccc(O)c(O)c1	N - NERVOUS SYSTEM
trimethaphan	CIDs00023576	Phase 4	approved	O=C1N(Cc2ccccc2)C2C[S+]3CCCC3C2N1Cc1ccccc1	C - CARDIOVASCULAR SYSTEM
molindone	CIDs00023897	Phase 4	approved	CCc1c(C)[nH]c2c1C(=O)C(CN1CCOCC1)CC2	N - NERVOUS SYSTEM
xenon	CIDs00023991	Phase 4	approved	[Xe]	N - NERVOUS SYSTEM
zalcitabine	CIDs00024066	Phase 4	approved	Nc1ccn([C@H]2CC[C@@H](CO)O2)c(=O)n1	J - ANTIINFECTIVES FOR SYSTEMIC USE
MgSO4	CIDs00024083	Phase 4	approved	O=S(=O)([O-])[O-].[Mg+2]	
chitin	CIDs00024139	Phase 2	unapproved	CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O	
hexocyclium	CIDs00024199	Phase 4	approved	C[N+]1(C)CCN(CC(O)(c2ccccc2)C2CCCCC2)CC1	A - ALIMENTARY TRACT AND METABOLISM
NaOCl	CIDs00024341	Phase 4	approved	OCl	
barium sulfate	CIDs00024414	Phase 4	approved	O=S(=O)([O-])[O-].[Ba+2]	
ZnSO4	CIDs00024424	Phase 4	approved	O=S(=O)([O-])[O-].[Zn+2]	A - ALIMENTARY TRACT AND METABOLISM | B - BLOOD AND BLOOD FORMING ORGANS
potassium nitrate	CIDs00024434	Phase 3	unapproved	O=[N+]([O-])[O-].[K+]	
silver nitrate	CIDs00024470	Phase 4	approved	O=[N+]([O-])[O-].[Ag+]	D - DERMATOLOGICALS
nitrite	CIDs00024529	Phase 4	approved	O=NO	
MgCl2	CIDs00024584	Phase 4	approved	[Cl-].[Cl-].[Mg+2]	
ozone	CIDs00024823	Phase 3	unapproved	O=[O+][O-]	
CaCl2	CIDs00024854	Phase 4	approved	[Ca+2].[Cl-].[Cl-]	G - GENITO URINARY SYSTEM AND SEX HORMONES | B - BLOOD AND BLOOD FORMING ORGANS | A - ALIMENTARY TRACT AND METABOLISM
stanozolol	CIDs00025249	Phase 4	approved	C[C@]12Cc3c[nH]nc3C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O	A - ALIMENTARY TRACT AND METABOLISM
melitracen	CIDs00025381	Phase 3	unapproved	CN(C)CCC=C1c2ccccc2C(C)(C)c2ccccc21	N - NERVOUS SYSTEM
clodronate	CIDs00025419	Phase 3	unapproved	O=P(O)(O)C(Cl)(Cl)P(=O)(O)O	M - MUSCULO-SKELETAL SYSTEM
carbendazim	CIDs00025429	Phase 1	unapproved	COC(=O)Nc1nc2ccccc2[nH]1	
coformycin	CIDs00025447	Phase 2	unapproved	OC[C@H]1O[C@@H](n2cnc3c2N=CNC[C@H]3O)[C@H](O)[C@@H]1O	
rose bengal	CIDs00025473	Phase 4	approved	O=C(O)c1c(Cl)c(Cl)c(Cl)c(Cl)c1-c1c2cc(I)c(=O)c(I)c-2oc2c(I)c(O)c(I)cc12	
reproterol	CIDs00025654	Phase 4	approved	Cn1c(=O)c2c(ncn2CCCNCC(O)c2cc(O)cc(O)c2)n(C)c1=O	R - RESPIRATORY SYSTEM | R - RESPIRATORY SYSTEM
azapropazone	CIDs00026098	Phase 4	approved	CCCC1C(=O)N2C(N(C)C)=Nc3ccc(C)cc3N2C1=O	M - MUSCULO-SKELETAL SYSTEM
misonidazole	CIDs00026105	Phase 2	unapproved	COCC(O)Cn1ccnc1[N+](=O)[O-]	
diacerein	CIDs00026248	Phase 4	approved	CC(=O)Oc1cccc2c1C(=O)c1c(OC(C)=O)cc(C(=O)O)cc1C2=O	M - MUSCULO-SKELETAL SYSTEM
selegiline	CIDs00026757	Phase 4	approved	C#CCN(C)[C@H](C)Cc1ccccc1	N - NERVOUS SYSTEM
levamisole	CIDs00026879	Phase 4	approved	c1ccc([C@H]2CN3CCSC3=N2)cc1	P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
clobutinol	CIDs00026937	Phase 4	approved	CC(CN(C)C)C(C)(O)Cc1ccc(Cl)cc1	R - RESPIRATORY SYSTEM
clemastine	CIDs00026986	Phase 4	approved	CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1	R - RESPIRATORY SYSTEM | R - RESPIRATORY SYSTEM | D - DERMATOLOGICALS
pancuronium	CIDs00027350	Phase 4	approved	CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@H]([N+]3(C)CCCCC3)[C@@H]4OC(C)=O)[C@@]2(C)C[C@@H]1[N+]1(C)CCCCC1	M - MUSCULO-SKELETAL SYSTEM
cephalexin	CIDs00027447	Phase 4	approved	CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1	
isosorbide-5-mononitrate	CIDs00027661	Phase 4	approved	O=[N+]([O-])O[C@@H]1CO[C@@H]2[C@@H](O)CO[C@H]12	C - CARDIOVASCULAR SYSTEM
gestrinone	CIDs00027812	Phase 4	approved	C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3C=C[C@@]21CC	G - GENITO URINARY SYSTEM AND SEX HORMONES
phorbol 12-myristate 13-acetate (PMA	CIDs00027924	Phase 2	unapproved	CCCCCCCCCCCCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(C)=O	
danazol	CIDs00028417	Phase 4	approved	C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C	G - GENITO URINARY SYSTEM AND SEX HORMONES
lithium	CIDs00028486	Phase 3	unapproved	[LiH]	
deslanoside	CIDs00028620	Phase 4	approved	C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3CC[C@]4(C)[C@H]5C[C@@H](O)[C@]6(C)[C@@H](C7=CC(=O)OC7)CC[C@]6(O)[C@@H]5CC[C@@H]4C3)O[C@@H]2C)C[C@H](O)[C@@H]1O[C@H]1C[C@H](O)[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](C)O1	C - CARDIOVASCULAR SYSTEM
metergoline	CIDs00028693	Phase 4	approved	CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@@H]2c3cccc4c3c(cn4C)C[C@H]21	G - GENITO URINARY SYSTEM AND SEX HORMONES
lisuride	CIDs00028864	Phase 4	approved	CCN(CC)C(=O)N[C@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1	G - GENITO URINARY SYSTEM AND SEX HORMONES | N - NERVOUS SYSTEM
1-deoxynojirimycin	CIDs00029435	Phase 2	unapproved	OC[C@H]1NC[C@H](O)[C@@H](O)[C@@H]1O	
taurolidine	CIDs00029566	Phase 4	approved	O=S1(=O)CCN(CN2CCS(=O)(=O)NC2)CN1	B - BLOOD AND BLOOD FORMING ORGANS
razoxane	CIDs00030623	Phase 4	approved	CC(CN1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1	
lofexidine	CIDs00030667	Phase 4	approved	CC(Oc1c(Cl)cccc1Cl)C1=NCCN1	N - NERVOUS SYSTEM
etifoxine	CIDs00030768	Phase 3	unapproved	CCNC1=Nc2ccc(Cl)cc2C(C)(c2ccccc2)O1	N - NERVOUS SYSTEM
carbimazole	CIDs00031072	Phase 4	approved	CCOC(=O)n1ccn(C)c1=S	H - SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
bromocriptine	CIDs00031100	Phase 4	approved	CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12	G - GENITO URINARY SYSTEM AND SEX HORMONES | N - NERVOUS SYSTEM
triamcinolone	CIDs00031307	Phase 4	approved	C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO	H - SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS | R - RESPIRATORY SYSTEM | R - RESPIRATORY SYSTEM | D - DERMATOLOGICALS | S - SENSORY ORGANS | C - CARDIOVASCULAR SYSTEM | D - DERMATOLOGICALS | A - ALIMENTARY TRACT AND METABOLISM
ethamicort	CIDs00031312	Phase 4	approved	CCN(CC)CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C	
UDCA	CIDs00031401	Phase 4	approved	C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C	A - ALIMENTARY TRACT AND METABOLISM
butylated hydroxytoluene	CIDs00031404	Phase 2	unapproved	Cc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1	
metipranolol	CIDs00031477	Phase 4	approved	CC(=O)Oc1c(C)cc(OCC(O)CNC(C)C)c(C)c1C	S - SENSORY ORGANS | S - SENSORY ORGANS
silymarin	CIDs00031553	Phase 3	unapproved	COc1cc([C@H]2Oc3cc([C@H]4Oc5cc(O)cc(O)c5C(=O)[C@@H]4O)ccc3O[C@@H]2CO)ccc1O	
benznidazole	CIDs00031593	Phase 4	approved	O=C(Cn1ccnc1[N+](=O)[O-])NCc1ccccc1	P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
halazepam	CIDs00031640	Phase 4	approved	O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1CC(F)(F)F	N - NERVOUS SYSTEM
clobetasol propionate	CIDs00032798	Phase 4	approved	CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C	D - DERMATOLOGICALS
dexchlorpheniramine	CIDs00033036	Phase 4	approved	CN(C)CC[C@@H](c1ccc(Cl)cc1)c1ccccn1	R - RESPIRATORY SYSTEM | R - RESPIRATORY SYSTEM
18F-FLT	CIDs00033039	Phase 2	unapproved	Cc1cn([C@H]2C[C@H](F)[C@@H](CO)O2)c(=O)[nH]c1=O	
cefazolin	CIDs00033255	Phase 4	approved	Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1	J - ANTIINFECTIVES FOR SYSTEMIC USE
timolol	CIDs00033624	Phase 4	approved	CC(C)(C)NC[C@H](O)COc1nsnc1N1CCOCC1	C - CARDIOVASCULAR SYSTEM | S - SENSORY ORGANS | S - SENSORY ORGANS
indoramin	CIDs00033625	Phase 4	approved	O=C(NC1CCN(CCc2c[nH]c3ccccc23)CC1)c1ccccc1	C - CARDIOVASCULAR SYSTEM
ketazolam	CIDs00033746	Phase 4	approved	CC1=CC(=O)N2CC(=O)N(C)c3ccc(Cl)cc3C2(c2ccccc2)O1	N - NERVOUS SYSTEM
almitrine	CIDs00033887	Phase 4	approved	C=CCNc1nc(NCC=C)nc(N2CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC2)n1	R - RESPIRATORY SYSTEM
nicergoline	CIDs00034040	Phase 4	approved	CO[C@]12C[C@@H](COC(=O)c3cncc(Br)c3)CN(C)[C@@H]1Cc1cn(C)c3cccc2c13	C - CARDIOVASCULAR SYSTEM
oxcarbazepine	CIDs00034312	Phase 4	approved	NC(=O)N1c2ccccc2CC(=O)c2ccccc21	N - NERVOUS SYSTEM
carbidopa	CIDs00034359	Phase 4	approved	C[C@@](Cc1ccc(O)c(O)c1)(NN)C(=O)O	
moricizine	CIDs00034632	Phase 4	approved	CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2	C - CARDIOVASCULAR SYSTEM
S-adenosylmethionine	CIDs00034755	Phase 4	approved	C[S+](CC[C@H](N)C(=O)[O-])C[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O	A - ALIMENTARY TRACT AND METABOLISM
amineptine	CIDs00034869	Phase 4	approved	O=C(O)CCCCCCNC1c2ccccc2CCc2ccccc21	N - NERVOUS SYSTEM
EFFECT IN	CIDs00035329	Phase 4	approved	Cc1ccc(C(=O)Oc2ccc(C(O)CNC(C)(C)C)cc2OC(=O)c2ccc(C)cc2)cc1	R - RESPIRATORY SYSTEM
zidovudine	CIDs00035370	Phase 4	approved	Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O	J - ANTIINFECTIVES FOR SYSTEMIC USE
pirprofen	CIDs00035935	Phase 4	approved	CC(C(=O)O)c1ccc(N2CC=CC2)c(Cl)c1	M - MUSCULO-SKELETAL SYSTEM
tobramycin	CIDs00036294	Phase 4	approved	NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O	J - ANTIINFECTIVES FOR SYSTEMIC USE | S - SENSORY ORGANS
substance P analogue	CIDs00036511	Phase 1	unapproved	CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCN=C(N)N)C(N)=O	
acesulfame-K	CIDs00036573	Phase 3	unapproved	CC1=CC(=O)NS(=O)(=O)O1	
dobutamine	CIDs00036811	Phase 4	approved	CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1	C - CARDIOVASCULAR SYSTEM
tertatolol	CIDs00036920	Phase 4	approved	CC(C)(C)NCC(O)COc1cccc2c1SCCC2	C - CARDIOVASCULAR SYSTEM
halofantrine	CIDs00037392	Phase 4	approved	CCCCN(CCCC)CCC(O)c1cc2c(Cl)cc(Cl)cc2c2cc(C(F)(F)F)ccc12	P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
penbutolol	CIDs00037464	Phase 4	approved	CC(C)(C)NC[C@H](O)COc1ccccc1C1CCCC1	C - CARDIOVASCULAR SYSTEM
ribavirin	CIDs00037542	Phase 4	approved	NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1	J - ANTIINFECTIVES FOR SYSTEMIC USE
amikacin	CIDs00037768	Phase 4	approved	NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O	S - SENSORY ORGANS | D - DERMATOLOGICALS | J - ANTIINFECTIVES FOR SYSTEMIC USE
cycloferon	CIDs00038072	Phase 2	unapproved	O=C(O)Cn1c2ccccc2c(=O)c2ccccc21	L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
cephradine	CIDs00038103	Phase 4	approved	CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)C3=CCC=CC3)[C@H]2SC1	J - ANTIINFECTIVES FOR SYSTEMIC USE
tienilic acid	CIDs00038409	Phase 4	approved	O=C(O)COc1ccc(C(=O)c2cccs2)c(Cl)c1Cl	C - CARDIOVASCULAR SYSTEM
guanadrel	CIDs00038521	Phase 4	approved	N=C(N)NCC1COC2(CCCCC2)O1	
methyldopa	CIDs00038852	Phase 4	approved	C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O	C - CARDIOVASCULAR SYSTEM
tocainide	CIDs00038945	Phase 4	approved	Cc1cccc(C)c1NC(=O)C(C)N	C - CARDIOVASCULAR SYSTEM
bezafibrate	CIDs00039042	Phase 4	approved	CC(C)(Oc1ccc(CCNC(=O)c2ccc(Cl)cc2)cc1)C(=O)O	C - CARDIOVASCULAR SYSTEM
nadolol	CIDs00039147	Phase 4	approved	CC(C)(C)NCC(O)COc1cccc2c1C[C@H](O)[C@H](O)C2	C - CARDIOVASCULAR SYSTEM
diltiazem	CIDs00039186	Phase 4	approved	COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1	C - CARDIOVASCULAR SYSTEM | C - CARDIOVASCULAR SYSTEM
levobunolol	CIDs00039468	Phase 4	approved	CC(C)(C)NC[C@H](O)COc1cccc2c1CCCC2=O	S - SENSORY ORGANS
vecuronium	CIDs00039764	Phase 4	approved	CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@H]([N+]3(C)CCCCC3)[C@@H]4OC(C)=O)[C@@]2(C)C[C@@H]1N1CCCCC1	M - MUSCULO-SKELETAL SYSTEM
l-NAME	CIDs00039836	Phase 2	unapproved	COC(=O)[C@@H](N)CCCNC(=N)N[N+](=O)[O-]	
nabilone	CIDs00039860	Phase 4	approved	CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)C1CCC(=O)CC21	A - ALIMENTARY TRACT AND METABOLISM
dexibuprofen	CIDs00039912	Phase 4	approved	CC(C)Cc1ccc([C@H](C)C(=O)O)cc1	M - MUSCULO-SKELETAL SYSTEM
benoxaprofen	CIDs00039941	Phase 4	approved	CC(C(=O)O)c1ccc2oc(-c3ccc(Cl)cc3)nc2c1	M - MUSCULO-SKELETAL SYSTEM
permethrin	CIDs00040326	Phase 4	approved	CC1(C)C(C=C(Cl)Cl)C1C(=O)OCc1cccc(Oc2ccccc2)c1	P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS | P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
pirfenidone	CIDs00040632	Phase 4	approved	Cc1ccc(=O)n(-c2ccccc2)c1	L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
oxfendazole	CIDs00040854	Phase 2	unapproved	COC(=O)Nc1nc2cc([S+]([O-])c3ccccc3)ccc2[nH]1	
desogestrel	CIDs00040973	Phase 4	approved	C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CCCC[C@@H]4[C@H]3C(=C)C[C@@]21CC	G - GENITO URINARY SYSTEM AND SEX HORMONES
nitazoxanide	CIDs00041684	Phase 4	approved	CC(=O)Oc1ccccc1C(=O)Nc1ncc([N+](=O)[O-])s1	P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
sufentanil	CIDs00041693	Phase 4	approved	CCC(=O)N(c1ccccc1)C1(COC)CCN(CCc2cccs2)CC1	N - NERVOUS SYSTEM
torasemide	CIDs00041781	Phase 4	approved	Cc1cccc(Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C)c1	C - CARDIOVASCULAR SYSTEM
cefmetazole	CIDs00042008	Phase 4	approved	CO[C@@]1(NC(=O)CSCC#N)C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CS[C@@H]21	J - ANTIINFECTIVES FOR SYSTEMIC USE
desflurane	CIDs00042113	Phase 4	approved	FC(F)OC(F)C(F)(F)F	N - NERVOUS SYSTEM
alizapride	CIDs00043008	Phase 3	unapproved	C=CCN1CCCC1CNC(=O)c1cc2nn[nH]c2cc1OC	A - ALIMENTARY TRACT AND METABOLISM
piperacillin	CIDs00043672	Phase 4	approved	CCN1CCN(C(=O)N[C@@H](C(=O)N[C@@H]2C(=O)N3[C@@H](C(=O)O)C(C)(C)S[C@H]23)c2ccccc2)C(=O)C1=O	J - ANTIINFECTIVES FOR SYSTEMIC USE
cefotiam	CIDs00043708	Phase 4	approved	CN(C)CCn1nnnc1SCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)Cc3csc(N)n3)[C@H]2SC1	J - ANTIINFECTIVES FOR SYSTEMIC USE
paroxetine	CIDs00043815	Phase 4	approved	Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1	N - NERVOUS SYSTEM
captopril	CIDs00044093	Phase 4	approved	C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O	C - CARDIOVASCULAR SYSTEM
sapropterin	CIDs00044257	Phase 4	approved	C[C@H](O)[C@H](O)[C@H]1CNc2nc(N)nc(O)c2N1	A - ALIMENTARY TRACT AND METABOLISM
R-baclofen	CIDs00044601	Phase 3	unapproved	NC[C@H](CC(=O)O)c1ccc(Cl)cc1	
indalpine	CIDs00044668	Phase 4	approved	c1ccc2c(CCC3CCNCC3)c[nH]c2c1	
oltipraz	CIDs00047318	Phase 3	unapproved	Cc1c(-c2cnccn2)ssc1=S	
atracurium	CIDs00047319	Phase 4	approved	COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC	M - MUSCULO-SKELETAL SYSTEM
butoconazole	CIDs00047471	Phase 4	approved	Clc1ccc(CCC(Cn2ccnc2)Sc2c(Cl)cccc2Cl)cc1	G - GENITO URINARY SYSTEM AND SEX HORMONES
moxalactam	CIDs00047499	Phase 4	approved	CO[C@@]1(NC(=O)C(C(=O)O)c2ccc(O)cc2)C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CO[C@@H]21	J - ANTIINFECTIVES FOR SYSTEMIC USE
nicorandil	CIDs00047528	Phase 4	approved	O=C(NCCO[N+](=O)[O-])c1cccnc1	C - CARDIOVASCULAR SYSTEM
Nizoral	CIDs00047576	Phase 3	unapproved	CC(=O)N1CCN(c2ccc(OC[C@@H]3CO[C@@](Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1	
naftifine	CIDs00047641	Phase 4	approved	CN(C/C=C/c1ccccc1)Cc1cccc2ccccc12	D - DERMATOLOGICALS
pergolide	CIDs00047811	Phase 4	approved	CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21	N - NERVOUS SYSTEM
bicifadine	CIDs00047952	Phase 3	unapproved	Cc1ccc(C23CNCC2C3)cc1	
encainide	CIDs00048040	Phase 4	approved	COc1ccc(C(=O)Nc2ccccc2CCC2CCCCN2C)cc1	C - CARDIOVASCULAR SYSTEM
pipecuronium	CIDs00050192	Phase 4	approved	CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@H](N3CC[N+](C)(C)CC3)[C@@H]4OC(C)=O)[C@@]2(C)C[C@@H]1N1CC[N+](C)(C)CC1	
buserelin	CIDs00050224	Phase 4	approved	CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1	L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
nedocromil sodium	CIDs00050294	Phase 4	approved	CCCc1c2oc(C(=O)O)cc(=O)c2cc2c(=O)cc(C(=O)O)n(CC)c12	R - RESPIRATORY SYSTEM | R - RESPIRATORY SYSTEM | S - SENSORY ORGANS
amonafide	CIDs00050515	Phase 3	unapproved	CN(C)CCN1C(=O)c2cccc3cc(N)cc(c23)C1=O	
didanosine	CIDs00050599	Phase 4	approved	O=c1[nH]cnc2c1ncn2[C@H]1CC[C@@H](CO)O1	J - ANTIINFECTIVES FOR SYSTEMIC USE
doxofylline	CIDs00050942	Phase 3	unapproved	Cn1c(=O)c2c(ncn2CC2OCCO2)n(C)c1=O	R - RESPIRATORY SYSTEM
cefaclor	CIDs00051038	Phase 4	approved	N[C@@H](C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(Cl)CS[C@H]12)c1ccccc1	
bucindolol	CIDs00051044	Phase 2	unapproved	CC(C)(Cc1c[nH]c2ccccc12)NCC(O)COc1ccccc1C#N	
pefloxacin	CIDs00051081	Phase 4	approved	CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCN(C)CC3)cc21	J - ANTIINFECTIVES FOR SYSTEMIC USE
alfentanil	CIDs00051263	Phase 4	approved	CCC(=O)N(c1ccccc1)C1(COC)CCN(CCn2nnn(CC)c2=O)CC1	N - NERVOUS SYSTEM
miglustat	CIDs00051634	Phase 4	approved	CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO	A - ALIMENTARY TRACT AND METABOLISM
indecainide	CIDs00052194	Phase 4	approved	CC(C)NCCCC1(C(N)=O)c2ccccc2-c2ccccc21	
cefotetan	CIDs00053024	Phase 4	approved	CO[C@@]1(NC(=O)C2SC(=C(C(N)=O)C(=O)O)S2)C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CS[C@@H]21	J - ANTIINFECTIVES FOR SYSTEMIC USE
lovastatin	CIDs00053232	Phase 4	approved	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21	C - CARDIOVASCULAR SYSTEM
flupirtine	CIDs00053275	Phase 2	unapproved	CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)nc1N	N - NERVOUS SYSTEM
tolrestat	CIDs00053359	Phase 4	approved	COc1ccc2c(C(=S)N(C)CC(=O)O)cccc2c1C(F)(F)F	A - ALIMENTARY TRACT AND METABOLISM
enoximone	CIDs00053708	Phase 4	approved	CSc1ccc(C(=O)c2[nH]c(=O)[nH]c2C)cc1	C - CARDIOVASCULAR SYSTEM
piritrexim	CIDs00054369	Phase 2	unapproved	COc1ccc(OC)c(Cc2cnc3nc(N)nc(N)c3c2C)c1	
levocabastine	CIDs00054384	Phase 4	approved	C[C@@H]1CN([C@H]2CC[C@](C#N)(c3ccc(F)cc3)CC2)CC[C@]1(C(=O)O)c1ccccc1	R - RESPIRATORY SYSTEM | S - SENSORY ORGANS
simvastatin	CIDs00054454	Phase 4	approved	CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21	C - CARDIOVASCULAR SYSTEM
idazoxan	CIDs00054459	Phase 3	unapproved	c1ccc2c(c1)OCC(C1=NCCN1)O2	
remoxipride	CIDs00054477	Phase 4	approved	CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(Br)c1OC	N - NERVOUS SYSTEM
pravastatin	CIDs00054687	Phase 4	approved	CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)O)[C@H]21	C - CARDIOVASCULAR SYSTEM
cabergoline	CIDs00054746	Phase 4	approved	C=CCN1C[C@H](C(=O)N(CCCN(C)C)C(=O)NCC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21	G - GENITO URINARY SYSTEM AND SEX HORMONES | N - NERVOUS SYSTEM
bambuterol	CIDs00054765	Phase 3	unapproved	CN(C)C(=O)Oc1cc(OC(=O)N(C)C)cc(C(O)CNC(C)(C)C)c1	R - RESPIRATORY SYSTEM
atomoxetine	CIDs00054840	Phase 4	approved	CNCC[C@@H](Oc1ccccc1C)c1ccccc1	N - NERVOUS SYSTEM
moexipril	CIDs00054889	Phase 4	approved	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2cc(OC)c(OC)cc2C[C@H]1C(=O)O	C - CARDIOVASCULAR SYSTEM
quinapril	CIDs00054891	Phase 4	approved	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2ccccc2C[C@H]1C(=O)O	C - CARDIOVASCULAR SYSTEM
alpidem	CIDs00054897	Phase 4	approved	CCCN(CCC)C(=O)Cc1c(-c2ccc(Cl)cc2)nc2ccc(Cl)cn12	
cicletanine	CIDs00054909	Phase 2	unapproved	Cc1ncc2c(c1O)COC2c1ccc(Cl)cc1	C - CARDIOVASCULAR SYSTEM
gepirone	CIDs00055190	Phase 2	unapproved	CC1(C)CC(=O)N(CCCCN2CCN(c3ncccn3)CC2)C(=O)C1	N - NERVOUS SYSTEM
mifepristone	CIDs00055245	Phase 4	approved	CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C	G - GENITO URINARY SYSTEM AND SEX HORMONES | G - GENITO URINARY SYSTEM AND SEX HORMONES
15-deoxyspergualin	CIDs00055361	Phase 3	unapproved	N=C(N)NCCCCCCC(=O)NC(O)C(=O)NCCCCNCCCN	L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
loxtidine	CIDs00055472	Phase 2	unapproved	Cn1nc(CO)nc1NCCCOc1cccc(CN2CCCCC2)c1	
dopexamine	CIDs00055483	Phase 4	approved	Oc1ccc(CCNCCCCCCNCCc2ccccc2)cc1O	C - CARDIOVASCULAR SYSTEM
quinagolide	CIDs00055645	Phase 2	unapproved	CCCN1CC(NS(=O)(=O)N(CC)CC)CC2Cc3c(O)cccc3CC21	G - GENITO URINARY SYSTEM AND SEX HORMONES
Antineoplaston A10	CIDs00056260	Phase 3	unapproved	O=C1CC[C@H](NC(=O)Cc2ccccc2)C(=O)N1	
cilazapril	CIDs00056329	Phase 4	approved	CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCCN2CCC[C@@H](C(=O)O)N2C1=O	C - CARDIOVASCULAR SYSTEM
fosphenytoin	CIDs00056338	Phase 4	approved	O=C1NC(c2ccccc2)(c2ccccc2)C(=O)N1COP(=O)(O)O	N - NERVOUS SYSTEM
ranolazine	CIDs00056959	Phase 4	approved	COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1	C - CARDIOVASCULAR SYSTEM
raclopride	CIDs00057346	Phase 1	unapproved	CCN1CCC[C@H]1CNC(=O)c1c(O)c(Cl)cc(Cl)c1OC	
finasteride	CIDs00057363	Phase 4	approved	CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C	G - GENITO URINARY SYSTEM AND SEX HORMONES | D - DERMATOLOGICALS
imiquimod	CIDs00057469	Phase 4	approved	CC(C)Cn1cnc2c(N)nc3ccccc3c21	D - DERMATOLOGICALS
pemirolast	CIDs00057697	Phase 4	approved	Cc1cccn2c(=O)c(-c3nnn[nH]3)cnc12	
rotigotine	CIDs00059226	Phase 4	approved	CCCN(CCc1cccs1)[C@H]1CCc2c(O)cccc2C1	N - NERVOUS SYSTEM
esmolol	CIDs00059768	Phase 4	approved	COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1	C - CARDIOVASCULAR SYSTEM
dexpramipexole	CIDs00059868	Phase 3	unapproved	CCCN[C@@H]1CCc2nc(N)sc2C1	
temafloxacin	CIDs00060020	Phase 4	approved	CC1CN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3-c2ccc(F)cc2F)CCN1	J - ANTIINFECTIVES FOR SYSTEMIC USE
sertindole	CIDs00060149	Phase 4	approved	O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1	N - NERVOUS SYSTEM
adapalene	CIDs00060164	Phase 4	approved	COc1ccc(-c2ccc3cc(C(=O)O)ccc3c2)cc1C12CC3CC(CC(C3)C1)C2	D - DERMATOLOGICALS | D - DERMATOLOGICALS
doxacurium	CIDs00060168	Phase 4	approved	COc1cc(CC2c3c(cc(OC)c(OC)c3OC)CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCc3cc(OC)c(OC)c(OC)c3C2Cc2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC	
adefovir	CIDs00060172	Phase 3	unapproved	Nc1ncnc2c1ncn2CCOCP(=O)(O)O	
exemestane	CIDs00060198	Phase 4	approved	C=C1C[C@@H]2[C@H](CC[C@]3(C)C(=O)CC[C@@H]23)[C@@]2(C)C=CC(=O)C=C12	L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
penclomedine	CIDs00060203	Phase 1	unapproved	COc1nc(C(Cl)(Cl)Cl)c(Cl)c(OC)c1Cl	
sparfloxacin	CIDs00060464	Phase 4	approved	C[C@H]1CN(c2c(F)c(N)c3c(=O)c(C(=O)O)cn(C4CC4)c3c2F)C[C@@H](C)N1	J - ANTIINFECTIVES FOR SYSTEMIC USE
zileuton	CIDs00060490	Phase 4	approved	CC(c1cc2ccccc2s1)N(O)C(N)=O	
clopidogrel	CIDs00060606	Phase 4	approved	COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1	B - BLOOD AND BLOOD FORMING ORGANS
cidofovir	CIDs00060613	Phase 4	approved	Nc1ccn(C[C@@H](CO)OCP(=O)(O)O)c(=O)n1	J - ANTIINFECTIVES FOR SYSTEMIC USE
tiagabine	CIDs00060648	Phase 4	approved	Cc1ccsc1C(=CCCN1CCC[C@@H](C(=O)O)C1)c1sccc1C	N - NERVOUS SYSTEM
levobetaxolol	CIDs00060656	Phase 4	approved	CC(C)NC[C@H](O)COc1ccc(CCOCC2CC2)cc1	
mibefradil	CIDs00060662	Phase 4	approved	COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C	C - CARDIOVASCULAR SYSTEM
bromfenac	CIDs00060726	Phase 4	approved	Nc1c(CC(=O)O)cccc1C(=O)c1ccc(Br)cc1	S - SENSORY ORGANS
celgosivir	CIDs00060734	Phase 2	unapproved	CCCC(=O)O[C@H]1CN2CC[C@H](O)[C@@H]2[C@@H](O)[C@@H]1O	
ibutilide	CIDs00060752	Phase 4	approved	CCCCCCCN(CC)CCCC(O)c1ccc(NS(C)(=O)=O)cc1	C - CARDIOVASCULAR SYSTEM
VACV	CIDs00060772	Phase 4	approved	CC(C)[C@H](N)C(=O)OCCOCn1cnc2c(=O)nc(N)[nH]c21	J - ANTIINFECTIVES FOR SYSTEMIC USE
genes A	CIDs00060789	Phase 4	approved	Oc1ccc(CCCCNC[C@H](O)c2ccc(O)c(O)c2)cc1	C - CARDIOVASCULAR SYSTEM
aripiprazole	CIDs00060795	Phase 4	approved	O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1	N - NERVOUS SYSTEM
xanomeline	CIDs00060809	Phase 3	unapproved	CCCCCCOc1nsnc1C1=CCCN(C)C1	
remifentanil	CIDs00060814	Phase 4	approved	CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCC(=O)OC)CC1	N - NERVOUS SYSTEM
atorvastatin	CIDs00060822	Phase 4	approved	CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)O	C - CARDIOVASCULAR SYSTEM
lamivudine	CIDs00060825	Phase 4	approved	Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1	J - ANTIINFECTIVES FOR SYSTEMIC USE
duloxetine	CIDs00060834	Phase 4	approved	CNCC[C@H](Oc1cccc2ccccc12)c1cccs1	N - NERVOUS SYSTEM
valsartan	CIDs00060846	Phase 4	approved	CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)[C@H](C(=O)O)C(C)C	C - CARDIOVASCULAR SYSTEM
ibandronate	CIDs00060852	Phase 4	approved	CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O	M - MUSCULO-SKELETAL SYSTEM
ziprasidone	CIDs00060853	Phase 4	approved	O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1	N - NERVOUS SYSTEM
zanamivir	CIDs00060855	Phase 4	approved	CC(=O)N[C@@H]1[C@@H](NC(=N)N)C=C(C(=O)O)O[C@H]1[C@H](O)[C@H](O)CO	J - ANTIINFECTIVES FOR SYSTEMIC USE
zolmitriptan	CIDs00060857	Phase 4	approved	CN(C)CCc1c[nH]c2ccc(C[C@H]3COC(=O)N3)cc12	N - NERVOUS SYSTEM
metaiodobenzylguanidine	CIDs00060860	Phase 4	approved	N=C(N)NCc1cccc(I)c1	
OSI-7904L	CIDs00060863	Phase 2	unapproved	Cc1nc2ccc3ccc(CNc4ccc5c(c4)CN([C@@H](CCC(=O)O)C(=O)O)C5=O)cc3c2c(=O)[nH]1	
adefovir dipivoxil	CIDs00060871	Phase 4	approved	CC(C)(C)C(=O)OCOP(=O)(COCCn1cnc2c(N)ncnc21)OCOC(=O)C(C)(C)C	J - ANTIINFECTIVES FOR SYSTEMIC USE
emtricitabine	CIDs00060877	Phase 4	approved	Nc1nc(=O)n([C@@H]2CS[C@H](CO)O2)cc1F	J - ANTIINFECTIVES FOR SYSTEMIC USE
saquinavir	CIDs00060934	Phase 4	approved	CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1	J - ANTIINFECTIVES FOR SYSTEMIC USE
tiludronate	CIDs00060936	Phase 4	approved	O=P(O)(O)C(Sc1ccc(Cl)cc1)P(=O)(O)O	M - MUSCULO-SKELETAL SYSTEM
relcovaptan	CIDs00060943	Phase 2	unapproved	COc1ccc(S(=O)(=O)N2c3ccc(Cl)cc3[C@](O)(c3ccccc3Cl)[C@@H]2C(=O)N2CCC[C@H]2C(N)=O)cc1OC	
tirofiban	CIDs00060946	Phase 4	approved	CCCCS(=O)(=O)N[C@@H](Cc1ccc(OCCCCC2CCNCC2)cc1)C(=O)O	B - BLOOD AND BLOOD FORMING ORGANS
adenosine	CIDs00060961	Phase 4	approved	Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O	C - CARDIOVASCULAR SYSTEM
D-lactate	CIDs00061503	Phase 3	unapproved	C[C@@H](O)C(=O)O	
netilmicin	CIDs00062115	Phase 4	approved	CCN[C@@H]1C[C@H](N)[C@@H](O[C@H]2OC(CN)=CC[C@H]2N)[C@H](O)[C@H]1O[C@H]1OC[C@](C)(O)[C@H](NC)[C@H]1O	J - ANTIINFECTIVES FOR SYSTEMIC USE | S - SENSORY ORGANS
carfentanil	CIDs00062156	Phase 2	unapproved	CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCc2ccccc2)CC1	
halofuginone	CIDs00062893	Phase 2	unapproved	O=C(CC1NCCCC1O)Cn1cnc2cc(Br)c(Cl)cc2c1=O	
laurina	CIDs00062957	Phase 3	unapproved	C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CCCC[C@@H]4[C@H]3C(=C)C[C@@]21CC.C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@@]21C	
trovafloxacin	CIDs00062959	Phase 4	approved	N[C@H]1[C@@H]2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)C[C@H]12	J - ANTIINFECTIVES FOR SYSTEMIC USE
sertraline	CIDs00063009	Phase 4	approved	CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21	N - NERVOUS SYSTEM
carmoterol	CIDs00063951	Phase 2	unapproved	COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1	
efavirenz	CIDs00064139	Phase 4	approved	O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1	J - ANTIINFECTIVES FOR SYSTEMIC USE
nelfinavir	CIDs00064142	Phase 4	approved	Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C	J - ANTIINFECTIVES FOR SYSTEMIC USE
rolofylline	CIDs00064627	Phase 3	unapproved	CCCn1c(=O)c2nc(C34CC5CC(CC3C5)C4)[nH]c2n(CCC)c1=O	
fenofibric acid	CIDs00064929	Phase 4	approved	CC(C)(Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1)C(=O)O	
H-NMR	CIDs00064945	Phase 2	unapproved	C[C@@H]1[C@H]2C3=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)CC[C@@]2(C(=O)O)CC[C@H]1C	
betulinic acid	CIDs00064971	Phase 1	unapproved	C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12	
plerixafor	CIDs00065014	Phase 4	approved	c1cc(CN2CCCNCCNCCCNCC2)ccc1CN1CCCNCCNCCCNCC1	L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
amprenavir	CIDs00065016	Phase 4	approved	CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1	J - ANTIINFECTIVES FOR SYSTEMIC USE
oseltamivir	CIDs00065028	Phase 4	approved	CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1	J - ANTIINFECTIVES FOR SYSTEMIC USE
cocaethylene	CIDs00065034	Phase 1	unapproved	CCOC(=O)[C@@H]1C2CCC(C[C@@H]1OC(=O)c1ccccc1)N2C	
allicin	CIDs00065036	Phase 2	unapproved	C=CCS[S+]([O-])CC=C	
EGCG	CIDs00065064	Phase 3	unapproved	O=C(O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1	
ara-CMP	CIDs00065177	Phase 3	unapproved	Nc1ccn([C@@H]2O[C@H](COP(=O)(O)O)[C@@H](O)[C@@H]2O)c(=O)n1	
GSSG	CIDs00065359	Phase 4	approved	N[C@@H](CCC(=O)N[C@@H](CSSC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)C(=O)NCC(=O)O)C(=O)O	
secoisolariciresinol	CIDs00065373	Phase 2	unapproved	COc1cc(C[C@@H](CO)[C@H](CO)Cc2ccc(O)c(OC)c2)ccc1O	
Celestone Soluspan	CIDs00065478	Phase 4	approved	C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(=O)(O)O	
Coenzyme	CIDs00065625	Phase 3	unapproved	O=S(=O)(O)CCSSCCS(=O)(=O)O	
erdosteine	CIDs00065632	Phase 4	approved	O=C(O)CSCC(=O)NC1CCSC1=O	R - RESPIRATORY SYSTEM
litoxetine	CIDs00065650	Phase 1	unapproved	c1ccc2cc(COC3CCNCC3)ccc2c1	
ecabet sodium	CIDs00065781	Phase 3	unapproved	CC(C)c1cc2c(cc1S(=O)(=O)O)[C@@]1(C)CCC[C@@](C)(C(=O)O)[C@@H]1CC2	
eltoprazine	CIDs00065853	Phase 2	unapproved	c1cc2c(c(N3CCNCC3)c1)OCCO2	
reboxetine	CIDs00065856	Phase 3	unapproved	CCOc1ccccc1O[C@@H](c1ccccc1)[C@@H]1CNCCO1	
sertaconazole	CIDs00065863	Phase 4	approved	Clc1ccc(C(Cn2ccnc2)OCc2csc3c(Cl)cccc23)c(Cl)c1	D - DERMATOLOGICALS | G - GENITO URINARY SYSTEM AND SEX HORMONES
lercanidipine	CIDs00065866	Phase 4	approved	COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)(C)CN(C)CCC(c2ccccc2)c2ccccc2)C1c1cccc([N+](=O)[O-])c1	C - CARDIOVASCULAR SYSTEM
ebrotidine	CIDs00065869	Phase 4	approved	N=C(N)Nc1nc(CSCCN/C=N/S(=O)(=O)c2ccc(Br)cc2)cs1	
mizolastine	CIDs00065906	Phase 4	approved	CN(c1nccc(=O)[nH]1)C1CCN(c2nc3ccccc3n2Cc2ccc(F)cc2)CC1	R - RESPIRATORY SYSTEM
dexloxiglumide	CIDs00065937	Phase 3	unapproved	CCCCCN(CCCOC)C(=O)[C@@H](CCC(=O)O)NC(=O)c1ccc(Cl)c(Cl)c1	
AcSDKP	CIDs00065938	Phase 1	unapproved	CC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)O	
azelnidipine	CIDs00065948	Phase 3	unapproved	CC1=C(C(=O)OC(C)C)C(c2cccc([N+](=O)[O-])c2)C(C(=O)OC2CN(C(c3ccccc3)c3ccccc3)C2)=C(N)N1	
repaglinide	CIDs00065981	Phase 4	approved	CCOc1cc(CC(=O)N[C@@H](CC(C)C)c2ccccc2N2CCCCC2)ccc1C(=O)O	A - ALIMENTARY TRACT AND METABOLISM
lerisetron	CIDs00065997	Phase 3	unapproved	c1ccc(Cn2c(N3CCNCC3)nc3ccccc32)cc1	
telmisartan	CIDs00065999	Phase 4	approved	CCCc1nc2c(C)cc(-c3nc4ccccc4n3C)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1	C - CARDIOVASCULAR SYSTEM
corticoid	CIDs00066249	Phase 4	approved	CC(=O)OCC(=O)[C@@]1(O)[C@H](C)C[C@H]2[C@@H]3C=C(C)C4=Cc5c(cnn5-c5ccccc5)C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C	H - SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
dexfenfluramine	CIDs00066264	Phase 4	approved	CCN[C@@H](C)Cc1cccc(C(F)(F)F)c1	A - ALIMENTARY TRACT AND METABOLISM
2-methoxyestradiol	CIDs00066414	Phase 2	unapproved	COc1cc2c(cc1O)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12	
L-cystine	CIDs00067678	Phase 4	approved	N[C@@H](CSSC[C@H](N)C(=O)O)C(=O)O	
pinocembrin	CIDs00068071	Phase 2	unapproved	O=C1C[C@@H](c2ccccc2)Oc2cc(O)cc(O)c21	
methylxanthine derivative	CIDs00068374	Phase 2	unapproved	Cn1cnc2nc(O)nc(O)c21	
medetomidine	CIDs00068601	Phase 3	unapproved	Cc1cccc(C(C)c2c[nH]cn2)c1C	
rilmenidine	CIDs00068712	Phase 3	unapproved	C1COC(NC(C2CC2)C2CC2)=N1	C - CARDIOVASCULAR SYSTEM
antrafenine	CIDs00068723	Phase 4	approved	O=C(OCCN1CCN(c2cccc(C(F)(F)F)c2)CC1)c1ccccc1Nc1ccnc2cc(C(F)(F)F)ccc12	
zoledronic acid	CIDs00068740	Phase 4	approved	O=P(O)(O)C(O)(Cn1ccnc1)P(=O)(O)O	M - MUSCULO-SKELETAL SYSTEM
talinolol	CIDs00068770	Phase 1	unapproved	CC(C)(C)NCC(O)COc1ccc(NC(=O)NC2CCCCC2)cc1	C - CARDIOVASCULAR SYSTEM
nomegestrol	CIDs00068783	Phase 4	approved	CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C	G - GENITO URINARY SYSTEM AND SEX HORMONES
imexon	CIDs00068791	Phase 2	unapproved	N=C1NC(=O)N2CC12	
brinzolamide	CIDs00068844	Phase 4	approved	CCN[C@H]1CN(CCCOC)S(=O)(=O)c2sc(S(N)(=O)=O)cc21	S - SENSORY ORGANS | S - SENSORY ORGANS
dienogest	CIDs00068861	Phase 4	approved	C[C@]12CCC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@]2(O)CC#N	G - GENITO URINARY SYSTEM AND SEX HORMONES
cinitapride	CIDs00068867	Phase 3	unapproved	CCOc1cc(N)c([N+](=O)[O-])cc1C(=O)NC1CCN(CC2CC=CCC2)CC1	A - ALIMENTARY TRACT AND METABOLISM
tianeptine	CIDs00068870	Phase 3	unapproved	CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O	N - NERVOUS SYSTEM
drospirenone	CIDs00068873	Phase 4	approved	C[C@]12CC[C@H]3[C@H]([C@@H]1[C@@H]1C[C@@H]1[C@@]21CCC(=O)O1)[C@H]1C[C@H]1C1=CC(=O)CC[C@@]13C	G - GENITO URINARY SYSTEM AND SEX HORMONES
artemether	CIDs00068911	Phase 4	approved	CO[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@]42OO3	P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
D-serine	CIDs00071077	Phase 3	unapproved	N[C@H](CO)C(=O)O	
nefiracetam	CIDs00071157	Phase 2	unapproved	Cc1cccc(C)c1NC(=O)CN1CCCC1=O	
acamprosate	CIDs00071158	Phase 4	approved	CC(=O)NCCCS(=O)(=O)O	N - NERVOUS SYSTEM
isaxonine	CIDs00071169	Phase 4	approved	CC(C)Nc1ncccn1	
N-methylscopolamine	CIDs00071183	Phase 4	approved	C[N+]1(C)[C@H]2C[C@H](OC(=O)[C@H](CO)c3ccccc3)C[C@@H]1[C@H]1O[C@@H]21	A - ALIMENTARY TRACT AND METABOLISM | S - SENSORY ORGANS
3,3',5-triiodo-D-thyronine	CIDs00071212	Phase 1	unapproved	N[C@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(=O)O	
nebivolol	CIDs00071301	Phase 4	approved	OC(CNCC(O)C1CCc2cc(F)ccc2O1)C1CCc2cc(F)ccc2O1	C - CARDIOVASCULAR SYSTEM
atipamezole	CIDs00071310	Phase 1	unapproved	CCC1(c2cnc[nH]2)Cc2ccccc2C1	
dofetilide	CIDs00071329	Phase 4	approved	CN(CCOc1ccc(NS(C)(=O)=O)cc1)CCc1ccc(NS(C)(=O)=O)cc1	C - CARDIOVASCULAR SYSTEM
dapoxetine	CIDs00071352	Phase 4	approved	CN(C)[C@@H](CCOc1cccc2ccccc12)c1ccccc1	G - GENITO URINARY SYSTEM AND SEX HORMONES
bindarit	CIDs00071354	Phase 2	unapproved	CC(C)(OCc1nn(Cc2ccccc2)c2ccccc12)C(=O)O	
iloperidone	CIDs00071360	Phase 4	approved	COc1cc(C(C)=O)ccc1OCCCN1CCC(c2noc3cc(F)ccc23)CC1	N - NERVOUS SYSTEM
dexrazoxane	CIDs00071384	Phase 4	approved	C[C@@H](CN1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1	V - VARIOUS
diflorasone diacetate	CIDs00071414	Phase 4	approved	CC(=O)OCC(=O)[C@@]1(OC(C)=O)[C@@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C	D - DERMATOLOGICALS
EpiBr	CIDs00071613	Phase 1	unapproved	C[C@]12CC[C@H]3[C@@H](CC[C@H]4C[C@@H](O)CC[C@@]43C)[C@@H]1C[C@@H](Br)C2=O	
voriconazole	CIDs00071616	Phase 4	approved	C[C@@H](c1ncncc1F)[C@](O)(Cn1cncn1)c1ccc(F)cc1F	J - ANTIINFECTIVES FOR SYSTEMIC USE
aceclofenac	CIDs00071771	Phase 4	approved	O=C(O)COC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl	M - MUSCULO-SKELETAL SYSTEM | M - MUSCULO-SKELETAL SYSTEM
terlipressin	CIDs00072081	Phase 4	approved	NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](NC(=O)CNC(=O)CNC(=O)CN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O	H - SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
S)-flurbiprofen	CIDs00072099	Phase 3	unapproved	C[C@H](C(=O)O)c1ccc(-c2ccccc2)c(F)c1	M - MUSCULO-SKELETAL SYSTEM
tritoqualine	CIDs00072145	Phase 4	approved	CCOc1c(N)c2c(c(OCC)c1OCC)C(C1c3c(cc4c(c3OC)OCO4)CCN1C)OC2=O	R - RESPIRATORY SYSTEM
bestatin	CIDs00072172	Phase 2	unapproved	CC(C)C[C@H](NC(=O)[C@@H](O)[C@H](N)Cc1ccccc1)C(=O)O	
epicatechin	CIDs00072276	Phase 2	unapproved	Oc1cc(O)c2c(c1)O[C@H](c1ccc(O)c(O)c1)[C@H](O)C2	
levomepromazine	CIDs00072286	Phase 4	approved	COc1ccc2c(c1)N(C[C@H](C)CN(C)C)c1ccccc1S2	N - NERVOUS SYSTEM
tetrahydropalmatine	CIDs00072301	Phase 2	unapproved	COc1cc2c(cc1OC)[C@@H]1Cc3ccc(OC)c(OC)c3CN1CC2	
isoflavone	CIDs00072304	Phase 3	unapproved	O=c1c(-c2ccccc2)coc2ccccc12	
C film	CIDs00072385	Phase 4	approved	CCCCCCCCCc1ccc(OCCOCCOCCOCCOCCOCCOCCOCCOCCO)cc1	
procysteine	CIDs00072390	Phase 2	unapproved	O=C1N[C@H](C(=O)O)CS1	
9-aminocamptothecin	CIDs00072402	Phase 2	unapproved	CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(N)cccc3nc2-1	
picropodophyllin	CIDs00072435	Phase 2	unapproved	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC	
grepafloxacin	CIDs00072474	Phase 4	approved	Cc1c(F)c(N2CCNC(C)C2)cc2c1c(=O)c(C(=O)O)cn2C1CC1	J - ANTIINFECTIVES FOR SYSTEMIC USE
clevudine	CIDs00073115	Phase 3	unapproved	Cc1cn([C@H]2O[C@@H](CO)[C@H](O)[C@H]2F)c(=O)[nH]c1=O	J - ANTIINFECTIVES FOR SYSTEMIC USE
fosfomycin	CIDs00073491	Phase 4	approved	C[C@@H]1O[C@@H]1P(=O)(O)O	J - ANTIINFECTIVES FOR SYSTEMIC USE
atovaquone	CIDs00074989	Phase 4	approved	O=C1C(O)=C([C@H]2CC[C@H](c3ccc(Cl)cc3)CC2)C(=O)c2ccccc21	P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
rivastigmine	CIDs00077990	Phase 4	approved	CCN(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1	N - NERVOUS SYSTEM
frovatriptan	CIDs00077992	Phase 4	approved	CN[C@@H]1CCc2[nH]c3ccc(C(N)=O)cc3c2C1	N - NERVOUS SYSTEM
eletriptan	CIDs00077993	Phase 4	approved	CN1CCC[C@@H]1Cc1c[nH]c2ccc(CCS(=O)(=O)c3ccccc3)cc12	N - NERVOUS SYSTEM
rosiglitazone	CIDs00077998	Phase 4	approved	CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1	A - ALIMENTARY TRACT AND METABOLISM
agomelatine	CIDs00082148	Phase 4	approved	COc1ccc2cccc(CCNC(C)=O)c2c1	N - NERVOUS SYSTEM
flunisolide	CIDs00082153	Phase 4	approved	CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1	R - RESPIRATORY SYSTEM | R - RESPIRATORY SYSTEM
D-aspartate	CIDs00083887	Phase 2	unapproved	N[C@H](CC(=O)O)C(=O)O	
clarithromycin	CIDs00084029	Phase 4	approved	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O	J - ANTIINFECTIVES FOR SYSTEMIC USE
coenzyme A	CIDs00087642	Phase 3	unapproved	CC(C)(COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1OP(=O)(O)O)[C@@H](O)C(=O)NCCC(=O)NCCS	
5-(aziridin-1-yl)-2,4-dinitrobenzamide	CIDs00089105	Phase 2	unapproved	NC(=O)c1cc(N2CC2)c([N+](=O)[O-])cc1[N+](=O)[O-]	
nicotine	CIDs00089594	Phase 4	approved	CN1CCC[C@H]1c1cccnc1	N - NERVOUS SYSTEM
quinine hydrochloride	CIDs00091429	Phase 4	approved	C=C[C@H]1CN2CC[C@H]1C[C@H]2[C@H](O)c1ccnc2ccc(OC)cc12	M - MUSCULO-SKELETAL SYSTEM | P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
equol	CIDs00091469	Phase 2	unapproved	Oc1ccc([C@H]2COc3cc(O)ccc3C2)cc1	
fluocinolone	CIDs00091488	Phase 1	unapproved	C[C@]12C[C@H](O)[C@@]3(F)[C@@H](C[C@H](F)C4=CC(=O)C=C[C@@]43C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO	
S)-propranolol	CIDs00091536	Phase 2	unapproved	CC(C)NC[C@H](O)COc1cccc2ccccc12	
gliquidone	CIDs00091610	Phase 4	approved	COc1ccc2c(c1)C(=O)N(CCc1ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc1)C(=O)C2(C)C	A - ALIMENTARY TRACT AND METABOLISM
hydroxyflutamide	CIDs00091649	Phase 2	unapproved	CC(C)(O)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1	
levobupivacaine	CIDs00092253	Phase 4	approved	CCCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C	N - NERVOUS SYSTEM
R-flurbiprofen	CIDs00092337	Phase 3	unapproved	C[C@@H](C(=O)O)c1ccc(-c2ccccc2)c(F)c1	
argatroban	CIDs00092721	Phase 4	approved	CC1CNc2c(cccc2S(=O)(=O)N[C@@H](CCCNC(=N)N)C(=O)N2CC[C@@H](C)C[C@@H]2C(=O)O)C1	B - BLOOD AND BLOOD FORMING ORGANS
lopinavir	CIDs00092727	Phase 4	approved	Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)N1CCCNC1=O	
gamma-tocopherol	CIDs00092729	Phase 2	unapproved	Cc1c(O)cc2c(c1C)O[C@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC2	
3 alpha-hydroxy-5 alpha-pregnan-20-one	CIDs00092786	Phase 4	approved	CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C	
allopregnanolone	CIDs00092787	Phase 2	unapproved	CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C	
L-DOPS	CIDs00092974	Phase 4	approved	N[C@H](C(=O)O)[C@H](O)c1ccc(O)c(O)c1	C - CARDIOVASCULAR SYSTEM
HCPT	CIDs00097226	Phase 3	unapproved	CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3cc(O)ccc3nc2-1	
8-Cl-cAMP	CIDs00100299	Phase 2	unapproved	Nc1ncnc2c1nc(Cl)n2[C@@H]1O[C@@H]2COP(=O)(O)O[C@H]2[C@H]1O	
moxifloxacin	CIDs00101526	Phase 4	approved	COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12	J - ANTIINFECTIVES FOR SYSTEMIC USE | S - SENSORY ORGANS
alpha-lobeline	CIDs00101615	Phase 2	unapproved	CN1[C@H](C[C@H](O)c2ccccc2)CCC[C@@H]1CC(=O)c1ccccc1	
fulvestrant	CIDs00104741	Phase 4	approved	C[C@]12CC[C@@H]3c4ccc(O)cc4C[C@@H](CCCCCCCCC[S+]([O-])CCCC(F)(F)C(F)(F)F)[C@H]3[C@@H]1CC[C@@H]2O	L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
mafosfamide	CIDs00104746	Phase 1	unapproved	O=P1(N(CCCl)CCCl)NC(SCCS(=O)(=O)O)CCO1	
mizoribine	CIDs00104762	Phase 3	unapproved	NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1O	
strontium	CIDs00104798	Phase 2	unapproved	[SrH2]	
imipenem	CIDs00104838	Phase 4	approved	C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(SCCNC=N)C[C@H]12	
7-ethyl-10-hydroxycamptothecin	CIDs00104842	Phase 2	unapproved	CCc1c2c(nc3ccc(O)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC	
rimonabant	CIDs00104849	Phase 4	approved	Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1	A - ALIMENTARY TRACT AND METABOLISM
bosentan	CIDs00104865	Phase 4	approved	COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C(C)(C)C)cc2)nc(-c2ncccn2)nc1OCCO	C - CARDIOVASCULAR SYSTEM
saredutant	CIDs00104974	Phase 3	unapproved	CC(=O)NC1(c2ccccc2)CCN(CC[C@H](CN(C)C(=O)c2ccccc2)c2ccc(Cl)c(Cl)c2)CC1	
SeMet	CIDs00105024	Phase 4	approved	C[Se]CC[C@H](N)C(=O)O	
indobufen	CIDs00107641	Phase 3	unapproved	CCC(C(=O)O)c1ccc(N2Cc3ccccc3C2=O)cc1	B - BLOOD AND BLOOD FORMING ORGANS
sivelestat	CIDs00107706	Phase 3	unapproved	CC(C)(C)C(=O)Oc1ccc(S(=O)(=O)Nc2ccccc2C(=O)NCC(=O)O)cc1	
racecadotril	CIDs00107751	Phase 4	approved	CC(=O)SCC(Cc1ccccc1)C(=O)NCC(=O)OCc1ccccc1	A - ALIMENTARY TRACT AND METABOLISM
dexanabinol	CIDs00107778	Phase 3	unapproved	CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)[C@H]1CC=C(CO)C[C@H]21	
perindopril	CIDs00107807	Phase 4	approved	CCC[C@H](N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21)C(=O)OCC	C - CARDIOVASCULAR SYSTEM
ecopipam	CIDs00107930	Phase 3	unapproved	CN1CCc2cc(Cl)c(O)cc2[C@H]2c3ccccc3CC[C@@H]21	
fingolimod	CIDs00107969	Phase 4	approved	CCCCCCCCc1ccc(CCC(N)(CO)CO)cc1	L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
triptolide	CIDs00107985	Phase 3	unapproved	CC(C)[C@]12O[C@H]1[C@@H]1O[C@@]13[C@@]1(C)CCC4=C(COC4=O)[C@@H]1C[C@@H]1O[C@@]13[C@@H]2O	
ramosetron	CIDs00107999	Phase 3	unapproved	Cn1cc(C(=O)[C@@H]2CCc3nc[nH]c3C2)c2ccccc21	
tesmilifene	CIDs00108092	Phase 2	unapproved	CCN(CC)CCOc1ccc(Cc2ccccc2)cc1	
tamibarotene	CIDs00108143	Phase 2	unapproved	CC1(C)CCC(C)(C)c2cc(NC(=O)c3ccc(C(=O)O)cc3)ccc21	
nolpitantium	CIDs00108166	Phase 2	unapproved	CC(C)Oc1cccc(CC(=O)N2CCC[C@](CC[N+]34CCC(c5ccccc5)(CC3)CC4)(c3ccc(Cl)c(Cl)c3)C2)c1	
CI 988	CIDs00108187	Phase 1	unapproved	C[C@](Cc1c[nH]c2ccccc12)(NC(=O)OC1[C@H]2C[C@@H]3C[C@@H](C[C@H]1C3)C2)C(=O)NC[C@H](NC(=O)CCC(=O)O)c1ccccc1	
nolatrexed	CIDs00108188	Phase 3	unapproved	Cc1ccc2nc(N)[nH]c(=O)c2c1Sc1ccncc1	
MTHF	CIDs00108194	Phase 3	unapproved	Nc1nc(=O)c2c([nH]1)NCC1CN(c3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)CN21	
vardenafil	CIDs00110634	Phase 4	approved	CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12	G - GENITO URINARY SYSTEM AND SEX HORMONES
tadalafil	CIDs00110635	Phase 4	approved	CN1CC(=O)N2[C@H](Cc3c([nH]c4ccccc34)[C@H]2c2ccc3c(c2)OCO3)C1=O	G - GENITO URINARY SYSTEM AND SEX HORMONES
licarbazepine	CIDs00114709	Phase 3	unapproved	NC(=O)N1c2ccccc2CC(O)c2ccccc21	
aluminum hydroxide	CIDs00114790	Phase 4	approved	[Al+3].[OH-].[OH-].[OH-]	A - ALIMENTARY TRACT AND METABOLISM
higenamine	CIDs00114840	Phase 1	unapproved	Oc1ccc(CC2NCCc3cc(O)c(O)cc32)cc1	
R-ibuprofen	CIDs00114864	Phase 1	unapproved	CC(C)Cc1ccc([C@@H](C)C(=O)O)cc1	
landiolol	CIDs00114905	Phase 3	unapproved	CC1(C)OC[C@@H](COC(=O)CCc2ccc(OC[C@@H](O)CNCCNC(=O)N3CCOCC3)cc2)O1	C - CARDIOVASCULAR SYSTEM
norbuprenorphine	CIDs00114976	Phase 1	unapproved	CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1Cc4ccc(O)c5c4[C@@]3(CCN1)[C@H]2O5	
paliperidone	CIDs00115237	Phase 4	approved	Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O	N - NERVOUS SYSTEM
NTBC	CIDs00115355	Phase 4	approved	O=C1CCCC(=O)C1C(=O)c1ccc(C(F)(F)F)cc1[N+](=O)[O-]	A - ALIMENTARY TRACT AND METABOLISM
NO-ASA	CIDs00119032	Phase 2	unapproved	CC(=O)Oc1ccccc1C(=O)Oc1cccc(CO[N+](=O)[O-])c1	
CNDAC	CIDs00119184	Phase 2	unapproved	N#C[C@H]1[C@H](O)[C@@H](CO)O[C@H]1n1ccc(N)nc1=O	
Meclinertant	CIDs00119192	Phase 3	unapproved	COc1cccc(OC)c1-c1cc(C(=O)NC2(C(=O)O)C3CC4CC(C3)CC2C4)nn1-c1ccnc2cc(Cl)ccc12	
HTHQ	CIDs00119193	Phase 1	unapproved	CCCCCCOc1cc(C)c(O)c(C)c1C	
PrePen	CIDs00119212	Phase 4	approved		
tartrate	CIDs00119400	Phase 2	unapproved	O=C(O)[C@H](O)[C@@H](O)C(=O)O	
pramipexole	CIDs00119569	Phase 4	approved	CCCN[C@H]1CCc2nc(N)sc2C1	N - NERVOUS SYSTEM
mosapride	CIDs00119583	Phase 3	unapproved	CCOc1cc(N)c(Cl)cc1C(=O)NCC1CN(Cc2ccc(F)cc2)CCO1	A - ALIMENTARY TRACT AND METABOLISM
valdecoxib	CIDs00119607	Phase 4	approved	Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1	M - MUSCULO-SKELETAL SYSTEM
parecoxib	CIDs00119828	Phase 4	approved	CCC(=O)NS(=O)(=O)c1ccc(-c2c(-c3ccccc3)noc2C)cc1	M - MUSCULO-SKELETAL SYSTEM
N-carbamylglutamate	CIDs00121396	Phase 4	approved	NC(=O)N[C@@H](CCC(=O)O)C(=O)O	A - ALIMENTARY TRACT AND METABOLISM
amibegron	CIDs00121888	Phase 3	unapproved	CCOC(=O)COc1ccc2c(c1)C[C@@H](NC[C@H](O)c1cccc(Cl)c1)CC2	
mitiglinide	CIDs00121891	Phase 3	unapproved	O=C(O)[C@H](CC(=O)N1C[C@H]2CCCC[C@H]2C1)Cc1ccccc1	A - ALIMENTARY TRACT AND METABOLISM
retigabine	CIDs00121892	Phase 4	approved	CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)cc1N	N - NERVOUS SYSTEM
piperaquine	CIDs00122262	Phase 3	unapproved	Clc1ccc2c(N3CCN(CCCN4CCN(c5ccnc6cc(Cl)ccc56)CC4)CC3)ccnc2c1	
levalbuterol	CIDs00123600	Phase 4	approved	CC(C)(C)NC[C@H](O)c1ccc(O)c(CO)c1	
almotriptan	CIDs00123606	Phase 4	approved	CN(C)CCc1c[nH]c2ccc(CS(=O)(=O)N3CCCC3)cc12	N - NERVOUS SYSTEM
etoricoxib	CIDs00123619	Phase 4	approved	Cc1ccc(-c2ncc(Cl)cc2-c2ccc(S(C)(=O)=O)cc2)cn1	M - MUSCULO-SKELETAL SYSTEM
BAYx 1005	CIDs00123723	Phase 3	unapproved	O=C(O)[C@@H](c1ccc(OCc2ccc3ccccc3n2)cc1)C1CCCC1	
ramatroban	CIDs00123879	Phase 2	unapproved	O=C(O)CCn1c2c(c3ccccc31)C[C@H](NS(=O)(=O)c1ccc(F)cc1)CC2	
5,6-dimethylxanthenone-4-acetic acid (DMXAA	CIDs00123964	Phase 3	unapproved	Cc1ccc2c(=O)c3cccc(CC(=O)O)c3oc2c1C	
desloratadine	CIDs00124087	Phase 4	approved	Clc1ccc2c(c1)CCc1cccnc1C2=C1CCNCC1	R - RESPIRATORY SYSTEM
L-674,573	CIDs00124437	Phase 1	unapproved	O=C(O)CSC(CCCc1ccccc1)c1ccc(OCc2ccc3ccccc3n2)cc1	
reduced glutathione	CIDs00124886	Phase 3	unapproved	N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(=O)O)C(=O)O	V - VARIOUS
desvenlafaxine	CIDs00125017	Phase 4	approved	CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1	N - NERVOUS SYSTEM
CPHPC	CIDs00125516	Phase 2	unapproved	O=C(O)[C@H]1CCCN1C(=O)CCCCC(=O)N1CCC[C@@H]1C(=O)O	
blonanserin	CIDs00125564	Phase 3	unapproved	CCN1CCN(c2cc(-c3ccc(F)cc3)c3c(n2)CCCCCC3)CC1	
sodium tanshinone IIA sulfonate	CIDs00125782	Phase 2	unapproved	Cc1c(S(=O)(=O)O)oc2c1C(=O)C(=O)c1c-2ccc2c1CCCC2(C)C	
lestaurtinib	CIDs00126565	Phase 3	unapproved	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O	
tezampanel	CIDs00127894	Phase 2	unapproved	O=C(O)[C@@H]1C[C@H]2C[C@@H](CCc3nn[nH]n3)CC[C@H]2CN1	
salvinorin A	CIDs00128563	Phase 1	unapproved	COC(=O)[C@@H]1C[C@H](OC(C)=O)C(=O)[C@H]2[C@@]1(C)CC[C@H]1C(=O)O[C@H](c3ccoc3)C[C@]21C	
xaliproden	CIDs00128918	Phase 3	unapproved	FC(F)(F)c1cccc(C2=CCN(CCc3ccc4ccccc4c3)CC2)c1	N - NERVOUS SYSTEM
tamsulosin	CIDs00129211	Phase 4	approved	CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(S(N)(=O)=O)c1	G - GENITO URINARY SYSTEM AND SEX HORMONES
rufinamide	CIDs00129228	Phase 4	approved	NC(=O)c1cn(Cc2c(F)cccc2F)nn1	N - NERVOUS SYSTEM
Atiprimod	CIDs00129869	Phase 2	unapproved	CCCC1(CCC)CCC2(CCN(CCCN(CC)CC)C2)CC1	
3-aminopropyl-n-butyl-phosphinic acid	CIDs00130021	Phase 2	unapproved	CCCCP(=O)(O)CCCN	
sulbactam	CIDs00130313	Phase 4	approved	CC1(C)[C@H](C(=O)O)N2C(=O)C[C@H]2S1(=O)=O	J - ANTIINFECTIVES FOR SYSTEMIC USE
talotrexin	CIDs00130731	Phase 1	unapproved	Nc1nc(N)c2nc(CNc3ccc(C(=O)N[C@@H](CCCNC(=O)c4ccccc4C(=O)O)C(=O)O)cc3)cnc2n1	
olmesartan medoxomil	CIDs00130881	Phase 4	approved	CCCc1nc(C(C)(C)O)c(C(=O)OCc2oc(=O)oc2C)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1	C - CARDIOVASCULAR SYSTEM
ulipristal acetate	CIDs00130904	Phase 4	approved	CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C	
minodronate	CIDs00130956	Phase 3	unapproved	O=P(O)(O)C(O)(Cc1cnc2ccccn12)P(=O)(O)O	
pagoclone	CIDs00131664	Phase 2	unapproved	CC(C)CCC(=O)CC1c2ccccc2C(=O)N1c1ccc2ccc(Cl)nc2n1	
Damp-cmumep	CIDs00131678	Phase 2	unapproved	CC(C)c1cccc(C(C)C)c1NC(=O)NCC1(c2ccc(N(C)C)cc2)CCCC1	
safinamide	CIDs00131682	Phase 4	approved	C[C@H](NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O	N - NERVOUS SYSTEM
t-arginine	CIDs00132862	Phase 3	unapproved	CNC(=N)NCCC[C@H](N)C(=O)O	
abiraterone	CIDs00132971	Phase 4	approved	C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC=C2c1cccnc1	L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
ivabradine	CIDs00132999	Phase 4	approved	COc1cc2c(cc1OC)CC(=O)N(CCCN(C)C[C@H]1Cc3cc(OC)c(OC)cc31)CC2	C - CARDIOVASCULAR SYSTEM
rupatadine	CIDs00133016	Phase 3	unapproved	Cc1cncc(CN2CCC(=C3c4ccc(Cl)cc4CCc4cccnc43)CC2)c1	R - RESPIRATORY SYSTEM
febuxostat	CIDs00134018	Phase 4	approved	Cc1nc(-c2ccc(OCC(C)C)c(C#N)c2)sc1C(=O)O	M - MUSCULO-SKELETAL SYSTEM
dilevalol	CIDs00134044	Phase 4	approved	C[C@H](CCc1ccccc1)NC[C@H](O)c1ccc(O)c(C(N)=O)c1	
aspartame	CIDs00134600	Phase 3	unapproved	COC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(=O)O	
pomalidomide	CIDs00134780	Phase 4	approved	Nc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O	L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
xyloside	CIDs00135191	Phase 4	approved	OC1OC[C@@H](O)[C@H](O)[C@H]1O	
Talactoferrin alfa	CIDs00135349	Phase 1	unapproved	CN(C(=O)Cc1ccc(Cl)c(Cl)c1)[C@@H]1CCCC[C@H]1N1CCCC1	
6R-leucovorin	CIDs00135548	Phase 4	approved	Nc1nc(=O)c2c([nH]1)NC[C@@H](CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1)N2C=O	
nitric oxide	CIDs00145068	Phase 4	approved	[N]=O	R - RESPIRATORY SYSTEM
escitalopram	CIDs00146570	Phase 4	approved	CN(C)CCC[C@@]1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	N - NERVOUS SYSTEM
Se-methylselenocysteine	CIDs00147004	Phase 1	unapproved	C[Se]C[C@H](N)C(=O)O	
perifosine	CIDs00148177	Phase 3	unapproved	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1	
irofulven	CIDs00148189	Phase 3	unapproved	CC1=C(CO)C2=C(C)C3(CC3)[C@@](C)(O)C(=O)C2=C1	
atazanavir	CIDs00148192	Phase 4	approved	COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(-c2ccccn2)cc1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C	J - ANTIINFECTIVES FOR SYSTEMIC USE
lonafarnib	CIDs00148195	Phase 4	approved	NC(=O)N1CCC(CC(=O)N2CCC([C@H]3c4ncc(Br)cc4CCc4cc(Cl)cc(Br)c43)CC2)CC1	
diquafosol	CIDs00148196	Phase 3	unapproved	O=c1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@H](O)[C@@H]3O)[C@@H](O)[C@H]2O)c(=O)[nH]1	
Chs 828	CIDs00148198	Phase 1	unapproved	N#CN/C(=N\CCCCCCOc1ccc(Cl)cc1)Nc1ccncc1	
tariquidar	CIDs00148201	Phase 3	unapproved	COc1cc2c(cc1OC)CN(CCc1ccc(NC(=O)c3cc(OC)c(OC)cc3NC(=O)c3cnc4ccccc4c3)cc1)CC2	
Cositecan	CIDs00148202	Phase 2	unapproved	CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1ccccc1c2CC[Si](C)(C)C	
levofloxacin	CIDs00149096	Phase 4	approved	C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23	S - SENSORY ORGANS | J - ANTIINFECTIVES FOR SYSTEMIC USE
5-formyltetrahydrofolate	CIDs00149436	Phase 4	approved	Nc1nc(=O)c2c([nH]1)NC[C@H](CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1)N2C=O	
ezetimibe	CIDs00150311	Phase 4	approved	O=C1[C@H](CC[C@H](O)c2ccc(F)cc2)[C@@H](c2ccc(O)cc2)N1c1ccc(F)cc1	C - CARDIOVASCULAR SYSTEM
ertapenem	CIDs00150610	Phase 4	approved	C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)Nc4cccc(C(=O)O)c4)C3)[C@H](C)[C@H]12	J - ANTIINFECTIVES FOR SYSTEMIC USE
nepafenac	CIDs00151075	Phase 4	approved	NC(=O)Cc1cccc(C(=O)c2ccccc2)c1N	S - SENSORY ORGANS
lumiracoxib	CIDs00151166	Phase 4	approved	Cc1ccc(Nc2c(F)cccc2Cl)c(CC(=O)O)c1	M - MUSCULO-SKELETAL SYSTEM
cilomilast	CIDs00151170	Phase 3	unapproved	COc1ccc([C@]2(C#N)CC[C@@H](C(=O)O)CC2)cc1OC1CCCC1	
conivaptan	CIDs00151171	Phase 4	approved	Cc1nc2c([nH]1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)c1ccccc1-2	C - CARDIOVASCULAR SYSTEM
tezosentan	CIDs00151174	Phase 3	unapproved	COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C(C)C)cn2)nc(-c2ccnc(-c3nn[nH]n3)c2)nc1OCCO	
vatalanib	CIDs00151193	Phase 3	unapproved	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1	
MMPD	CIDs00153241	Phase 2	unapproved	COc1cc(NC(=O)Nc2cccc(CNC(=O)O[C@H]3CCOC3)c2)ccc1-c1cnco1	
AS-3201	CIDs00153948	Phase 3	unapproved	O=C1C[C@@]2(C(=O)N1)C(=O)N(Cc1ccc(Br)cc1F)C(=O)c1cccn12	
clevidipine	CIDs00153994	Phase 4	approved	CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl	C - CARDIOVASCULAR SYSTEM
zosuquidar	CIDs00153997	Phase 3	unapproved	O[C@@H](COc1cccc2ncccc12)CN1CCN([C@@H]2c3ccccc3[C@@H]3[C@H](c4ccccc42)C3(F)F)CC1	
ruboxistaurin	CIDs00153999	Phase 3	unapproved	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1	
solifenacin	CIDs00154058	Phase 4	approved	O=C(O[C@H]1CN2CCC1CC2)N1CCc2ccccc2[C@@H]1c1ccccc1	G - GENITO URINARY SYSTEM AND SEX HORMONES
dexmethylphenidate	CIDs00154100	Phase 4	approved	COC(=O)[C@H](c1ccccc1)[C@H]1CCCCN1	N - NERVOUS SYSTEM
pumosetrag	CIDs00154103	Phase 2	unapproved	O=C(N[C@H]1CN2CCC1CC2)c1c[nH]c2ccsc2c1=O	
peramivir	CIDs00154234	Phase 4	approved	CCC(CC)[C@H](NC(C)=O)[C@@H]1[C@H](O)[C@@H](C(=O)O)C[C@H]1NC(=N)N	J - ANTIINFECTIVES FOR SYSTEMIC USE
bazedoxifene	CIDs00154256	Phase 4	approved	Cc1c(-c2ccc(O)cc2)n(Cc2ccc(OCCN3CCCCCC3)cc2)c2ccc(O)cc12	G - GENITO URINARY SYSTEM AND SEX HORMONES
hyoscyamine	CIDs00154417	Phase 4	approved	CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)[C@H](CO)c1ccccc1)C2	A - ALIMENTARY TRACT AND METABOLISM
acolbifene	CIDs00155435	Phase 3	unapproved	CC1=C(c2ccc(O)cc2)[C@H](c2ccc(OCCN3CCCCC3)cc2)Oc2cc(O)ccc21	
xamoterol	CIDs00155773	Phase 4	approved	O=C(NCCNCC(O)COc1ccc(O)cc1)N1CCOCC1	C - CARDIOVASCULAR SYSTEM
varespladib	CIDs00155815	Phase 2	unapproved	CCc1c(C(=O)C(N)=O)c2c(OCC(=O)O)cccc2n1Cc1ccccc1	
naproxen	CIDs00156391	Phase 4	approved	COc1ccc2cc([C@H](C)C(=O)O)ccc2c1	G - GENITO URINARY SYSTEM AND SEX HORMONES | M - MUSCULO-SKELETAL SYSTEM | M - MUSCULO-SKELETAL SYSTEM
canertinib	CIDs00156413	Phase 3	unapproved	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1	
cinacalcet	CIDs00156418	Phase 4	approved	C[C@@H](NCCCc1cccc(C(F)(F)F)c1)c1cccc2ccccc12	H - SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
BIRB796	CIDs00156422	Phase 2	unapproved	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1	
lidorestat	CIDs00157838	Phase 2	unapproved	O=C(O)Cn1cc(Cc2nc3c(F)c(F)cc(F)c3s2)c2ccccc21	
lubiprostone	CIDs00157920	Phase 4	approved	CCCCC(F)(F)[C@@]1(O)CC[C@H]2[C@@H](CC(=O)[C@@H]2CCCCCCC(=O)O)O1	A - ALIMENTARY TRACT AND METABOLISM
olmesartan	CIDs00158781	Phase 3	unapproved	CCCc1nc(C(C)(C)O)c(C(=O)O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1	
DOTATOC	CIDs00158782	Phase 3	unapproved	C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](NC(=O)[C@@H](Cc2ccccc2)NC(=O)CN2CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC2)CSSC[C@@H](C(=O)N[C@H](CO)[C@@H](C)O)NC1=O	
aplindore	CIDs00158784	Phase 2	unapproved	O=C1Cc2c(ccc3c2O[C@@H](CNCc2ccccc2)CO3)N1	
selenocompounds	CIDs00158795	Phase 2	unapproved	OC[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCOC4)ncnc32)[C@H](O)[C@@H]1O	
NPS-R 568	CIDs00158796	Phase 2	unapproved	COc1cccc([C@@H](C)NCCCc2ccccc2Cl)c1	
telbivudine	CIDs00159269	Phase 4	approved	Cc1cn([C@@H]2C[C@@H](O)[C@H](CO)O2)c(=O)[nH]c1=O	J - ANTIINFECTIVES FOR SYSTEMIC USE
tipifarnib	CIDs00159324	Phase 3	unapproved	Cn1cncc1[C@@](N)(c1ccc(Cl)cc1)c1ccc2c(c1)c(-c1cccc(Cl)c1)cc(=O)n2C	
torcetrapib	CIDs00159325	Phase 3	unapproved	CCOC(=O)N1c2ccc(C(F)(F)F)cc2[C@@H](N(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)C(=O)OC)C[C@H]1CC	
atrasentan	CIDs00159594	Phase 3	unapproved	CCCCN(CCCC)C(=O)CN1C[C@H](c2ccc3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1c1ccc(OC)cc1	
resiquimod	CIDs00159603	Phase 2	unapproved	CCOCc1nc2c(N)nc3ccccc3c2n1CC(C)(C)O	
dipalmitoylphosphatidylcholine	CIDs00160339	Phase 4	approved	CCCCCCCCCCCCCCCC(=O)OC[C@H](CO[P@](=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC	R - RESPIRATORY SYSTEM
roscovitine	CIDs00160355	Phase 2	unapproved	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1	
DITPA	CIDs00160565	Phase 2	unapproved	O=C(O)CCc1cc(I)c(Oc2ccc(O)cc2)c(I)c1	
L-kynurenine	CIDs00161165	Phase 1	unapproved	Nc1ccccc1C(=O)C[C@H](N)C(=O)O	
icilin	CIDs00161930	Phase 3	unapproved	O=C1NC(c2cccc([N+](=O)[O-])c2)=CCN1c1ccccc1O	
fenobam	CIDs00162834	Phase 1	unapproved	CN1CC(=O)N=C1NC(=O)Nc1cccc(Cl)c1	
tipranavir	CIDs00163296	Phase 4	approved	CCC[C@@]1(CCc2ccccc2)CC(O)=C([C@H](CC)c2cccc(NS(=O)(=O)c3ccc(C(F)(F)F)cn3)c2)C(=O)O1	J - ANTIINFECTIVES FOR SYSTEMIC USE
talampanel	CIDs00164509	Phase 2	unapproved	CC(=O)N1N=C(c2ccc(N)cc2)c2cc3c(cc2C[C@H]1C)OCO3	
bepotastine	CIDs00164522	Phase 4	approved	O=C(O)CCCN1CCC(O[C@@H](c2ccc(Cl)cc2)c2ccccn2)CC1	
levonordefrin	CIDs00164739	Phase 4	approved	C[C@H](N)[C@H](O)c1ccc(O)c(O)c1	
paromomycin	CIDs00165579	Phase 4	approved	NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O	A - ALIMENTARY TRACT AND METABOLISM
aminopterin	CIDs00169370	Phase 2	unapproved	Nc1nc(N)c2nc(CNc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)cnc2n1	
17-OHPC	CIDs00169870	Phase 4	approved	CCCCCC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C	G - GENITO URINARY SYSTEM AND SEX HORMONES
varenicline	CIDs00170361	Phase 4	approved	c1cnc2cc3c(cc2n1)C1CNCC3C1	N - NERVOUS SYSTEM
farglitazar	CIDs00170364	Phase 2	unapproved	Cc1oc(-c2ccccc2)nc1CCOc1ccc(C[C@H](Nc2ccccc2C(=O)c2ccccc2)C(=O)O)cc1	
anti-biotin	CIDs00171548	Phase 4	approved	O=C(O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@H]12	A - ALIMENTARY TRACT AND METABOLISM
dezocine	CIDs00171575	Phase 4	approved	C[C@@]12CCCCC[C@@H](Cc3ccc(O)cc31)[C@@H]2N	N - NERVOUS SYSTEM
angiotensin	CIDs00172197	Phase 4	approved	CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(=O)O)C(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O	C - CARDIOVASCULAR SYSTEM
lixivaptan	CIDs00172997	Phase 3	unapproved	Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)c(Cl)c1	
atropine	CIDs00174174	Phase 4	approved	CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)C(CO)c1ccccc1)C2	A - ALIMENTARY TRACT AND METABOLISM | S - SENSORY ORGANS
ropivacaine	CIDs00175804	Phase 4	approved	CCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C	N - NERVOUS SYSTEM
migalastat HCl	CIDs00176077	Phase 4	approved	OC[C@H]1NC[C@H](O)[C@@H](O)[C@H]1O	A - ALIMENTARY TRACT AND METABOLISM
enzastaurin	CIDs00176166	Phase 3	unapproved	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21	
cilengitide	CIDs00176873	Phase 3	unapproved	CC(C)[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](Cc2ccccc2)C(=O)N1C	
ECyd	CIDs00176885	Phase 2	unapproved	C#C[C@@]1(O)[C@@H](CO)O[C@@H](n2ccc(N)nc2=O)[C@@H]1O	
darusentan	CIDs00177236	Phase 3	unapproved	COc1cc(OC)nc(O[C@H](C(=O)O)C(OC)(c2ccccc2)c2ccccc2)n1	
piboserod	CIDs00177335	Phase 2	unapproved	CCCCN1CCC(CNC(=O)c2c3n(c4ccccc24)CCCO3)CC1	
LY293111Na	CIDs00177941	Phase 2	unapproved	CCCc1c(OCCCOc2cc(O)c(-c3ccc(F)cc3)cc2CC)cccc1Oc1ccccc1C(=O)O	
Crescendo	CIDs00178024	Phase 2	unapproved	CC(C)(N)C(=O)N[C@H](COCc1ccccc1)C(=O)N1CCC2(CC1)CN(S(C)(=O)=O)c1ccccc12	
Pozanicline	CIDs00178052	Phase 2	unapproved	Cc1ncccc1OC[C@@H]1CCCN1	
enrasentan	CIDs00178103	Phase 2	unapproved	CCCOc1ccc2c(c1)[C@@H](c1ccc(OC)cc1OCCO)[C@H](C(=O)O)[C@H]2c1ccc2c(c1)OCO2	
arzoxifene	CIDs00179337	Phase 3	unapproved	COc1ccc(-c2sc3cc(O)ccc3c2Oc2ccc(OCCN3CCCCC3)cc2)cc1	
asimadoline	CIDs00179340	Phase 3	unapproved	CN(C(=O)C(c1ccccc1)c1ccccc1)[C@H](CN1CC[C@H](O)C1)c1ccccc1	
betadex	CIDs00181264	Phase 3	unapproved	OC[C@H]1O[C@@H]2O[C@@H]3[C@@H](CO)O[C@H](O[C@@H]4[C@@H](CO)O[C@H](O[C@@H]5[C@@H](CO)O[C@H](O[C@@H]6[C@@H](CO)O[C@H](O[C@@H]7[C@@H](CO)O[C@H](O[C@@H]8[C@@H](CO)O[C@H](O[C@H]1[C@H](O)[C@H]2O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O	
ezlopitant	CIDs00188927	Phase 2	unapproved	COc1ccc(C(C)C)cc1CN[C@H]1C2CCN(CC2)[C@H]1C(c1ccccc1)c1ccccc1	
deflazacort	CIDs00189821	Phase 4	approved	CC(=O)OCC(=O)[C@@]12N=C(C)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]12C	H - SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
norUDCA	CIDs00192254	Phase 3	unapproved	C[C@H](CC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C	
carbocisteine	CIDs00193653	Phase 4	approved	N[C@@H](CSCC(=O)O)C(=O)O	R - RESPIRATORY SYSTEM
etravirine	CIDs00193962	Phase 4	approved	Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc(N)c1Br	J - ANTIINFECTIVES FOR SYSTEMIC USE
latrepirdine	CIDs00197033	Phase 3	unapproved	Cc1ccc2c(c1)c1c(n2CCc2ccc(C)nc2)CCN(C)C1	
donitriptan	CIDs00197705	Phase 2	unapproved	N#Cc1ccc(N2CCN(C(=O)COc3ccc4[nH]cc(CCN)c4c3)CC2)cc1	
etomidate	CIDs00198290	Phase 4	approved	CCOC(=O)c1cncn1[C@H](C)c1ccccc1	N - NERVOUS SYSTEM
osemozotan	CIDs00198746	Phase 3	unapproved	c1ccc2c(c1)OC[C@H](CNCCCOc1ccc3c(c1)OCO3)O2	
repinotan	CIDs00198756	Phase 2	unapproved	O=C1c2ccccc2S(=O)(=O)N1CCCCNC[C@H]1CCc2ccccc2O1	
troleandomycin	CIDs00202225	Phase 4	approved	CO[C@H]1C[C@H](O[C@@H]2[C@@H](C)C(=O)O[C@H](C)[C@H](C)[C@H](OC(C)=O)[C@@H](C)C(=O)[C@]3(CO3)C[C@H](C)[C@H](O[C@@H]3O[C@H](C)C[C@H](N(C)C)[C@H]3OC(C)=O)[C@H]2C)O[C@@H](C)[C@@H]1OC(C)=O	J - ANTIINFECTIVES FOR SYSTEMIC USE
dextofisopam	CIDs00204105	Phase 2	unapproved	CC[C@H]1C(C)=NN=C(c2ccc(OC)c(OC)c2)c2cc(OC)c(OC)cc21	
netoglitazone	CIDs00204109	Phase 2	unapproved	O=C1NC(=O)C(Cc2ccc3cc(OCc4ccccc4F)ccc3c2)S1	
muraglitazar	CIDs00206044	Phase 3	unapproved	COc1ccc(OC(=O)N(CC(=O)O)Cc2ccc(OCCc3nc(-c4ccccc4)oc3C)cc2)cc1	
dronedarone	CIDs00208898	Phase 4	approved	CCCCc1oc2ccc(NS(C)(=O)=O)cc2c1C(=O)c1ccc(OCCCN(CCCC)CCCC)cc1	C - CARDIOVASCULAR SYSTEM
tesaglitazar	CIDs00208901	Phase 3	unapproved	CCO[C@@H](Cc1ccc(OCCc2ccc(OS(C)(=O)=O)cc2)cc1)C(=O)O	
ramelteon	CIDs00208902	Phase 4	approved	CCC(=O)NCC[C@@H]1CCc2ccc3c(c21)CCO3	N - NERVOUS SYSTEM
proglia	CIDs00208925	Phase 2	unapproved	CCCCCC[C@@H](CCC)C(=O)O	
bifeprunox	CIDs00208951	Phase 3	unapproved	O=c1[nH]c2cccc(N3CCN(Cc4cccc(-c5ccccc5)c4)CC3)c2o1	
MPQX	CIDs00208953	Phase 1	unapproved	O=c1[nH]c2cc(C(F)(F)F)c(N3CCOCC3)cc2n(CP(=O)(O)O)c1=O	
plevitrexed	CIDs00213022	Phase 2	unapproved	C#CCN(Cc1cc2c(O)nc(C)nc2cc1C)c1ccc(C(=O)N[C@@H](CCc2nnn[nH]2)C(=O)O)c(F)c1	
ataciguat	CIDs00213037	Phase 2	unapproved	O=C(Nc1ccc(S(=O)(=O)N2CCOCC2)cc1)c1cc(Cl)ccc1NS(=O)(=O)c1ccc(Cl)s1	
darunavir	CIDs00213039	Phase 4	approved	CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@@H]12)S(=O)(=O)c1ccc(N)cc1	J - ANTIINFECTIVES FOR SYSTEMIC USE
fipamezole	CIDs00213041	Phase 2	unapproved	CCC1(c2c[nH]cn2)Cc2ccc(F)cc2C1	
iclaprim	CIDs00213043	Phase 3	unapproved	COc1cc(Cc2cnc(N)nc2N)c2c(c1OC)OC(C1CC1)C=C2	J - ANTIINFECTIVES FOR SYSTEMIC USE
lurasidone	CIDs00213046	Phase 4	approved	O=C1[C@H]2[C@@H]3CC[C@@H](C3)[C@H]2C(=O)N1C[C@@H]1CCCC[C@H]1CN1CCN(c2nsc3ccccc23)CC1	N - NERVOUS SYSTEM
cimicoxib	CIDs00213053	Phase 2	unapproved	COc1ccc(-c2c(Cl)ncn2-c2ccc(S(N)(=O)=O)cc2)cc1F	
ilaprazole	CIDs00214351	Phase 3	unapproved	COc1ccnc(C[S+]([O-])c2nc3cc(-n4cccc4)ccc3[nH]2)c1C	
capromorelin	CIDs00216208	Phase 2	unapproved	CN1N=C2CCN(C(=O)[C@@H](COCc3ccccc3)NC(=O)C(C)(C)N)C[C@@]2(Cc2ccccc2)C1=O	
dabigatran	CIDs00216210	Phase 3	unapproved	Cn1c(CNc2ccc(C(=N)N)cc2)nc2cc(C(=O)N(CCC(=O)O)c3ccccn3)ccc21	
sitaxsentan	CIDs00216235	Phase 4	approved	Cc1cc2c(cc1CC(=O)c1sccc1S(=O)(=O)Nc1onc(C)c1Cl)OCO2	C - CARDIOVASCULAR SYSTEM
tolvaptan	CIDs00216237	Phase 4	approved	Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(O)c3cc(Cl)ccc32)c(C)c1	C - CARDIOVASCULAR SYSTEM
alagebrium	CIDs00216304	Phase 2	unapproved	Cc1sc[n+](CC(=O)c2ccccc2)c1C	
T138067-sodium	CIDs00216324	Phase 2	unapproved	COc1ccc(NS(=O)(=O)c2c(F)c(F)c(F)c(F)c2F)cc1F	
succinobucol	CIDs00216325	Phase 3	unapproved	CC(C)(Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)Sc1cc(C(C)(C)C)c(OC(=O)CCC(=O)O)c(C(C)(C)C)c1	
lenalidomide	CIDs00216326	Phase 4	approved	Nc1cccc2c1CN(C1CCC(=O)NC1=O)C2=O	L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Senicapoc	CIDs00216327	Phase 3	unapproved	NC(=O)C(c1ccccc1)(c1ccc(F)cc1)c1ccc(F)cc1	
lasofoxifene	CIDs00216416	Phase 4	approved	Oc1ccc2c(c1)CC[C@H](c1ccccc1)[C@@H]2c1ccc(OCCN2CCCC2)cc1	G - GENITO URINARY SYSTEM AND SEX HORMONES
L-778123	CIDs00216453	Phase 1	unapproved	N#Cc1ccc(Cn2cncc2CN2CCN(c3cccc(Cl)c3)C(=O)C2)cc1	
tonapofylline	CIDs00216466	Phase 3	unapproved	CCCn1c(=O)c2nc(C34CCC(CCC(=O)O)(CC3)CC4)[nH]c2n(CCC)c1=O	
indisulam	CIDs00216468	Phase 2	unapproved	NS(=O)(=O)c1ccc(S(=O)(=O)Nc2cccc3c(Cl)c[nH]c23)cc1	
regadenoson	CIDs00219024	Phase 4	approved	CNC(=O)c1cnn(-c2nc(N)c3ncn([C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)c3n2)c1	
lacosamide	CIDs00219078	Phase 4	approved	COC[C@@H](NC(C)=O)C(=O)NCc1ccccc1	N - NERVOUS SYSTEM
fosaprepitant	CIDs00219090	Phase 4	approved	C[C@@H](O[C@H]1OCCN(Cc2nn(P(=O)(O)O)c(=O)[nH]2)[C@H]1c1ccc(F)cc1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1	
phenoxodiol	CIDs00219100	Phase 1	unapproved	Oc1ccc(C2=Cc3ccc(O)cc3OC2)cc1	
traxoprodil	CIDs00219101	Phase 2	unapproved	C[C@@H]([C@@H](O)c1ccc(O)cc1)N1CCC(O)(c2ccccc2)CC1	
1-methylpropyl 2-imidazolyl disulfide	CIDs00219104	Phase 2	unapproved	CCC(C)SSc1ncc[nH]1	
cholic acid	CIDs00221493	Phase 4	approved	C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@H]3[C@H](C[C@H](O)[C@@]21C)[C@@]1(C)CC[C@@H](O)C[C@H]1C[C@H]3O	A - ALIMENTARY TRACT AND METABOLISM
sodium deoxycholate	CIDs00222528	Phase 4	approved	C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@@]21C	D - DERMATOLOGICALS
oestradiol benzoate	CIDs00222757	Phase 4	approved	C[C@]12CC[C@@H]3c4ccc(OC(=O)c5ccccc5)cc4CC[C@H]3[C@@H]1CC[C@@H]2O	
NTPP	CIDs00229455	Phase 4	approved	C[C@]12CC[C@@H]3[C@H]4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@H]2OC(=O)CCc1ccccc1	A - ALIMENTARY TRACT AND METABOLISM | S - SENSORY ORGANS
5-hydroxymethylfurfural	CIDs00237332	Phase 2	unapproved	O=Cc1ccc(CO)o1	
medrysone	CIDs00247839	Phase 4	approved	CC(=O)[C@H]1CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@]12C	S - SENSORY ORGANS
noscapine	CIDs00275196	Phase 4	approved	COc1ccc2c(c1OC)C(=O)O[C@@H]2[C@H]1c2c(cc3c(c2OC)OCO3)CCN1C	R - RESPIRATORY SYSTEM
rosoxacin	CIDs00287180	Phase 4	approved	CCn1cc(C(=O)O)c(=O)c2ccc(-c3ccncc3)cc21	J - ANTIINFECTIVES FOR SYSTEMIC USE
sorbinil	CIDs00337359	Phase 3	unapproved	O=C1NC(=O)[C@@]2(CCOc3ccc(F)cc32)N1	
perillyl alcohol	CIDs00369312	Phase 2	unapproved	C=C(C)[C@@H]1CC=C(CO)CC1	
caplostatin	CIDs00369976	Phase 2	unapproved	CO[C@H]1[C@H]([C@@]2(C)O[C@@H]2CC=C(C)C)[C@]2(CC[C@H]1OC(=O)NC(=O)CCl)CO2	
ritonavir	CIDs00392622	Phase 4	approved	CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1	J - ANTIINFECTIVES FOR SYSTEMIC USE
NSC-694501	CIDs00393111	Phase 2	unapproved	C=C1C[C@H]2C=Nc3cc(OCCCOc4cc5c(cc4OC)C(=O)N4CC(=C)C[C@H]4C=N5)c(OC)cc3C(=O)N2C1	
CDDO	CIDs00400010	Phase 1	unapproved	CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](C(=O)C=C4[C@@]3(C)CC[C@H]3C(C)(C)C(=O)C(C#N)=C[C@]43C)[C@@H]2C1	
CDDO-Me	CIDs00400769	Phase 3	unapproved	COC(=O)[C@]12CCC(C)(C)C[C@H]1[C@H]1C(=O)C=C3[C@@](C)(CC[C@H]4C(C)(C)C(=O)C(C#N)=C[C@]34C)[C@]1(C)CC2	
caricotamide	CIDs00403128	Phase 2	unapproved	NC(=O)CN1C=CCC(C(N)=O)=C1	
1-methyl-D-tryptophan	CIDs00405012	Phase 2	unapproved	Cn1cc(C[C@@H](N)C(=O)O)c2ccccc21	
L bradykinin	CIDs00439201	Phase 2	unapproved	N=C(N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O	
2-amino-2-deoxy-D-glucopyranose	CIDs00439213	Phase 4	approved	N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O	M - MUSCULO-SKELETAL SYSTEM
carnosine	CIDs00439224	Phase 2	unapproved	NCCC(=O)N[C@@H](Cc1cnc[nH]1)C(=O)O	
norepinephrine	CIDs00439260	Phase 4	approved	NC[C@H](O)c1ccc(O)c(O)c1	C - CARDIOVASCULAR SYSTEM
5-hydroxytryptophan	CIDs00439280	Phase 4	approved	N[C@@H](Cc1c[nH]c2ccc(O)cc12)C(=O)O	N - NERVOUS SYSTEM
sn-glycero-3-phosphocholine	CIDs00439285	Phase 3	unapproved	C[N+](C)(C)CCOP(=O)([O-])OC[C@H](O)CO	N - NERVOUS SYSTEM
ocytocin	CIDs00439302	Phase 4	approved	CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O	H - SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
D-galactopyranoside	CIDs00439357	Phase 3	unapproved	OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O	V - VARIOUS
theanine	CIDs00439378	Phase 3	unapproved	CCNC(=O)CC[C@H](N)C(=O)O	
ouabain	CIDs00439501	Phase 4	approved	C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@@H](C6=CC(=O)OC6)CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)[C@H](O)[C@H](O)[C@H]1O	
d-tartrate	CIDs00439655	Phase 4	approved	O=C(O)[C@@H](O)[C@H](O)C(=O)O	
fructose	CIDs00439709	Phase 4	approved	OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O	V - VARIOUS
alpha-L-arabinose	CIDs00439731	Phase 1	unapproved	O[C@H]1CO[C@@H](O)[C@H](O)[C@H]1O	
acetyl-L-carnitine	CIDs00439756	Phase 4	approved	CC(=O)O[C@H](CC(=O)[O-])C[N+](C)(C)C	N - NERVOUS SYSTEM
taurolithocholate	CIDs00439763	Phase 3	unapproved	C[C@H](CCC(=O)NCCS(=O)(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C	
nicotinamide ribose	CIDs00439924	Phase 3	unapproved	NC(=O)c1ccc[n+]([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1	
11-deoxycortisol	CIDs00440707	Phase 2	unapproved	C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO	
d-limonene	CIDs00440917	Phase 1	unapproved	C=C(C)[C@H]1CC=C(C)CC1	
arbutin	CIDs00440936	Phase 2	unapproved	OC[C@H]1O[C@@H](Oc2ccc(O)cc2)[C@H](O)[C@@H](O)[C@@H]1O	
quinidine sulfate	CIDs00441074	Phase 4	approved	C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12	C - CARDIOVASCULAR SYSTEM | C - CARDIOVASCULAR SYSTEM | C - CARDIOVASCULAR SYSTEM
carbapenem	CIDs00441133	Phase 2	unapproved	O=C(O)C1=CC[C@@H]2CC(=O)N12	
griseofulvin	CIDs00441140	Phase 4	approved	COC1=CC(=O)C[C@@H](C)[C@]12Oc1c(Cl)c(OC)cc(OC)c1C2=O	D - DERMATOLOGICALS | D - DERMATOLOGICALS
cefoxitin	CIDs00441199	Phase 4	approved	CO[C@@]1(NC(=O)Cc2cccs2)C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@@H]21	J - ANTIINFECTIVES FOR SYSTEMIC USE
digitoxin	CIDs00441207	Phase 4	approved	C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@]5(C)[C@H]6CC[C@]7(C)[C@@H](C8=CC(=O)OC8)CC[C@]7(O)[C@@H]6CC[C@@H]5C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O	C - CARDIOVASCULAR SYSTEM
rocuronium	CIDs00441290	Phase 4	approved	C=CC[N+]1([C@H]2C[C@H]3[C@@H]4CC[C@H]5C[C@H](O)[C@@H](N6CCOCC6)C[C@]5(C)[C@H]4CC[C@]3(C)[C@H]2OC(C)=O)CCCC1	
abacavir	CIDs00441300	Phase 4	approved	Nc1nc(NC2CC2)c2ncn([C@H]3C=C[C@@H](CO)C3)c2n1	J - ANTIINFECTIVES FOR SYSTEMIC USE
miglitol	CIDs00441314	Phase 4	approved	OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO	A - ALIMENTARY TRACT AND METABOLISM
mometasone furoate	CIDs00441336	Phase 4	approved	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)CCl	D - DERMATOLOGICALS | D - DERMATOLOGICALS | R - RESPIRATORY SYSTEM | R - RESPIRATORY SYSTEM
alpha-methyl-p-tyrosine	CIDs00441350	Phase 4	approved	C[C@](N)(Cc1ccc(O)cc1)C(=O)O	C - CARDIOVASCULAR SYSTEM
terconazole	CIDs00441383	Phase 4	approved	CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1	G - GENITO URINARY SYSTEM AND SEX HORMONES
linezolid	CIDs00441401	Phase 4	approved	CC(=O)NC[C@H]1CN(c2ccc(N3CCOCC3)c(F)c2)C(=O)O1	J - ANTIINFECTIVES FOR SYSTEMIC USE
ribose	CIDs00441481	Phase 2	unapproved	O[C@@H]1CO[C@@H](O)[C@H](O)[C@@H]1O	
ingenol	CIDs00442042	Phase 3	unapproved	CC1=C[C@]23C(=O)[C@@H](C=C(CO)[C@@H](O)[C@]2(O)[C@H]1O)[C@H]1[C@@H](C[C@H]3C)C1(C)C	
ibogaine	CIDs00442108	Phase 2	unapproved	CC[C@H]1C[C@H]2C[C@H]3c4[nH]c5ccc(OC)cc5c4CCN(C2)[C@@H]13	
clindamycin phosphate	CIDs00443385	Phase 4	approved	CCC[C@@H]1C[C@@H](C(=O)N[C@H]([C@H](C)Cl)[C@H]2O[C@H](SC)[C@H](OP(=O)(O)O)[C@@H](O)[C@H]2O)N(C)C1	D - DERMATOLOGICALS
eplerenone	CIDs00443872	Phase 4	approved	COC(=O)[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@@]23O[C@@H]2C[C@@]2(C)[C@@H](CC[C@@]24CCC(=O)O4)[C@H]13	C - CARDIOVASCULAR SYSTEM
tolterodine	CIDs00443878	Phase 4	approved	Cc1ccc(O)c([C@H](CCN(C(C)C)C(C)C)c2ccccc2)c1	G - GENITO URINARY SYSTEM AND SEX HORMONES
ergonovine	CIDs00443884	Phase 4	approved	C[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1	G - GENITO URINARY SYSTEM AND SEX HORMONES
difluprednate	CIDs00443936	Phase 4	approved	CCCC(=O)O[C@]1(C(=O)COC(C)=O)CC[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C	D - DERMATOLOGICALS
halcinonide	CIDs00443943	Phase 4	approved	CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)CC[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CCl)O1	D - DERMATOLOGICALS
vinpocetine	CIDs00443955	Phase 4	approved	CCOC(=O)C1=C[C@]2(CC)CCCN3CCc4c(n1c1ccccc41)[C@@H]32	N - NERVOUS SYSTEM
amcinonide	CIDs00443958	Phase 4	approved	CC(=O)OCC(=O)[C@@]12OC3(CCCC3)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C	D - DERMATOLOGICALS
flumethasone pivalate	CIDs00443980	Phase 4	approved	C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C(C)(C)C	D - DERMATOLOGICALS | D - DERMATOLOGICALS
tibolone	CIDs00444008	Phase 4	approved	C#C[C@]1(O)CC[C@H]2[C@H]3[C@H](CC[C@@]21C)C1=C(CC(=O)CC1)C[C@H]3C	G - GENITO URINARY SYSTEM AND SEX HORMONES
voglibose	CIDs00444020	Phase 3	unapproved	OCC(CO)N[C@H]1C[C@](O)(CO)[C@@H](O)[C@H](O)[C@H]1O	A - ALIMENTARY TRACT AND METABOLISM
loteprednol etabonate	CIDs00444025	Phase 4	approved	CCOC(=O)O[C@]1(C(=O)OCCl)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C	S - SENSORY ORGANS
darifenacin	CIDs00444030	Phase 4	approved	NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(CCc2ccc3c(c2)CCO3)C1	G - GENITO URINARY SYSTEM AND SEX HORMONES
fluticasone propionate	CIDs00444036	Phase 4	approved	CCC(=O)O[C@]1(C(=O)SCF)[C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C	D - DERMATOLOGICALS | R - RESPIRATORY SYSTEM | R - RESPIRATORY SYSTEM | R - RESPIRATORY SYSTEM
S)-amisulpride	CIDs00444254	Phase 4	approved	C[C@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@H](O[C@@H]3[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O	A - ALIMENTARY TRACT AND METABOLISM
5-methyltetrahydrofolate	CIDs00444412	Phase 4	approved	CN1c2c([nH]c(N)nc2=O)NC[C@@H]1CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1	
forodesine	CIDs00444499	Phase 2	unapproved	O=c1[nH]cnc2c([C@@H]3N[C@H](CO)[C@@H](O)[C@H]3O)c[nH]c12	
trichostatin A	CIDs00444732	Phase 1	unapproved	CC(/C=C/C(=O)NO)=C\[C@@H](C)C(=O)c1ccc(N(C)C)cc1	
S-glucuronide	CIDs00444791	Phase 4	approved	O=C([O-])[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O.[Na+]	
fumarate	CIDs00444972	Phase 4	approved	O=C(O)/C=C/C(=O)O	D - DERMATOLOGICALS
resveratrol	CIDs00445154	Phase 3	unapproved	Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1	
vitamin A	CIDs00445354	Phase 4	approved	CC1=C(/C=C/C(C)=C/C=C/C(C)=C/CO)C(C)(C)CCC1	D - DERMATOLOGICALS | S - SENSORY ORGANS | A - ALIMENTARY TRACT AND METABOLISM | R - RESPIRATORY SYSTEM
docosahexaenoic acid	CIDs00445580	Phase 3	unapproved	CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O	
oleic acid	CIDs00445639	Phase 2	unapproved	CCCCCCCC/C=C\CCCCCCCC(=O)O	
tacrolimus	CIDs00445643	Phase 4	approved	C=CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC	
Statins	CIDs00446156	Phase 4	approved	COCc1c(C(C)C)nc(C(C)C)c(/C=C/[C@@H](O)C[C@@H](O)CC(=O)O)c1-c1ccc(F)cc1	C - CARDIOVASCULAR SYSTEM
rosuvastatin	CIDs00446157	Phase 4	approved	CC(C)c1nc(N(C)S(C)(=O)=O)nc(-c2ccc(F)cc2)c1/C=C/[C@@H](O)C[C@@H](O)CC(=O)O	C - CARDIOVASCULAR SYSTEM
cocaine	CIDs00446220	Phase 4	approved	COC(=O)[C@H]1[C@@H](OC(=O)c2ccccc2)C[C@@H]2CC[C@H]1N2C	N - NERVOUS SYSTEM | S - SENSORY ORGANS | S - SENSORY ORGANS | R - RESPIRATORY SYSTEM
eicosapentanoic acid	CIDs00446284	Phase 3	unapproved	CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O	
mupirocin	CIDs00446596	Phase 4	approved	C/C(=C\C(=O)OCCCCCCCCC(=O)O)C[C@@H]1OC[C@H](C[C@@H]2O[C@H]2[C@@H](C)[C@H](C)O)[C@@H](O)[C@H]1O	D - DERMATOLOGICALS | R - RESPIRATORY SYSTEM
clindamycin	CIDs00446598	Phase 4	approved	CCC[C@@H]1C[C@@H](C(=O)N[C@H]([C@H](C)Cl)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)N(C)C1	G - GENITO URINARY SYSTEM AND SEX HORMONES | D - DERMATOLOGICALS | D - DERMATOLOGICALS | J - ANTIINFECTIVES FOR SYSTEMIC USE
BVDU	CIDs00446727	Phase 2	unapproved	O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1/C=C/Br	J - ANTIINFECTIVES FOR SYSTEMIC USE
lycopene	CIDs00446925	Phase 3	unapproved	CC(C)=CCC/C(C)=C/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C=C(\C)CCC=C(C)C	
azithromycin	CIDs00447043	Phase 4	approved	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O	J - ANTIINFECTIVES FOR SYSTEMIC USE | S - SENSORY ORGANS
alpha-D-mannose-6-phosphate	CIDs00447096	Phase 2	unapproved	O=P(O)(O)OC[C@H]1O[C@H](O)[C@@H](O)[C@@H](O)[C@@H]1O	
DADMeimmucillin-H	CIDs00447268	Phase 2	unapproved	O=c1[nH]cnc2c(CN3C[C@H](O)[C@@H](CO)C3)c[nH]c12	
isofagomine	CIDs00447607	Phase 2	unapproved	OC[C@H]1CNC[C@@H](O)[C@@H]1O	
6-ECDCA	CIDs00447715	Phase 4	approved	CC[C@@H]1[C@@H]2C[C@H](O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@H]3[C@H](C)CCC(=O)O)[C@@H]2[C@@H]1O	A - ALIMENTARY TRACT AND METABOLISM
epothilone D	CIDs00447865	Phase 2	unapproved	C/C1=C/C[C@@H](/C(C)=C/c2csc(C)n2)OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@@H](O)[C@@H](C)CCC1	
patupilone	CIDs00448013	Phase 3	unapproved	C/C(=C\c1csc(C)n1)[C@@H]1C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@H](O)[C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)O1	
MLN-4760	CIDs00448281	Phase 1	unapproved	CC(C)C[C@H](N[C@@H](Cc1cncn1Cc1cc(Cl)cc(Cl)c1)C(=O)O)C(=O)O	
estrogen	CIDs00448537	Phase 4	approved	CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1	G - GENITO URINARY SYSTEM AND SEX HORMONES | G - GENITO URINARY SYSTEM AND SEX HORMONES | L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
BMS-214662 mesylate	CIDs00448545	Phase 1	unapproved	N#Cc1ccc2c(c1)CN(S(=O)(=O)c1cccs1)[C@H](Cc1ccccc1)CN2Cc1c[nH]cn1	
eptifibatide	CIDs00448812	Phase 4	approved	N=C(N)NCCCC[C@@H]1NC(=O)CCSSC[C@@H](C(N)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CC(=O)O)NC(=O)CNC1=O	B - BLOOD AND BLOOD FORMING ORGANS
roflumilast	CIDs00449193	Phase 4	approved	O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1	R - RESPIRATORY SYSTEM
4-hydroxytamoxifen	CIDs00449459	Phase 3	unapproved	CC/C(=C(\c1ccc(O)cc1)c1ccc(OCCN(C)C)cc1)c1ccccc1	
pantethine	CIDs00452306	Phase 3	unapproved	CC(C)(CO)[C@@H](O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)CO	A - ALIMENTARY TRACT AND METABOLISM
Q-4344	CIDs00454194	Phase 2	unapproved	Nc1ccn([C@@H]2CO[C@H](CO)O2)c(=O)n1	
pretomanid	CIDs00456199	Phase 4	approved	O=[N+]([O-])c1cn2c(n1)OC[C@@H](OCc1ccc(OC(F)(F)F)cc1)C2	J - ANTIINFECTIVES FOR SYSTEMIC USE
bevirimat	CIDs00457928	Phase 2	unapproved	C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12	
tenofovir	CIDs00464205	Phase 3	unapproved	C[C@H](Cn1cnc2c(N)ncnc21)OCP(=O)(O)O	
prinomastat	CIDs00466151	Phase 3	unapproved	CC1(C)SCCN(S(=O)(=O)c2ccc(Oc3ccncc3)cc2)[C@H]1C(=O)NO	
ravuconazole	CIDs00467825	Phase 1	unapproved	C[C@@H](c1nc(-c2ccc(C#N)cc2)cs1)[C@](O)(Cn1cncn1)c1ccc(F)cc1F	
posaconazole	CIDs00468595	Phase 4	approved	CC[C@@H]([C@H](C)O)n1ncn(-c2ccc(N3CCN(c4ccc(OC[C@@H]5CO[C@@](Cn6cncn6)(c6ccc(F)cc6F)C5)cc4)CC3)cc2)c1=O	J - ANTIINFECTIVES FOR SYSTEMIC USE
terameprocol	CIDs00476861	Phase 1	unapproved	COc1ccc(C[C@H](C)[C@H](C)Cc2ccc(OC)c(OC)c2)cc1OC	
micafungin	CIDs00477468	Phase 4	approved	CCCCCOc1ccc(-c2cc(-c3ccc(C(=O)N[C@H]4C[C@@H](O)[C@@H](O)NC(=O)[C@@H]5[C@@H](O)[C@@H](C)CN5C(=O)[C@H]([C@H](O)CC(N)=O)NC(=O)[C@H]([C@H](O)[C@@H](O)c5ccc(O)c(OS(=O)(=O)O)c5)NC(=O)[C@@H]5C[C@@H](O)CN5C(=O)[C@H]([C@@H](C)O)NC4=O)cc3)no2)cc1	J - ANTIINFECTIVES FOR SYSTEMIC USE
riboflavin	CIDs00493570	Phase 4	approved	Cc1cc2nc3c(=O)[nH]c(=O)nc-3n(C[C@H](O)[C@H](O)[C@H](O)CO)c2cc1C	A - ALIMENTARY TRACT AND METABOLISM | S - SENSORY ORGANS
lisophylline	CIDs00501254	Phase 2	unapproved	C[C@@H](O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O	
tolfenamic acid	CIDs00610479	Phase 4	approved	Cc1c(Cl)cccc1Nc1ccccc1C(=O)O	M - MUSCULO-SKELETAL SYSTEM
fondaparinux	CIDs00636380	Phase 4	approved	CO[C@H]1O[C@H](COS(=O)(=O)O)[C@@H](O[C@@H]2O[C@@H](C(=O)O)[C@@H](O[C@H]3O[C@H](COS(=O)(=O)O)[C@@H](O[C@@H]4O[C@H](C(=O)O)[C@@H](O[C@H]5O[C@H](COS(=O)(=O)O)[C@@H](O)[C@H](O)[C@H]5NS(=O)(=O)O)[C@H](O)[C@H]4O)[C@H](OS(=O)(=O)O)[C@H]3NS(=O)(=O)O)[C@H](O)[C@H]2OS(=O)(=O)O)[C@H](O)[C@H]1NS(=O)(=O)O	B - BLOOD AND BLOOD FORMING ORGANS
Bio-Plex	CIDs00636402	Phase 4	approved	CC1(C)[C@@H](OC(=O)CCC(=O)O)CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@@](C)(C(=O)O)CC[C@]3(C)CC[C@]21C	A - ALIMENTARY TRACT AND METABOLISM | A - ALIMENTARY TRACT AND METABOLISM | A - ALIMENTARY TRACT AND METABOLISM
dimethyl fumarate	CIDs00637568	Phase 4	approved	COC(=O)/C=C/C(=O)OC	L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
piperine	CIDs00638024	Phase 2	unapproved	O=C(/C=C/C=C/c1ccc2c(c1)OCO2)N1CCCCC1	
trans-delta 8-tetrahydrocannabinol	CIDs00638026	Phase 2	unapproved	CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CC=C(C)C[C@@H]21	
thyrotrophin-releasing hormone	CIDs00638678	Phase 4	approved	NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1	V - VARIOUS
follicle-stimulating hormone-releasing factor	CIDs00638792	Phase 4	approved	CC(C)C[C@H](NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O	H - SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS | V - VARIOUS
xanthohumol	CIDs00639665	Phase 2	unapproved	COc1cc(O)c(CC=C(C)C)c(O)c1C(=O)/C=C/c1ccc(O)cc1	
flavin mononucleotide	CIDs00643976	Phase 4	approved	Cc1cc2nc3c(=O)[nH]c(=O)nc-3n(C[C@H](O)[C@H](O)[C@H](O)COP(=O)(O)O)c2cc1C	
cannabidiol (CBD	CIDs00644019	Phase 4	approved	C=C(C)[C@@H]1CCC(C)=C[C@H]1c1c(O)cc(CCCCC)cc1O	N - NERVOUS SYSTEM
Arg8-vasopressin	CIDs00644077	Phase 4	approved	N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O	
2-acetamido-2-deoxy-beta-D-glucopyranoside	CIDs00644170	Phase 2	unapproved	CC(=O)N[C@@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O	
mezlocillin	CIDs00656511	Phase 4	approved	CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)N3CCN(S(C)(=O)=O)C3=O)c3ccccc3)C(=O)N2[C@H]1C(=O)O	J - ANTIINFECTIVES FOR SYSTEMIC USE
trilostane	CIDs00656583	Phase 4	approved	C[C@]12CC[C@H]3[C@@H](CC[C@@]45O[C@@H]4C(O)=C(C#N)C[C@]35C)[C@@H]1CC[C@@H]2O	H - SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
tropisetron	CIDs00656664	Phase 4	approved	CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)c1c[nH]c3ccccc13)C2	A - ALIMENTARY TRACT AND METABOLISM
anisotropine methylbromide	CIDs00657201	Phase 4	approved	CCCC(CCC)C(=O)O[C@@H]1C[C@@H]2CC[C@H](C1)[N+]2(C)C	
propylthiouracil (PTU	CIDs00657298	Phase 4	approved	CCCc1cc(=O)[nH]c(=S)[nH]1	H - SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
ipratropium bromide	CIDs00657308	Phase 4	approved	CC(C)[N+]1(C)[C@H]2CC[C@@H]1C[C@H](OC(=O)C(CO)c1ccccc1)C2	
chlorprothixene	CIDs00667467	Phase 4	approved	CN(C)CC/C=C1/c2ccccc2Sc2ccc(Cl)cc21	N - NERVOUS SYSTEM
dienestrol	CIDs00667476	Phase 4	approved	C/C=C(C(=C/C)/c1ccc(O)cc1)\c1ccc(O)cc1	G - GENITO URINARY SYSTEM AND SEX HORMONES | G - GENITO URINARY SYSTEM AND SEX HORMONES
R-etodolac	CIDs00667528	Phase 2	unapproved	CCc1cccc2c3c([nH]c12)[C@@](CC)(CC(=O)O)OCC3	
dexketoprofen	CIDs00667550	Phase 4	approved	C[C@H](C(=O)O)c1cccc(C(=O)c2ccccc2)c1	M - MUSCULO-SKELETAL SYSTEM | M - MUSCULO-SKELETAL SYSTEM
levosulpiride	CIDs00688272	Phase 2	unapproved	CCN1CCC[C@H]1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC	N - NERVOUS SYSTEM
caffeic acid	CIDs00689043	Phase 3	unapproved	O=C(O)/C=C/c1ccc(O)c(O)c1	
pyrantel	CIDs00708857	Phase 4	approved	CN1CCCN=C1/C=C/c1cccs1	P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
cotinine	CIDs00854019	Phase 2	unapproved	CN1C(=O)CC[C@H]1c1cccnc1	
AC1LH2S9	CIDs00855908	Phase 2	unapproved	Nc1sc2c(c1C(=O)c1ccc(Cl)cc1)CCCC2	
flunarizine	CIDs00941361	Phase 4	approved	Fc1ccc(C(c2ccc(F)cc2)N2CCN(C/C=C/c3ccccc3)CC2)cc1	N - NERVOUS SYSTEM
thiothixene	CIDs00941651	Phase 4	approved	CN1CCN(CC/C=C2/c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1	N - NERVOUS SYSTEM
eszopiclone	CIDs00969472	Phase 4	approved	CN1CCN(C(=O)O[C@H]2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1	N - NERVOUS SYSTEM
benztropine	CIDs01201549	Phase 4	approved	CN1[C@H]2CC[C@@H]1C[C@H](OC(c1ccccc1)c1ccccc1)C2	N - NERVOUS SYSTEM
methimazole	CIDs01349907	Phase 4	approved	Cn1cc[nH]c1=S	H - SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS | H - SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
3'-carbamoyl-biphenyl-3-yl-cyclohexylcarbamate	CIDs01383884	Phase 1	unapproved	NC(=O)c1cccc(-c2cccc(OC(=O)NC3CCCCC3)c2)c1	
cinnarizine	CIDs01547484	Phase 4	approved	C(=C/c1ccccc1)\CN1CCN(C(c2ccccc2)c2ccccc2)CC1	N - NERVOUS SYSTEM | N - NERVOUS SYSTEM
sulindac	CIDs01548886	Phase 4	approved	CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\c1ccc([S+](C)[O-])cc1	M - MUSCULO-SKELETAL SYSTEM
capsaicin	CIDs01548943	Phase 4	approved	COc1cc(CNC(=O)CCCC/C=C/C(C)C)ccc1O	N - NERVOUS SYSTEM | M - MUSCULO-SKELETAL SYSTEM
clomiphene	CIDs01548952	Phase 3	unapproved	CCN(CC)CCOc1ccc(/C(=C(/Cl)c2ccccc2)c2ccccc2)cc1	
levocetirizine	CIDs01548999	Phase 4	approved	O=C(O)COCCN1CCN([C@H](c2ccccc2)c2ccc(Cl)cc2)CC1	R - RESPIRATORY SYSTEM
terbinafine	CIDs01549007	Phase 4	approved	CN(C/C=C/C#CC(C)(C)C)Cc1cccc2ccccc12	D - DERMATOLOGICALS | D - DERMATOLOGICALS
epalrestat	CIDs01549119	Phase 2	unapproved	CC(/C=C1\SC(=S)N(CC(=O)O)C1=O)=C\c1ccccc1	
tosyl-L-arginine methyl ester	CIDs01550285	Phase 1	unapproved	COC(=O)[C@H](CCCN=C(N)N)NS(=O)(=O)c1ccc(C)cc1	
drotaverine	CIDs01712095	Phase 3	unapproved	CCOc1ccc(/C=C2\NCCc3cc(OCC)c(OCC)cc32)cc1OCC	A - ALIMENTARY TRACT AND METABOLISM
chlorogenic acid	CIDs01794426	Phase 2	unapproved	O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1C[C@](O)(C(=O)O)C[C@@H](O)[C@H]1O	
succimer	CIDs02724354	Phase 4	approved	O=C(O)[C@H](S)[C@H](S)C(=O)O	
digoxin	CIDs02724385	Phase 4	approved	C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@]5(C)[C@H]6C[C@@H](O)[C@]7(C)[C@@H](C8=CC(=O)OC8)CC[C@]7(O)[C@@H]6CC[C@@H]5C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O	C - CARDIOVASCULAR SYSTEM
tamoxifen	CIDs02733525	Phase 4	approved	CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1	L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
alpha-GalCer	CIDs02826713	Phase 1	unapproved	CCCCCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO[C@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)[C@H](O)CCCCCCCCCCCCCC	
caspofungin	CIDs02826718	Phase 4	approved	CCC(C)CC(C)CCCCCCCCC(=O)N[C@H]1C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]2[C@@H](O)CCN2C(=O)[C@H]([C@H](O)CCN)NC(=O)[C@H]([C@H](O)[C@@H](O)c2ccc(O)cc2)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@H]([C@@H](C)O)NC1=O	J - ANTIINFECTIVES FOR SYSTEMIC USE
fusidic acid	CIDs03000226	Phase 4	approved	CC(=O)O[C@H]1C[C@@]2(C)[C@@H](C[C@@H](O)[C@H]3[C@@]4(C)CC[C@@H](O)[C@@H](C)[C@@H]4CC[C@@]32C)/C1=C(\CCC=C(C)C)C(=O)O	J - ANTIINFECTIVES FOR SYSTEMIC USE | S - SENSORY ORGANS | D - DERMATOLOGICALS | D - DERMATOLOGICALS
scopolamine (SCO	CIDs03000322	Phase 4	approved	CN1[C@H]2C[C@H](OC(=O)[C@H](CO)c3ccccc3)C[C@@H]1[C@H]1O[C@@H]21	S - SENSORY ORGANS | A - ALIMENTARY TRACT AND METABOLISM | A - ALIMENTARY TRACT AND METABOLISM | N - NERVOUS SYSTEM
thiopentone	CIDs03000715	Phase 4	approved	CCCC(C)C1(CC)C(=O)NC(=S)NC1=O	N - NERVOUS SYSTEM | N - NERVOUS SYSTEM
Oestrogen	CIDs03001028	Phase 4	approved	C[C@]12CC[C@@H]3c4ccc(OS(=O)(=O)O)cc4CC[C@H]3[C@@H]1CCC2=O	
aplaviroc	CIDs03001322	Phase 3	unapproved	CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2	
telithromycin	CIDs03002190	Phase 4	approved	CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C	J - ANTIINFECTIVES FOR SYSTEMIC USE
maraviroc	CIDs03002977	Phase 4	approved	Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1	J - ANTIINFECTIVES FOR SYSTEMIC USE
ZnCl2	CIDs03007855	Phase 4	approved	[Cl-].[Cl-].[Zn+2]	B - BLOOD AND BLOOD FORMING ORGANS
Rwj 67657	CIDs03008319	Phase 1	unapproved	OCCC#Cc1nc(-c2ccc(F)cc2)c(-c2ccncc2)n1CCCc1ccccc1	
vicriviroc	CIDs03009355	Phase 3	unapproved	COC[C@@H](c1ccc(C(F)(F)F)cc1)N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C	
telaprevir	CIDs03010818	Phase 4	approved	CCC[C@H](NC(=O)[C@@H]1[C@H]2CCC[C@H]2CN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)c1cnccn1)C1CCCCC1)C(C)(C)C)C(=O)C(=O)NC1CC1	J - ANTIINFECTIVES FOR SYSTEMIC USE
FCE-20124	CIDs03022644	Phase 4	approved	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	N - NERVOUS SYSTEM
tetomilast	CIDs03025803	Phase 3	unapproved	CCOc1ccc(-c2nc(-c3cccc(C(=O)O)n3)cs2)cc1OCC	
Sns-032	CIDs03025986	Phase 1	unapproved	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1	
thiamylal	CIDs03032285	Phase 4	approved	C=CCC1(C(C)CCC)C(=O)N=C(S)NC1=O	
DES-DP	CIDs03032325	Phase 4	approved	CC/C(=C(/CC)c1ccc(OP(=O)(O)O)cc1)c1ccc(OP(=O)(O)O)cc1	L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
dapiprazole	CIDs03033538	Phase 4	approved	Cc1ccccc1N1CCN(CCc2nnc3n2CCCC3)CC1	S - SENSORY ORGANS
levosimendan	CIDs03033825	Phase 3	unapproved	C[C@@H]1CC(=O)NN=C1c1ccc(NN=C(C#N)C#N)cc1	C - CARDIOVASCULAR SYSTEM
gestodene	CIDs03033968	Phase 3	unapproved	C#C[C@]1(O)C=C[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21CC	
orlistat	CIDs03034010	Phase 4	approved	CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O	A - ALIMENTARY TRACT AND METABOLISM
ABT-751	CIDs03035714	Phase 2	unapproved	COc1ccc(S(=O)(=O)Nc2cccnc2Nc2ccc(O)cc2)cc1	
Cl-IB-MECA	CIDs03035850	Phase 2	unapproved	CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCc4cccc(I)c4)nc(Cl)nc32)[C@H](O)[C@@H]1O	
ospemifene	CIDs03036505	Phase 4	approved	OCCOc1ccc(/C(=C(/CCCl)c2ccccc2)c2ccccc2)cc1	G - GENITO URINARY SYSTEM AND SEX HORMONES
asenapine	CIDs03036780	Phase 4	approved	CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1	N - NERVOUS SYSTEM
ifetroban	CIDs03037233	Phase 2	unapproved	CCCCCNC(=O)c1coc([C@@H]2[C@H]3CC[C@H](O3)[C@@H]2Cc2ccccc2CCC(=O)O)n1	
biricodar	CIDs03037617	Phase 2	unapproved	COc1cc(C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc2cccnc2)CCCc2cccnc2)cc(OC)c1OC	
fospropofol	CIDs03038497	Phase 4	approved	CC(C)c1cccc(C(C)C)c1OCOP(=O)(O)O	
sufugolix	CIDs03038517	Phase 2	unapproved	CONC(=O)Nc1ccc(-c2sc3c(c2CN(C)Cc2ccccc2)c(=O)n(-c2ccccc2)c(=O)n3Cc2c(F)cccc2F)cc1	
tandutinib	CIDs03038522	Phase 2	unapproved	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1	
Vx-745	CIDs03038525	Phase 2	unapproved	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl	
prucalopride	CIDs03052762	Phase 4	approved	COCCCN1CCC(NC(=O)c2cc(Cl)c(N)c3c2OCC3)CC1	A - ALIMENTARY TRACT AND METABOLISM
rasagiline	CIDs03052775	Phase 4	approved	C#CCN[C@@H]1CCc2ccccc21	N - NERVOUS SYSTEM
robalzotan	CIDs03055171	Phase 2	unapproved	NC(=O)c1ccc(F)c2c1C[C@@H](N(C1CCC1)C1CCC1)CO2	
tebanicline	CIDs03075702	Phase 2	unapproved	Clc1ccc(OC[C@H]2CCN2)cn1	
nerispirdine	CIDs03081185	Phase 2	unapproved	CCCN(c1ccncc1F)n1cc(C)c2ccccc21	
telavancin	CIDs03081362	Phase 4	approved	CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O	J - ANTIINFECTIVES FOR SYSTEMIC USE
selodenoson	CIDs03082555	Phase 2	unapproved	CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)ncnc32)[C@H](O)[C@@H]1O	
anti-oxLDL	CIDs03083542	Phase 3	unapproved	CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)[C@@H]1CC=C(C(=O)O)C[C@@H]21	
arformoterol	CIDs03083544	Phase 4	approved	COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1	
esmirtazapine	CIDs03085218	Phase 3	unapproved	CN1CCN2c3ncccc3Cc3ccccc3[C@H]2C1	
Atreleuton	CIDs03086671	Phase 2	unapproved	C[C@H](C#Cc1ccc(Cc2ccc(F)cc2)s1)N(O)C(N)=O	
CTS-1027	CIDs03342298	Phase 2	unapproved	O=C(NO)C1(CS(=O)(=O)c2ccc(Oc3ccc(Cl)cc3)cc2)CCOCC1	
4-methylumbelliferone	CIDs03364573	Phase 1	unapproved	Cc1cc(=O)oc2cc(O)ccc12	A - ALIMENTARY TRACT AND METABOLISM
farampator	CIDs04118151	Phase 2	unapproved	O=C(c1ccc2nonc2c1)N1CCCCC1	
sitagliptin	CIDs04369359	Phase 4	approved	N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F	A - ALIMENTARY TRACT AND METABOLISM
tolcapone	CIDs04659569	Phase 4	approved	Cc1ccc(C(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)cc1	N - NERVOUS SYSTEM
warfarin	CIDs05001396	Phase 4	approved	CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O	B - BLOOD AND BLOOD FORMING ORGANS
butyric acid sodium salt	CIDs05222465	Phase 2	unapproved	CCCC(=O)[O-].[Na+]	
SQ109	CIDs05274428	Phase 2	unapproved	CC(C)=CCC/C(C)=C/CNCCNC1C2CC3CC(C2)CC1C3	
quercetin	CIDs05280343	Phase 3	unapproved	O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12	
bilirubin	CIDs05280352	Phase 1	unapproved	C=CC1=C(C)/C(=C/c2[nH]c(Cc3[nH]c(/C=C4\NC(=O)C(C)=C4C=C)c(C)c3CCC(=O)O)c(CCC(=O)O)c2C)NC1=O	
prostaglandin E2	CIDs05280360	Phase 4	approved	CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O	G - GENITO URINARY SYSTEM AND SEX HORMONES
PGF2 alpha	CIDs05280363	Phase 4	approved	CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1C/C=C\CCCC(=O)O	G - GENITO URINARY SYSTEM AND SEX HORMONES
formononetin	CIDs05280378	Phase 2	unapproved	COc1ccc(-c2coc3cc(O)ccc3c2=O)cc1	
luteolin	CIDs05280445	Phase 2	unapproved	O=c1cc(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12	
linoleic acid	CIDs05280450	Phase 2	unapproved	CCCCC/C=C\C/C=C\CCCCCCCC(=O)O	
calcitriol	CIDs05280453	Phase 4	approved	C=C1/C(=C\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CCCC(C)(C)O)C[C@@H](O)C[C@@H]1O	A - ALIMENTARY TRACT AND METABOLISM | D - DERMATOLOGICALS
carotene	CIDs05280489	Phase 4	approved	CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C2=C(C)CCCC2(C)C)C(C)(C)CCC1	D - DERMATOLOGICALS | A - ALIMENTARY TRACT AND METABOLISM
vitamin A palmitate	CIDs05280531	Phase 4	approved	CCCCCCCCCCCCCCCC(=O)OC/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C	
DGLA	CIDs05280581	Phase 2	unapproved	CCCCC/C=C\C/C=C\C/C=C\CCCCCCC(=O)O	
prostaglandin E1	CIDs05280723	Phase 4	approved	CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O	G - GENITO URINARY SYSTEM AND SEX HORMONES | C - CARDIOVASCULAR SYSTEM
bryostatin 1	CIDs05280757	Phase 2	unapproved	CCC/C=C/C=C/C(=O)O[C@H]1/C(=C/C(=O)OC)C[C@H]2C[C@H]([C@@H](C)O)OC(=O)C[C@H](O)C[C@@H]3C[C@H](OC(C)=O)C(C)(C)[C@](O)(C[C@@H]4C/C(=C/C(=O)OC)C[C@H](/C=C/C(C)(C)[C@]1(O)O2)O4)O3	
vitamin D2	CIDs05280793	Phase 4	approved	C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)/C=C/[C@H](C)C(C)C	A - ALIMENTARY TRACT AND METABOLISM
vitamin D	CIDs05280795	Phase 4	approved	C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CCCC(C)C	A - ALIMENTARY TRACT AND METABOLISM
isoquercitrin	CIDs05280804	Phase 2	unapproved	O=c1c(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12	
rutin	CIDs05280805	Phase 2	unapproved	C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(O)c(O)c4)oc4cc(O)cc(O)c4c3=O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O	C - CARDIOVASCULAR SYSTEM | C - CARDIOVASCULAR SYSTEM
gamma-linolenic acid	CIDs05280933	Phase 4	approved	CCCCC/C=C\C/C=C\C/C=C\CCCCC(=O)O	D - DERMATOLOGICALS | D - DERMATOLOGICALS
rescinnamine	CIDs05280954	Phase 4	approved	COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)/C=C/c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC	C - CARDIOVASCULAR SYSTEM
genistein	CIDs05280961	Phase 2	unapproved	O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12	
amphotericin B	CIDs05280965	Phase 4	approved	C[C@@H]1OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@]2(O)C[C@H](O)[C@@H](C(=O)O)[C@H](C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@H]1C)O2	J - ANTIINFECTIVES FOR SYSTEMIC USE | A - ALIMENTARY TRACT AND METABOLISM | A - ALIMENTARY TRACT AND METABOLISM | G - GENITO URINARY SYSTEM AND SEX HORMONES
clavulanic acid	CIDs05280980	Phase 4	approved	O=C(O)[C@H]1/C(=C/CO)O[C@@H]2CC(=O)N21	
budesonide	CIDs05281004	Phase 4	approved	CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1	A - ALIMENTARY TRACT AND METABOLISM | R - RESPIRATORY SYSTEM | D - DERMATOLOGICALS | R - RESPIRATORY SYSTEM
oxymetholone	CIDs05281034	Phase 4	approved	C[C@]12C/C(=C/O)C(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O	A - ALIMENTARY TRACT AND METABOLISM
pyrvinium	CIDs05281035	Phase 4	approved	Cc1cc(/C=C/c2ccc3cc(N(C)C)ccc3[n+]2C)c(C)n1-c1ccccc1	P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
eprosartan	CIDs05281037	Phase 4	approved	CCCCc1ncc(/C=C(\Cc2cccs2)C(=O)O)n1Cc1ccc(C(=O)O)cc1	C - CARDIOVASCULAR SYSTEM
montelukast	CIDs05281040	Phase 4	approved	CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1	R - RESPIRATORY SYSTEM | R - RESPIRATORY SYSTEM
mivacurium	CIDs05281042	Phase 4	approved	COc1cc2c(cc1OC)[C@@H](Cc1cc(OC)c(OC)c(OC)c1)[N+](C)(CCCOC(=O)CC/C=C/CCC(=O)OCCC[N+]1(C)CCc3cc(OC)c(OC)cc3[C@H]1Cc1cc(OC)c(OC)c(OC)c1)CC2	
hypericin	CIDs05281051	Phase 3	unapproved	Cc1cc(O)c2c(=O)c3c(O)cc(O)c4c5c(O)cc(O)c6c(=O)c7c(O)cc(C)c8c1c2c(c34)c(c78)c65	
olopatadine	CIDs05281071	Phase 4	approved	CN(C)CC/C=C1/c2ccccc2COc2ccc(CC(=O)O)cc21	R - RESPIRATORY SYSTEM | S - SENSORY ORGANS
ethchlorvynol	CIDs05281077	Phase 4	approved	C#CC(O)(/C=C/Cl)CC	N - NERVOUS SYSTEM
mycophenolate mofetil	CIDs05281078	Phase 4	approved	COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)OCCN1CCOCC1)C(=O)OC2	
entacapone	CIDs05281081	Phase 4	approved	CCN(CC)C(=O)/C(C#N)=C/c1cc(O)c(O)c([N+](=O)[O-])c1	N - NERVOUS SYSTEM
paricalcitol	CIDs05281104	Phase 4	approved	C[C@@H](/C=C/[C@@H](C)[C@H]1CC[C@H]2/C(=C/C=C3C[C@@H](O)C[C@H](O)C3)CCC[C@@]21C)C(C)(C)O	H - SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
doxercalciferol	CIDs05281107	Phase 4	approved	C=C1/C(=C\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)/C=C/[C@H](C)C(C)C)C[C@@H](O)C[C@@H]1O	H - SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
astaxanthin	CIDs05281224	Phase 3	unapproved	CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C2=C(C)C(=O)[C@@H](O)CC2(C)C)C(C)(C)C[C@H](O)C1=O	
crocetin	CIDs05281232	Phase 3	unapproved	CC(/C=C/C=C(\C)C(=O)O)=C\C=C\C=C(C)\C=C\C=C(/C)C(=O)O	
crocin	CIDs05281233	Phase 3	unapproved	CC(/C=C/C=C(\C)C(=O)O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O)=C\C=C\C=C(C)\C=C\C=C(/C)C(=O)O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O	
lutein	CIDs05281243	Phase 3	unapproved	CC1=C[C@H](O)CC(C)(C)[C@H]1/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C[C@@H](O)CC1(C)C	
baicalein	CIDs05281605	Phase 2	unapproved	O=c1cc(-c2ccccc2)oc2cc(O)c(O)c(O)c12	
diosmin	CIDs05281613	Phase 4	approved	COc1ccc(-c2cc(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3o2)cc1O	C - CARDIOVASCULAR SYSTEM | C - CARDIOVASCULAR SYSTEM
fisetin	CIDs05281614	Phase 2	unapproved	O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)ccc12	
daidzein	CIDs05281708	Phase 2	unapproved	O=c1c(-c2ccc(O)cc2)coc2cc(O)ccc12	
polydatin	CIDs05281718	Phase 2	unapproved	OC[C@H]1O[C@@H](Oc2cc(O)cc(/C=C/c3ccc(O)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O	
pterostilbene	CIDs05281727	Phase 2	unapproved	COc1cc(/C=C/c2ccc(O)cc2)cc(OC)c1	
curcumin	CIDs05281767	Phase 3	unapproved	COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O	
salvianolic acid	CIDs05281793	Phase 1	unapproved	O=C(/C=C/c1ccc(O)c(O)c1/C=C/c1ccc(O)c(O)c1)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O	
acteoside	CIDs05281800	Phase 2	unapproved	C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](OCCc3ccc(O)c(O)c3)O[C@H](CO)[C@H]2OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H](O)[C@H](O)[C@H]1O	
puerarin	CIDs05281807	Phase 2	unapproved	O=c1c(-c2ccc(O)cc2)coc2c([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)ccc12	
ellagic acid	CIDs05281855	Phase 2	unapproved	O=c1oc2c(O)c(O)cc3c(=O)oc4c(O)c(O)cc1c4c23	
trans-flupenthixol	CIDs05281878	Phase 2	unapproved	OCCN1CCN(CC/C=C2\c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1	
flupenthixol	CIDs05281881	Phase 3	unapproved	OCCN1CCN(CC/C=C2/c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1	N - NERVOUS SYSTEM
valspodar	CIDs05281884	Phase 3	unapproved	C/C=C/C[C@@H](C)C(=O)[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C	
coenzyme Q10	CIDs05281915	Phase 3	unapproved	COC1=C(OC)C(=O)C(C/C=C(\C)CC/C=C(\C)CC/C=C(\C)CC/C=C(\C)CC/C=C(\C)CC/C=C(\C)CC/C=C(\C)CC/C=C(\C)CC/C=C(\C)CCC=C(C)C)=C(C)C1=O	C - CARDIOVASCULAR SYSTEM
lafutidine	CIDs05282136	Phase 3	unapproved	O=C(C[S+]([O-])Cc1ccco1)NC/C=C\COc1cc(CN2CCCCC2)ccn1	A - ALIMENTARY TRACT AND METABOLISM
cilnidipine	CIDs05282138	Phase 3	unapproved	COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC/C=C/c2ccccc2)C1c1cccc([N+](=O)[O-])c1	C - CARDIOVASCULAR SYSTEM
alfacalcidol	CIDs05282181	Phase 4	approved	C=C1/C(=C\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CCCC(C)C)C[C@@H](O)C[C@@H]1O	A - ALIMENTARY TRACT AND METABOLISM
travoprost	CIDs05282226	Phase 4	approved	CC(C)OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1/C=C/[C@@H](O)COc1cccc(C(F)(F)F)c1	S - SENSORY ORGANS
tranilast	CIDs05282230	Phase 3	unapproved	COc1ccc(/C=C/C(=O)Nc2ccccc2C(=O)O)cc1OC	
ceftibuten	CIDs05282241	Phase 4	approved	Nc1nc(/C(=C/CC(=O)O)C(=O)N[C@@H]2C(=O)N3C(C(=O)O)=CCS[C@H]23)cs1	J - ANTIINFECTIVES FOR SYSTEMIC USE
acotiamide	CIDs05282338	Phase 3	unapproved	COc1cc(O)c(C(=O)Nc2nc(C(=O)NCCN(C(C)C)C(C)C)cs2)cc1OC	
SSR125543A	CIDs05282340	Phase 3	unapproved	C#CCN(c1nc(-c2cc(C)c(OC)cc2Cl)c(C)s1)[C@@H](CC1CC1)c1ccc(C)c(F)c1	
etretinate	CIDs05282375	Phase 4	approved	CCOC(=O)/C=C(C)/C=C/C=C(C)/C=C/c1c(C)cc(OC)c(C)c1C	D - DERMATOLOGICALS
isotretinoin	CIDs05282379	Phase 4	approved	CC1=C(/C=C/C(C)=C/C=C/C(C)=C\C(=O)O)C(C)(C)CCC1	D - DERMATOLOGICALS | D - DERMATOLOGICALS | D - DERMATOLOGICALS
misoprostol	CIDs05282381	Phase 4	approved	CCCCC(C)(O)C/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC	G - GENITO URINARY SYSTEM AND SEX HORMONES | A - ALIMENTARY TRACT AND METABOLISM
epoprostenol	CIDs05282411	Phase 4	approved	CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@@H]2O/C(=C\CCCC(=O)O)C[C@@H]21	B - BLOOD AND BLOOD FORMING ORGANS
indigo carmine	CIDs05282429	Phase 1	unapproved	O=C1/C(=C2\Nc3ccc(S(=O)(=O)O)cc3C2=O)Nc2ccc(S(=O)(=O)O)cc21	
GRN163L	CIDs05282439	Phase 3	unapproved	O=C(O)/C=C/c1ccc(Cn2ccnc2)cc1	
triprolidine	CIDs05282442	Phase 4	approved	Cc1ccc(/C(=C\CN2CCCC2)c2ccccn2)cc1	R - RESPIRATORY SYSTEM
pitavastatin	CIDs05282451	Phase 4	approved	O=C(O)C[C@H](O)C[C@H](O)/C=C/c1c(C2CC2)nc2ccccc2c1-c1ccc(F)cc1	C - CARDIOVASCULAR SYSTEM
homatropine methylbromide	CIDs05282592	Phase 4	approved	C[N+]1(C)[C@H]2CC[C@@H]1C[C@H](OC(=O)C(O)c1ccccc1)C2	
25-hydroxyvitamin D	CIDs05283731	Phase 4	approved	C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CCCC(C)(C)O	
tacalcitol	CIDs05283734	Phase 4	approved	C=C1/C(=C\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CC[C@@H](O)C(C)C)C[C@@H](O)C[C@@H]1O	D - DERMATOLOGICALS
hyodeoxycholic acid	CIDs05283820	Phase 1	unapproved	C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3C[C@H](O)[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C	
codeine	CIDs05284371	Phase 4	approved	COc1ccc2c3c1O[C@H]1[C@@H](O)C=C[C@H]4[C@@H](C2)N(C)CC[C@]314	N - NERVOUS SYSTEM | N - NERVOUS SYSTEM | R - RESPIRATORY SYSTEM
ciclosporin A	CIDs05284373	Phase 4	approved	C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C	S - SENSORY ORGANS | L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
acitretin	CIDs05284513	Phase 4	approved	COc1cc(C)c(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)c(C)c1C	D - DERMATOLOGICALS
acrivastine	CIDs05284514	Phase 4	approved	Cc1ccc(/C(=C\CN2CCCC2)c2cccc(/C=C/C(=O)O)n2)cc1	R - RESPIRATORY SYSTEM
dihydrocodeine	CIDs05284543	Phase 4	approved	COc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@H]4[C@@H](C2)N(C)CC[C@]314	N - NERVOUS SYSTEM | N - NERVOUS SYSTEM
dorzolamide	CIDs05284549	Phase 4	approved	CCN[C@H]1C[C@H](C)S(=O)(=O)c2sc(S(N)(=O)=O)cc21	S - SENSORY ORGANS
17 alpha-ethinyltestosterone	CIDs05284557	Phase 3	unapproved	C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C	G - GENITO URINARY SYSTEM AND SEX HORMONES
hydrocodone	CIDs05284569	Phase 4	approved	COc1ccc2c3c1O[C@H]1C(=O)CC[C@H]4[C@@H](C2)N(C)CC[C@]314	R - RESPIRATORY SYSTEM
hydromorphone	CIDs05284570	Phase 4	approved	CN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@H]3[C@H]1C5	N - NERVOUS SYSTEM
levetiracetam	CIDs05284583	Phase 4	approved	CC[C@@H](C(N)=O)N1CCCC1=O	N - NERVOUS SYSTEM
nalmefene	CIDs05284594	Phase 4	approved	C=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5	N - NERVOUS SYSTEM
naloxone	CIDs05284596	Phase 4	approved	C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5	A - ALIMENTARY TRACT AND METABOLISM | V - VARIOUS
oxycodone	CIDs05284603	Phase 4	approved	COc1ccc2c3c1O[C@H]1C(=O)CC[C@@]4(O)[C@@H](C2)N(C)CC[C@]314	N - NERVOUS SYSTEM
oxymorphone	CIDs05284604	Phase 4	approved	CN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5	N - NERVOUS SYSTEM
vitamin K1	CIDs05284607	Phase 4	approved	CC1=C(C/C=C(\C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=O)c2ccccc2C1=O	B - BLOOD AND BLOOD FORMING ORGANS
rapamycin	CIDs05284616	Phase 4	approved	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C	L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | S - SENSORY ORGANS
topiramate	CIDs05284627	Phase 4	approved	CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1	N - NERVOUS SYSTEM
trospium	CIDs05284631	Phase 4	approved	O=C(O[C@@H]1C[C@@H]2CC[C@H](C1)[N+]21CCCC1)C(O)(c1ccccc1)c1ccccc1	G - GENITO URINARY SYSTEM AND SEX HORMONES
irosustat	CIDs05287541	Phase 2	unapproved	NS(=O)(=O)Oc1ccc2c3c(c(=O)oc2c1)CCCCC3	
flavopiridol	CIDs05287969	Phase 3	unapproved	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1	
seocalcitol	CIDs05288149	Phase 3	unapproved	C=C1/C(=C\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)/C=C/C=C/C(O)(CC)CC)C[C@@H](O)C[C@@H]1O	
topiroxostat	CIDs05288320	Phase 2	unapproved	N#Cc1cc(-c2n[nH]c(-c3ccncc3)n2)ccn1	
geldanamycin	CIDs05288382	Phase 2	unapproved	COC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O	
17-DMAG	CIDs05288674	Phase 2	unapproved	CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NCCN(C)C)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O	
calcipotriol	CIDs05288783	Phase 4	approved	C=C1/C(=C\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)/C=C/[C@@H](O)C2CC2)C[C@@H](O)C[C@@H]1O	D - DERMATOLOGICALS | D - DERMATOLOGICALS
morphine	CIDs05288826	Phase 4	approved	CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5	N - NERVOUS SYSTEM | A - ALIMENTARY TRACT AND METABOLISM | N - NERVOUS SYSTEM
SU9516	CIDs05289419	Phase 1	unapproved	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2	
AC1NRDH7	CIDs05289549	Phase 2	unapproved	C=C1[C@H](O)CC(=C/C=C2\CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@@H](C)CCCC(C)(C)O)C[C@H]1O	
ezatiostat	CIDs05310939	Phase 2	unapproved	CCOC(=O)[C@@H](N)CCC(=O)N[C@@H](CSCc1ccccc1)C(=O)N[C@@H](C(=O)OCC)c1ccccc1	
DMXBA	CIDs05310985	Phase 2	unapproved	COc1ccc(/C=C2\CCCN=C2c2cccnc2)c(OC)c1	
acipimox	CIDs05310993	Phase 4	approved	Cc1cnc(C(=O)O)c[n+]1[O-]	C - CARDIOVASCULAR SYSTEM
atosiban	CIDs05311010	Phase 4	approved	CCOc1ccc(C[C@H]2NC(=O)CCSSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1	G - GENITO URINARY SYSTEM AND SEX HORMONES
bimatoprost	CIDs05311027	Phase 4	approved	CCNC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1/C=C/[C@@H](O)CCc1ccccc1	S - SENSORY ORGANS
istradefylline	CIDs05311037	Phase 4	approved	CCn1c(=O)c2c(nc(/C=C/c3ccc(OC)c(OC)c3)n2C)n(CC)c1=O	N - NERVOUS SYSTEM
desmopressin acetate	CIDs05311065	Phase 4	approved	N=C(N)NCCC[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O	H - SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
desonide	CIDs05311066	Phase 4	approved	CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1	S - SENSORY ORGANS | D - DERMATOLOGICALS
desoximetasone	CIDs05311067	Phase 4	approved	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@H]1C(=O)CO	D - DERMATOLOGICALS | D - DERMATOLOGICALS
dexmedetomidine	CIDs05311068	Phase 4	approved	Cc1cccc([C@H](C)c2c[nH]cn2)c1C	N - NERVOUS SYSTEM
dihydrotachysterol	CIDs05311071	Phase 4	approved	CC(C)[C@@H](C)/C=C/[C@@H](C)[C@H]1CC[C@H]2/C(=C/C=C3\C[C@@H](O)CC[C@@H]3C)CCC[C@@]21C	A - ALIMENTARY TRACT AND METABOLISM
gosereline	CIDs05311128	Phase 4	approved	CC(C)C[C@H](NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NNC(N)=O	L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
iloprost	CIDs05311181	Phase 4	approved	CC#CCC(C)[C@H](O)/C=C/[C@@H]1[C@H]2C/C(=C/CCCC(=O)O)C[C@H]2C[C@H]1O	B - BLOOD AND BLOOD FORMING ORGANS
lacidipine	CIDs05311217	Phase 4	approved	CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC)C1c1ccccc1/C=C/C(=O)OC(C)(C)C	C - CARDIOVASCULAR SYSTEM
latanoprost	CIDs05311221	Phase 4	approved	CC(C)OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCc1ccccc1	S - SENSORY ORGANS
Q-3721	CIDs05311271	Phase 3	unapproved	COc1cccc([C@H](O)C2CCN(CCc3ccc(F)cc3)CC2)c1OC	
nalbuphine	CIDs05311304	Phase 4	approved	Oc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@@]4(O)[C@@H](C2)N(CC2CCC2)CC[C@]314	N - NERVOUS SYSTEM
nateglinide	CIDs05311309	Phase 4	approved	CC(C)[C@H]1CC[C@H](C(=O)N[C@H](Cc2ccccc2)C(=O)O)CC1	A - ALIMENTARY TRACT AND METABOLISM
Pd166285	CIDs05311382	Phase 1	unapproved	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1	
rimexolone	CIDs05311412	Phase 4	approved	CCC(=O)[C@@]1(C)[C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C	H - SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS | S - SENSORY ORGANS
talnetant	CIDs05311424	Phase 2	unapproved	CC[C@H](NC(=O)c1c(O)c(-c2ccccc2)nc2ccccc12)c1ccccc1	
spirapril	CIDs05311447	Phase 4	approved	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CC2(C[C@H]1C(=O)O)SCCS2	C - CARDIOVASCULAR SYSTEM
stiripentol	CIDs05311454	Phase 4	approved	CC(C)(C)C(O)/C=C/c1ccc2c(c1)OCO2	N - NERVOUS SYSTEM
onapristone	CIDs05311505	Phase 4	approved	CN(C)c1ccc([C@H]2C[C@]3(C)[C@@H](CC[C@]3(O)CCCO)[C@@H]3CCC4=CC(=O)CCC4=C32)cc1	
zuclopenthixol	CIDs05311507	Phase 3	unapproved	OCCN1CCN(CC/C=C2/c3ccccc3Sc3ccc(Cl)cc32)CC1	N - NERVOUS SYSTEM
silodosin	CIDs05312125	Phase 4	approved	C[C@H](Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccccc1OCC(F)(F)F	G - GENITO URINARY SYSTEM AND SEX HORMONES
andrographolide	CIDs05318517	Phase 3	unapproved	C=C1CC[C@H]2[C@@](C)(CC[C@@H](O)[C@@]2(C)CO)[C@@H]1C/C=C1/C(=O)OC[C@H]1O	
Icaritin	CIDs05318980	Phase 3	unapproved	COc1ccc(-c2oc3c(CC=C(C)C)c(O)cc(O)c3c(=O)c2O)cc1	
icariin	CIDs05318997	Phase 3	unapproved	COc1ccc(-c2oc3c(CC=C(C)C)c(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)cc(O)c3c(=O)c2O[C@@H]2O[C@@H](C)[C@H](O)[C@@H](O)[C@H]2O)cc1	
furazolidone	CIDs05323714	Phase 4	approved	O=C1OCCN1/N=C/c1ccc([N+](=O)[O-])o1	G - GENITO URINARY SYSTEM AND SEX HORMONES
fluvoxamine	CIDs05324345	Phase 4	approved	COCCCC/C(=N\OCCN)c1ccc(C(F)(F)F)cc1	N - NERVOUS SYSTEM
AC1NS1L4	CIDs05327067	Phase 1	unapproved	Nc1c(C(=O)c2cccc(OC[C@@H](O)CO)c2)cnn1-c1ccc(F)cc1	
MKC-1	CIDs05327686	Phase 2	unapproved	Cn1cc(C2=C(c3cn(C)c4cc([N+](=O)[O-])ccc34)C(=O)NC2=O)c2ccccc21	
romiplostim	CIDs05329098	Phase 3	unapproved	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1	
orantinib	CIDs05329099	Phase 3	unapproved	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O	
pyrazoloacridine	CIDs05351360	Phase 2	unapproved	COc1ccc2c(c1)-c1nn(CCCN(C)C)c3ccc([N+](=O)[O-])c(c13)N2	
CA4DP	CIDs05351386	Phase 3	unapproved	COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1OP(=O)(O)O	
oleoyl	CIDs05353734	Phase 2	unapproved	CCCCCCCC/C=C/CCCCCCCC(=O)OCC(O)COP(=O)(O)O	
oxiconazole	CIDs05353853	Phase 4	approved	Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1	G - GENITO URINARY SYSTEM AND SEX HORMONES | D - DERMATOLOGICALS
pralidoxime	CIDs05353894	Phase 4	approved	C[n+]1ccccc1C=NO	V - VARIOUS
sulphasalazine	CIDs05353980	Phase 4	approved	O=C(O)c1cc(/N=N/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O	A - ALIMENTARY TRACT AND METABOLISM
levorphanol	CIDs05359272	Phase 4	approved	CN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(O)cc13	
levallorphan	CIDs05359371	Phase 4	approved	C=CCN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(O)cc13	
arsenic	CIDs05359596	Phase 4	approved	[AsH3]	
naltrexone	CIDs05360515	Phase 4	approved	O=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5	N - NERVOUS SYSTEM
dextromethorphan	CIDs05360696	Phase 4	approved	COc1ccc2c(c1)[C@]13CCCC[C@@H]1[C@H](C2)N(C)CC3	N - NERVOUS SYSTEM | R - RESPIRATORY SYSTEM
butorphanol	CIDs05361092	Phase 4	approved	Oc1ccc2c(c1)[C@@]13CCCC[C@@]1(O)[C@@H](C2)N(CC1CCC1)CC3	N - NERVOUS SYSTEM
methylnaltrexone	CIDs05361917	Phase 4	approved	C[N+]1(CC2CC2)CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5	
delapril	CIDs05362115	Phase 3	unapproved	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N(CC(=O)O)C1Cc2ccccc2C1	C - CARDIOVASCULAR SYSTEM
lisinopril	CIDs05362118	Phase 4	approved	NCCCC[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O	
benazepril	CIDs05362123	Phase 4	approved	CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCc2ccccc2N(CC(=O)O)C1=O	C - CARDIOVASCULAR SYSTEM
ramipril	CIDs05362129	Phase 4	approved	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCC[C@@H]21	C - CARDIOVASCULAR SYSTEM
tegaserod	CIDs05362436	Phase 4	approved	CCCCCNC(=N)N/N=C/c1c[nH]c2ccc(OC)cc12	A - ALIMENTARY TRACT AND METABOLISM
indinavir	CIDs05362440	Phase 4	approved	CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@H]1c2ccccc2C[C@H]1O	J - ANTIINFECTIVES FOR SYSTEMIC USE
zimelidine	CIDs05365247	Phase 4	approved	CN(C)C/C=C(/c1ccc(Br)cc1)c1cccnc1	N - NERVOUS SYSTEM
monomethylfumarate	CIDs05369209	Phase 4	approved	COC(=O)/C=C/C(=O)O	
rifampicin	CIDs05381226	Phase 4	approved	CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C	J - ANTIINFECTIVES FOR SYSTEMIC USE
prinaberel	CIDs05388909	Phase 2	unapproved	C=Cc1cc(O)cc2nc(-c3ccc(O)c(F)c3)oc12	
enalapril	CIDs05388961	Phase 4	approved	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O	C - CARDIOVASCULAR SYSTEM
nitrofurazone	CIDs05447130	Phase 4	approved	NC(=O)N/N=C/c1ccc([N+](=O)[O-])o1	B - BLOOD AND BLOOD FORMING ORGANS | P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS | S - SENSORY ORGANS | D - DERMATOLOGICALS | D - DERMATOLOGICALS | S - SENSORY ORGANS
dextran	CIDs05460037	Phase 3	unapproved	O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O	
threonate	CIDs05460407	Phase 2	unapproved	O=C(O)[C@H](O)[C@@H](O)CO	
heroin	CIDs05462328	Phase 4	approved	CC(=O)Oc1ccc2c3c1O[C@H]1[C@@H](OC(C)=O)C=C[C@H]4[C@@H](C2)N(C)CC[C@]314	
enalaprilat	CIDs05462501	Phase 4	approved	C[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O	
Evans blue	CIDs05462628	Phase 4	approved	Cc1cc(-c2ccc(/N=N/c3ccc4c(S(=O)(=O)O)cc(S(=O)(=O)O)c(N)c4c3O)c(C)c2)ccc1/N=N/c1ccc2c(S(=O)(=O)O)cc(S(=O)(=O)O)c(N)c2c1O	
imidapril	CIDs05464343	Phase 4	approved	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1C(=O)N(C)C[C@H]1C(=O)O	C - CARDIOVASCULAR SYSTEM
bakuchiol	CIDs05468522	Phase 1	unapproved	C=C[C@@](C)(/C=C/c1ccc(O)cc1)CCC=C(C)C	
salirasib	CIDs05469318	Phase 2	unapproved	CC(C)=CCC/C(C)=C/CC/C(C)=C/CSc1ccccc1C(=O)O	
exisulind	CIDs05472495	Phase 3	unapproved	CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\c1ccc(S(C)(=O)=O)cc1	
cefuroxime	CIDs05479529	Phase 4	approved	CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1	J - ANTIINFECTIVES FOR SYSTEMIC USE | S - SENSORY ORGANS
ceftriaxone	CIDs05479530	Phase 4	approved	CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(CSc3nc(=O)c(O)nn3C)CS[C@H]12)c1csc(N)n1	J - ANTIINFECTIVES FOR SYSTEMIC USE | J - ANTIINFECTIVES FOR SYSTEMIC USE
cefepime	CIDs05479537	Phase 4	approved	CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[N+]3(C)CCCC3)CS[C@H]12)c1csc(N)n1	J - ANTIINFECTIVES FOR SYSTEMIC USE
ceftazidime	CIDs05481173	Phase 4	approved	CC(C)(O/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[n+]3ccccc3)CS[C@H]12)c1csc(N)n1)C(=O)O	J - ANTIINFECTIVES FOR SYSTEMIC USE
tenofovir disoproxil fumarate	CIDs05481350	Phase 4	approved	CC(C)OC(=O)OCOP(=O)(CO[C@H](C)Cn1cnc2c(N)ncnc21)OCOC(=O)OC(C)C	J - ANTIINFECTIVES FOR SYSTEMIC USE
trandolapril	CIDs05484727	Phase 4	approved	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@H]2CCCC[C@@H]21	C - CARDIOVASCULAR SYSTEM
pyronaridine	CIDs05485198	Phase 3	unapproved	COc1ccc2nc3cc(Cl)ccc3c(Nc3cc(CN4CCCC4)c(O)c(CN4CCCC4)c3)c2n1	
eplivanserin	CIDs05486684	Phase 3	unapproved	CN(C)CCO/N=C(/C=C/c1ccc(O)cc1)c1ccccc1F	
troxerutin	CIDs05486699	Phase 3	unapproved	C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(OCCO)c(OCCO)c4)oc4cc(OCCO)cc(O)c4c3=O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O	C - CARDIOVASCULAR SYSTEM | C - CARDIOVASCULAR SYSTEM
pregabalin	CIDs05486971	Phase 4	approved	CC(C)C[C@H](CN)CC(=O)O	N - NERVOUS SYSTEM
tiotropium bromide	CIDs05487426	Phase 4	approved	C[N+]1(C)[C@H]2C[C@H](OC(=O)C(O)(c3cccs3)c3cccs3)C[C@@H]1[C@H]1O[C@@H]21	
alvimopan	CIDs05488547	Phase 4	approved	C[C@H]1CN(C[C@H](Cc2ccccc2)C(=O)NCC(=O)O)CC[C@@]1(C)c1cccc(O)c1	A - ALIMENTARY TRACT AND METABOLISM
methoxime	CIDs05489503	Phase 1	unapproved	O/N=C/c1cc[n+](C[n+]2ccc(/C=N/O)cc2)cc1	
Rafabegron	CIDs05493324	Phase 2	unapproved	C[C@H](Cc1c[nH]c2c(OCC(=O)O)cccc12)NC[C@H](O)c1cccc(Cl)c1	
aliskiren	CIDs05493444	Phase 4	approved	COCCCOc1cc(C[C@@H](C[C@H](N)[C@@H](O)C[C@H](C(=O)NCC(C)(C)C(N)=O)C(C)C)C(C)C)ccc1OC	C - CARDIOVASCULAR SYSTEM
tozasertib	CIDs05494449	Phase 2	unapproved	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1	
otamixaban	CIDs05496659	Phase 3	unapproved	COC(=O)[C@H](Cc1cccc(C(=N)N)c1)[C@@H](C)NC(=O)c1ccc(-c2cc[n+]([O-])cc2)cc1	
clupanodonic acid	CIDs05497182	Phase 2	unapproved	CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)O	
guanabenz	CIDs05702062	Phase 4	approved	N=C(N)N/N=C/c1c(Cl)cccc1Cl	
famotidine	CIDs05702160	Phase 4	approved	NC(N)=Nc1nc(CSCC/C(N)=N/S(N)(=O)=O)cs1	A - ALIMENTARY TRACT AND METABOLISM | A - ALIMENTARY TRACT AND METABOLISM
cefotaxime	CIDs05742673	Phase 4	approved	CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(C)=O)CS[C@H]12)c1csc(N)n1	J - ANTIINFECTIVES FOR SYSTEMIC USE
implitapide	CIDs05745206	Phase 2	unapproved	Cc1cc(C)c2c3ccccc3n(Cc3cccc([C@@H](C(=O)N[C@@H](CO)c4ccccc4)C4CCCC4)c3)c2n1	
ralfinamide	CIDs05745207	Phase 3	unapproved	C[C@H](NCc1ccc(OCc2ccccc2F)cc1)C(N)=O	
semapimod	CIDs05745214	Phase 2	unapproved	C/C(=N\NC(=N)N)c1cc(NC(=O)CCCCCCCCC(=O)Nc2cc(/C(C)=N/NC(=N)N)cc(/C(C)=N/NC(=N)N)c2)cc(/C(C)=N/NC(=N)N)c1	
apaziquone	CIDs05813717	Phase 3	unapproved	Cn1c(/C=C/CO)c(CO)c2c1C(=O)C=C(N1CC1)C2=O	
proguanil	CIDs06178111	Phase 4	approved	CC(C)NC(=N)NC(=N)Nc1ccc(Cl)cc1	P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS | P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
tipiracil hydrochloride	CIDs06323266	Phase 4	approved	N=C1CCCN1Cc1nc(O)nc(O)c1Cl	
rifabutin	CIDs06323490	Phase 4	approved	CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(c3C2=O)C2=NC3(CCN(CC(C)C)CC3)NC2=C(NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C4=O	J - ANTIINFECTIVES FOR SYSTEMIC USE
rifapentine	CIDs06323497	Phase 4	approved	CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C6CCCC6)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C	J - ANTIINFECTIVES FOR SYSTEMIC USE
rifamycin	CIDs06324616	Phase 4	approved	CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(cc(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C	S - SENSORY ORGANS | A - ALIMENTARY TRACT AND METABOLISM | J - ANTIINFECTIVES FOR SYSTEMIC USE | D - DERMATOLOGICALS | S - SENSORY ORGANS
saralasin	CIDs06324663	Phase 4	approved	CNCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C	
palonosetron	CIDs06337614	Phase 4	approved	O=C1c2cccc3c2[C@H](CCC3)CN1[C@@H]1CN2CCC1CC2	A - ALIMENTARY TRACT AND METABOLISM | A - ALIMENTARY TRACT AND METABOLISM
maxacalcitol	CIDs06398761	Phase 3	unapproved	C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)OCCC(C)(C)O)CC[C@@H]23)C[C@@H](O)C[C@@H]1O	
CYC116	CIDs06420138	Phase 1	unapproved	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1	
imidafenacin	CIDs06433090	Phase 3	unapproved	Cc1nccn1CCC(C(N)=O)(c1ccccc1)c1ccccc1	
clazosentan	CIDs06433095	Phase 3	unapproved	COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C)cn2)nc(-c2ccnc(-c3nn[nH]n3)c2)nc1OCCO	
fadolmidine	CIDs06433097	Phase 2	unapproved	Oc1ccc2c(c1)C(Cc1c[nH]cn1)CC2	
neramexane	CIDs06433106	Phase 3	unapproved	CC1(C)CC(C)(C)CC(C)(N)C1	
emapunil	CIDs06433109	Phase 2	unapproved	CCN(Cc1ccccc1)C(=O)Cn1c(=O)n(C)c2cnc(-c3ccccc3)nc21	
pruvanserin	CIDs06433122	Phase 2	unapproved	N#Cc1c[nH]c2c(C(=O)N3CCN(CCc4ccc(F)cc4)CC3)cccc12	
cilastatin	CIDs06435415	Phase 4	approved	CC1(C)C[C@@H]1C(=O)N/C(=C\CCCCSC[C@H](N)C(=O)O)C(=O)O	
rifaximin	CIDs06436173	Phase 4	approved	CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c5c(nc6cc(C)ccn65)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C	D - DERMATOLOGICALS | A - ALIMENTARY TRACT AND METABOLISM
lumefantrine	CIDs06437380	Phase 4	approved	CCCCN(CCCC)CC(O)c1cc(Cl)cc2c1-c1ccc(Cl)cc1/C2=C/c1ccc(Cl)cc1	
C23H25N3O2	CIDs06439091	Phase 1	unapproved	O=C(/C=C/c1c(-c2ccccc2)nn2ccccc12)N1CCCC[C@@H]1CCO	
E3330	CIDs06439397	Phase 2	unapproved	CCCCCCCCC/C(=C\C1=C(C)C(=O)C(OC)=C(OC)C1=O)C(=O)O	
mubritinib	CIDs06444692	Phase 1	unapproved	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1	
nalfurafine	CIDs06445230	Phase 3	unapproved	CN(C(=O)/C=C/c1ccoc1)[C@@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5	V - VARIOUS
pelitinib	CIDs06445562	Phase 2	unapproved	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C	
terbogrel	CIDs06449876	Phase 2	unapproved	CC(C)(C)/N=C(\NC#N)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1	
eritoran	CIDs06450173	Phase 3	unapproved	CCCCCC/C=C\CCCCCCCCCC(=O)N[C@H]1[C@H](OC[C@H]2O[C@H](OP(=O)(O)O)[C@H](NC(=O)CC(=O)CCCCCCCCCCC)[C@@H](OCCCCCCCCCC)[C@@H]2O)O[C@H](COC)[C@@H](OP(=O)(O)O)[C@@H]1OCC[C@@H](CCCCCCC)OC	
indiplon	CIDs06450813	Phase 3	unapproved	CC(=O)N(C)c1cccc(-c2ccnc3c(C(=O)c4cccs4)cnn23)c1	
ispinesib	CIDs06450816	Phase 2	unapproved	Cc1ccc(C(=O)N(CCCN)[C@@H](c2nc3cc(Cl)ccc3c(=O)n2Cc2ccccc2)C(C)C)cc1	
perceptin	CIDs06450822	Phase 1	unapproved	CC(C)(C)CCC#C[C@@H]1C[C@H]1c1c[nH]cn1	
netupitant	CIDs06451149	Phase 4	approved	Cc1ccccc1-c1cc(N2CCN(C)CC2)ncc1N(C)C(=O)C(C)(C)c1cc(C(F)(F)F)cc(C(F)(F)F)c1	
rilpivirine	CIDs06451164	Phase 4	approved	Cc1cc(/C=C/C#N)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1	J - ANTIINFECTIVES FOR SYSTEMIC USE
SDZ-NIM811	CIDs06473876	Phase 2	unapproved	C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C	
tanespimycin	CIDs06505803	Phase 3	unapproved	C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O	
D03983	CIDs06506050	Phase 2	unapproved	CN1CCN(c2ccccc2/C=C2\SCCN(c3ccc(Cl)c(Cl)c3)C2=O)CC1	
pimecrolimus	CIDs06509979	Phase 4	approved	CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@H](Cl)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC	D - DERMATOLOGICALS
ceftizoxime	CIDs06533629	Phase 4	approved	CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=CCS[C@H]12)c1csc(N)n1	J - ANTIINFECTIVES FOR SYSTEMIC USE
norgestimate	CIDs06540478	Phase 4	approved	C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=C/C(=N/O)CC[C@@H]4[C@H]3CC[C@@]21CC	
dihydrexidine	CIDs06603820	Phase 2	unapproved	Oc1cc2c(cc1O)[C@H]1c3ccccc3CN[C@@H]1CC2	
dantrolene	CIDs06604100	Phase 4	approved	O=C1CN(/N=C/c2ccc(-c3ccc([N+](=O)[O-])cc3)o2)C(=O)N1	M - MUSCULO-SKELETAL SYSTEM
nitrofurantoin	CIDs06604200	Phase 4	approved	O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)N1	J - ANTIINFECTIVES FOR SYSTEMIC USE | J - ANTIINFECTIVES FOR SYSTEMIC USE
ceramide	CIDs06610273	Phase 2	unapproved	CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O	
7-t-butyldimethylsilyl-10-hydroxycamptothecin	CIDs06712744	Phase 2	unapproved	CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1ccc(O)cc1c2[Si](C)(C)C(C)(C)C	
prednicarbate	CIDs06714002	Phase 4	approved	CCOC(=O)O[C@]1(C(=O)COC(=O)CC)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C	D - DERMATOLOGICALS
Hyaluronate	CIDs06852395	Phase 4	approved	CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(=O)O)O[C@@H](O)[C@H](O)[C@H]1O	S - SENSORY ORGANS
daporinad	CIDs06914657	Phase 2	unapproved	O=C(/C=C/c1cccnc1)NCCCCC1CCN(C(=O)c2ccccc2)CC1	
roxithromycin	CIDs06915744	Phase 4	approved	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)/C(=N\OCOCCOC)[C@H](C)[C@@H](O)[C@]1(C)O	J - ANTIINFECTIVES FOR SYSTEMIC USE
inecalcitol	CIDs06915835	Phase 2	unapproved	C[C@H](CC#CC(C)(C)O)[C@H]1CC[C@@H]2/C(=C/C=C3C[C@@H](O)C[C@H](O)C3)CCC[C@@]21C	
cefdinir	CIDs06915944	Phase 4	approved	C=CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)/C(=N\O)c3csc(N)n3)[C@H]2SC1	J - ANTIINFECTIVES FOR SYSTEMIC USE
etonogestrel	CIDs06917715	Phase 4	approved	C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3C(=C)C[C@@]21CC	G - GENITO URINARY SYSTEM AND SEX HORMONES
levomilnacipran	CIDs06917778	Phase 4	approved	CCN(CC)C(=O)[C@@]1(c2ccccc2)C[C@H]1CN	
artesunate	CIDs06917864	Phase 4	approved	C[C@@H]1CC[C@H]2[C@@H](C)[C@H](OC(=O)CCC(=O)O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4	P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
beraprost sodium	CIDs06917951	Phase 3	unapproved	CC#CCC(C)[C@H](O)/C=C/[C@@H]1[C@H]2c3cccc(CCCC(=O)O)c3O[C@H]2C[C@H]1O	B - BLOOD AND BLOOD FORMING ORGANS
treprostinil	CIDs06918140	Phase 4	approved	CCCCC[C@H](O)CC[C@@H]1[C@H]2Cc3cccc(OCC(=O)O)c3C[C@H]2C[C@H]1O	B - BLOOD AND BLOOD FORMING ORGANS
ciclesonide	CIDs06918155	Phase 4	approved	CC(C)C(=O)OCC(=O)[C@@]12O[C@H](C3CCCCC3)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]12C	R - RESPIRATORY SYSTEM | R - RESPIRATORY SYSTEM
Icatibant acetate	CIDs06918172	Phase 4	approved	N=C(N)NCCC[C@H](NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2N1C(=O)[C@H]1Cc2ccccc2CN1C(=O)[C@H](CO)NC(=O)[C@H](Cc1cccs1)NC(=O)CNC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](N)CCCNC(=N)N)C(=O)O	B - BLOOD AND BLOOD FORMING ORGANS
BIMT 17 BS	CIDs06918248	Phase 4	approved	O=c1[nH]c2ccccc2n1CCN1CCN(c2cccc(C(F)(F)F)c2)CC1	G - GENITO URINARY SYSTEM AND SEX HORMONES
TT232	CIDs06918265	Phase 2	unapproved	C[C@@H](O)[C@H](NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](N)Cc2ccccc2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCCN)C(=O)N1)C(N)=O	
mitemcinal	CIDs06918266	Phase 2	unapproved	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C(C)C)[C@H]2O)[C@@]2(C)CC(C)=C(O2)[C@H](C)C(=O)[C@]1(C)OC	
Cereport	CIDs06918284	Phase 2	unapproved	COc1ccc(C[C@@H](CN[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CO)NC(=O)[C@H](Cc2cccs2)NC(=O)CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H]2CCCN2C(=O)[C@@H](N)CCCN=C(N)N)cc1	
dutasteride	CIDs06918296	Phase 4	approved	C[C@]12CC[C@H]3[C@@H](CC[C@H]4NC(=O)C=C[C@]34C)[C@@H]1CC[C@@H]2C(=O)Nc1cc(C(F)(F)F)ccc1C(F)(F)F	G - GENITO URINARY SYSTEM AND SEX HORMONES
vilazodone	CIDs06918313	Phase 4	approved	N#Cc1ccc2[nH]cc(CCCCN3CCN(c4ccc5oc(C(N)=O)cc5c4)CC3)c2c1	N - NERVOUS SYSTEM
vofopitant	CIDs06918330	Phase 2	unapproved	COc1ccc(-n2nnnc2C(F)(F)F)cc1CN[C@H]1CCCN[C@H]1c1ccccc1	
aprepitant	CIDs06918365	Phase 4	approved	C[C@@H](O[C@H]1OCCN(Cc2n[nH]c(=O)[nH]2)[C@H]1c1ccc(F)cc1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1	A - ALIMENTARY TRACT AND METABOLISM
sarizotan	CIDs06918387	Phase 3	unapproved	Fc1ccc(-c2cncc(CNC[C@H]3CCc4ccccc4O3)c2)cc1	
pki-166	CIDs06918403	Phase 1	unapproved	C[C@@H](Nc1ncnc2[nH]c(-c3ccc(O)cc3)cc12)c1ccccc1	
ortataxel	CIDs06918412	Phase 2	unapproved	CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]23OC(=O)O[C@H]2[C@H](OC(=O)[C@H](O)[C@H](CC(C)C)NC(=O)OC(C)(C)C)C(C)=C1C3(C)C	
Ci-1040	CIDs06918454	Phase 2	unapproved	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl	
prasugrel	CIDs06918456	Phase 4	approved	CC(=O)Oc1cc2c(s1)CCN(C(C(=O)C1CC1)c1ccccc1F)C2	B - BLOOD AND BLOOD FORMING ORGANS
ambrisentan	CIDs06918493	Phase 4	approved	COC(c1ccccc1)(c1ccccc1)[C@H](Oc1nc(C)cc(C)n1)C(=O)O	C - CARDIOVASCULAR SYSTEM
BIBN4096BS	CIDs06918509	Phase 2	unapproved	NCCCC[C@H](NC(=O)[C@@H](Cc1cc(Br)c(O)c(Br)c1)NC(=O)N1CCC(N2Cc3ccccc3NC2=O)CC1)C(=O)N1CCN(c2ccncc2)CC1	
udenafil	CIDs06918523	Phase 3	unapproved	CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc2c(CCC)nn(C)c2c(=O)[nH]1	G - GENITO URINARY SYSTEM AND SEX HORMONES
pardoprunox	CIDs06918524	Phase 3	unapproved	CN1CCN(c2cccc3[nH]c(=O)oc23)CC1	
vildagliptin	CIDs06918537	Phase 4	approved	N#C[C@@H]1CCCN1C(=O)CNC12CC3CC(CC(O)(C3)C1)C2	A - ALIMENTARY TRACT AND METABOLISM
dalcetrapib	CIDs06918540	Phase 3	unapproved	CCC(CC)CC1(C(=O)Nc2ccccc2SC(=O)C(C)C)CCCCC1	
Lonaprisan	CIDs06918548	Phase 2	unapproved	CC(=O)c1ccc([C@H]2C[C@@]3(C)[C@@H](CC[C@@]3(O)C(F)(F)C(F)(F)F)[C@@H]3CCC4=CC(=O)CCC4=C32)cc1	
indacaterol	CIDs06918554	Phase 4	approved	CCc1cc2c(cc1CC)CC(NC[C@H](O)c1ccc(O)c3[nH]c(=O)ccc13)C2	R - RESPIRATORY SYSTEM
fesoterodine	CIDs06918558	Phase 4	approved	CC(C)C(=O)Oc1ccc(CO)cc1[C@H](CCN(C(C)C)C(C)C)c1ccccc1	G - GENITO URINARY SYSTEM AND SEX HORMONES
ABT510	CIDs06918562	Phase 2	unapproved	CCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)CN(C)C(C)=O)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NCC)[C@@H](C)CC	
Val-boroPro	CIDs06918572	Phase 3	unapproved	CC(C)[C@H](N)C(=O)N1CCC[C@H]1B(O)O	
relacatib	CIDs06918602	Phase 1	unapproved	CC(C)C[C@H](NC(=O)c1cc2ccccc2o1)C(=O)N[C@H]1CC[C@@H](C)N(S(=O)(=O)c2ccccn2)CC1=O	
emodepside	CIDs06918632	Phase 1	unapproved	CC(C)C[C@H]1C(=O)O[C@H](Cc2ccc(N3CCOCC3)cc2)C(=O)N(C)[C@@H](CC(C)C)C(=O)O[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)O[C@H](Cc2ccc(N3CCOCC3)cc2)C(=O)N(C)[C@@H](CC(C)C)C(=O)O[C@H](C)C(=O)N1C	
ingenol mebutate	CIDs06918670	Phase 4	approved	C/C=C(/C)C(=O)O[C@H]1C(C)=C[C@]23C(=O)[C@@H](C=C(CO)[C@@H](O)[C@]12O)[C@H]1[C@@H](C[C@H]3C)C1(C)C	D - DERMATOLOGICALS
rigosertib	CIDs06918736	Phase 3	unapproved	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1	
R-547	CIDs06918852	Phase 2	unapproved	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N	
BT-PABA	CIDs06957672	Phase 4	approved	O=C(O)c1ccc(NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)c2ccccc2)cc1	V - VARIOUS
gamma-D-glutamyl-L-tryptophan	CIDs06992139	Phase 2	unapproved	N[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)O	
TYU	CIDs09543506	Phase 2	unapproved	O=C1N[C@H](O)CCN1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O	
creatine phosphate	CIDs09548602	Phase 3	unapproved	CN(CC(=O)O)C(=N)NP(=O)(O)O	C - CARDIOVASCULAR SYSTEM
PU-H71-hydrochloride	CIDs09549213	Phase 1	unapproved	CC(C)NCCCn1c(Sc2cc3c(cc2I)OCO3)nc2c(N)ncnc21	
KRN-633	CIDs09549295	Phase 1	unapproved	CCCNC(=O)Nc1ccc(Oc2ncnc3cc(OC)c(OC)cc23)cc1Cl	
arimoclomol	CIDs09568077	Phase 3	unapproved	[O-][n+]1cccc(/C(Cl)=N/OC[C@H](O)CN2CCCCC2)c1	
esomeprazole	CIDs09568613	Phase 4	approved	COc1ccc2[nH]c([S@@+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1	A - ALIMENTARY TRACT AND METABOLISM
azimilide	CIDs09571003	Phase 3	unapproved	CN1CCN(CCCCN2C(=O)CN(/N=C/c3ccc(-c4ccc(Cl)cc4)o3)C2=O)CC1	
chlorproguanil	CIDs09571037	Phase 3	unapproved	CC(C)NC(=N)NC(=N)Nc1ccc(Cl)c(Cl)c1	
gemifloxacin	CIDs09571107	Phase 4	approved	CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN	J - ANTIINFECTIVES FOR SYSTEMIC USE
Triapine	CIDs09571836	Phase 3	unapproved	NC(=S)N/N=C/c1ncccc1N	
2 adenosine	CIDs09576912	Phase 3	unapproved	Nc1nc(N/N=C/C2CCCCC2)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O	
lefradafiban	CIDs09576916	Phase 1	unapproved	COC(=O)C[C@@H]1C[C@@H](COc2ccc(-c3ccc(C(=N)NC(=O)OC)cc3)cc2)NC1=O	
asoprisnil	CIDs09577221	Phase 3	unapproved	COC[C@]1(OC)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(/C=N/O)cc3)C[C@@]21C	
dexlansoprazole	CIDs09578005	Phase 4	approved	Cc1c(OCC(F)(F)F)ccnc1C[S@@+]([O-])c1nc2ccccc2[nH]1	A - ALIMENTARY TRACT AND METABOLISM
dabigatran etexilate	CIDs09578572	Phase 4	approved	CCCCCCOC(=O)/N=C(\N)c1ccc(NCc2nc3cc(C(=O)N(CCC(=O)OCC)c4ccccn4)ccc3n2C)cc1	B - BLOOD AND BLOOD FORMING ORGANS
remofovir mesylate	CIDs09604653	Phase 3	unapproved	Nc1ncnc2c1ncn2CCOC[P@@]1(=O)OCC[C@@H](c2cccc(Cl)c2)O1	
AZD-0328	CIDs09794392	Phase 2	unapproved	c1cnc2c(c1)C[C@@]1(CN3CCC1CC3)O2	
CHEMBL1255901	CIDs09794806	Phase 2	unapproved	C/C=C1\[C@H]2C=C(C)C[C@@]1(N)c1ccc(=O)[nH]c1C2	
radafaxine	CIDs09795056	Phase 2	unapproved	C[C@@H]1NC(C)(C)CO[C@@]1(O)c1cccc(Cl)c1	
iniparib	CIDs09796068	Phase 3	unapproved	NC(=O)c1ccc(I)c([N+](=O)[O-])c1	
nepicastat	CIDs09796181	Phase 2	unapproved	NCc1cnc(S)n1[C@H]1CCc2c(F)cc(F)cc2C1	
orteronel	CIDs09796590	Phase 3	unapproved	CNC(=O)c1ccc2cc([C@@]3(O)CCn4cncc43)ccc2c1	
SSR-180711A	CIDs09797360	Phase 2	unapproved	O=C(Oc1ccc(Br)cc1)N1CCN2CCC1CC2	
GSK189254A	CIDs09798547	Phase 2	unapproved	CNC(=O)c1ccc(Oc2ccc3c(c2)CCN(C2CCC2)CC3)nc1	
talarozole	CIDs09799888	Phase 2	unapproved	CCC(CC)C(c1ccc(Nc2nc3ccccc3s2)cc1)n1cncn1	
piclozotan	CIDs09801640	Phase 2	unapproved	O=C1c2ccccc2OC=C(Cl)N1CCCCN1CC=C(c2ccccn2)CC1	
ONO-4819CD	CIDs09803828	Phase 2	unapproved	COCc1cccc(C[C@H](O)/C=C/[C@H]2[C@H](O)CC(=O)[C@@H]2CCSCCCC(=O)OC)c1	
GW 501516	CIDs09803963	Phase 2	unapproved	Cc1cc(SCc2sc(-c3ccc(C(F)(F)F)cc3)nc2C)ccc1OCC(=O)O	
HDAC inhibitors	CIDs09804991	Phase 3	unapproved	CCN(CC)Cc1ccc2cc(COC(=O)Nc3ccc(C(=O)NO)cc3)ccc2c1	
ATL-146e	CIDs09805430	Phase 3	unapproved	CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(C#CC[C@H]4CC[C@H](C(=O)OC)CC4)nc32)[C@H](O)[C@@H]1O	
A4215	CIDs09805718	Phase 2	unapproved	Nc1c(Cl)cc(-c2nn(C3CCN(CCc4ccccc4)CC3)c(=O)o2)c2c1OCCO2	
cinaciguat	CIDs09808022	Phase 2	unapproved	O=C(O)CCCCN(CCc1ccccc1OCc1ccc(CCc2ccccc2)cc1)Cc1ccc(C(=O)O)cc1	
telatinib	CIDs09808844	Phase 2	unapproved	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1	
edotecarin	CIDs09808998	Phase 3	unapproved	O=C1c2c(c3c4ccc(O)cc4n([C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)c3c3[nH]c4cc(O)ccc4c23)C(=O)N1NC(CO)CO	
tabimorelin	CIDs09810101	Phase 2	unapproved	CNC(=O)[C@@H](Cc1ccccc1)N(C)C(=O)[C@@H](Cc1ccc2ccccc2c1)N(C)C(=O)/C=C/CC(C)(C)N	
bimosiamose	CIDs09811353	Phase 2	unapproved	O=C(O)Cc1cccc(-c2cc(CCCCCCc3ccc(O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]4O)c(-c4cccc(CC(=O)O)c4)c3)ccc2O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]2O)c1	
CP-547632	CIDs09811611	Phase 2	unapproved	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1	
sumanirole	CIDs09818478	Phase 3	unapproved	CN[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1	
apricoxib	CIDs09820073	Phase 2	unapproved	CCOc1ccc(-c2cc(C)cn2-c2ccc(S(N)(=O)=O)cc2)cc1	
bicyclol	CIDs09821754	Phase 2	unapproved	COC(=O)c1cc(OC)c2c(c1-c1c(CO)cc(OC)c3c1OCO3)OCO2	
abiraterone acetate	CIDs09821849	Phase 4	approved	CC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC=C(c5cccnc5)[C@@]4(C)CC[C@@H]32)C1	L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
ispronicline	CIDs09824145	Phase 2	unapproved	CN[C@@H](C)C/C=C/c1cncc(OC(C)C)c1	
azilsartan	CIDs09825285	Phase 3	unapproved	CCOc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2-c2noc(O)n2)cc1	
PD 0325901	CIDs09826528	Phase 2	unapproved	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F	
tetrahydrofolate (THF	CIDs09826589	Phase 3	unapproved	Nc1nc(=O)c2c([nH]1)NC[C@@H](CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1)N2	
ibipinabant	CIDs09826744	Phase 2	unapproved	CN/C(=N\S(=O)(=O)c1ccc(Cl)cc1)N1C[C@H](c2ccccc2)C(c2ccc(Cl)cc2)=N1	
GSK256066	CIDs09827968	Phase 2	unapproved	COc1cccc(Nc2c(C(N)=O)cnc3c(C)cc(S(=O)(=O)c4cccc(C(=O)N(C)C)c4)cc23)c1	
anamorelin	CIDs09828911	Phase 3	unapproved	CN(C)N(C)C(=O)[C@@]1(Cc2ccccc2)CCCN(C(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)C(C)(C)N)C1	
EPA-E	CIDs09831415	Phase 4	approved	CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OCC	
Lopixibat	CIDs09831642	Phase 4	approved	CCCCC1(CCCC)CS(=O)(=O)c2ccc(N(C)C)cc2[C@@H](c2ccc(OCc3ccc(C[N+]45CCN(CC4)CC5)cc3)cc2)[C@H]1O	
Anatibant	CIDs09831652	Phase 2	unapproved	Cc1cc(C)c2cccc(OCc3c(Cl)ccc(S(=O)(=O)N4CCC[C@H]4C(=O)NCCCNC(=O)c4ccc(C(=N)N)cc4)c3Cl)c2n1	
vestipitant	CIDs09832383	Phase 2	unapproved	Cc1cc(F)ccc1[C@H]1CNCCN1C(=O)N(C)[C@H](C)c1cc(C(F)(F)F)cc(C(F)(F)F)c1	
davunetide	CIDs09832404	Phase 2	unapproved	CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H](N)CC(N)=O)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)O	
5Y869C2THE	CIDs09832687	Phase 3	unapproved	CCOc1ccc(-c2nn3ncccc3c2-c2ccc(S(C)(=O)=O)cc2)cc1	
pancreozymin	CIDs09833444	Phase 4	approved	CSCC[C@H](NC(=O)[C@H](Cc1ccc(OS(=O)(=O)O)cc1)NC(=O)[C@@H](N)CC(=O)O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O	V - VARIOUS
8L3OAJ1R5A	CIDs09833519	Phase 2	unapproved	CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCC(c4ccccc4)c4ccccc4)nc(C(=O)NCCNC(=O)NC4CCN(c5ccccn5)CC4)nc32)[C@H](O)[C@@H]1O	
LY404039	CIDs09834591	Phase 1	unapproved	N[C@@]1(C(=O)O)CS(=O)(=O)[C@H]2[C@H](C(=O)O)[C@H]21	
brivaracetam	CIDs09837243	Phase 4	approved	CCC[C@@H]1CC(=O)N([C@@H](CC)C(N)=O)C1	N - NERVOUS SYSTEM
tapentadol	CIDs09838021	Phase 4	approved	CC[C@@H](c1cccc(O)c1)[C@@H](C)CN(C)C	N - NERVOUS SYSTEM
nebicapone	CIDs09838389	Phase 2	unapproved	O=C(Cc1ccccc1)c1cc(O)c(O)c([N+](=O)[O-])c1	
reparixin	CIDs09838712	Phase 3	unapproved	CC(C)Cc1ccc([C@@H](C)C(=O)NS(C)(=O)=O)cc1	
neoandrographolide	CIDs09848024	Phase 2	unapproved	C=C1CC[C@H]2[C@@](C)(CCC[C@@]2(C)CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H]1CCC1=CCOC1=O	
L001571	CIDs09848499	Phase 2	unapproved	O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(c2cc(Cl)cc3c2OCCO3)CC1	
U- 952	CIDs09848989	Phase 4	approved	CO[C@@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1Cc4ccc(O)c5c4[C@@]3(CCN1CC1CC1)[C@H]2O5	N - NERVOUS SYSTEM | N - NERVOUS SYSTEM | N - NERVOUS SYSTEM
surinabant	CIDs09849616	Phase 2	unapproved	CCc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Br)cc1	
OCC6TB3P6K	CIDs09849699	Phase 2	unapproved	CC(C)(Cc1ccc(Oc2ccc(C(N)=O)cn2)cc1)NC[C@H](O)COc1cccc2[nH]c3ccccc3c12	
Px-866	CIDs09849735	Phase 2	unapproved	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C	
orvepitant	CIDs09852175	Phase 2	unapproved	Cc1cc(F)ccc1[C@H]1C[C@@H](N2CCN3C(=O)CC[C@H]3C2)CCN1C(=O)N(C)[C@H](C)c1cc(C(F)(F)F)cc(C(F)(F)F)c1	
avatrombopag	CIDs09852519	Phase 4	approved	O=C(Nc1nc(-c2cc(Cl)cs2)c(N2CCN(C3CCCCC3)CC2)s1)c1cnc(N2CCC(C(=O)O)CC2)c(Cl)c1	B - BLOOD AND BLOOD FORMING ORGANS
lomitapide	CIDs09853053	Phase 4	approved	O=C(NC1CCN(CCCCC2(C(=O)NCC(F)(F)F)c3ccccc3-c3ccccc32)CC1)c1ccccc1-c1ccc(C(F)(F)F)cc1	C - CARDIOVASCULAR SYSTEM
pentagastrin	CIDs09853654	Phase 4	approved	CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CCNC(=O)OC(C)(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O	V - VARIOUS
cangrelor	CIDs09854011	Phase 4	approved	CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)C(Cl)(Cl)P(=O)(O)O)[C@@H](O)[C@H]1O	B - BLOOD AND BLOOD FORMING ORGANS
fluticasone furoate	CIDs09854489	Phase 4	approved	C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)SCF	R - RESPIRATORY SYSTEM | R - RESPIRATORY SYSTEM
ST-1535	CIDs09860294	Phase 1	unapproved	CCCCc1nc(N)c2nc(-n3nccn3)n(C)c2n1	
sobetirome	CIDs09862248	Phase 1	unapproved	Cc1cc(OCC(=O)O)cc(C)c1Cc1ccc(O)c(C(C)C)c1	
AGN-194204	CIDs09863341	Phase 2	unapproved	CC(/C=C/[C@@H]1C[C@]1(C)c1ccc2c(c1)C(C)(C)CCC2(C)C)=C\C(=O)O	
befiradol	CIDs09865384	Phase 2	unapproved	Cc1ccc(CNCC2(F)CCN(C(=O)c3ccc(F)c(Cl)c3)CC2)nc1	
MGCD0103	CIDs09865515	Phase 2	unapproved	Nc1ccccc1NC(=O)c1ccc(CNc2nccc(-c3cccnc3)n2)cc1	
mirabegron	CIDs09865528	Phase 4	approved	Nc1nc(CC(=O)Nc2ccc(CCNC[C@H](O)c3ccccc3)cc2)cs1	G - GENITO URINARY SYSTEM AND SEX HORMONES
navarixin	CIDs09865554	Phase 2	unapproved	CC[C@@H](Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccc(C)o1	
SD-06	CIDs09865587	Phase 1	unapproved	O=C(CO)N1CCC(c2n[nH]c(-c3ccc(Cl)cc3)c2-c2ccncn2)CC1	
D07592	CIDs09865603	Phase 2	unapproved	C[S+](CCC(N)C(=O)[O-])C[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O	
laropiprant	CIDs09867642	Phase 3	unapproved	CS(=O)(=O)c1cc(F)cc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CC3	
OSI-930	CIDs09868037	Phase 1	unapproved	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12	
tafluprost	CIDs09868491	Phase 4	approved	CC(C)OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1/C=C/C(F)(F)COc1ccccc1	S - SENSORY ORGANS
diazepinomicin	CIDs09868980	Phase 2	unapproved	CC(C)=CCC/C(C)=C/CC/C(C)=C/CN1C(=O)c2cccc(O)c2Nc2c(O)cc(O)cc21	
GW328267	CIDs09869857	Phase 1	unapproved	CCn1nnc([C@H]2O[C@@H](n3cnc4c(N)nc(N[C@H](CO)Cc5ccccc5)nc43)[C@H](O)[C@@H]2O)n1	
avanafil	CIDs09869929	Phase 4	approved	COc1ccc(C/N=c2\[nH]c(N3CCC[C@H]3CO)ncc2C(=O)NCc2ncccn2)cc1Cl	G - GENITO URINARY SYSTEM AND SEX HORMONES
netazepide	CIDs09870520	Phase 2	unapproved	CNc1cccc(NC(=O)N[C@@H]2N=C(c3ccccn3)c3ccccc3N(CC(=O)C(C)(C)C)C2=O)c1	
fimasartan	CIDs09870652	Phase 3	unapproved	CCCCc1nc(C)c(CC(=S)N(C)C)c(=O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1	C - CARDIOVASCULAR SYSTEM
talmapimod	CIDs09871074	Phase 2	unapproved	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1	
ticagrelor	CIDs09871419	Phase 4	approved	CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1	B - BLOOD AND BLOOD FORMING ORGANS
remogliflozin etabonate	CIDs09871420	Phase 2	unapproved	CCOC(=O)OC[C@H]1O[C@@H](Oc2nn(C(C)C)c(C)c2Cc2ccc(OC(C)C)cc2)[C@H](O)[C@@H](O)[C@@H]1O	
lapaquistat	CIDs09874248	Phase 3	unapproved	COc1cccc([C@H]2O[C@H](CC(=O)N3CCC(CC(=O)O)CC3)C(=O)N(CC(C)(C)COC(C)=O)c3ccc(Cl)cc32)c1OC	
Berubicin	CIDs09874591	Phase 2	unapproved	COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](OCc2ccccc2)[C@H](C)O1	
CP-724714	CIDs09874912	Phase 2	unapproved	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1	
rivaroxaban	CIDs09875401	Phase 4	approved	O=C(NC[C@H]1CN(c2ccc(N3CCOCC3=O)cc2)C(=O)O1)c1ccc(Cl)s1	B - BLOOD AND BLOOD FORMING ORGANS
zatarolimus	CIDs09876378	Phase 3	unapproved	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@H](n3cnnn3)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C	
AGN-PC-0MUZ6H	CIDs09876393	Phase 2	unapproved	Cc1ccc(O)c(C(=O)N[C@H]2CC[C@@H](NC(=O)c3cc(F)cnc3Oc3ccc(F)c(F)c3)CC2)c1	
gabapentin enacarbil	CIDs09883933	Phase 4	approved	CC(OC(=O)NCC1(CC(=O)O)CCCCC1)OC(=O)C(C)C	N - NERVOUS SYSTEM
CRF1 antagonist	CIDs09884366	Phase 3	unapproved	CC[C@@H](C)Nc1nc(C)nc2c(-c3ccc(OC)nc3C)c(C)nn12	
W26I0D1D6J	CIDs09884876	Phase 2	unapproved	CSc1ccc(Oc2ccc(S(N)(=O)=O)cc2CN(C)C)cc1	
adoprazine	CIDs09887537	Phase 1	unapproved	Fc1ccc(-c2cncc(CN3CCN(c4cccc5c4OCCO5)CC3)c2)cc1	
dapagliflozin	CIDs09887712	Phase 4	approved	CCOc1ccc(Cc2cc([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)ccc2Cl)cc1	A - ALIMENTARY TRACT AND METABOLISM
denagliptin	CIDs09887754	Phase 2	unapproved	N#C[C@@H]1C[C@H](F)CN1C(=O)[C@@H](N)C(c1ccc(F)cc1)c1ccc(F)cc1	
solabegron	CIDs09887812	Phase 2	unapproved	O=C(O)c1cccc(-c2cccc(NCCNC[C@H](O)c3cccc(Cl)c3)c2)c1	
evatanepag	CIDs09890801	Phase 2	unapproved	CC(C)(C)c1ccc(CN(Cc2cccc(OCC(=O)O)c2)S(=O)(=O)c2cccnc2)cc1	
imiglitazar	CIDs09890879	Phase 3	unapproved	Cc1oc(-c2ccccc2)nc1COc1ccc(CO/N=C(\CCC(=O)O)c2ccccc2)cc1	
2-5A-anti-hTR	CIDs09892480	Phase 2	unapproved	O=CNc1cc([C@@H](O)CNCCc2ccc(NC[C@H](O)c3ccccc3)cc2)ccc1O	
gisadenafil	CIDs09892860	Phase 2	unapproved	CCOc1ncc(S(=O)(=O)N2CCN(CC)CC2)cc1-c1nc2c(CC)n(CCOC)nc2c(=O)[nH]1	
tasidotin	CIDs09895066	Phase 2	unapproved	CC(C)[C@H](NC(=O)[C@H](C(C)C)N(C)C)C(=O)N(C)[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NC(C)(C)C)C(C)C	
nelivaptan	CIDs09895468	Phase 2	unapproved	COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3ccccc3OC)(N3C[C@H](O)C[C@H]3C(=O)N(C)C)c3cc(Cl)ccc32)c(OC)c1	
tofimilast	CIDs09896267	Phase 2	unapproved	CCc1nn(C2CCCC2)c2c1CCn1c(-c3cccs3)nnc1-2	
Z-3282	CIDs09897468	Phase 2	unapproved	N=C(N)NCCC[C@H](NC(=O)CCC(=O)OC[N+]1(c2cc(=O)c3cccc(-c4ccccc4)c3o2)CCOCC1)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)[O-]	
9cUAB30	CIDs09904203	Phase 1	unapproved	CC(=C/C=C/C(C)=C/C(=O)O)/C=C1\CCCc2ccccc21	
Sonedenoson	CIDs09910098	Phase 2	unapproved	Nc1nc(OCCc2ccc(Cl)cc2)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O	
zibotentan	CIDs09910224	Phase 3	unapproved	COc1nc(C)cnc1NS(=O)(=O)c1cccnc1-c1ccc(-c2nnco2)cc1	
sb-705498	CIDs09910486	Phase 2	unapproved	O=C(Nc1ccccc1Br)N[C@@H]1CCN(c2ccc(C(F)(F)F)cn2)C1	
DB07278	CIDs09911502	Phase 2	unapproved	C[C@@H](C(=O)N1CCOCC1)N1CC[C@H](NS(=O)(=O)/C=C/c2ccc(Cl)s2)C1=O	
darexaban	CIDs09912771	Phase 3	unapproved	COc1ccc(C(=O)Nc2cccc(O)c2NC(=O)c2ccc(N3CCCN(C)CC3)cc2)cc1	
alpha-TEA	CIDs09913401	Phase 1	unapproved	Cc1c(C)c2c(c(C)c1OCC(=O)O)CC[C@@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)O2	
ABT-925	CIDs09916103	Phase 2	unapproved	CC(C)(C)c1nc(N2CCN(CCCSc3nccc(O)n3)CC2)cc(C(F)(F)F)n1	
CEP-1347	CIDs09917013	Phase 3	unapproved	CCSCc1ccc2c(c1)c1c3c(c4c5cc(CSCC)ccc5n5c4c1n2[C@H]1C[C@](O)(C(=O)OC)[C@]5(C)O1)CNC3=O	
casopitant	CIDs09917021	Phase 3	unapproved	CC(=O)N1CCN([C@H]2CCN(C(=O)N(C)[C@H](C)c3cc(C(F)(F)F)cc(C(F)(F)F)c3)[C@@H](c3ccc(F)cc3C)C2)CC1	A - ALIMENTARY TRACT AND METABOLISM
NKP608	CIDs09917079	Phase 2	unapproved	O=C(N[C@H]1CCN(C(=O)c2cc(C(F)(F)F)cc(C(F)(F)F)c2)[C@H](Cc2ccc(Cl)cc2)C1)c1ccnc2ccccc12	
dirlotapide	CIDs09917862	Phase 1	unapproved	CN(Cc1ccccc1)C(=O)[C@@H](NC(=O)c1cc2cc(NC(=O)c3ccccc3-c3ccc(C(F)(F)F)cc3)ccc2n1C)c1ccccc1	
rilapladib	CIDs09918381	Phase 2	unapproved	COCCN1CCC(N(Cc2ccc(-c3ccc(C(F)(F)F)cc3)cc2)C(=O)Cn2c(SCc3cccc(F)c3F)cc(=O)c3ccccc32)CC1	
tofacitinib	CIDs09926791	Phase 4	approved	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12	L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
mavoglurant	CIDs09926832	Phase 2	unapproved	COC(=O)N1CC[C@@H]2[C@H]1CCC[C@@]2(O)C#Cc1cccc(C)c1	
vernakalant	CIDs09930048	Phase 4	approved	COc1ccc(CCO[C@@H]2CCCC[C@H]2N2CC[C@@H](O)C2)cc1OC	C - CARDIOVASCULAR SYSTEM
PHA-543613 hydrochloride	CIDs09930120	Phase 1	unapproved	O=C(N[C@H]1CN2CCC1CC2)c1cc2ccoc2cn1	
firategrast	CIDs09935681	Phase 2	unapproved	CCOCc1cc(OC)c(-c2ccc(C[C@H](NC(=O)c3c(F)cccc3F)C(=O)O)cc2)c(OC)c1	
SB 743921	CIDs09936388	Phase 1	unapproved	Cc1ccc(C(=O)N(CCCN)[C@@H](c2oc3cc(Cl)ccc3c(=O)c2Cc2ccccc2)C(C)C)cc1	
capadenoson	CIDs09936489	Phase 2	unapproved	N#Cc1c(N)nc(SCc2csc(-c3ccc(Cl)cc3)n2)c(C#N)c1-c1ccc(OCCO)cc1	
PD-126055	CIDs09937291	Phase 2	unapproved	COc1ccc2c(c1OCc1ccccc1)C[C@@H](C(=O)O)N(C(=O)C(c1ccccc1)c1ccccc1)C2	
darapladib	CIDs09939609	Phase 3	unapproved	CCN(CC)CCN(Cc1ccc(-c2ccc(C(F)(F)F)cc2)cc1)C(=O)Cn1c(SCc2ccc(F)cc2)nc(=O)c2c1CCC2	
bremelanotide	CIDs09941379	Phase 4	approved	CCCC[C@H](NC(C)=O)C(=O)N[C@H]1CC(=O)NCCCC[C@@H](C(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2cnc[nH]2)NC1=O	G - GENITO URINARY SYSTEM AND SEX HORMONES
pitolisant	CIDs09948102	Phase 4	approved	Clc1ccc(CCCOCCCN2CCCCC2)cc1	N - NERVOUS SYSTEM
Tak-715	CIDs09952773	Phase 2	unapproved	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1	
cetilistat	CIDs09952916	Phase 2	unapproved	CCCCCCCCCCCCCCCCOc1nc2ccc(C)cc2c(=O)o1	
SLV 320	CIDs09953064	Phase 2	unapproved	OC1CCC(Nc2nc(-c3ccccc3)nc3[nH]ccc23)CC1	
KB-19281	CIDs09955534	Phase 1	unapproved	O=C(Cn1c(Cl)cnc(NCC(F)(F)c2ccccn2)c1=O)NCc1ncccc1F	
JDTic	CIDs09956146	Phase 1	unapproved	CC(C)[C@@H](CN1CC[C@@](C)(c2cccc(O)c2)[C@@H](C)C1)NC(=O)[C@H]1Cc2ccc(O)cc2CN1	
GW 590735	CIDs09956726	Phase 2	unapproved	Cc1nc(-c2ccc(C(F)(F)F)cc2)sc1C(=O)NCc1ccc(OC(C)(C)C(=O)O)cc1	
Teglarinad	CIDs09961434	Phase 1	unapproved	COCCOCCOCCOCCOC(=O)OC[n+]1ccc(N/C(=N/CCCCCCOc2ccc(Cl)cc2)NC#N)cc1	
vortioxetine	CIDs09966051	Phase 4	approved	Cc1ccc(Sc2ccccc2N2CCNCC2)c(C)c1	N - NERVOUS SYSTEM
GSK239512	CIDs09976892	Phase 2	unapproved	O=C1CCCN1c1ccc(Oc2ccc3c(c2)CCN(C2CCC2)CC3)nc1	
dovitinib	CIDs09977819	Phase 3	unapproved	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1	
fallypride	CIDs10021692	Phase 2	unapproved	C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCF)cc(OC)c1OC	
WAY-362450	CIDs10026128	Phase 1	unapproved	CC(C)OC(=O)C1=CN(C(=O)c2ccc(F)c(F)c2)CC(C)(C)c2c1[nH]c1ccccc21	
OSU-03012	CIDs10027278	Phase 1	unapproved	NCC(=O)Nc1ccc(-n2nc(C(F)(F)F)cc2-c2ccc3c(ccc4ccccc43)c2)cc1	
LY2090314	CIDs10029385	Phase 2	unapproved	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cc(F)cc13)CN(C(=O)N1CCCCC1)CC2	
otenabant	CIDs10052040	Phase 3	unapproved	CCNC1(C(N)=O)CCN(c2ncnc3c2nc(-c2ccccc2Cl)n3-c2ccc(Cl)cc2)CC1	
pimavanserin	CIDs10071196	Phase 4	approved	CC(C)COc1ccc(CNC(=O)N(Cc2ccc(F)cc2)C2CCN(C)CC2)cc1	N - NERVOUS SYSTEM
vorapaxar	CIDs10077129	Phase 4	approved	CCOC(=O)N[C@@H]1CC[C@@H]2[C@@H](C1)C[C@H]1C(=O)O[C@H](C)[C@H]1[C@H]2/C=C/c1ccc(-c2cccc(F)c2)cn1	B - BLOOD AND BLOOD FORMING ORGANS
galunisertib	CIDs10090485	Phase 2	unapproved	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1	
endoxifen	CIDs10090750	Phase 3	unapproved	CC/C(=C(\c1ccc(O)cc1)c1ccc(OCCNC)cc1)c1ccccc1	
NVP-AUY922	CIDs10096043	Phase 2	unapproved	CCNC(=O)c1noc(-c2cc(C(C)C)c(O)cc2O)c1-c1ccc(CN2CCOCC2)cc1	
linagliptin	CIDs10096344	Phase 4	approved	CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C	A - ALIMENTARY TRACT AND METABOLISM
lecozotan	CIDs10116877	Phase 3	unapproved	C[C@H](CN(C(=O)c1ccc(C#N)cc1)c1ccccn1)N1CCN(c2cccc3c2OCCO3)CC1	
preladenant	CIDs10117987	Phase 3	unapproved	COCCOc1ccc(N2CCN(CCn3ncc4c3nc(N)n3nc(-c5ccco5)nc43)CC2)cc1	
sepantronium	CIDs10126189	Phase 2	unapproved	COCC[n+]1c2c(n(Cc3cnccn3)c1C)C(=O)c1ccccc1C2=O	
sofinicline	CIDs10131048	Phase 2	unapproved	Clc1cc(N2C[C@@H]3CN[C@@H]3C2)cnc1Cl	
SU14813	CIDs10138259	Phase 2	unapproved	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1	
odanacatib	CIDs10152654	Phase 3	unapproved	CC(C)(F)C[C@H](N[C@@H](c1ccc(-c2ccc(S(C)(=O)=O)cc2)cc1)C(F)(F)F)C(=O)NC1(C#N)CC1	
palosuran	CIDs10173280	Phase 2	unapproved	Cc1cc(NC(=O)NCCN2CCC(O)(Cc3ccccc3)CC2)c2ccccc2n1	
besifloxacin	CIDs10178705	Phase 4	approved	N[C@@H]1CCCCN(c2c(F)cc3c(=O)c(C(=O)O)cn(C4CC4)c3c2Cl)C1	S - SENSORY ORGANS
apixaban	CIDs10182969	Phase 4	approved	COc1ccc(-n2nc(C(N)=O)c3c2C(=O)N(c2ccc(N4CCCCC4=O)cc2)CC3)cc1	B - BLOOD AND BLOOD FORMING ORGANS
vilanterol	CIDs10184665	Phase 4	approved	OCc1cc([C@@H](O)CNCCCCCCOCCOCc2c(Cl)cccc2Cl)ccc1O	
balicatib	CIDs10201696	Phase 2	unapproved	CCCN1CCN(c2ccc(C(=O)NC3(C(=O)NCC#N)CCCCC3)cc2)CC1	
CHEMBL427683	CIDs10225083	Phase 2	unapproved	COc1ccc(C)c(OC(CCN2CCC(n3c(=O)[nH]c4ccccc43)CC2)C(C)C)c1	
E7ILQ6U50J	CIDs10229498	Phase 2	unapproved	O=S(=O)(Nc1cc(Cl)c(Oc2cnc3ccccc3c2)c(Cl)c1)c1ccc(Cl)cc1Cl	
GW 842166X	CIDs10253143	Phase 2	unapproved	O=C(NCC1CCOCC1)c1cnc(Nc2ccc(Cl)cc2Cl)nc1C(F)(F)F	
L023324	CIDs10257882	Phase 3	unapproved	CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2S(=O)(=O)Nc2noc(C)c2C)c(COCC)c1	
aleglitazar	CIDs10274777	Phase 3	unapproved	CO[C@@H](Cc1ccc(OCCc2nc(-c3ccccc3)oc2C)c2ccsc12)C(=O)O	
CEP-5214	CIDs10275001	Phase 1	unapproved	CC(C)OCc1ccc2c(c1)c1c3c(c4c(c1n2CCCO)Cc1ccccc1-4)C(=O)NC3	
betrixaban	CIDs10275777	Phase 4	approved	COc1ccc(NC(=O)c2ccc(C(=N)N(C)C)cc2)c(C(=O)Nc2ccc(Cl)cn2)c1	B - BLOOD AND BLOOD FORMING ORGANS
edoxaban	CIDs10280735	Phase 4	approved	CN1CCc2nc(C(=O)N[C@@H]3C[C@@H](C(=O)N(C)C)CC[C@@H]3NC(=O)C(=O)Nc3ccc(Cl)cn3)sc2C1	B - BLOOD AND BLOOD FORMING ORGANS
SERBA-1	CIDs10286159	Phase 2	unapproved	Oc1ccc([C@@H]2Oc3ccc(O)cc3[C@@H]3CCC[C@@H]32)cc1	
sotrastaurin	CIDs10296883	Phase 2	unapproved	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1	
NVP-AEE788	CIDs10297043	Phase 2	unapproved	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1	
dilmapimod	CIDs10297982	Phase 2	unapproved	Cc1cc(F)ccc1-c1nc(NC(CO)CO)nc2c1ccc(=O)n2-c1c(F)cccc1F	
Fedovapagon	CIDs10298385	Phase 2	unapproved	Cc1cc(C(=O)N2CCCCc3ccccc32)ccc1CNC(=O)N1CCC[C@H]1C(=O)N(C)C	
eprotirome	CIDs10299876	Phase 3	unapproved	CC(C)c1cc(Oc2c(Br)cc(NC(=O)CC(=O)O)cc2Br)ccc1O	
saracatinib	CIDs10302451	Phase 3	unapproved	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1	
R306465	CIDs10309899	Phase 1	unapproved	O=C(NO)c1cnc(N2CCN(S(=O)(=O)c3ccc4ccccc4c3)CC2)nc1	
NTBI	CIDs10316203	Phase 1	unapproved	CC(C)(C)NCc1ccc(Nc2ccnc3cc(Cl)ccc23)cc1O	
boceprevir	CIDs10324367	Phase 4	approved	CC(C)(C)NC(=O)N[C@H](C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)NC(CC1CCC1)C(=O)C(N)=O)C2(C)C)C(C)(C)C	J - ANTIINFECTIVES FOR SYSTEMIC USE
vx-702	CIDs10341154	Phase 2	unapproved	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F	
ronacaleret	CIDs10345213	Phase 2	unapproved	CC(C)(CC1Cc2ccccc2C1)NC[C@@H](O)COc1cc(CCC(=O)O)cc(F)c1F	
TAK-385	CIDs10348973	Phase 4	approved	CONC(=O)Nc1ccc(-c2sc3c(c2CN(C)C)c(=O)n(-c2ccc(OC)nn2)c(=O)n3Cc2c(F)cccc2F)cc1	
AZD-4877	CIDs10368812	Phase 2	unapproved	Cc1ccc(C(=O)N(CCCN)C(c2nc3snc(C)c3c(=O)n2Cc2ccccc2)C(C)C)cc1	
AGN-PC-0H78E3	CIDs10406644	Phase 2	unapproved	CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4)oc23)C1CO	
3Z6GAP3R9Q	CIDs10409068	Phase 2	unapproved	CCCNC(=O)c1cn2ncnc(Nc3cc(C(=O)NC4CC4)ccc3C)c2c1C	
lecithin	CIDs10425705	Phase 3	unapproved	C[N+](C)(C)CCOP(=O)([O-])OCC(COC=O)OC=O	
TG100-115	CIDs10427712	Phase 2	unapproved	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1	
MSDC-0160	CIDs10429242	Phase 2	unapproved	CCc1ccc(C(=O)COc2ccc(CC3SC(=O)NC3=O)cc2)nc1	
cc-401	CIDs10430360	Phase 2	unapproved	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1	
BMS-599626	CIDs10437018	Phase 1	unapproved	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12	
ipragliflozin	CIDs10453870	Phase 3	unapproved	OC[C@H]1O[C@@H](c2ccc(F)c(Cc3cc4ccccc4s3)c2)[C@H](O)[C@@H](O)[C@@H]1O	A - ALIMENTARY TRACT AND METABOLISM
volasertib	CIDs10461508	Phase 3	unapproved	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C	
resolvin E1	CIDs10473088	Phase 1	unapproved	CC[C@@H](O)/C=C/C=C\C[C@@H](O)/C=C/C=C/C=C\[C@@H](O)CCCC(=O)O	
Elubrixin	CIDs10479502	Phase 2	unapproved	O=C(Nc1ccc(Cl)c(S(=O)(=O)N2CCNCC2)c1O)Nc1cccc(F)c1Cl	
bacitracin	CIDs10909430	Phase 4	approved	CC[C@H](C)[C@H](N)C1=N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H]2CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](Cc3cnc[nH]3)NC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CCCN)NC2=O)[C@@H](C)CC)CS1	D - DERMATOLOGICALS | J - ANTIINFECTIVES FOR SYSTEMIC USE | R - RESPIRATORY SYSTEM
tafamidis	CIDs11001318	Phase 4	approved	O=C(O)c1ccc2nc(-c3cc(Cl)cc(Cl)c3)oc2c1	N - NERVOUS SYSTEM
ABT-PR1	CIDs11151363	Phase 1	unapproved	c1cc2cc(-c3ccc(O[C@H]4CN5CCC4CC5)nn3)ccc2[nH]1	
AZD7762	CIDs11152667	Phase 1	unapproved	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1	
C11T0WZN2R	CIDs11154544	Phase 2	unapproved	CC[C@@]1(c2cccc(NS(C)(=O)=O)c2)[C@H]2CN(CC3(O)Cc4ccccc4C3)C[C@H]21	
cariprazine	CIDs11154555	Phase 4	approved	CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1	N - NERVOUS SYSTEM
brivanib alaninate	CIDs11154925	Phase 3	unapproved	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1	
tetrodotoxin	CIDs11174599	Phase 3	unapproved	NC1=N[C@H](O)[C@H]2[C@H]3O[C@]4(O)O[C@@H]([C@@H](O)[C@@]2(N1)[C@@H]4O)[C@]3(O)CO	
galeterone	CIDs11188409	Phase 3	unapproved	C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC=C2n1cnc2ccccc21	
ADL5747	CIDs11200189	Phase 2	unapproved	CCN(CC)C(=O)c1ccc(C2=CC3(CCNCC3)Oc3ccccc32)c(O)c1	
WP1066	CIDs11210478	Phase 1	unapproved	C[C@H](NC(=O)/C(C#N)=C/c1cccc(Br)n1)c1ccccc1	
R406 free base	CIDs11213558	Phase 2	unapproved	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC	
ataluren	CIDs11219835	Phase 4	approved	O=C(O)c1cccc(-c2noc(-c3ccccc3F)n2)c1	M - MUSCULO-SKELETAL SYSTEM
emicerfont	CIDs11223423	Phase 2	unapproved	COc1ccc(N2CCc3c(-n4ccc(N5CCNC5=O)n4)cc(C)nc32)c(C)c1	
taranabant	CIDs11226090	Phase 3	unapproved	C[C@H](NC(=O)C(C)(C)Oc1ccc(C(F)(F)F)cn1)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1	
ABT-737	CIDs11228183	Phase 1	unapproved	CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]	
brivanib	CIDs11234052	Phase 3	unapproved	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1	
CHEMBL230158	CIDs11236126	Phase 3	unapproved	CCO[C@H](COc1ccc(C(F)(F)F)cc1)CSc1ccc(OCC(=O)O)c(C)c1	
azilsartan medoxomil	CIDs11238823	Phase 4	approved	CCOc1nc2cccc(C(=O)OCc3oc(=O)oc3C)c2n1Cc1ccc(-c2ccccc2-c2noc(=O)[nH]2)cc1	C - CARDIOVASCULAR SYSTEM
UK-396082	CIDs11241908	Phase 1	unapproved	CCCn1cnc(C[C@H](CCCN)C(=O)O)c1	
saxagliptin	CIDs11243969	Phase 4	approved	N#C[C@@H]1C[C@@H]2C[C@@H]2N1C(=O)[C@@H](N)C12CC3CC(CC(O)(C3)C1)C2	
mu-delta	CIDs11250029	Phase 4	approved	COc1ccc(CN(C(=O)[C@@H](N)Cc2c(C)cc(C(N)=O)cc2C)[C@@H](C)c2nc(-c3ccccc3)c[nH]2)cc1C(=O)O	A - ALIMENTARY TRACT AND METABOLISM
elagolix	CIDs11250647	Phase 4	approved	COc1cccc(-c2c(C)n(Cc3c(F)cccc3C(F)(F)F)c(=O)n(C[C@H](NCCCC(=O)O)c3ccccc3)c2=O)c1F	H - SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
ABT-102	CIDs11256560	Phase 1	unapproved	CC(C)(C)c1ccc2c(c1)CC[C@H]2NC(=O)Nc1cccc2[nH]ncc12	
AMD070	CIDs11256587	Phase 3	unapproved	NCCCCN(Cc1nc2ccccc2[nH]1)[C@H]1CCCc2cccnc21	
FG-4592	CIDs11256664	Phase 3	unapproved	Cc1nc(C(=O)NCC(=O)O)c(O)c2ccc(Oc3ccccc3)cc12	B - BLOOD AND BLOOD FORMING ORGANS
SB-742457	CIDs11256720	Phase 3	unapproved	O=S(=O)(c1ccccc1)c1cnc2c(N3CCNCC3)cccc2c1	
CVT-6883	CIDs11270783	Phase 1	unapproved	CCCn1c(=O)c2[nH]c(-c3cnn(Cc4cccc(C(F)(F)F)c4)c3)nc2n(CC)c1=O	
amuvatinib	CIDs11282283	Phase 2	unapproved	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1	
sagopilone	CIDs11284169	Phase 2	unapproved	C=CC[C@H]1C(=O)C(C)(C)[C@@H](O)CC(=O)O[C@H](c2ccc3sc(C)nc3c2)C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@@H]1O	
cenicriviroc	CIDs11285791	Phase 3	unapproved	CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCN3CC(C)C)cc1	
AZD-1981	CIDs11292191	Phase 2	unapproved	CC(=O)Nc1cccc2c1c(Sc1ccc(Cl)cc1)c(C)n2CC(=O)O	
KB-68875	CIDs11292933	Phase 2	unapproved	Cc1ccc2c(N3CCN(CCc4cccc(N5CCNC5=O)c4)CC3)cccc2n1	
telcagepant	CIDs11319053	Phase 3	unapproved	O=C(N[C@@H]1CC[C@@H](c2cccc(F)c2F)CN(CC(F)(F)F)C1=O)N1CCC(n2c(O)nc3ncccc32)CC1	
enobosarm	CIDs11326715	Phase 3	unapproved	C[C@](O)(COc1ccc(C#N)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1	
AT7519	CIDs11338033	Phase 2	unapproved	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl	
GSK221149A	CIDs11340891	Phase 3	unapproved	CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCOCC1)c1coc(C)n1	
salinosporamide A	CIDs11347535	Phase 3	unapproved	C[C@@]12OC(=O)[C@]1([C@@H](O)[C@@H]1C=CCCC1)NC(=O)[C@@H]2CCCl	
ponesimod	CIDs11363176	Phase 4	approved	CCC/N=C1\S/C(=C\c2ccc(OC[C@H](O)CO)c(Cl)c2)C(=O)N1c1ccccc1C	
BI 2536	CIDs11364421	Phase 2	unapproved	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1	
AZD-6703	CIDs11373432	Phase 1	unapproved	Cc1ccc(C(=O)NC2CC2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O	
bafetinib	CIDs11387605	Phase 2	unapproved	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1	
indeglitazar	CIDs11395145	Phase 2	unapproved	COc1ccc(S(=O)(=O)n2cc(CCC(=O)O)c3cc(OC)ccc32)cc1	
paquinimod	CIDs11399957	Phase 2	unapproved	CCc1cccc2c1c(O)c(C(=O)N(CC)c1ccccc1)c(=O)n2C	
obatoclax	CIDs11404337	Phase 3	unapproved	COC1=CC(c2cc3ccccc3[nH]2)=N/C1=C\c1[nH]c(C)cc1C	
R-1487	CIDs11406590	Phase 1	unapproved	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21	
NVP-AST487	CIDs11409972	Phase 1	unapproved	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1	
carmegliptin	CIDs11417567	Phase 2	unapproved	COc1cc2c(cc1OC)[C@@H]1C[C@H](N)[C@@H](N3C[C@@H](CF)CC3=O)CN1CC2	
ADL-5859	CIDs11417954	Phase 2	unapproved	CCN(CC)C(=O)c1ccc(C2=CC3(CCNCC3)Oc3cccc(O)c32)cc1	
KW-2449	CIDs11427553	Phase 1	unapproved	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1	
Naluzotan	CIDs11430856	Phase 3	unapproved	CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1	
aclidinium	CIDs11434515	Phase 4	approved	O=C(O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)C(O)(c1cccs1)c1cccs1	
danusertib	CIDs11442891	Phase 2	unapproved	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1	
alogliptin	CIDs11450633	Phase 4	approved	Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c1=O	A - ALIMENTARY TRACT AND METABOLISM
apratastat	CIDs11452716	Phase 2	unapproved	CC1(C)SCCN(S(=O)(=O)c2ccc(OCC#CCO)cc2)[C@H]1C(=O)NO	
OC000459	CIDs11462174	Phase 2	unapproved	Cc1c(Cc2ccc3ccccc3n2)c2cc(F)ccc2n1CC(=O)O	
linifanib	CIDs11485656	Phase 3	unapproved	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1	
Sapitinib	CIDs11488320	Phase 2	unapproved	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1	
MK-0557	CIDs11491176	Phase 3	unapproved	O=C1O[C@]2(CC[C@H](C(=O)Nc3ccn(-c4ccccc4F)n3)CC2)c2cnccc21	
tivantinib	CIDs11494412	Phase 3	unapproved	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12	
AT-9283	CIDs11496628	Phase 2	unapproved	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1	
AZD1152	CIDs11497983	Phase 3	unapproved	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O	
fasitibant	CIDs11498852	Phase 2	unapproved	Cc1cc(C)c2cccc(OCc3c(Cl)ccc(S(=O)(=O)NC4(C(=O)N5CCN(C(=O)[C@@H](N)CCC[N+](C)(C)C)CC5)CCOCC4)c3Cl)c2n1	
tavaborole	CIDs11499245	Phase 4	approved	OB1OCc2cc(F)ccc21	D - DERMATOLOGICALS
olodaterol	CIDs11504294	Phase 4	approved	COc1ccc(CC(C)(C)NC[C@H](O)c2cc(O)cc3c2OCC(=O)N3)cc1	R - RESPIRATORY SYSTEM
ZH5SMU97AJ	CIDs11505444	Phase 2	unapproved	CC(C)(Cc1cccc(CC(=O)NCc2cccc(-c3ccc(O)cc3)c2)c1)NC[C@H](O)c1ccc(O)c(NS(C)(=O)=O)c1	
NVP-QAV680	CIDs11508736	Phase 2	unapproved	Cc1c(CC(=O)O)c2cccnc2n1Cc1ccc(S(C)(=O)=O)cc1	
alisporivir	CIDs11513676	Phase 3	unapproved	C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)[C@H](C)C(=O)N(CC)[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C	
gosogliptin	CIDs11516136	Phase 3	unapproved	O=C([C@@H]1C[C@H](N2CCN(c3ncccn3)CC2)CN1)N1CCC(F)(F)C1	
umeclidinium	CIDs11519069	Phase 4	approved	OC(c1ccccc1)(c1ccccc1)C12CC[N+](CCOCc3ccccc3)(CC1)CC2	
vabicaserin	CIDs11521821	Phase 2	unapproved	c1cc2c3c(c1)[C@H]1CCC[C@H]1CN3CCNC2	
17VGG92R23	CIDs11526038	Phase 3	unapproved	CC[C@@H](Oc1cccc(CN(CCCOc2ccc(OC)cc2)c2nc3ccccc3o2)c1)C(=O)O	
ulimorelin	CIDs11526696	Phase 3	unapproved	C[C@@H]1CN[C@@H](C2CC2)C(=O)N(C)[C@H](C)C(=O)N[C@H](Cc2ccc(F)cc2)C(=O)NCCCc2ccccc2O1	
retaspimycin HCl	CIDs11534420	Phase 3	unapproved	C=CCNc1c(O)cc2c(O)c1C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)N2	
quisinostat	CIDs11538455	Phase 2	unapproved	Cn1cc(CNCC2CCN(c3ncc(C(=O)NO)cn3)CC2)c2ccccc21	
CE-224535	CIDs11547499	Phase 2	unapproved	COC[C@H](O)Cn1c(=O)cnn(-c2ccc(Cl)c(C(=O)NCC3(O)CCCCCC3)c2)c1=O	
RO4987655	CIDs11548630	Phase 1	unapproved	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F	
losmapimod	CIDs11552706	Phase 3	unapproved	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1	
anacetrapib	CIDs11556427	Phase 3	unapproved	COc1cc(F)c(C(C)C)cc1-c1ccc(C(F)(F)F)cc1CN1C(=O)O[C@H](c2cc(C(F)(F)F)cc(C(F)(F)F)c2)[C@@H]1C	
nesbuvir	CIDs11561383	Phase 2	unapproved	CNC(=O)c1c(-c2ccc(F)cc2)oc2cc(N(CCO)S(C)(=O)=O)c(C3CC3)cc12	
apremilast	CIDs11561674	Phase 4	approved	CCOc1cc([C@@H](CS(C)(=O)=O)N2C(=O)c3cccc(NC(C)=O)c3C2=O)ccc1OC	L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
MK-0893	CIDs11570626	Phase 2	unapproved	COc1ccc2cc(-c3cc(-c4cc(Cl)cc(Cl)c4)nn3[C@@H](C)c3ccc(C(=O)NCCC(=O)O)cc3)ccc2c1	
MP-10	CIDs11581936	Phase 2	unapproved	Cn1cc(-c2ccncc2)c(-c2ccc(OCc3ccc4ccccc4n3)cc2)n1	
verucerfont	CIDs11596613	Phase 2	unapproved	CC[C@H](Nc1cc(C)nc2c(-c3ccc(OC)cc3C)c(C)nn12)c1nc(C)no1	
lisdexamfetamine	CIDs11597697	Phase 4	approved	C[C@@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN	N - NERVOUS SYSTEM
Temanogrel	CIDs11604525	Phase 2	unapproved	COc1cccc(C(=O)Nc2ccc(OCCN3CCOCC3)c(-c3ccnn3C)c2)c1	
Serdemetan	CIDs11609586	Phase 1	unapproved	c1ccc2c(CCNc3ccc(Nc4ccncc4)cc3)c[nH]c2c1	
AZD-5672	CIDs11614352	Phase 2	unapproved	CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cc(F)cc(F)c2)C2CCN(S(C)(=O)=O)CC2)CC1	
tozadenant	CIDs11618368	Phase 3	unapproved	COc1ccc(N2CCOCC2)c2sc(NC(=O)N3CCC(C)(O)CC3)nc12	
TAK-285	CIDs11620908	Phase 1	unapproved	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21	
milnacipran HCl	CIDs11622909	Phase 4	approved	CCN(CC)C(=O)C1(c2ccccc2)CC1CN	N - NERVOUS SYSTEM
evodenoson	CIDs11627443	Phase 2	unapproved	COC(=O)N1CCC(CC#Cc2nc(N)c3ncn([C@@H]4O[C@H](C(=O)NC5CC5)[C@@H](O)[C@H]4O)c3n2)CC1	
epelsiban	CIDs11634973	Phase 2	unapproved	CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCOCC1)c1ccc(C)nc1C	
linsitinib	CIDs11640390	Phase 3	unapproved	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1	
letaxaban	CIDs11641515	Phase 2	unapproved	O=C([C@H](O)CS(=O)(=O)c1ccc2cc(Cl)ccc2c1)N1CCC(N2CCCNC2=O)CC1	
CHIR-265	CIDs11656518	Phase 2	unapproved	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21	
amitifadine	CIDs11658655	Phase 2	unapproved	Clc1ccc([C@]23CNC[C@H]2C3)cc1Cl	
lorcaserin	CIDs11658859	Phase 4	approved	C[C@H]1CNCCc2ccc(Cl)cc21	A - ALIMENTARY TRACT AND METABOLISM
samidorphan	CIDs11667832	Phase 4	approved	NC(=O)c1ccc2c(c1O)[C@]13CCN(CC4CC4)[C@H](C2)[C@]1(O)CCC(=O)C3	
motesanib	CIDs11667893	Phase 3	unapproved	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21	
fostamatinib	CIDs11671467	Phase 4	approved	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC	B - BLOOD AND BLOOD FORMING ORGANS
L-MTP-PE	CIDs11672602	Phase 4	approved	CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCNC(=O)[C@H](C)NC(=O)CC[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@@H]1NC(C)=O)C(N)=O)OC(=O)CCCCCCCCCCCCCCC	
MK-0533	CIDs11678533	Phase 2	unapproved	CC[C@@H](Oc1cccc(-n2c(C)c(C(=O)c3ccc(OC)cc3)c3ccc(OC(F)(F)F)cc32)c1)C(=O)O	
GSRd	CIDs11679800	Phase 3	unapproved	CC(C)=CCC[C@](C)(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@@H]3CC[C@]12C	
imrecoxib	CIDs11682175	Phase 1	unapproved	CCCN1CC(c2ccc(S(C)(=O)=O)cc2)=C(c2ccc(C)cc2)C1=O	
darinaparsin	CIDs11683005	Phase 2	unapproved	C[As](C)SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O	
nelotanserin	CIDs11683556	Phase 2	unapproved	COc1ccc(NC(=O)Nc2ccc(F)cc2F)cc1-c1c(Br)cnn1C	
omecamtiv mecarbil	CIDs11689883	Phase 3	unapproved	COC(=O)N1CCN(Cc2cccc(NC(=O)Nc3ccc(C)nc3)c2F)CC1	
APD597	CIDs11691484	Phase 1	unapproved	COc1c(Nc2ccc(S(C)(=O)=O)nc2C)ncnc1OC1CCN(C(=O)OC(C)C)CC1	
NP-BN	CIDs11697676	Phase 2	unapproved	O=C1CCc2ccc(OCCCCN3CCN(c4cccc5ccccc45)CC3)nc2N1	
MK-0249	CIDs11697697	Phase 2	unapproved	Cc1nc2cccc(C(F)(F)F)c2c(=O)n1-c1ccc(OCCCN2CCCC2)cc1	
resatorvid	CIDs11703255	Phase 3	unapproved	CCOC(=O)C1=CCCC[C@H]1S(=O)(=O)Nc1ccc(F)cc1Cl	
MLN8054	CIDs11712649	Phase 1	unapproved	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1	
PF-562271	CIDs11713159	Phase 1	unapproved	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O	
PF-03715455	CIDs11714580	Phase 2	unapproved	CC(C)(C)c1cc(NC(=O)NCc2ccccc2Sc2ccc3nnc(-c4ccccc4SCCO)n3c2)n(-c2ccc(O)c(Cl)c2)n1	
Abexinostat	CIDs11749858	Phase 3	unapproved	CN(C)Cc1c(C(=O)NCCOc2ccc(C(=O)NO)cc2)oc2ccccc12	
Z-3152	CIDs11751922	Phase 2	unapproved	CC(C)Cn1c2ccc(Nc3ncccn3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3	
velusetrag	CIDs11842632	Phase 2	unapproved	CC(C)n1c(=O)c(C(=O)N[C@@H]2C[C@@H]3CC[C@H](C2)N3C[C@@H](O)CN(C)S(C)(=O)=O)cc2ccccc21	
desoxycorticosterone pivalate	CIDs11876263	Phase 4	approved	CC(C)(C)C(=O)OCC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C	H - SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
empagliflozin	CIDs11949646	Phase 4	approved	OC[C@H]1O[C@@H](c2ccc(Cl)c(Cc3ccc(O[C@H]4CCOC4)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O	A - ALIMENTARY TRACT AND METABOLISM
teneligliptin	CIDs11949652	Phase 3	unapproved	Cc1cc(N2CCN([C@@H]3CN[C@H](C(=O)N4CCSC4)C3)CC2)n(-c2ccccc2)n1	A - ALIMENTARY TRACT AND METABOLISM
KD-025	CIDs11950170	Phase 4	approved	CC(C)NC(=O)COc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3ccccc3n2)c1	
Safotibant	CIDs11953367	Phase 2	unapproved	COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c(C)c1	
AT13387	CIDs11955716	Phase 2	unapproved	CC(C)c1cc(C(=O)N2Cc3ccc(CN4CCN(C)CC4)cc3C2)c(O)cc1O	
LY2603618	CIDs11955855	Phase 2	unapproved	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1	
calcium ionophore A23187	CIDs11957499	Phase 2	unapproved	CNc1ccc2oc(C[C@H]3O[C@@]4(CC[C@H]3C)O[C@H]([C@H](C)C(=O)c3ccc[nH]3)[C@H](C)C[C@H]4C)nc2c1C(=O)O	
AGN-PC-0I7Q4Y	CIDs11961293	Phase 2	unapproved	COC(=O)N1CCC(CN2CCC(CNC(=O)c3cccc4[nH]c(C(C)C)nc34)CC2)CC1	
lifitegrast	CIDs11965427	Phase 4	approved	CS(=O)(=O)c1cccc(C[C@H](NC(=O)c2c(Cl)cc3c(c2Cl)CCN(C(=O)c2ccc4ccoc4c2)C3)C(=O)O)c1	S - SENSORY ORGANS
NVP-BEZ235	CIDs11977753	Phase 3	unapproved	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21	
NVP-BGT226	CIDs11978790	Phase 2	unapproved	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1	
Palomid 529	CIDs11998575	Phase 1	unapproved	COc1ccc(COc2cc3oc(=O)c4cc(C(C)O)ccc4c3cc2OC)cc1	
N-(1-Acetylpiperidin-4-yl)-N'-(adamant-1-yl) urea	CIDs12000797	Phase 2	unapproved	CC(=O)N1CCC(NC(=O)NC23CC4CC(CC(C4)C2)C3)CC1	
ulipristal	CIDs13559281	Phase 4	approved	CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C	G - GENITO URINARY SYSTEM AND SEX HORMONES | G - GENITO URINARY SYSTEM AND SEX HORMONES
CHEMBL2391146	CIDs15171724	Phase 3	unapproved	CC(C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)O)C(C)C	
tosedostat	CIDs15547703	Phase 2	unapproved	CC(C)C[C@@H](C(=O)N[C@H](C(=O)OC1CCCC1)c1ccccc1)[C@H](O)C(=O)NO	
CHEMBL1089318	CIDs15602694	Phase 4	approved	Cc1c(Cl)c(C)[n+]([O-])c(Cl)c1-c1noc(-c2cc(O)c(O)c([N+](=O)[O-])c2)n1	N - NERVOUS SYSTEM
ABC294640	CIDs15604015	Phase 2	unapproved	O=C(NCc1ccncc1)C12CC3CC(C1)CC(c1ccc(Cl)cc1)(C3)C2	
novobiocin	CIDs15940185	Phase 4	approved	CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](Oc2ccc3c(O)c(NC(=O)c4ccc(O)c(CC=C(C)C)c4)c(=O)oc3c2C)OC1(C)C	
enzalutamide	CIDs15951529	Phase 4	approved	CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F	L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
GSK461364A	CIDs15983966	Phase 1	unapproved	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F	
trelagliptin	CIDs15983988	Phase 3	unapproved	Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2cc(F)ccc2C#N)c1=O	
camicinal	CIDs15984937	Phase 3	unapproved	C[C@H]1CN(Cc2ccc(CC(=O)N3CCC(Nc4cccc(F)c4)CC3)cc2)CCN1	
macitentan	CIDs16004692	Phase 4	approved	CCCNS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1	C - CARDIOVASCULAR SYSTEM
KB-73550	CIDs16005981	Phase 1	unapproved	Cc1cc(/C(=C/Nc2ccc(Cl)cc2)C(=O)Nc2ccc(Cl)cc2)on1	
AMG-517	CIDs16007367	Phase 1	unapproved	CC(=O)Nc1nc2c(Oc3cc(-c4ccc(C(F)(F)F)cc4)ncn3)cccc2s1	
ENMD-2076	CIDs16041424	Phase 2	unapproved	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1	
Tox21_303623	CIDs16051930	Phase 4	approved	C#CC1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21CC	
CPMP	CIDs16061579	Phase 4	approved	Nc1nc2c(c(=O)[nH]1)N[C@@H]1[C@H](N2)O[C@@H]2COP(=O)(O)O[C@@H]2C1(O)O	
PF-3635659	CIDs16065403	Phase 2	unapproved	CC(C)(CCC(C(N)=O)(c1ccccc1)c1ccccc1)N1CC(Oc2cccc(O)c2)C1	
elinogrel	CIDs16066663	Phase 2	unapproved	CNc1cc2[nH]c(=O)n(-c3ccc(NC(=O)NS(=O)(=O)c4ccc(Cl)s4)cc3)c(=O)c2cc1F	
Mk-0686	CIDs16102897	Phase 2	unapproved	COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1	
C569673	CIDs16119082	Phase 2	unapproved	CC(C)CNC(=O)[C@H]1C[C@@](F)(c2ccc(CN3CCCC3)c(F)c2)C1	
V600I6H7T6	CIDs16119086	Phase 2	unapproved	CCNC(=O)[C@H]1C[C@@](F)(c2ccc(CN3CCCC3)c(F)c2)C1	
QC-4593	CIDs16126898	Phase 1	unapproved	CN[C@H](CNC(=O)N1CCC[C@@H]([C@@H](OCCNC(=O)OC)c2cccc(Cl)c2)C1)C[C@H]1CCCOC1	
caerulein	CIDs16129675	Phase 4	approved	CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(OS(=O)(=O)O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCC(=O)N1)[C@@H](C)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O	V - VARIOUS
Bivalirudin	CIDs16129704	Phase 4	approved	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](N)Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O	B - BLOOD AND BLOOD FORMING ORGANS
SRIF-14	CIDs16129706	Phase 3	unapproved	C[C@H](N)C(=O)NCC(=O)N[C@H]1CSSC[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC1=O	H - SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
tannic acid	CIDs16129778	Phase 4	approved	O=C(OC[C@H]1O[C@@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H]1OC(=O)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1	
IRL-1620	CIDs16130933	Phase 3	unapproved	CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCC(=O)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)CC	
ganirelix acetate	CIDs16130957	Phase 4	approved	CC/N=C(\NCC)NCCCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CCCCN/C(=N/CC)NCC)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@@H](Cc1cccnc1)NC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(C)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O	H - SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
abarelix	CIDs16131215	Phase 4	approved	CC(=O)N[C@H](Cc1ccc2ccccc2c1)C(=O)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@H](Cc1cccnc1)C(=O)N[C@@H](CO)C(=O)N(C)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O	L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
2-Tyr-alpha-msh	CIDs16132144	Phase 1	unapproved	CSCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(N)=O)C(C)C	
Teriparatide	CIDs16132392	Phase 4	approved	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C	H - SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
Ularitide	CIDs16132416	Phase 3	unapproved	CC[C@H](C)[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)CSSC[C@@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)CNC1=O	
Cosyntropin	CIDs16133802	Phase 4	approved	CSCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C)C(C)C	H - SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
daptomycin	CIDs16134395	Phase 4	approved	CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C	J - ANTIINFECTIVES FOR SYSTEMIC USE
degarelix	CIDs16136245	Phase 4	approved	CC(=O)N[C@H](Cc1ccc2ccccc2c1)C(=O)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@H](Cc1cccnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(NC(=O)[C@@H]2CC(=O)NC(=O)N2)cc1)C(=O)N[C@H](Cc1ccc(NC(N)=O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O	L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Insulin detemir	CIDs16137271	Phase 4	approved	CCCCCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CSSC[C@@H](C(=O)N[C@@H](CC(N)=O)C(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H]2CSSC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc3c[nH]cn3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc3ccccc3)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc3c[nH]cn3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N2)[C@@H](C)O)C(=O)O	A - ALIMENTARY TRACT AND METABOLISM
acyline	CIDs16137348	Phase 2	unapproved	CC(=O)Nc1ccc(C[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](Cc2cccnc2)NC(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)[C@@H](Cc2ccc3ccccc3c2)NC(C)=O)C(=O)N[C@H](Cc2ccc(NC(C)=O)cc2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N2CCC[C@H]2C(=O)N[C@H](C)C(N)=O)cc1	
exenatide	CIDs16157882	Phase 4	approved	CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(N)=O	A - ALIMENTARY TRACT AND METABOLISM
linaclotide	CIDs16158207	Phase 4	approved	C[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(N)=O)NC(=O)[C@@H]2CSSC[C@H](N)C(=O)N[C@H]3CSSC[C@H](NC1=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)CSSC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC3=O)C(=O)N2	A - ALIMENTARY TRACT AND METABOLISM
Secrelux	CIDs16158473	Phase 4	approved	CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@H](C(N)=O)C(C)C	V - VARIOUS
NDP-MSH	CIDs16197727	Phase 4	approved	CCCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(N)=O)C(C)C	D - DERMATOLOGICALS
Bombesin	CIDs16201612	Phase 1	unapproved	CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCC(=O)N1)C(C)C)C(N)=O	
ivacaftor	CIDs16220172	Phase 4	approved	CC(C)(C)c1cc(C(C)(C)C)c(NC(=O)c2c[nH]c3ccccc3c2=O)cc1O	R - RESPIRATORY SYSTEM
pamapimod	CIDs16220188	Phase 2	unapproved	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC(CCO)CCO)nc21	
NVP-BKM120	CIDs16654980	Phase 3	unapproved	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1	
AZD1480	CIDs16659841	Phase 2	unapproved	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1	
famitinib	CIDs16662431	Phase 3	unapproved	CCN(CC)CCN1CCc2[nH]c(/C=C3\C(=O)Nc4ccc(F)cc43)c(C)c2C1=O	
carbetocin	CIDs16681432	Phase 4	approved	CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CCCSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O	H - SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
milciclib	CIDs16718576	Phase 2	unapproved	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2	
pevonedistat	CIDs16720766	Phase 3	unapproved	NS(=O)(=O)OC[C@@H]1C[C@@H](n2ccc3c(N[C@H]4CCc5ccccc54)ncnc32)C[C@@H]1O	
GSK690693	CIDs16725726	Phase 1	unapproved	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21	
BIIB021	CIDs16736529	Phase 2	unapproved	COc1c(C)cnc(Cn2cnc3c(Cl)nc(N)nc32)c1C	
SB1317/TG02	CIDs16739650	Phase 1	unapproved	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1	
LGD2941	CIDs16750192	Phase 1	unapproved	C[C@@H]1CC[C@H]([C@@H](O)C(F)(F)F)N1c1ccc2[nH]c(=O)cc(C(F)(F)F)c2c1	
S08212J4ZR	CIDs17747460	Phase 2	unapproved	O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C[C@H]1CCCN1CCCCc1ccc(OCCCN2CCCCCC2)cc1	
PF-04217903	CIDs17754438	Phase 1	unapproved	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1	
pictilisib	CIDs17755052	Phase 2	unapproved	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1	
BGC-201531	CIDs18444613	Phase 2	unapproved	COc1ccc(-c2ccc(OCc3cc(C(=O)NS(=O)(=O)c4ccccc4C)oc3C)cc2)nc1	
alcaftadine	CIDs19371515	Phase 4	approved	CN1CCC(=C2c3ccccc3CCn3c(C=O)cnc32)CC1	S - SENSORY ORGANS
Pred	CIDs20055008	Phase 2	unapproved	C=C1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO	H - SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
velneperit	CIDs20629114	Phase 2	unapproved	CC(C)(C)S(=O)(=O)N[C@H]1CC[C@H](C(=O)Nc2ccc(C(F)(F)F)cn2)CC1	
idalopirdine	CIDs21071390	Phase 3	unapproved	Fc1ccc2c(CCNCc3cccc(OCC(F)(F)C(F)F)c3)c[nH]c2c1	
ITI007	CIDs21302490	Phase 4	approved	CN1CCN2c3c(cccc31)[C@@H]1CN(CCCC(=O)c3ccc(F)cc3)CC[C@@H]12	
CHEMBL592868	CIDs21628493	Phase 3	unapproved	CC#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@@]21C	
vipadenant	CIDs21874557	Phase 2	unapproved	Cc1cc(Cn2nnc3c(-c4ccco4)nc(N)nc32)ccc1N	
PH-797804	CIDs22049997	Phase 2	unapproved	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1	
CHEMBL1761322	CIDs22591684	Phase 2	unapproved	CCS(=O)(=O)CCCC12CCC(c3nnc(-c4ccccc4C(F)(F)F)n3C)(CC1)CC2	
ganetespib	CIDs23624255	Phase 3	unapproved	CC(C)c1cc(-c2n[nH]c(=O)n2-c2ccc3c(ccn3C)c2)c(O)cc1O	
florbenazine	CIDs23652686	Phase 2	unapproved	COc1cc2c(cc1OCCCF)CCN1C[C@@H](CC(C)C)[C@H](O)C[C@H]21	
Genz-112638	CIDs23652731	Phase 4	approved	CCCCCCCC(=O)N[C@H](CN1CCCC1)[C@H](O)c1ccc2c(c1)OCCO2	A - ALIMENTARY TRACT AND METABOLISM
serlopitant	CIDs23653789	Phase 3	unapproved	C[C@@H](O[C@H]1CC[C@@H]2CN(C3=CC(=O)CC3)C[C@H]2[C@@H]1c1ccc(F)cc1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1	
raltegravir	CIDs23668479	Phase 4	approved	Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)o1	J - ANTIINFECTIVES FOR SYSTEMIC USE
laquinimod	CIDs23676880	Phase 3	unapproved	CCN(C(=O)c1c(O)c2c(Cl)cccc2n(C)c1=O)c1ccccc1	N - NERVOUS SYSTEM
piroxicam	CIDs23690938	Phase 4	approved	CN1C(C(=O)Nc2ccccn2)=C(O)c2ccccc2S1(=O)=O	M - MUSCULO-SKELETAL SYSTEM | M - MUSCULO-SKELETAL SYSTEM | S - SENSORY ORGANS
almorexant	CIDs23727689	Phase 3	unapproved	CNC(=O)[C@@H](c1ccccc1)N1CCc2cc(OC)c(OC)cc2[C@@H]1CCc1ccc(C(F)(F)F)cc1	
LCL161	CIDs24737642	Phase 2	unapproved	CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(C(=O)c2ccc(F)cc2)cs1)C1CCCCC1	
PF-3893787	CIDs24745335	Phase 2	unapproved	CN[C@@H]1CCN(c2cc(NCC3CC3)nc(N)n2)C1	
MK-5108	CIDs24748204	Phase 1	unapproved	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1	
CX-4945 (Silmitasertib	CIDs24748573	Phase 2	unapproved	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12	
CUDC-101	CIDs24756910	Phase 1	unapproved	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1	
TAK-593	CIDs24767976	Phase 1	unapproved	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1	
AGN-PC-0H4AQT	CIDs24771368	Phase 2	unapproved	O=C(c1ccc(Oc2ccc(F)cc2)nc1)N1CCCN(C2CCC2)CC1	
PF-04457845	CIDs24771824	Phase 2	unapproved	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1	
alisertib	CIDs24771867	Phase 3	unapproved	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O	
AZD7268	CIDs24772484	Phase 2	unapproved	CN(CCO)C(=O)c1ccc(C(=C2CCN(Cc3cscn3)CC2)c2cccc3cccnc23)cc1	
SGX-523	CIDs24779724	Phase 1	unapproved	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1	
BMS-754807	CIDs24785538	Phase 2	unapproved	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1	
GDC-0068	CIDs24788740	Phase 3	unapproved	CC(C)NC[C@@H](C(=O)N1CCN(c2ncnc3c2[C@H](C)C[C@H]3O)CC1)c1ccc(Cl)cc1	
BMS-777607	CIDs24794418	Phase 2	unapproved	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1	
SGI-1776	CIDs24795070	Phase 1	unapproved	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1	
mapracorat	CIDs24795088	Phase 3	unapproved	Cc1ccc2c(NC[C@](O)(CC(C)(C)c3cc(F)cc4c3OCC4)C(F)(F)F)cccc2n1	
delanzomib	CIDs24800541	Phase 1	unapproved	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)c1cccc(-c2ccccc2)n1)[C@@H](C)O)B(O)O	
DNC011026	CIDs24802842	Phase 1	unapproved	COC[C@@]12CNCC[C@]1(c1ccc(Cl)c(Cl)c1)C2	
canagliflozin	CIDs24812758	Phase 4	approved	Cc1ccc([C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1Cc1ccc(-c2ccc(F)cc2)s1	
ibrutinib	CIDs24821094	Phase 4	approved	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1	
sotagliflozin	CIDs24831714	Phase 4	approved	CCOc1ccc(Cc2cc([C@@H]3O[C@H](SC)[C@@H](O)[C@H](O)[C@H]3O)ccc2Cl)cc1	A - ALIMENTARY TRACT AND METABOLISM
10-nitro-oleic acid	CIDs24836820	Phase 2	unapproved	CCCCCCCC/C(=C\CCCCCCCC(=O)O)[N+](=O)[O-]	
AMG 900	CIDs24856041	Phase 1	unapproved	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1	
MK-1775	CIDs24856436	Phase 2	unapproved	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1	
fasiglifam	CIDs24857286	Phase 3	unapproved	Cc1cc(OCCCS(C)(=O)=O)cc(C)c1-c1cccc(COc2ccc3c(c2)OC[C@H]3CC(=O)O)c1	
AMG-208	CIDs24864821	Phase 2	unapproved	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1	
neuropeptide Y	CIDs24868177	Phase 1	unapproved	CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC	
RVX-208	CIDs24871506	Phase 3	unapproved	COc1cc(OC)c2c(=O)[nH]c(-c3cc(C)c(OCCO)c(C)c3)nc2c1	
ARN-509	CIDs24872560	Phase 4	approved	CNC(=O)c1ccc(N2C(=S)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=O)C23CCC3)cc1F	L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
AGN-PC-045KG3	CIDs24895172	Phase 2	unapproved	CCN(CC)C(=O)Cc1c(-c2ccc(OCCF)cc2)nn2c(C)cc(C)nc12	
AZD-4017	CIDs24946280	Phase 2	unapproved	CCCSc1nc(N2CCC[C@@H](CC(=O)O)C2)ccc1C(=O)NC1CCCCC1	
TAK-733	CIDs24963252	Phase 1	unapproved	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21	
GE-0036	CIDs24963293	Phase 2	unapproved	CCCOCCn1c(=O)c(N2CCN(CCO)CC2)nc2cnc(-c3ccc(OC)nc3)cc21	
MK-2206 dihydrochloride	CIDs24964624	Phase 2	unapproved	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1	
suvorexant	CIDs24965990	Phase 4	approved	Cc1ccc(-n2nccn2)c(C(=O)N2CCN(c3nc4cc(Cl)ccc4o3)CC[C@H]2C)c1	N - NERVOUS SYSTEM
navitoclax	CIDs24978538	Phase 3	unapproved	CC1(C)CCC(c2ccc(Cl)cc2)=C(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(N[C@H](CCN5CCOCC5)CSc5ccccc5)c(S(=O)(=O)C(F)(F)F)c4)cc3)CC2)C1	
MK-8245	CIDs24988881	Phase 1	unapproved	O=C(O)Cn1nnc(-c2cc(N3CCC(Oc4cc(F)ccc4Br)CC3)no2)n1	
SNS-314 mesylate	CIDs24995523	Phase 1	unapproved	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1	
GSK1292263	CIDs24996872	Phase 2	unapproved	CC(C)c1noc(N2CCC(COc3ccc(-c4ccc(S(C)(=O)=O)cc4)nc3)CC2)n1	
MK-3207	CIDs25019940	Phase 2	unapproved	O=C(CN1C(=O)C2(CCCC2)NC[C@H]1c1cc(F)cc(F)c1)Nc1ccc2c(c1)C[C@@]1(C2)C(=O)Nc2ncccc21	
AT-406	CIDs25022339	Phase 3	unapproved	CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)CC(C)C)CC[C@H]2CC[C@@H](C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O	
evogliptin	CIDs25022353	Phase 3	unapproved	CC(C)(C)OC[C@@H]1C(=O)NCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F	A - ALIMENTARY TRACT AND METABOLISM
MBX-2982	CIDs25025505	Phase 2	unapproved	CCc1cnc(N2CCC(c3nc(COc4ccc(-n5cnnn5)cc4)cs3)CC2)nc1	
saridegib	CIDs25027363	Phase 3	unapproved	CC1=C2C[C@H]3[C@@H](CC[C@@H]4C[C@H](NS(C)(=O)=O)CC[C@]34C)[C@@H]2CC[C@@]2(C1)O[C@@H]1C[C@H](C)CN[C@H]1[C@H]2C	
PF-04691502	CIDs25033539	Phase 2	unapproved	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1	
momelotinib	CIDs25062766	Phase 3	unapproved	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1	
rebastinib	CIDs25066467	Phase 2	unapproved	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1	
oprozomib	CIDs25067547	Phase 1	unapproved	COC[C@H](NC(=O)c1cnc(C)s1)C(=O)N[C@@H](COC)C(=O)N[C@@H](Cc1ccccc1)C(=O)[C@@]1(C)CO1	
irdabisant	CIDs25070031	Phase 1	unapproved	C[C@@H]1CCCN1CCCOc1ccc(-c2ccc(=O)[nH]n2)cc1	
cetrorelix	CIDs25074886	Phase 4	approved	CC(=O)N[C@H](Cc1ccc2ccccc2c1)C(=O)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@H](Cc1cccnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](CCCNC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O	H - SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
ACT-132577	CIDs25099191	Phase 3	unapproved	NS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1	
SMTC1100	CIDs25109292	Phase 2	unapproved	CCS(=O)(=O)c1ccc2oc(-c3ccc4ccccc4c3)nc2c1	
PF-04447943	CIDs25115162	Phase 2	unapproved	C[C@@H]1CN(Cc2ncccn2)C[C@H]1c1nc2c(cnn2C2CCOCC2)c(=O)[nH]1	
filorexant	CIDs25128145	Phase 2	unapproved	Cc1ccc(-c2ncccn2)c(C(=O)N2C[C@H](COc3ccc(F)cn3)CC[C@H]2C)c1	
bradanicline	CIDs25147644	Phase 2	unapproved	O=C(N[C@@H]1C2CCN(CC2)[C@H]1Cc1cccnc1)c1cc2ccccc2o1	
tarafenacin	CIDs25147683	Phase 2	unapproved	O=C(O[C@H]1CN2CCC1CC2)N(Cc1cc(F)c(F)c(F)c1)c1cccc(F)c1	
cobicistat	CIDs25151504	Phase 4	approved	CC(C)c1nc(CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1	V - VARIOUS
litronesib	CIDs25167017	Phase 2	unapproved	CCNCCS(=O)(=O)NC[C@@]1(c2ccccc2)SC(NC(=O)C(C)(C)C)=NN1C(=O)C(C)(C)C	
GSK2126458	CIDs25167777	Phase 1	unapproved	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F	
eltrombopag	CIDs25181561	Phase 4	approved	CC1=NN(c2ccc(C)c(C)c2)C(=O)/C1=N\Nc1cccc(-c2cccc(C(=O)O)c2)c1O	B - BLOOD AND BLOOD FORMING ORGANS
SB-649868	CIDs25195495	Phase 2	unapproved	Cc1nc(C(=O)N2CCCC[C@H]2CNC(=O)c2cccc3occc23)c(-c2ccc(F)cc2)s1	
Bexagliflozin	CIDs25195624	Phase 3	unapproved	OC[C@H]1O[C@@H](c2ccc(Cl)c(Cc3ccc(OCCOC4CC4)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O	
dicumarol	CIDs25201794	Phase 4	approved	O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O	B - BLOOD AND BLOOD FORMING ORGANS
AZD5363	CIDs25227436	Phase 3	unapproved	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1	
PF-3758309	CIDs25227462	Phase 1	unapproved	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1	
kisspeptin-10	CIDs25240297	Phase 3	unapproved	CC(C)C[C@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(N)=O	
Apitolisib	CIDs25254071	Phase 2	unapproved	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12	
AZD2014	CIDs25262792	Phase 2	unapproved	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1	
AZD8055	CIDs25262965	Phase 1	unapproved	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO	
minocycline	CIDs26275995	Phase 4	approved	CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O	A - ALIMENTARY TRACT AND METABOLISM | D - DERMATOLOGICALS | J - ANTIINFECTIVES FOR SYSTEMIC USE
tetracycline	CIDs27885548	Phase 4	approved	CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12	D - DERMATOLOGICALS | S - SENSORY ORGANS | S - SENSORY ORGANS | S - SENSORY ORGANS | A - ALIMENTARY TRACT AND METABOLISM | J - ANTIINFECTIVES FOR SYSTEMIC USE
faldaprevir	CIDs42601552	Phase 3	unapproved	C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H](Oc2cc(-c3csc(NC(=O)C(C)C)n3)nc3c(Br)c(OC)ccc23)CN1C(=O)[C@@H](NC(=O)OC1CCCC1)C(C)(C)C)C(=O)O	J - ANTIINFECTIVES FOR SYSTEMIC USE
vidupiprant	CIDs42641863	Phase 2	unapproved	CC(C)(C)NC(=O)c1ccc(Oc2cc(F)c(CC(=O)O)cc2Cl)c(NS(=O)(=O)c2ccc(C3CC3)cc2Cl)c1	
Foretinib	CIDs42642645	Phase 2	unapproved	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1	
JSPA0658	CIDs44129648	Phase 2	unapproved	Cc1cc(C)cc([C@@H]2CCCN2Cc2ccc(Oc3ccc(C(N)=O)cc3F)cc2)c1	
AZD-6482	CIDs44137675	Phase 1	unapproved	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1	
MK-2461	CIDs44137945	Phase 2	unapproved	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1	
LCI699	CIDs44139752	Phase 4	approved	N#Cc1ccc([C@H]2CCc3cncn32)c(F)c1	H - SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
AGN-PC-0JF4UF	CIDs44156921	Phase 1	unapproved	CN(C)c1cc2c(cc1Sc1nc3c(N)nccc3n1CCNCC(C)(C)C)OCO2	
AM-211	CIDs44158492	Phase 1	unapproved	CCN(Cc1cc(C(F)(F)F)ccc1-c1cc(CC(=O)O)ccc1OC)C(=O)NCc1ccccc1	
pimasertib	CIDs44187362	Phase 2	unapproved	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F	
TAK-441	CIDs44187367	Phase 1	unapproved	CCc1cc2c(c(OCC(F)(F)F)c(C(=O)NC3CCN(C(=O)CO)CC3)n2C)c(=O)n1CC(=O)c1ccccc1	
RAD140	CIDs44200882	Phase 1	unapproved	Cc1c(N[C@@H](c2nnc(-c3ccc(C#N)cc3)o2)[C@H](C)O)ccc(C#N)c1Cl	
DBPR-108	CIDs44201003	Phase 3	unapproved	CC(C)(CC(=O)N1CCCC1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N	
AGN-PC-072HH4	CIDs44201334	Phase 1	unapproved	C#CCOc1ccc2c(c1)c(-c1ccc(C(C)C)cc1)nc(=O)n2Cc1ccc(OC)c(OCC)c1	
baricitinib	CIDs44205240	Phase 4	approved	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1	L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
OSI-027	CIDs44224160	Phase 2	unapproved	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12	
ARRY-520	CIDs44224257	Phase 2	unapproved	CON(C)C(=O)N1N=C(c2cc(F)ccc2F)S[C@@]1(CCCN)c1ccccc1	
LY2811376	CIDs44251605	Phase 1	unapproved	C[C@@]1(c2cc(-c3cncnc3)c(F)cc2F)CCSC(N)=N1	
Glucagon acetate	CIDs44278361	Phase 4	approved	CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)[C@@H](C)O	H - SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
endothelin-1	CIDs44284481	Phase 2	unapproved	CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CSSC[C@@H](N)C(=O)N[C@H](CO)C(=O)N[C@H]2CSSC[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](CO)NC2=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)CC	
GASTRIN	CIDs44288444	Phase 2	unapproved	CSCC[C@@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)[C@@H](C)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H](N)CCC(=O)O)C(=O)N[C@H](CC(=O)O)C(=O)N[C@H](Cc1ccccc1)C(N)=O	
CHEMBL244243	CIDs44428551	Phase 2	unapproved	C[C@@H](NC(=O)[C@@H](CC(=O)N1CCC(N2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1)c1cccc(C(F)(F)F)c1	
CORT 108297	CIDs44454750	Phase 1	unapproved	CCOC[C@]12Cc3cnn(-c4ccc(F)cc4)c3C=C1CCN(S(=O)(=O)c1ccc(C(F)(F)F)cc1)C2	
Sodium salt	CIDs44473150	Phase 3	unapproved	CCOc1ccc(-c2ccc(Cn3c(CC(C)(C)C(=O)O)c(SC(C)(C)C)c4cc(OCc5ccc(C)cn5)ccc43)cc2)cn1	
anagliptin	CIDs44513473	Phase 3	unapproved	Cc1cc2ncc(C(=O)NCC(C)(C)NCC(=O)N3CCC[C@H]3C#N)cn2n1	
PKI-587	CIDs44516953	Phase 2	unapproved	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1	
CHEMBL1921904	CIDs44517831	Phase 2	unapproved	C[C@@](C(=O)O[C@H]1C[N+]2(CCc3ccc(F)cc3)CCC1CC2)(c1ccccc1)N1CCCCC1	
dipraglurant	CIDs44557636	Phase 2	unapproved	Fc1ccc2nc(CCC#Cc3ccccn3)cn2c1	
mipomersen	CIDs44564107	Phase 4	approved	COCCO[C@H]1[C@@H](O)[C@H](COP(=O)(O)S[C@H]2[C@H](COP(=O)(O)S[C@H]3[C@H](COP(=O)(O)S[C@H]4[C@H](COP(=O)(O)S[C@H]5[C@@H](OCCOC)[C@H](n6cnc7c(=O)[nH]c(N)nc76)O[C@@H]5COP(=O)(O)S[C@H]5C[C@H](n6cc(C)c(N)nc6=O)O[C@@H]5COP(=O)(O)S[C@H]5C[C@H](n6cc(C)c(=O)[nH]c6=O)O[C@@H]5COP(=O)(O)S[C@H]5C[C@H](n6cc(C)c(=O)[nH]c6=O)O[C@@H]5COP(=O)(O)S[C@H]5C[C@H](n6cc(C)c(N)nc6=O)O[C@@H]5COP(=O)(O)S[C@H]5C[C@H](n6cnc7c(=O)[nH]c(N)nc76)O[C@@H]5COP(=O)(O)S[C@H]5C[C@H](n6cc(C)c(=O)[nH]c6=O)O[C@@H]5COP(=O)(O)S[C@H]5C[C@H](n6cc(C)c(N)nc6=O)O[C@@H]5COP(=O)(O)S[C@H]5C[C@H](n6cc(C)c(=O)[nH]c6=O)O[C@@H]5COP(=O)(O)S[C@H]5C[C@H](n6cnc7c(=O)[nH]c(N)nc76)O[C@@H]5COP(=O)(O)S[C@H]5C[C@H](n6cnc7c(N)ncnc76)O[C@@H]5COP(=O)(O)S[C@H]5[C@@H](OCCOC)[C@H](n6cc(C)c(N)nc6=O)O[C@@H]5COP(=O)(O)S[C@H]5[C@@H](OCCOC)[C@H](n6cc(C)c(=O)[nH]c6=O)O[C@@H]5COP(=O)(O)S[C@H]5[C@@H](OCCOC)[C@H](n6cc(C)c(N)nc6=O)O[C@@H]5COP(=O)(O)S[C@H]5[C@@H](OCCOC)[C@H](n6cc(C)c(N)nc6=O)O[C@@H]5COP(=O)(O)S[C@H]5[C@@H](OCCOC)[C@H](n6cnc7c(=O)[nH]c(N)nc76)O[C@@H]5CO)O[C@H](n5cc(C)c(N)nc5=O)[C@H]4OCCOC)O[C@H](n4cnc5c(N)ncnc54)[C@H]3OCCOC)O[C@H](n3cc(C)c(N)nc3=O)[C@H]2OCCOC)O[C@@H]1n1cc(C)c(N)nc1=O	C - CARDIOVASCULAR SYSTEM
Ghrelin	CIDs44576256	Phase 3	unapproved	CCCCCCCC(=O)OC[C@H](NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)O	
siponimod	CIDs44599207	Phase 4	approved	CCc1cc(/C(C)=N/OCc2ccc(C3CCCCC3)c(C(F)(F)F)c2)ccc1CN1CC(C(=O)O)C1	L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
W2XT1FW9V4	CIDs44599828	Phase 1	unapproved	CC(C)CNCc1ccc(-c2ccccc2S(=O)(=O)N2CCCC2)cc1	
N6022	CIDs44623946	Phase 3	unapproved	Cc1cc(C(N)=O)ccc1-n1c(CCC(=O)O)ccc1-c1ccc(-n2ccnc2)cc1	
ertugliflozin	CIDs44814423	Phase 4	approved	CCOc1ccc(Cc2cc([C@]34OC[C@](CO)(O3)[C@@H](O)[C@H](O)[C@H]4O)ccc2Cl)cc1	A - ALIMENTARY TRACT AND METABOLISM
MK-8033	CIDs45142457	Phase 1	unapproved	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1	
MK-7246	CIDs45268455	Phase 1	unapproved	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1	
NVP-AEW541	CIDs45270897	Phase 1	unapproved	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1	
AK-59738	CIDs45375955	Phase 1	unapproved	O=c1[nH]c2cnc(-n3cnc4ccc(F)cc43)nc2n1[C@@H]1CCOc2c(F)cccc21	
AJ212MS2O2	CIDs46181428	Phase 2	unapproved	O=C(O)c1ccc(NC(=O)[C@H](CC2CCCC2)n2cnc(C(F)(F)F)c2)nc1	
PHA-793887	CIDs46191454	Phase 1	unapproved	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C	
encenicline	CIDs46196517	Phase 3	unapproved	O=C(N[C@H]1CN2CCC1CC2)c1cc2cccc(Cl)c2s1	
CHEMBL2177913	CIDs46202416	Phase 1	unapproved	NC1=N[C@@](c2cccc(-c3cncnc3)c2)(c2ccnc(C(F)F)c2)c2cccc(F)c21	
Ilorasertib	CIDs46207586	Phase 2	unapproved	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12	
omarigliptin	CIDs46209133	Phase 3	unapproved	CS(=O)(=O)n1cc2c(n1)CN([C@H]1CO[C@H](c3cc(F)ccc3F)[C@@H](N)C1)C2	
gandotinib	CIDs46213929	Phase 2	unapproved	Cc1cc(Nc2cc(CN3CCOCC3)c3nc(C)c(Cc4ccc(Cl)cc4F)n3n2)n[nH]1	
dolutegravir	CIDs46216142	Phase 4	approved	C[C@@H]1CCO[C@H]2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c(O)c3C(=O)N21	J - ANTIINFECTIVES FOR SYSTEMIC USE
pacritinib	CIDs46216795	Phase 3	unapproved	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1	
CHEMBL1082508	CIDs46220503	Phase 2	unapproved	NC(=O)NC[C@@H]1CCCc2cc(S(=O)(=O)c3cccc(F)c3)ccc21	
Y0217	CIDs46239015	Phase 2	unapproved	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1	
CHEMBL1933350	CIDs46240797	Phase 2	unapproved	CCC[C@H](c1ccc(C(=O)NCCC(=O)O)cc1)[C@H](c1ccc(Cl)cc1)c1c[nH]c2c(F)cc(C)cc12	
GS-9620	CIDs46241268	Phase 2	unapproved	CCCCOc1nc(N)c2c(n1)N(Cc1cccc(CN3CCCC3)c1)CC(=O)N2	
18-methoxycoronaridine	CIDs46877888	Phase 2	unapproved	COCC[C@H]1CC2CN3CCc4c([nH]c5ccccc45)[C@](C(=O)OC)(C2)[C@H]13	
ARRY-797	CIDs46883775	Phase 3	unapproved	CC(C)Cn1ncc2cc(Oc3ccc(F)cc3F)c(C(=O)NCCN(C)C)cc21	
GSK1070916A	CIDs46885626	Phase 1	unapproved	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1	
tofogliflozin	CIDs46908928	Phase 3	unapproved	CCc1ccc(Cc2ccc3c(c2)[C@]2(OC3)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1	
CHEMBL2386558	CIDs46909057	Phase 1	unapproved	CN(C)C(=O)[C@H]1C[C@@H]1c1ccc(-c2ncn(C)c2Sc2ccc(Cl)cn2)cc1	
AGN-PC-080XDF	CIDs46916694	Phase 2	unapproved	Cc1cnc(NC(=O)c2cc(Oc3cnc(C(=O)N(C)C)nc3)c3cc(C)oc3c2)cn1	
Encaleret	CIDs46917559	Phase 2	unapproved	Cc1cc(-c2ccccc2[C@@H](C)OC[C@H](O)CNC(C)(C)Cc2ccc(Cl)c(F)c2)ccc1C(=O)O	
dinaciclib	CIDs46926350	Phase 3	unapproved	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12	
PF-04620110	CIDs46926360	Phase 1	unapproved	Nc1ncnc2c1C(=O)N(c1ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc1)CCO2	
I-BET762	CIDs46943432	Phase 2	unapproved	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21	
PKI-179	CIDs46947264	Phase 1	unapproved	O=C(Nc1ccncc1)Nc1ccc(-c2nc(N3CCOCC3)nc(N3C4CCC3COC4)n2)cc1	
CH5132799	CIDs49784945	Phase 1	unapproved	CS(=O)(=O)N1CCc2c(-c3cnc(N)nc3)nc(N3CCOCC3)nc21	
NMS-P937	CIDs49792852	Phase 2	unapproved	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3CCO)CC4)c2)CC1	
Kinome_754	CIDs49830398	Phase 1	unapproved	Cc1cc(Nc2ncc(F)c(NC3C4C=CC(C4)C3C(N)=O)n2)ccc1N1CCN(C)CC1	
birinapant	CIDs49836020	Phase 2	unapproved	CC[C@H](NC(=O)[C@H](C)NC)C(=O)N1C[C@@H](O)C[C@H]1Cc1c(-c2[nH]c3cc(F)ccc3c2C[C@@H]2C[C@H](O)CN2C(=O)[C@H](CC)NC(=O)[C@H](C)NC)[nH]c2cc(F)ccc12	
evacetrapib	CIDs49836058	Phase 3	unapproved	Cc1cc(C)c2c(c1)[C@@H](N(Cc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1nnn(C)n1)CCCN2C[C@H]1CC[C@H](C(=O)O)CC1	
setipiprant	CIDs49843471	Phase 3	unapproved	O=C(O)Cn1c2c(c3cc(F)ccc31)CN(C(=O)c1cccc3ccccc13)CC2	
LY2940680	CIDs49848070	Phase 2	unapproved	CN(C(=O)c1ccc(F)cc1C(F)(F)F)C1CCN(c2nnc(-c3ccnn3C)c3ccccc23)CC1	
CHR-3996	CIDs49857317	Phase 1	unapproved	O=C(NO)c1cnc(N2C[C@H]3[C@H](NCc4ccc5cc(F)ccc5n4)[C@H]3C2)nc1	
INCB9471	CIDs49871007	Phase 2	unapproved	CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C	
taselisib	CIDs51001932	Phase 3	unapproved	Cc1nc(-c2cn3c(n2)-c2ccc(-c4cnn(C(C)(C)C(N)=O)c4)cc2OCC3)n(C(C)C)n1	
GZD824	CIDs51038269	Phase 2	unapproved	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2[nH]ncc2c1	
AZD-4547	CIDs51039095	Phase 2	unapproved	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1	
Rimegepant	CIDs51049968	Phase 4	approved	N[C@@H]1c2cccnc2[C@H](OC(=O)N2CCC(n3c(=O)[nH]c4ncccc43)CC2)CC[C@H]1c1cccc(F)c1F	
Dasolampanel	CIDs51049972	Phase 2	unapproved	O=C(O)[C@@H]1C[C@H]2C[C@@H](Oc3cccc(Cl)c3-c3nnn[nH]3)CC[C@H]2CN1	
tenoxicam	CIDs51508717	Phase 4	approved	CN1C(C(=O)Nc2ccccn2)=C(O)c2sccc2S1(=O)=O	M - MUSCULO-SKELETAL SYSTEM
gimeracil	CIDs51529148	Phase 3	unapproved	Oc1cc(O)c(Cl)cn1	
demeclocycline	CIDs51601240	Phase 4	approved	CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)ccc(Cl)c4[C@@H](O)[C@H]3C[C@@H]12	D - DERMATOLOGICALS | J - ANTIINFECTIVES FOR SYSTEMIC USE
AGN-PC-0H9XZ7	CIDs52914971	Phase 2	unapproved	Cc1nn(-c2ncccc2CO)cc1CN1CCC2(CC1)OCC(F)(F)c1cc(Cl)sc12	
PRIMA-1MET	CIDs52918385	Phase 3	unapproved	COCC1(CO)C(=O)C2CCN1CC2	
CHEMBL1240772	CIDs52943177	Phase 2	unapproved	CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C	
BQ-123	CIDs52943236	Phase 2	unapproved	CC(C)C[C@@H]1NC(=O)[C@@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(=O)O)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC1=O	
1FGZ6L9SF2	CIDs52949124	Phase 2	unapproved	CC(C)N(Cc1ccccc1)C(=O)CN1C(=O)[C@@H](Cc2c[nH]c3ccccc23)c2nnc(-c3ccccc3)n2-c2ccccc21	
NVP-BGJ398	CIDs53235510	Phase 4	approved	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1	
PF-232798	CIDs53316710	Phase 2	unapproved	CC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CCN(C(=O)C(C)C)C3)C2)c1cccc(F)c1	
selepressin	CIDs53330936	Phase 2	unapproved	CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCC(N)=O)NC1=O	
ricolinostat	CIDs53340666	Phase 2	unapproved	O=C(CCCCCCNC(=O)c1cnc(N(c2ccccc2)c2ccccc2)nc1)NO	
XI179PG9LV	CIDs53354764	Phase 1	unapproved	OC1(CN2CCC(COc3noc4cccc(O[C@@H]5CCOC5)c34)CC2)CCOCC1	
yl)benzamide	CIDs53357478	Phase 1	unapproved	COc1cc(C(=O)NC2CCN(C)CC2)c(F)cc1Nc1ncc2c(n1)N(C1CCCC1)CC(F)(F)C(=O)N2C	
RG7388	CIDs53358942	Phase 3	unapproved	COc1cc(C(=O)O)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@](C#N)(c2ccc(Cl)cc2F)[C@H]1c1cccc(Cl)c1F	
pradigastat	CIDs53387034	Phase 3	unapproved	O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc(Nc4ccc(C(F)(F)F)nc4)cn3)cc2)CC1	
CHEMBL2397415	CIDs53472683	Phase 3	unapproved	Cc1cc(C[C@@H](NC(=O)N2CCC(c3cc4ccccc4[nH]c3=O)CC2)C(=O)N2CCN(C3CCN(C)CC3)CC2)cc2cn[nH]c12	
386012Z45S	CIDs53492727	Phase 3	unapproved	CCCC[C@]1(CC)CS(=O)(=O)c2cc(CNC(CC(=O)O)CC(=O)O)c(OC)cc2[C@@H](c2ccccc2)N1	
doxycycline	CIDs54671203	Phase 4	approved	C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21	
oxytetracycline	CIDs54675779	Phase 4	approved	CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3[C@H](O)[C@@H]12	J - ANTIINFECTIVES FOR SYSTEMIC USE | D - DERMATOLOGICALS | S - SENSORY ORGANS | G - GENITO URINARY SYSTEM AND SEX HORMONES | J - ANTIINFECTIVES FOR SYSTEMIC USE
acenocoumarol	CIDs54676537	Phase 4	approved	CC(=O)CC(c1ccc([N+](=O)[O-])cc1)c1c(O)c2ccccc2oc1=O	B - BLOOD AND BLOOD FORMING ORGANS
isoxicam	CIDs54677972	Phase 4	approved	Cc1cc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)no1	
Metastat	CIDs54678924	Phase 2	unapproved	NC(=O)C1=C(O)C[C@@H]2C[C@@H]3Cc4cccc(O)c4C(=O)C3=C(O)[C@]2(O)C1=O	
tasquinimod	CIDs54682876	Phase 3	unapproved	COc1cccc2c1c(O)c(C(=O)N(C)c1ccc(C(F)(F)F)cc1)c(=O)n2C	
teriflunomide	CIDs54684141	Phase 4	approved	C/C(O)=C(\C#N)C(=O)Nc1ccc(C(F)(F)F)cc1	L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
tigecycline	CIDs54686904	Phase 4	approved	CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O	J - ANTIINFECTIVES FOR SYSTEMIC USE
lornoxicam	CIDs54690031	Phase 4	approved	CN1C(C(=O)Nc2ccccn2)=C(O)c2sc(Cl)cc2S1(=O)=O	M - MUSCULO-SKELETAL SYSTEM
EW-7197	CIDs54766013	Phase 2	unapproved	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1	
tafetinib	CIDs56935577	Phase 1	unapproved	CCN(CC)CCNC(=O)c1c(C)[nH]c2c1CCC/C2=C1/C(=O)Nc2ccc(F)cc21	
GSK2636771	CIDs56949517	Phase 2	unapproved	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F	
SCH-900271	CIDs56950369	Phase 2	unapproved	CC1(CCCc2cc(=O)oc3[nH]c(=O)[nH]c(=O)c23)CC1	
naloxegol	CIDs56959086	Phase 4	approved	C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](OCCOCCOCCOCCOCCOCCOCCOC)CC[C@@]3(O)[C@H]1C5	A - ALIMENTARY TRACT AND METABOLISM
idraparinux	CIDs57391679	Phase 3	unapproved	CO[C@H]1O[C@H](COS(=O)(=O)O)[C@@H](O[C@H]2O[C@@H](C(=O)O)[C@@H](O[C@H]3O[C@H](COS(=O)(=O)O)[C@@H](O[C@@H]4O[C@H](C(=O)O)[C@@H](O[C@H]5O[C@H](COS(=O)(=O)O)[C@@H](OC)[C@H](OC)[C@H]5OC)[C@H](OC)[C@H]4OC)[C@H](OS(=O)(=O)O)[C@H]3OS(=O)(=O)O)[C@H](OC)[C@H]2OC)[C@H](OS(=O)(=O)O)[C@H]1OS(=O)(=O)O	
C568960	CIDs57398040	Phase 1	unapproved	CCN(C)C(=O)c1ccc(-c2ccc3c(n2)Oc2ccccc2[C@H]3C(C)(C)C(=O)Nc2nncs2)cc1F	
4mo8	CIDs57413968	Phase 1	unapproved	Cc1ncc([N+](=O)[O-])n1CCNS(N)(=O)=O	
ASP015K	CIDs57928403	Phase 3	unapproved	NC(=O)c1cnc2[nH]ccc2c1N[C@H]1[C@H]2CC3C[C@@H]1C[C@](O)(C3)C2	
CHEMBL3287218	CIDs58438464	Phase 2	unapproved	Cc1cc(-c2ccc3c(c2)CC[C@H]3N2CC3(CCN(C(=O)Cc4cn5cc(C)sc5n4)CC3)C2)ncn1	
AMG-232	CIDs58573469	Phase 2	unapproved	CC(C)[C@@H](CS(=O)(=O)C(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1	
GDC-0349	CIDs59239165	Phase 1	unapproved	CCNC(=O)Nc1ccc(-c2nc3c(c(N4CCOC[C@@H]4C)n2)CCN(C2COC2)C3)cc1	
decernotinib	CIDs59422203	Phase 2	unapproved	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F	
entospletinib	CIDs59473233	Phase 2	unapproved	c1cn2cc(-c3ccc4cn[nH]c4c3)nc(Nc3ccc(N4CCOCC4)cc3)c2n1	
AGN-PC-0DAAXA	CIDs60143346	Phase 1	unapproved	Cc1nc(-c2cnn(C)c2-c2ccc(C(F)(F)F)cn2)c2c(N3CCC3)ncnn12	
pyrethrins	CIDs60202781	Phase 4	approved	C=C/C=C\CC1=C(C)[C@@H](OC(=O)[C@@H]2[C@@H](/C=C(\C)C(=O)OC)C2(C)C)CC1=O.C=C/C=C\CC1=C(C)[C@@H](OC(=O)[C@@H]2[C@@H](C=C(C)C)C2(C)C)CC1=O	
TRV130	CIDs66553195	Phase 4	approved	COc1ccsc1CNCC[C@@]1(c2ccccn2)CCOC2(CCCC2)C1	
5R7X34Y6Q1	CIDs67029278	Phase 1	unapproved	CC(C)(C)NC(=O)c1nn(-c2ccc(F)cc2F)c2c1[C@H]1CC[C@@H]2C1	
CHEMBL2338801	CIDs71270546	Phase 2	unapproved	O=c1[nH]nc(CCc2ccc(C(F)(F)F)cc2)cc1O	
QPE81T4KH0	CIDs71451950	Phase 1	unapproved	CC1(C)C(=O)N(C(=O)NCC2CCN(CC3(O)CCOCC3)CC2)c2cc(F)ccc21	
pasireotide	CIDs73348210	Phase 4	approved	NCCCC[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](c2ccccc2)NC(=O)[C@@H]2C[C@H](OC(=O)NCCN)CN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(OCc3ccccc3)cc2)NC1=O	H - SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
